<modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="todu0001">
			<namePart type="family">Dunås</namePart>
			<namePart type="given">Tora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<affiliation>Umeå Universitet</affiliation>
			<description>orcid.org=0000-0002-5911-9511</description>
			<description>diva-portal.org=authority-person:64151</description>
		</name>
		<name type="personal" authority="umu" xlink:href="arswan02">
			<namePart type="family">Wåhlin</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<affiliation>Umeå universitet, Umeå centrum för funktionell hjärnavbildning (UFBI)</affiliation>
			<description>diva-portal.org=authority-person:64152</description>
		</name>
		<name type="personal" authority="umu" xlink:href="laza0003">
			<namePart type="family">Zarrinkoob</namePart>
			<namePart type="given">Laleh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Klinisk neurovetenskap</affiliation>
			<description>diva-portal.org=authority-person:64153</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jama0002">
			<namePart type="family">Malm</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Klinisk neurovetenskap</affiliation>
			<description>orcid.org=0000-0001-6451-1940</description>
			<description>diva-portal.org=authority-person:63098</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anek0025">
			<namePart type="family">Eklund</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<affiliation>Umeå universitet, Umeå centrum för funktionell hjärnavbildning (UFBI)</affiliation>
			<description>diva-portal.org=authority-person:63097</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="776">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5752">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå centrum för funktionell hjärnavbildning (UFBI)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="10950">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för farmakologi och klinisk neurovetenskap</namePart>
			<namePart>Klinisk neurovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>4D flow MRI</title>
			<subTitle>automatic assessment of blood flow in cerebral arteries</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Institute of Physics Publishing (IOPP)</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-04-30T11:06:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-147254</identifier>
		<identifier type="doi">10.1088/2057-1976/aae8d1</identifier>
		<identifier type="isi">000457627700003</identifier>
		<identifier type="articleId">015003</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1088/2057-1976/aae8d1</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>cerebral arteries</topic>
		</subject>
		<subject lang="eng">
			<topic>hemodynamics</topic>
		</subject>
		<subject lang="eng">
			<topic>carotid stenosis</topic>
		</subject>
		<subject lang="eng">
			<topic>magnetic resonance imaging</topic>
		</subject>
		<subject lang="eng">
			<topic>circle of willis</topic>
		</subject>
		<subject lang="eng">
			<topic>cerebrovascular circulation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20603">
			<topic>Engineering and Technology</topic>
			<topic>Medical Engineering</topic>
			<topic>Medical Image Processing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20603">
			<topic>Teknik och teknologier</topic>
			<topic>Medicinteknik</topic>
			<topic>Medicinsk bildbehandling</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Objective: With a 10-minute 4D flow MRI scan, the distribution of blood flow to individual arteries throughout the brain can be analyzed. This technique has potential to become a biomarker for treatment decisions, and to predict prognosis after stroke. To efficiently analyze and model the large dataset in clinical practice, automatization is needed. We hypothesized that identification of selected arterial regions using an atlas with a priori probability information on their spatial distribution can provide standardized measurements of blood flow in the main cerebral arteries.&lt;/p&gt;&lt;p&gt;Approach: A new method for automatic placement of measurement locations in 4D flow MRI was developed based on an existing atlas-based method for arterial labeling, by defining specific regions of interest within the corresponding arterial atlas. The suggested method was evaluated on 38 subjects with carotid artery stenosis, by comparing measurements of blood flow rate at automatically selected locations to reference measurements at manually selected locations.&lt;/p&gt;&lt;p&gt;Main results: Automatic and reference measurement ranged from 10 to 580 ml min&lt;sup&gt;−1&lt;/sup&gt; and were highly correlated (r = 0.99) with a mean flow difference of 0.61 ± 10.7 ml min&lt;sup&gt;−1&lt;/sup&gt; (p = 0.21). Out of the 559 arterial segments in the manual reference, 489 were correctly labeled, yielding a sensitivity of 88%, a specificity of 85%, and a labeling accuracy of 87%.&lt;/p&gt;&lt;p&gt;Significance: This study confirms that atlas-based labeling of 4D flow MRI data is suitable for efficient flow quantification in the major cerebral arteries. The suggested method improves the feasibility of analyzing cerebral 4D flow data, and fills a gap necessary for implementation in clinical use.&lt;/p&gt;</abstract>
		<note>&lt;p&gt;Originally included in thesis in manuscript form&lt;/p&gt;</note>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Biomedical Physics &amp; Engineering Express</title>
			</titleInfo>
			<identifier type="issn">2057-1976</identifier>
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [2015-05616]</note>
		<note type="funder">Hjärt-Lungfonden [20110383, 20140592]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1202719/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>todu0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-04-30</recordCreationDate>
			<recordChangeDate>2019-11-19</recordChangeDate>
			<recordIdentifier>diva2:1202719</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="febr0009">
			<namePart type="family">Brunoni</namePart>
			<namePart type="given">Federica</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå Plant Science Centre, Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences (SLU), Umeå, Sweden; Present address: Laboratory of Growth Regulators, Faculty of Science, Palacký University &amp; Institute of Experimental Botany, The Czech Academy of Sciences, Šlechtitelů 27, 78371 Olomouc, Czech Republic</affiliation>
			<description>diva-portal.org=authority-person:74279</description>
		</name>
		<name type="personal" authority="umu" xlink:href="sico0005">
			<namePart type="family">Collani</namePart>
			<namePart type="given">Silvio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<description>diva-portal.org=authority-person:68713</description>
		</name>
		<name type="personal">
			<namePart type="family">Simura</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="masc0089">
			<namePart type="family">Schmid</namePart>
			<namePart type="given">Markus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<description>diva-portal.org=authority-person:62606</description>
		</name>
		<name type="personal">
			<namePart type="family">Bellini</namePart>
			<namePart type="given">Catherine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ljung</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2901-189X</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="867">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysiologisk botanik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="874">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Umeå Plant Science Centre (UPSC)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A bacterial assay for rapid screening of IAA catabolic enzymes</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-26T10:28:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165335</identifier>
		<identifier type="doi">10.1186/s13007-019-0509-6</identifier>
		<identifier type="pmid">31700527</identifier>
		<identifier type="isi">000494725300001</identifier>
		<identifier type="articleId">126</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s13007-019-0509-6</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>IAA metabolism</topic>
		</subject>
		<subject lang="eng">
			<topic>UHPLC-ESI-MS</topic>
		</subject>
		<subject lang="eng">
			<topic>MS</topic>
		</subject>
		<subject lang="eng">
			<topic>Enzyme assay</topic>
		</subject>
		<subject lang="eng">
			<topic>Arabidopsis</topic>
		</subject>
		<subject lang="eng">
			<topic>Conjugation</topic>
		</subject>
		<subject lang="eng">
			<topic>Degradation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Plants rely on concentration gradients of the native auxin, indole-3-acetic acid (IAA), to modulate plant growth and development. Both metabolic and transport processes participate in the dynamic regulation of IAA homeostasis. Free IAA levels can be reduced by inactivation mechanisms, such as conjugation and degradation. IAA can be conjugated via ester linkage to glucose, or via amide linkage to amino acids, and degraded via oxidation. Members of the UDP glucosyl transferase (UGT) family catalyze the conversion of IAA to indole-3-acetyl-1-glucosyl ester (IAGlc); by contrast, IAA is irreversibly converted to indole-3-acetyl-L-aspartic acid (IAAsp) and indole-3-acetyl glutamic acid (IAGlu) by Group II of the GRETCHEN HAGEN3 (GH3) family of acyl amido synthetases. Dioxygenase for auxin oxidation (DAO) irreversibly oxidizes IAA to oxindole-3-acetic acid (oxIAA) and, in turn, oxIAA can be further glucosylated to oxindole-3-acetyl-1-glucosyl ester (oxIAGlc) by UGTs. These metabolic pathways have been identified based on mutant analyses, in vitro activity measurements, and &lt;em&gt;in planta&lt;/em&gt; feeding assays. In vitro assays for studying protein activity are based on producing Arabidopsis enzymes in a recombinant form in bacteria or yeast followed by recombinant protein purification. However, the need to extract and purify the recombinant proteins represents a major obstacle when performing in vitro assays.&lt;/p&gt;&lt;p&gt;Results: In this work we report a rapid, reproducible and cheap method to screen the enzymatic activity of recombinant proteins that are known to inactivate IAA. The enzymatic reactions are carried out directly in bacteria that produce the recombinant protein. The enzymatic products can be measured by direct injection of a small supernatant fraction from the bacterial culture on ultrahigh-performance liquid chromatography coupled to electrospray ionization tandem spectrometry (UHPLC–ESI-MS/MS). Experimental procedures were optimized for testing the activity of different classes of IAA-modifying enzymes without the need to purify recombinant protein.&lt;/p&gt;&lt;p&gt;Conclusions: This new method represents an alternative to existing in vitro assays. It can be applied to the analysis of IAA metabolites that are produced upon supplementation of substrate to engineered bacterial cultures and can be used for a rapid screening of orthologous candidate genes from non-model species.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Plant Methods</title>
			</titleInfo>
			<identifier type="issn">1746-4811</identifier>
			<identifier type="eissn">1746-4811</identifier>
			<part>
				<detail type="volume">
					<number>15</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Forskningsrådet Formas</note>
		<note type="funder">Vinnova</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1373080/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-26</recordCreationDate>
			<recordChangeDate>2019-11-26</recordChangeDate>
			<recordIdentifier>diva2:1373080</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="tefr0009">
			<namePart type="family">Frisan</namePart>
			<namePart type="given">Teresa</namePart>
			<namePart type="date">1967-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Teknisk-naturvetenskaplig fakultet)</affiliation>
			<affiliation>Department of Cell and Molecular Biology Karolinska Institutet, Stockholm, Sweden</affiliation>
			<affiliation>Frisan</affiliation>
			<description>orcid.org=0000-0002-1209-0942</description>
			<description>diva-portal.org=authority-person:70649</description>
		</name>
		<name type="corporate">
			<namePart>Frisan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Nagy</namePart>
			<namePart type="given">Noemi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chioureas</namePart>
			<namePart type="given">Dimitrios</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Terol</namePart>
			<namePart type="given">Marie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Grasso</namePart>
			<namePart type="given">Francesca</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Masucci</namePart>
			<namePart type="given">Maria G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="883">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Teknisk-naturvetenskaplig fakultet)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-11T14:17:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154014</identifier>
		<identifier type="doi">10.1002/ijc.31652</identifier>
		<identifier type="pmid">29978480</identifier>
		<identifier type="isi">000451479900010</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1002/ijc.31652</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>DNA damage</topic>
		</subject>
		<subject lang="eng">
			<topic>Epstein-Barr virus</topic>
		</subject>
		<subject lang="eng">
			<topic>Gram-negative bacteria</topic>
		</subject>
		<subject lang="eng">
			<topic>cytolethal distending toxin</topic>
		</subject>
		<subject lang="eng">
			<topic>virus reactivation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30108">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Cell and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30108">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Cell- och molekylärbiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30109">
			<topic>Microbiology in the medical area</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30109">
			<topic>Mikrobiologi inom det medicinska området</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2204">
			<topic>mikrobiologi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2204">
			<topic>Microbiology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2086">
			<topic>Infectious Diseases</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2086">
			<topic>infektionssjukdomar</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;We have addressed the role of bacterial co-infection in viral oncogenesis using as model Epstein-Barr virus (EBV), a human herpesvirus that causes lymphoid malignancies and epithelial cancers. Infection of EBV carrying epithelial cells with the common oral pathogenic Gram-negative bacterium Aggregatibacter actinomycetemcomitans (Aa) triggered reactivation of the productive virus cycle. Using isogenic Aa strains that differ in the production of the cytolethal distending toxin (CDT) and purified catalytically active or inactive toxin, we found that the CDT acts via induction of DNA double strand breaks and activation of the Ataxia Telangectasia Mutated (ATM) kinase. Exposure of EBV-negative epithelial cells to the virus in the presence of sub-lethal doses of CDT was accompanied by the accumulation of latently infected cells exhibiting multiple signs of genomic instability. These findings illustrate a scenario where co-infection with certain bacterial species may favor the establishment of a microenvironment conducive to the EBV-induced malignant transformation of epithelial cells.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Cancer</title>
			</titleInfo>
			<identifier type="issn">0020-7136</identifier>
			<identifier type="eissn">1097-0215</identifier>
			<part>
				<detail type="volume">
					<number>144</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>98</start>
					<end>109</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1269844/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>tefr0009</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-11</recordCreationDate>
			<recordChangeDate>2018-12-12</recordChangeDate>
			<recordIdentifier>diva2:1269844</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Kusmierek</namePart>
			<namePart type="given">Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hossmann</namePart>
			<namePart type="given">Joern</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Witte</namePart>
			<namePart type="given">Rebekka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Opitz</namePart>
			<namePart type="given">Wiebke</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vollmer</namePart>
			<namePart type="given">Ines</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Volk</namePart>
			<namePart type="given">Marcel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Heroven</namePart>
			<namePart type="given">Ann Kathrin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-2040-1747</description>
		</name>
		<name type="personal" authority="umu" xlink:href="hawo0001">
			<namePart type="family">Wolf-Watz</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:62574</description>
		</name>
		<name type="personal">
			<namePart type="family">Dersch</namePart>
			<namePart type="given">Petra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A bacterial secreted translocator hijacks riboregulators to control type III secretion in response to host cell contact</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Public Library Science</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-03T13:56:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162892</identifier>
		<identifier type="doi">10.1371/journal.ppat.1007813</identifier>
		<identifier type="pmid">31173606</identifier>
		<identifier type="isi">000479154700022</identifier>
		<identifier type="articleId">e1007813</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1371/journal.ppat.1007813</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30109">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Microbiology in the medical area</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30109">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Mikrobiologi inom det medicinska området</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30209">
			<topic>Clinical Medicine</topic>
			<topic>Infectious Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30209">
			<topic>Klinisk medicin</topic>
			<topic>Infektionsmedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Numerous Gram-negative pathogens use a Type III Secretion System (T3SS) to promote virulence by injecting effector proteins into targeted host cells, which subvert host cell processes. Expression of T3SS and the effectors is triggered upon host cell contact, but the underlying mechanism is poorly understood. Here, we report a novel strategy of Yersinia pseudotuberculosis in which this pathogen uses a secreted T3SS translocator protein (YopD) to control global RNA regulators. Secretion of the YopD translocator upon host cell contact increases the ratio of post-transcriptional regulator CsrA to its antagonistic small RNAs CsrB and CsrC and reduces the degradosome components PNPase and RNase E levels. This substantially elevates the amount of the common transcriptional activator (LcrF) of T3SS/Yop effector genes and triggers the synthesis of associated virulence-relevant traits. The observed hijacking of global riboregulators allows the pathogen to coordinate virulence factor expression and also readjusts its physiological response upon host cell contact. Author summary Many bacterial pathogens sense contact to host cells and respond by inducing expression of crucial virulence factors. This includes the type III secretion systems (T3SSs) and their substrates, which manipulate different host cell functions to promote colonization and survival of the pathogen within its host. In this study, we used enteropathogenic Yersinia pseudotuberculosis to elucidate the molecular mechanism of how cell contact is transmitted and translated to trigger this process. We found that multiple global riboregulators control the decay and/or translation of the major transcriptional activator of the T3SS. In the absence of cell contact, these important RNA regulators are coopted by one of the substrate proteins of the T3SS to repress expression of the secretion machinery. Translocation of the substrate protein upon cell contact relieves riboregulator-mediated repression. This leads to a strong induction of the master regulator of T3SS/effector gene expression promoting an increase of the virulence potential and provokes a fast adaptation of the pathogen's fitness, e.g. to compensate for the imposed energetic burden.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>PLoS Pathogens</title>
			</titleInfo>
			<identifier type="issn">1553-7366</identifier>
			<identifier type="eissn">1553-7374</identifier>
			<part>
				<detail type="volume">
					<number>15</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1348120/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-03</recordCreationDate>
			<recordChangeDate>2019-09-03</recordChangeDate>
			<recordIdentifier>diva2:1348120</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Hakvoort</namePart>
			<namePart type="given">Ilse</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Göteborgs universitet</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="joslil01">
			<namePart type="family">Lindahl</namePart>
			<namePart type="given">Jonas</namePart>
			<namePart type="date">1978-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Sociologiska institutionen</affiliation>
			<affiliation>Inforsk</affiliation>
			<description>diva-portal.org=authority-person:65315</description>
		</name>
		<name type="corporate">
			<namePart>Inforsk</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="aglu0001">
			<namePart type="family">Lundström</namePart>
			<namePart type="given">Agneta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad utbildningsvetenskap</affiliation>
			<description>diva-portal.org=authority-person:67757</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="850">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Sociologiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5301">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad utbildningsvetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A bibliometric review of approaches to address conflicts in schools</title>
			<subTitle>Exploring the intellectual base</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-06T19:37:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163105</identifier>
		<identifier type="doi">10.1002/crq.21266</identifier>
		<identifier type="isi">000483976100001</identifier>
		<identifier type="scopus">2-s2.0-85071268545</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>author co-citation analysis</topic>
		</subject>
		<subject lang="eng">
			<topic>intellectual base</topic>
		</subject>
		<subject lang="eng">
			<topic>conflict resolution</topic>
		</subject>
		<subject lang="eng">
			<topic>conflict management</topic>
		</subject>
		<subject lang="eng">
			<topic>bibliometrics</topic>
		</subject>
		<subject lang="eng">
			<topic>school</topic>
		</subject>
		<subject lang="eng">
			<topic>education</topic>
		</subject>
		<subject lang="eng">
			<topic>teacher</topic>
		</subject>
		<subject lang="eng">
			<topic>student</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="503">
			<topic>Social Sciences</topic>
			<topic>Educational Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="503">
			<topic>Samhällsvetenskap</topic>
			<topic>Utbildningsvetenskap</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Increasing numbers of student teachers, teachers, and teacher educators require training in research‐based knowledge about how to address conflicts in schools. There are also increasing numbers of relevant publications, and hence, a perceived need to map influential theories, methods, and topics that shaped the field of research. To meet this need, a bibliometric study was conducted. The reviewed literature, 608 publications referring to studies by 197 influential authors, was subdivided into two periods: 1996–2010 and 2011–2015. The intellectual structure was examined by author co‐citation analysis. The findings indicate seven clusters of authors from period one and four from period two.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Conflict Resolution Quarterly</title>
			</titleInfo>
			<identifier type="issn">1536-5581</identifier>
			<identifier type="eissn">1541-1508</identifier>
			<part>
				<detail type="volume">
					<number>37</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
				<extent>
					<start>123</start>
					<end>145</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [2014-02132]</note>
		<recordInfo>
			<recordOrigin>joslil01</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-06</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1349221</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="ulalet02">
			<namePart type="family">Leijerholt</namePart>
			<namePart type="given">Ulrika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Företagsekonomi</affiliation>
			<description>orcid.org=0000-0002-0271-7887</description>
			<description>diva-portal.org=authority-person:71516</description>
		</name>
		<name type="personal">
			<namePart type="family">Chapleo</namePart>
			<namePart type="given">Chris</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Företagsekonomi</affiliation>
			<affiliation>Bournemouth University</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">O'Sullivan</namePart>
			<namePart type="given">Helen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Företagsekonomi</affiliation>
			<affiliation>Bournemouth University</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="11051">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Företagsekonomi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A brand within a brand</title>
			<subTitle>an integrated understanding of internal brand management and brand architecture in the public sector</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-15T14:38:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158933</identifier>
		<identifier type="doi">10.1057/s41262-018-0128-y</identifier>
		<identifier type="isi">000466193900005</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Brand management</topic>
		</subject>
		<subject lang="eng">
			<topic>Brand architecture</topic>
		</subject>
		<subject lang="eng">
			<topic>Internal brand management</topic>
		</subject>
		<subject lang="eng">
			<topic>Public organization</topic>
		</subject>
		<subject lang="eng">
			<topic>Public sector</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50202">
			<topic>Social Sciences</topic>
			<topic>Economics and Business</topic>
			<topic>Business Administration</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50202">
			<topic>Samhällsvetenskap</topic>
			<topic>Ekonomi och näringsliv</topic>
			<topic>Företagsekonomi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Branding in the public sector is emerging as an interesting area of research, as diverse organisations find themselves using branding principles to promote a consistent, clear brand. However, very little is known how public organisations could, or should, manage their brands. The purpose of this research, therefore, is to explore brand management processes in the public sector, and its implication for brand architecture, from an employee perspective. With a qualitative approach, the study argues that branding is important not only for the organisation, but also for individual departments. Further, unlike branding in the private sector, public organisations may be more concerned with supporting a positive perception and organisational attractiveness rather than a unique and differentiated brand. This may have implications for brand architecture. By allowing individual departments to manage their brand with support from organisational structures that provide alignment and focus, organisations can form a brand architecture that supports a strong organisational brand and employee brand commitment.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Brand Management</title>
			</titleInfo>
			<identifier type="issn">1350-231X</identifier>
			<identifier type="eissn">1479-1803</identifier>
			<part>
				<detail type="volume">
					<number>26</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>277</start>
					<end>290</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>ulalet02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-15</recordCreationDate>
			<recordChangeDate>2019-07-02</recordChangeDate>
			<recordIdentifier>diva2:1316022</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="inrann97">
			<namePart type="family">Anan</namePart>
			<namePart type="given">Intissar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:65167</description>
		</name>
		<name type="personal" authority="umu" xlink:href="joba0108">
			<namePart type="family">Bång</namePart>
			<namePart type="given">Joakim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för kirurgisk och perioperativ vetenskap</affiliation>
			<description>diva-portal.org=authority-person:73174</description>
		</name>
		<name type="personal" authority="umu" xlink:href="halu0014">
			<namePart type="family">Lundgren</namePart>
			<namePart type="given">Hans-Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:65281</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jowi0065">
			<namePart type="family">Wixner</namePart>
			<namePart type="given">Jonas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0002-1536-1277</description>
			<description>diva-portal.org=authority-person:65399</description>
		</name>
		<name type="personal">
			<namePart type="family">Westermark</namePart>
			<namePart type="given">Per</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="792">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-16T09:03:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162352</identifier>
		<identifier type="doi">10.1080/13506129.2019.1593132</identifier>
		<identifier type="pmid">31343355</identifier>
		<identifier type="isi">000477775700017</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30210">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Rheumatology and Autoimmunity</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30210">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Reumatologi och inflammation</topic>
		</subject>
		<note>&lt;p&gt;Special Issue. Supplement 1.&lt;/p&gt;</note>
		<name type="conference">
			<namePart>16th International Symposium on Amyloidosis (ISA), Kumamoto, JAPAN, March 26-29, 2018.</namePart>
		</name>
		<relatedItem type="host">
			<titleInfo>
				<title>Amyloid</title>
				<subTitle>Journal of Protein Folding Disorders</subTitle>
			</titleInfo>
			<identifier type="issn">1350-6129</identifier>
			<identifier type="eissn">1744-2818</identifier>
			<part>
				<detail type="volume">
					<number>26</number>
				</detail>
				<extent>
					<start>29</start>
					<end>30</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-16</recordCreationDate>
			<recordChangeDate>2019-08-27</recordChangeDate>
			<recordIdentifier>diva2:1343281</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="maek0021">
			<namePart type="family">Ekström</namePart>
			<namePart type="given">Magnus</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Statistik</affiliation>
			<affiliation>Department of Forest Resource Management, Swedish University of Agricultural Sciences, Umeå, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63517</description>
		</name>
		<name type="personal">
			<namePart type="family">Mirakhmedov</namePart>
			<namePart type="given">S. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jammalamadaka</namePart>
			<namePart type="given">S. Rao</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="11053">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A class of asymptotically efficient estimators based on sample spacings</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer Berlin/Heidelberg</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-12T14:33:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163292</identifier>
		<identifier type="doi">10.1007/s11749-019-00637-7</identifier>
		<identifier type="scopus">2-s2.0-85069960299</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s11749-019-00637-7</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Sample spacings</topic>
		</subject>
		<subject lang="eng">
			<topic>Estimation</topic>
		</subject>
		<subject lang="eng">
			<topic>Asymptotic efficiency</topic>
		</subject>
		<subject lang="eng">
			<topic>Robustness</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10106">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Probability Theory and Statistics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10106">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Sannolikhetsteori och statistik</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2150">
			<topic>Statistics</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2150">
			<topic>statistik</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;In this paper, we consider general classes of estimators based on higher-order sample spacings, called the Generalized Spacings Estimators. Such classes of estimators are obtained by minimizing the Csiszár divergence between the empirical and true distributions for various convex functions, include the “maximum spacing estimators” as well as the maximum likelihood estimators (MLEs) as special cases, and are especially useful when the latter do not exist. These results generalize several earlier studies on spacings-based estimation, by utilizing non-overlapping spacings that are of an order which increases with the sample size. These estimators are shown to be consistent as well as asymptotically normal under a fairly general set of regularity conditions. When the step size and the number of spacings grow with the sample size, an asymptotically efficient class of estimators, called the “Minimum Power Divergence Estimators,” are shown to exist. Simulation studies give further support to the performance of these asymptotically efficient estimators in finite samples and compare well relative to the MLEs. Unlike the MLEs, some of these estimators are also shown to be quite robust under heavy contamination.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Test (Madrid)</title>
			</titleInfo>
			<identifier type="issn">1133-0686</identifier>
			<identifier type="eissn">1863-8260</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1350874/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>maek0021</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-12</recordCreationDate>
			<recordChangeDate>2019-09-16</recordChangeDate>
			<recordIdentifier>diva2:1350874</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Laleci Erturkmen</namePart>
			<namePart type="given">Gokce B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yuksel</namePart>
			<namePart type="given">Mustafa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sarigul</namePart>
			<namePart type="given">Bunyamin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arvanitis</namePart>
			<namePart type="given">Theodoros N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lindman</namePart>
			<namePart type="given">Pontus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Rong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhao</namePart>
			<namePart type="given">Lei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sadou</namePart>
			<namePart type="given">Eric</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bouaud</namePart>
			<namePart type="given">Jacques</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Traore</namePart>
			<namePart type="given">Lamine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Teoman</namePart>
			<namePart type="given">Alper</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lim Choi Keung</namePart>
			<namePart type="given">Sarah N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Despotou</namePart>
			<namePart type="given">George</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Manuel</namePart>
			<namePart type="given">Esteban</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Verdoy</namePart>
			<namePart type="given">Dolores</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Blas</namePart>
			<namePart type="given">Antonio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gonzalez</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="millia03">
			<namePart type="family">Lilja</namePart>
			<namePart type="given">Mikael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Unit of Research, Education, and Development, Östersund Hospital, Umeå University, Umeå, Sweden</affiliation>
			<description>orcid.org=0000-0002-5203-9877</description>
			<description>diva-portal.org=authority-person:64866</description>
		</name>
		<name type="personal">
			<namePart type="family">von Tottleben</namePart>
			<namePart type="given">Malte</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beach</namePart>
			<namePart type="given">Marie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marguerie</namePart>
			<namePart type="given">Christopher</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klein</namePart>
			<namePart type="given">Gunnar O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kalra</namePart>
			<namePart type="given">Dipak</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Collaborative Platform for Management of Chronic Diseases via Guideline-Driven Individualized Care Plans</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-24T18:05:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163527</identifier>
		<identifier type="doi">10.1016/j.csbj.2019.06.003</identifier>
		<identifier type="pmid">31333814</identifier>
		<identifier type="isi">000504205700087</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.csbj.2019.06.003</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Chronic disease management</topic>
		</subject>
		<subject lang="eng">
			<topic>Clinical decision support systems</topic>
		</subject>
		<subject lang="eng">
			<topic>Evidence based clinical guidelines</topic>
		</subject>
		<subject lang="eng">
			<topic>Integrated care</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Older age is associated with an increased accumulation of multiple chronic conditions. The clinical management of patients suffering from multiple chronic conditions is very complex, disconnected and time-consuming with the traditional care settings. Integrated care is a means to address the growing demand for improved patient experience and health outcomes of multimorbid and long-term care patients. Care planning is a prevalent approach of integrated care, where the aim is to deliver more personalized and targeted care creating shared care plans by clearly articulating the role of each provider and patient in the care process. In this paper, we present a method and corresponding implementation of a semi-automatic care plan management tool, integrated with clinical decision support services which can seamlessly access and assess the electronic health records (EHRs) of the patient in comparison with evidence based clinical guidelines to suggest personalized recommendations for goals and interventions to be added to the individualized care plans. We also report the results of usability studies carried out in four pilot sites by patients and clinicians.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>17</number>
				</detail>
				<extent>
					<start>869</start>
					<end>885</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Computational and structural biotechnology journal</title>
			</titleInfo>
			<identifier type="issn">2001-0370</identifier>
			<part>
				<detail type="volume">
					<number>17</number>
				</detail>
				<extent>
					<start>869</start>
					<end>885</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1354255/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>millia03</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-24</recordCreationDate>
			<recordChangeDate>2020-01-10</recordChangeDate>
			<recordIdentifier>diva2:1354255</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="adli0019">
			<namePart type="family">Ramadona</namePart>
			<namePart type="given">Aditya Lia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<affiliation>Center for Environmental Studies, Universitas Gadjah Mada, Yogyakarta, Indonesia</affiliation>
			<description>diva-portal.org=authority-person:62975</description>
		</name>
		<name type="personal">
			<namePart type="family">Tozan</namePart>
			<namePart type="given">Yesim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lazuardi</namePart>
			<namePart type="given">Lutfan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="joro0003">
			<namePart type="family">Rocklöv</namePart>
			<namePart type="given">Joacim</namePart>
			<namePart type="termsOfAddress">Professor</namePart>
			<namePart type="date">1979-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<description>orcid.org=0000-0003-4030-0449</description>
			<description>diva-portal.org=authority-person:62759</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881550">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Avdelningen för hållbar hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A combination of incidence data and mobility proxies from social media predicts the intra-urban spread of dengue in Yogyakarta, Indonesia</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-09T09:37:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158806</identifier>
		<identifier type="doi">10.1371/journal.pntd.0007298</identifier>
		<identifier type="pmid">30986218</identifier>
		<identifier type="isi">000466742100035</identifier>
		<identifier type="articleId">e0007298</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1371/journal.pntd.0007298</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Only a few studies have investigated the potential of using geotagged social media data for predicting the patterns of spatio-temporal spread of vector-borne diseases. We herein demonstrated the role of human mobility in the intra-urban spread of dengue by weighting local incidence data with geo-tagged Twitter data as a proxy for human mobility across 45 neighborhoods in Yogyakarta city, Indonesia. To estimate the dengue virus importation pressure in each study neighborhood monthly, we developed an algorithm to estimate a dynamic mobility-weighted incidence index (MI), which quantifies the level of exposure to virus importation in any given neighborhood. Using a Bayesian spatio-temporal regression model, we estimated the coefficients and predictiveness of the MI index for lags up to 6 months. Specifically, we used a Poisson regression model with an unstructured spatial covariance matrix. We compared the predictability of the MI index to that of the dengue incidence rate over the preceding months in the same neighborhood (autocorrelation) and that of the mobility information alone. We based our estimates on a volume of 1·302·405 geotagged tweets (from 118·114 unique users) and monthly dengue incidence data for the 45 study neighborhoods in Yogyakarta city over the period from August 2016 to June 2018. The MI index, as a standalone variable, had the highest explanatory power for predicting dengue transmission risk in the study neighborhoods, with the greatest predictive ability at a 3-months lead time. The MI index was a better predictor of the dengue risk in a neighborhood than the recent transmission patterns in the same neighborhood, or just the mobility patterns between neighborhoods. Our results suggest that human mobility is an important driver of the spread of dengue within cities when combined with information on local circulation of the dengue virus. The geotagged Twitter data can provide important information on human mobility patterns to improve our understanding of the direction and the risk of spread of diseases, such as dengue. The proposed MI index together with traditional data sources can provide useful information for the development of more accurate and efficient early warning and response systems.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>PLoS Neglected Tropical Diseases</title>
			</titleInfo>
			<identifier type="issn">1935-2727</identifier>
			<identifier type="eissn">1935-2735</identifier>
			<part>
				<detail type="volume">
					<number>13</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1314565/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>lrtjon02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-09</recordCreationDate>
			<recordChangeDate>2019-06-13</recordChangeDate>
			<recordIdentifier>diva2:1314565</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Karlsson</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cirenajwis</namePart>
			<namePart type="given">Helena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ericson-Lindquist</namePart>
			<namePart type="given">Kajsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brunnström</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Reuterswärd</namePart>
			<namePart type="given">Christel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jönsson</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ortiz-Villalon</namePart>
			<namePart type="given">Cristian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hussein</namePart>
			<namePart type="given">Aziz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bergman</namePart>
			<namePart type="given">Bengt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vikström</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Monsef</namePart>
			<namePart type="given">Nastaran</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Branden</namePart>
			<namePart type="given">Eva</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Koyi</namePart>
			<namePart type="given">Hirsh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Petris</namePart>
			<namePart type="given">Luigi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Micke</namePart>
			<namePart type="given">Patrick</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Patthey</namePart>
			<namePart type="given">Annika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anbe0145">
			<namePart type="family">Behndig</namePart>
			<namePart type="given">Annelie F.</namePart>
			<namePart type="date">1963-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för medicin</affiliation>
			<description>diva-portal.org=authority-person:63233</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mijo0025">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Mikael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<description>diva-portal.org=authority-person:63749</description>
		</name>
		<name type="personal">
			<namePart type="family">Planck</namePart>
			<namePart type="given">Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Staaf</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881551">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Avdelningen för medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="778">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<namePart>Onkologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Nature Publishing Group</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-12T15:53:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158094</identifier>
		<identifier type="doi">10.1038/s41598-019-41585-4</identifier>
		<identifier type="pmid">30914778</identifier>
		<identifier type="isi">000462298600094</identifier>
		<identifier type="articleId">5207</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1038/s41598-019-41585-4</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Accurate histological classification and identification of fusion genes represent two cornerstones of clinical diagnostics in non-small cell lung cancer (NSCLC). Here, we present a NanoString gene expression platform and a novel platform-independent, single sample predictor (SSP) of NSCLC histology for combined, simultaneous, histological classification and fusion gene detection in minimal formalin fixed paraffin embedded (FFPE) tissue. The SSP was developed in 68 NSCLC tumors of adenocarcinoma (AC), squamous cell carcinoma (SqCC) and large-cell neuroendocrine carcinoma (LCNEC) histology, based on NanoString expression of 11 (CHGA, SYP, CD56, SFTPG, NAPSA, TTF-1, TP73L, KRT6A, KRT5, KRT40, KRT16) relevant genes for IHC-based NSCLC histology classification. The SSP was combined with a gene fusion detection module (analyzing ALK, RET, ROS1, MET, NRG1, and NTRK1) into a multicomponent NanoString assay. The histological SSP was validated in six cohorts varying in size (n = 11-199), tissue origin (early or advanced disease), histological composition (including undifferentiated cancer), and gene expression platform. Fusion gene detection revealed five EML4-ALK fusions, four KIF5B-RET fusions, two CD74-NRG1 fusion and three MET exon 14 skipping events among 131 tested cases. The histological SSP was successfully trained and tested in the development cohort (mean AUC = 0.96 in iterated test sets). The SSP proved successful in predicting histology of NSCLC tumors of well-defined subgroups and difficult undifferentiated morphology irrespective of gene expression data platform. Discrepancies between gene expression prediction and histologic diagnosis included cases with mixed histologies, true large cell carcinomas, or poorly differentiated adenocarcinomas with mucin expression. In summary, we present a proof-of-concept multicomponent assay for parallel histological classification and multiplexed fusion gene detection in archival tissue, including a novel platform-independent histological SSP classifier. The assay and SSP could serve as a promising complement in the routine evaluation of diagnostic lung cancer biopsies.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Scientific Reports</title>
			</titleInfo>
			<identifier type="issn">2045-2322</identifier>
			<identifier type="eissn">2045-2322</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1304644/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-12</recordCreationDate>
			<recordChangeDate>2019-04-12</recordChangeDate>
			<recordIdentifier>diva2:1304644</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<genre authority="diva" type="publicationSubTypeCode">letter</genre>
		<name type="personal" authority="umu" xlink:href="mike0005">
			<namePart type="family">Kesek</namePart>
			<namePart type="given">Milos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Arrhythmia Unit, Heart Centre, University Hospital, Umeå, Sweden</affiliation>
			<description>diva-portal.org=authority-person:64206</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A comment on postmortem interrogation of cardiac implantable electronic devices</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-20T10:55:36</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165095</identifier>
		<identifier type="doi">10.1007/s00414-019-02136-8</identifier>
		<identifier type="pmid">31388793</identifier>
		<identifier type="isi">000492038100024</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<relatedItem type="host">
			<titleInfo>
				<title>International journal of legal medicine (Print)</title>
			</titleInfo>
			<identifier type="issn">0937-9827</identifier>
			<identifier type="eissn">1437-1596</identifier>
			<part>
				<detail type="volume">
					<number>133</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
				<extent>
					<start>1851</start>
					<end>1851</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-20</recordCreationDate>
			<recordChangeDate>2019-11-20</recordChangeDate>
			<recordIdentifier>diva2:1371528</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Coates</namePart>
			<namePart type="given">Matthew M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8474-4992</description>
		</name>
		<name type="personal">
			<namePart type="family">Kamanda</namePart>
			<namePart type="given">Mamusu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kintuc</namePart>
			<namePart type="given">Alexander</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arikpo</namePart>
			<namePart type="given">Iwara</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-8487-6461</description>
		</name>
		<name type="personal">
			<namePart type="family">Chauque</namePart>
			<namePart type="given">Alberto</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mengesha</namePart>
			<namePart type="given">Melkamu Merid</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Price</namePart>
			<namePart type="given">Alison J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sifuna</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wamukoya</namePart>
			<namePart type="given">Marylene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-2900-9178</description>
		</name>
		<name type="personal">
			<namePart type="family">Sacoor</namePart>
			<namePart type="given">Charfudin N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ogwang</namePart>
			<namePart type="given">Sheila</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Assefa</namePart>
			<namePart type="given">Nega</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-0341-2329</description>
		</name>
		<name type="personal">
			<namePart type="family">Crampin</namePart>
			<namePart type="given">Amelia C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Macete</namePart>
			<namePart type="given">Eusebio, V</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kyobutungi</namePart>
			<namePart type="given">Catherine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Meremikwu</namePart>
			<namePart type="given">Martin M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Otieno</namePart>
			<namePart type="given">Walter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Adjaye-Gbewonyo</namePart>
			<namePart type="given">Kafui</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marx</namePart>
			<namePart type="given">Andrew</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="peby0002">
			<namePart type="family">Byass</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<description>diva-portal.org=authority-person:62912</description>
		</name>
		<name type="personal">
			<namePart type="family">Sankoh</namePart>
			<namePart type="given">Osman</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bukhman</namePart>
			<namePart type="given">Gene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A comparison of all-cause and cause-specific mortality by household socioeconomic status across seven INDEPTH network health and demographic surveillance systems in sub-Saharan Africa</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis Group</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-03T13:16:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159639</identifier>
		<identifier type="doi">10.1080/16549716.2019.1608013</identifier>
		<identifier type="pmid">31092155</identifier>
		<identifier type="isi">000468041100001</identifier>
		<identifier type="articleId">1608013</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/16549716.2019.1608013</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Cause of death</topic>
		</subject>
		<subject lang="eng">
			<topic>verbal autopsy</topic>
		</subject>
		<subject lang="eng">
			<topic>non-communicable disease</topic>
		</subject>
		<subject lang="eng">
			<topic>life expectancy</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Understanding socioeconomic disparities in all-cause and cause-specific mortality can help inform prevention and treatment strategies.&lt;/p&gt;&lt;p&gt;Objectives: To quantify cause-specific mortality rates by socioeconomic status across seven health and demographic surveillance systems (HDSS) in five countries (Ethiopia, Kenya, Malawi, Mozambique, and Nigeria) in the INDEPTH Network in sub-Saharan Africa.&lt;/p&gt;&lt;p&gt;Methods: We linked demographic residence data with household survey data containing living standards and education information we used to create a poverty index. Person-years lived and deaths between 2003 and 2016 (periods varied by HDSS) were stratified in each HDSS by age, sex, year, and number of deprivations on the poverty index (0-8). Causes of death were assigned to each death using the InterVA-4 model based on responses to verbal autopsy questionnaires. We estimated rate ratios between socioeconomic groups (2-4 and 5-8 deprivations on our poverty index compared to 0-2 deprivations) for specific causes of death and calculated life expectancy for the deprivation groups.&lt;/p&gt;&lt;p&gt;Results: Our pooled data contained almost 3.5 million person-years of observation and 25,038 deaths. All-cause mortality rates were higher among people in households with 5-8 deprivations on our poverty index compared to 0-2 deprivations, controlling for age, sex, and year (rate ratios ranged 1.42 to 2.06 across HDSS sites). The poorest group had consistently higher death rates in communicable, maternal, neonatal, and nutritional conditions (rate ratios ranged 1.34-4.05) and for non-communicable diseases in several sites (1.14-1.93). The disparities in mortality between 5-8 deprivation groups and 0-2 deprivation groups led to lower life expectancy in the higher-deprivation groups by six years in all sites and more than 10 years in five sites.&lt;/p&gt;&lt;p&gt;Conclusions: We show large disparities in mortality on the basis of socioeconomic status across seven HDSS in sub-Saharan Africa due to disparities in communicable disease mortality and from non-communicable diseases in some sites. Life expectancy gaps between socioeconomic groups within sites were similar to the gaps between high-income and lower-middle-income countries. Prevention and treatment efforts can benefit from understanding subpopulations facing higher mortality from specific conditions.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Global Health Action</title>
			</titleInfo>
			<identifier type="issn">1654-9716</identifier>
			<identifier type="eissn">1654-9880</identifier>
			<part>
				<detail type="volume">
					<number>12</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1319776/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-03</recordCreationDate>
			<recordChangeDate>2019-06-03</recordChangeDate>
			<recordIdentifier>diva2:1319776</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Lindh</namePart>
			<namePart type="given">Åsa U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dahlin</namePart>
			<namePart type="given">Marie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beckman</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="loastn02">
			<namePart type="family">Strömsten</namePart>
			<namePart type="given">Lotta M. J.</namePart>
			<namePart type="termsOfAddress">PhD</namePart>
			<namePart type="date">1979-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Psykiatri</affiliation>
			<description>orcid.org=0000-0001-8440-6881</description>
			<description>diva-portal.org=authority-person:62938</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jujo0022">
			<namePart type="family">Jokinen</namePart>
			<namePart type="given">Jussi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Psykiatri</affiliation>
			<description>orcid.org=0000-0001-6766-7983</description>
			<description>diva-portal.org=authority-person:68590</description>
		</name>
		<name type="personal">
			<namePart type="family">Wiktorsson</namePart>
			<namePart type="given">Stefan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="elsa0001">
			<namePart type="family">Salander Renberg</namePart>
			<namePart type="given">Ellinor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Psykiatri</affiliation>
			<description>diva-portal.org=authority-person:62939</description>
		</name>
		<name type="personal">
			<namePart type="family">Waern</namePart>
			<namePart type="given">Margda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Runeson</namePart>
			<namePart type="given">Bo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="740">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Psykiatri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Comparison of Suicide Risk Scales in Predicting Repeat Suicide Attempt and Suicide</title>
			<subTitle>A Clinical Cohort Study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-25T10:59:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165430</identifier>
		<identifier type="doi">10.4088/JCP.18m12707</identifier>
		<identifier type="pmid">31747488</identifier>
		<identifier type="articleId">18m12707</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;OBJECTIVE: To compare the predictive accuracy of the Suicide Intent Scale (SIS), the Suicide Assessment Scale (SUAS), the Karolinska Interpersonal Violence Scale (KIVS), and the Columbia-Suicide Severity Rating Scale (C-SSRS) for suicide attempts and suicides within 3 and 12 months of an episode of self-harm.&lt;/p&gt;&lt;p&gt;METHODS: This prospective multicenter cohort study included patients (N = 804) aged 18-95 years with a recent episode of self-harm assessed in psychiatric emergency settings from April 2012 to April 2016. Suicide attempts and suicides were identified in medical records and in the National Cause of Death Register. Receiver operating characteristic curves were constructed, and accuracy statistics were calculated. A sensitivity of at least 80% combined with a specificity of at least 50% were considered minimally acceptable.&lt;/p&gt;&lt;p&gt;RESULTS: At least 1 suicide attempt was recorded for 216 participants during follow-up, and 19 participants died by suicide. The SUAS and C-SSRS were better than chance in classifying the 114 suicide attempts occurring within the first 3 months; a C-SSRS score ≥ 27 yielded a sensitivity/specificity of 79.8%/51.5% (P &amp;lt; .001). During 1-year follow-up, the SUAS and C-SSRS also performed better than chance, but no cutoff on either instrument gave a sensitivity/specificity of ≥ 80%/≥ 50%. The SIS was the only instrument that could classify suicides correctly. At 3 months, the area under the curve (AUC) was 0.94 (95% CI, 0.89-0.99), and a score ≥ 21 predicted suicide with a sensitivity/specificity of 100%/81.9%, based on only 4 suicides. At 1-year follow-up, the AUC was 0.74 (95% CI, 0.61-0.87), and a score ≥ 17 predicted suicide with a sensitivity/specificity of 72.2%/57.9%.&lt;/p&gt;&lt;p&gt;CONCLUSIONS: Instruments that predicted nonfatal repeat suicide attempts did not predict suicide and vice versa. With the possible exception of the prediction of suicide by the SIS in a short time frame, the specificity of these instruments was low, giving them a limited relevance in the prediction of suicidal behaviors.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Clinical Psychiatry</title>
			</titleInfo>
			<identifier type="issn">0160-6689</identifier>
			<identifier type="eissn">1555-2101</identifier>
			<part>
				<detail type="volume">
					<number>80</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>loastn02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-25</recordCreationDate>
			<recordChangeDate>2019-12-12</recordChangeDate>
			<recordIdentifier>diva2:1372634</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Guillemot</namePart>
			<namePart type="given">Vincent</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Bioinformatics and Biostatistics Hub, Institut Pasteur, Paris, France</affiliation>
			<description>orcid.org=0000-0002-7421-0655</description>
		</name>
		<name type="personal">
			<namePart type="family">Beaton</namePart>
			<namePart type="given">Derek</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>The Rotman Research Institute, Institution at Baycrest, Toronto, Canada</affiliation>
			<description>orcid.org=0000-0001-6118-4366</description>
		</name>
		<name type="personal">
			<namePart type="family">Gloaguen</namePart>
			<namePart type="given">Arnaud</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>L2S, UMR CNRS 8506, CNRS–Centrale Supélec–Université Paris-Sud, Université Paris-Saclay, 3 rue Joliot-Curie, 91192 Gif-sur-Yvette, France</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="toklot02">
			<namePart type="family">Löfstedt</namePart>
			<namePart type="given">Tommy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Radiofysik</affiliation>
			<description>orcid.org=0000-0001-7119-7646</description>
			<description>diva-portal.org=authority-person:65519</description>
		</name>
		<name type="personal">
			<namePart type="family">Levine</namePart>
			<namePart type="given">Brian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>The Rotman Research Institute, Institution at Baycrest, Toronto, Canada</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Raymond</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>IRMAR, UMR 6625, Université de Rennes, Rennes, France</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Tenenhaus</namePart>
			<namePart type="given">Arthur</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>L2S, UMR CNRS 8506, CNRS–Centrale Supélec–Université Paris-Sud, Université Paris-Saclay, 3 rue Joliot-Curie, Gif-sur-Yvette, France</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Abdi</namePart>
			<namePart type="given">Hervé</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>School of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, TX, United States of America</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="779">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<namePart>Radiofysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A constrained singular value decomposition method that integrates sparsity and orthogonality</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-25T10:29:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157498</identifier>
		<identifier type="doi">10.1371/journal.pone.0211463</identifier>
		<identifier type="pmid">30865639</identifier>
		<identifier type="isi">000461048900010</identifier>
		<identifier type="scopus">2-s2.0-85062854732</identifier>
		<identifier type="articleId">e0211463</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1371/journal.pone.0211463</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="10207">
			<topic>Natural Sciences</topic>
			<topic>Computer and Information Sciences</topic>
			<topic>Computer Vision and Robotics (Autonomous Systems)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10207">
			<topic>Naturvetenskap</topic>
			<topic>Data- och informationsvetenskap</topic>
			<topic>Datorseende och robotik (autonoma system)</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="101">
			<topic>Mathematics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="101">
			<topic>Matematik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;We propose a new sparsification method for the singular value decomposition—called the constrained singular value decomposition (CSVD)—that can incorporate multiple constraints such as sparsification and orthogonality for the left and right singular vectors. The CSVD can combine different constraints because it implements each constraint as a projection onto a convex set, and because it integrates these constraints as projections onto the intersection of multiple convex sets. We show that, with appropriate sparsification constants, the algorithm is guaranteed to converge to a stable point. We also propose and analyze the convergence of an efficient algorithm for the specific case of the projection onto the balls defined by the norms &lt;em&gt;L&lt;/em&gt;&lt;sub&gt;1&lt;/sub&gt; and &lt;em&gt;L&lt;/em&gt;&lt;sub&gt;2&lt;/sub&gt;. We illustrate the CSVD and compare it to the standard singular value decomposition and to a non-orthogonal related sparsification method with: 1) a simulated example, 2) a small set of face images (corresponding to a configuration with a number of variables much larger than the number of observations), and 3) a psychometric application with a large number of observations and a small number of variables. The companion R-package, csvd, that implements the algorithms described in this paper, along with reproducible examples, are available for download from https://github.com/vguillemot/csvd.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>PLoS ONE</title>
			</titleInfo>
			<identifier type="issn">1932-6203</identifier>
			<identifier type="eissn">1932-6203</identifier>
			<part>
				<detail type="volume">
					<number>14</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1298651/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>toklot02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-25</recordCreationDate>
			<recordChangeDate>2019-04-04</recordChangeDate>
			<recordIdentifier>diva2:1298651</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<genre authority="svep" type="publicationType">kfa</genre>
		<name type="personal" authority="umu" xlink:href="xich0011">
			<namePart type="family">Cheng</namePart>
			<namePart type="given">Xiaogang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>College of Telecommunications and Information Engineering, Nanjing University of Posts and Telecommunications, Nanjing 210003, China; Computer Vision Laboratory (CVL), ETH Zürich, 8092 Zürich, Switzerland</affiliation>
			<description>diva-portal.org=authority-person:68207</description>
		</name>
		<name type="personal" authority="umu" xlink:href="biya0002">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Bin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<affiliation>School of Building Services Science and Engineering, Xi’an University of Architecture and Technology, Xi’an 710055, China</affiliation>
			<description>diva-portal.org=authority-person:63262</description>
		</name>
		<name type="personal">
			<namePart type="family">Tan</namePart>
			<namePart type="given">Kaige</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Isaksson</namePart>
			<namePart type="given">Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hedman</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="thol0001">
			<namePart type="family">Olofsson</namePart>
			<namePart type="given">Thomas</namePart>
			<namePart type="date">1968-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<description>orcid.org=0000-0002-8704-8538</description>
			<description>diva-portal.org=authority-person:63263</description>
		</name>
		<name type="personal">
			<namePart type="family">Li</namePart>
			<namePart type="given">Haibo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="870">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad fysik och elektronik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Contactless Measuring Method of Skin Temperature based on the Skin Sensitivity Index and Deep Learning</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<place>
				<placeTerm>Switzerland</placeTerm>
			</place>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-05T19:59:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159773</identifier>
		<identifier type="doi">10.3390/app9071375</identifier>
		<identifier type="isi">000466547500110</identifier>
		<identifier type="scopus">2-s2.0-85064083775</identifier>
		<identifier type="articleId">1375</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/app9071375</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>contactless measurements</topic>
		</subject>
		<subject lang="eng">
			<topic>skin sensitivity index</topic>
		</subject>
		<subject lang="eng">
			<topic>thermal comfort</topic>
		</subject>
		<subject lang="eng">
			<topic>subtleness magnification</topic>
		</subject>
		<subject lang="eng">
			<topic>deep learning</topic>
		</subject>
		<subject lang="eng">
			<topic>piecewise stationary time series</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="201">
			<topic>Engineering and Technology</topic>
			<topic>Civil Engineering</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="201">
			<topic>Teknik och teknologier</topic>
			<topic>Samhällsbyggnadsteknik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;In human-centered intelligent building, real-time measurements of human thermal comfort play critical roles and supply feedback control signals for building heating, ventilation, and air conditioning (HVAC) systems. Due to the challenges of intra- and inter-individual differences and skin subtleness variations, there has not been any satisfactory solution for thermal comfort measurements until now. In this paper, a contactless measuring method based on a skin sensitivity index and deep learning (NISDL) was proposed to measure real-time skin temperature. A new evaluating index, named the skin sensitivity index (SSI), was defined to overcome individual differences and skin subtleness variations. To illustrate the effectiveness of SSI proposed, a two multi-layers deep learning framework (NISDL method I and II) was designed and the DenseNet201 was used for extracting features from skin images. The partly personal saturation temperature (NIPST) algorithm was use for algorithm comparisons. Another deep learning algorithm without SSI (DL) was also generated for algorithm comparisons. Finally, a total of 1.44 million image data was used for algorithm validation. The results show that 55.62% and 52.25% error values (NISDL method I, II) are scattered at (0 °C, 0.25 °C), and the same error intervals distribution of NIPST is 35.39%. &lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Applied Sciences</title>
				<subTitle>APPS</subTitle>
			</titleInfo>
			<identifier type="issn">1454-5101</identifier>
			<identifier type="eissn">1454-5101</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
				<detail type="issue">
					<number>7</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1320864/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>xich0011</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-05</recordCreationDate>
			<recordChangeDate>2019-11-27</recordChangeDate>
			<recordIdentifier>diva2:1320864</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Burman</namePart>
			<namePart type="given">Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hansbo</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mala0002">
			<namePart type="family">Larson</namePart>
			<namePart type="given">Mats G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:63088</description>
		</name>
		<name type="personal">
			<namePart type="family">Samvin</namePart>
			<namePart type="given">David</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A cut finite element method for elliptic bulk problems with embedded surfaces</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer Berlin/Heidelberg</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-13T10:35:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158762</identifier>
		<identifier type="doi">10.1007/s13137-019-0120-z</identifier>
		<identifier type="pmid">30873244</identifier>
		<identifier type="isi">000463142200001</identifier>
		<identifier type="articleId">UNSP 10</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s13137-019-0120-z</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Finite element</topic>
		</subject>
		<subject lang="eng">
			<topic>Unfitted</topic>
		</subject>
		<subject lang="eng">
			<topic>Embedded</topic>
		</subject>
		<subject lang="eng">
			<topic>Fractures</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10201">
			<topic>Natural Sciences</topic>
			<topic>Computer and Information Sciences</topic>
			<topic>Computer Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10201">
			<topic>Naturvetenskap</topic>
			<topic>Data- och informationsvetenskap</topic>
			<topic>Datavetenskap (datalogi)</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10106">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Probability Theory and Statistics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10106">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Sannolikhetsteori och statistik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;We propose an unfitted finite element method for flow in fractured porous media. The coupling across the fracture uses a Nitsche type mortaring, allowing for an accurate representation of the jump in the normal component of the gradient of the discrete solution across the fracture. The flow field in the fracture is modelled simultaneously, using the average of traces of the bulk variables on the fractures. In particular the Laplace-Beltrami operator for the transport in the fracture is included using the average of the projection on the tangential plane of the fracture of the trace of the bulk gradient. Optimal order error estimates are proven under suitable regularity assumptions on the domain geometry. The extension to the case of bifurcating fractures is discussed. Finally the theory is illustrated by a series of numerical examples.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>GEM - International Journal on Geomathematics</title>
			</titleInfo>
			<identifier type="issn">1869-2672</identifier>
			<identifier type="eissn">1869-2680</identifier>
			<part>
				<detail type="volume">
					<number>10</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1315213/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-13</recordCreationDate>
			<recordChangeDate>2019-05-13</recordChangeDate>
			<recordIdentifier>diva2:1315213</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="abla0005">
			<namePart type="family">Lakehal</namePart>
			<namePart type="given">Abdellah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:68627</description>
		</name>
		<name type="personal">
			<namePart type="family">Dob</namePart>
			<namePart type="given">Asma</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="onno0001">
			<namePart type="family">Novak</namePart>
			<namePart type="given">Ondrej</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Department of Forest Genetics and Physiology, Swedish Agriculture University, Umea, Sweden</affiliation>
			<description>diva-portal.org=authority-person:73197</description>
		</name>
		<name type="personal" authority="umu" xlink:href="cabe0042">
			<namePart type="family">Bellini</namePart>
			<namePart type="given">Catherine</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Institut Jean-Pierre Bourgin, INRA, AgroParisTech, CNRS, Université Paris-Saclay, Versailles, France</affiliation>
			<description>orcid.org=0000-0003-2985-6649</description>
			<description>diva-portal.org=authority-person:64218</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="867">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysiologisk botanik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="874">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Umeå Plant Science Centre (UPSC)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A DAO1-Mediated Circuit Controls Auxin and Jasmonate Crosstalk Robustness during Adventitious Root Initiation in &lt;em&gt;Arabidopsis&lt;/em&gt;</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-05T13:38:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164948</identifier>
		<identifier type="doi">10.3390/ijms20184428</identifier>
		<identifier type="pmid">31505771</identifier>
		<identifier type="isi">000489100500107</identifier>
		<identifier type="articleId">4428</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/ijms20184428</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>adventitious roots</topic>
		</subject>
		<subject lang="eng">
			<topic>auxin</topic>
		</subject>
		<subject lang="eng">
			<topic>auxin oxidation</topic>
		</subject>
		<subject lang="eng">
			<topic>jasmonates</topic>
		</subject>
		<subject lang="eng">
			<topic>organogenesis</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10614">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Developmental Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10614">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Utvecklingsbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Adventitious rooting is a post-embryonic developmental program governed by a multitude of endogenous and environmental cues. Auxin, along with other phytohormones, integrates and translates these cues into precise molecular signatures to provide a coherent developmental output. Auxin signaling guides every step of adventitious root (AR) development from the early event of cell reprogramming and identity transitions until emergence. We have previously shown that auxin signaling controls the early events of AR initiation (ARI) by modulating the homeostasis of the negative regulator jasmonate (JA). Although considerable knowledge has been acquired about the role of auxin and JA in ARI, the genetic components acting downstream of JA signaling and the mechanistic basis controlling the interaction between these two hormones are not well understood. Here we provide evidence that &lt;em&gt;COI1&lt;/em&gt;-dependent JA signaling controls the expression of &lt;em&gt;DAO1&lt;/em&gt; and its closely related paralog &lt;em&gt;DAO2&lt;/em&gt;. In addition, we show that the &lt;em&gt;dao1-1&lt;/em&gt; loss of function mutant produces more ARs than the wild type, probably due to its deficiency in accumulating JA and its bioactive metabolite JA-Ile. Together, our data indicate that &lt;em&gt;DAO1&lt;/em&gt; controls a sensitive feedback circuit that stabilizes the auxin and JA crosstalk during ARI.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Molecular Sciences</title>
			</titleInfo>
			<identifier type="issn">1422-0067</identifier>
			<identifier type="eissn">1422-0067</identifier>
			<part>
				<detail type="volume">
					<number>20</number>
				</detail>
				<detail type="issue">
					<number>18</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1367960/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>abla0005</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-05</recordCreationDate>
			<recordChangeDate>2019-11-06</recordChangeDate>
			<recordIdentifier>diva2:1367960</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Klingberg</namePart>
			<namePart type="given">Eva</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-6858-6413</description>
		</name>
		<name type="personal">
			<namePart type="family">Magnusson</namePart>
			<namePart type="given">Maria K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Strid</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Deminger</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ståhl</namePart>
			<namePart type="given">Arne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sundin</namePart>
			<namePart type="given">Johanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Simren</namePart>
			<namePart type="given">Magnus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carlsten</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Öhman</namePart>
			<namePart type="given">Lena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="hefo0034">
			<namePart type="family">Forsblad-d'Elia</namePart>
			<namePart type="given">Helena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Reumatologi</affiliation>
			<affiliation>Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63549</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="729">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Reumatologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-03T08:58:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166834</identifier>
		<identifier type="doi">10.1186/s13075-019-2018-4</identifier>
		<identifier type="pmid">31771630</identifier>
		<identifier type="isi">000499977300002</identifier>
		<identifier type="articleId">248</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s13075-019-2018-4</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Ankylosing spondylitis</topic>
		</subject>
		<subject lang="eng">
			<topic>Spondyloarthritis</topic>
		</subject>
		<subject lang="eng">
			<topic>Microbiota</topic>
		</subject>
		<subject lang="eng">
			<topic>Intestinal inflammation</topic>
		</subject>
		<subject lang="eng">
			<topic>Inflammatory bowel disease</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30210">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Rheumatology and Autoimmunity</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30210">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Reumatologi och inflammation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30213">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Gastroenterology and Hepatology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30213">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Gastroenterologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Ankylosing spondylitis (AS) shares many characteristics with inflammatory bowel disease (IBD). Intestinal microbiota most likely plays an important role in the development of IBDs and may also be involved in the pathogenesis of AS. We aimed to define and compare the fecal microbiota composition in patients with AS, ulcerative colitis (UC), and healthy controls (HC) and to determine relationships between fecal microbiota, fecal calprotectin, and disease-related variables in AS.&lt;/p&gt;&lt;p&gt;Methods: Fecal microbiota composition was assessed with GA-map™ Dysbiosis Test (Genetic Analysis, Oslo, Norway), which also reports the degree of deviation of the microbiota composition compared with a healthy control population, a Dysbiosis Index (DI) score 1–5. The AS patients were assessed with questionnaires, back mobility tests, fecal calprotectin, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP).&lt;/p&gt;&lt;p&gt;Results: Totally, 150 patients with AS (55% men, median age 55.5 years, median BASDAI 3.2), 18 patients with UC (56% men, median age 30.5 years), and 17 HC (65% men, median age 22 years) were included. Principal component analysis showed highly separate clustering of fecal microbiota from the patients with AS, UC, and HC. Compared with HC, fecal microbiota in AS was characterized by a higher abundance of &lt;em&gt;Proteobacteria&lt;/em&gt;, &lt;em&gt;Enterobacteriaceae&lt;/em&gt;, &lt;em&gt;Bacilli&lt;/em&gt;, &lt;em&gt;Streptococcus&lt;/em&gt; species, and &lt;em&gt;Actinobacteria&lt;/em&gt;, but lower abundance of &lt;em&gt;Bacteroides&lt;/em&gt; and &lt;em&gt;Lachnospiraceae&lt;/em&gt;.&lt;/p&gt;&lt;p&gt;Further, fecal microbiota composition differed between patients with normal (≤ 50 mg/kg, &lt;em&gt;n&lt;/em&gt; = 57) and increased (≥ 200 mg/kg, &lt;em&gt;n&lt;/em&gt; = 36) fecal calprotectin. Patients with increased fecal calprotectin had lower abundance of bacteria with anti-inflammatory properties such as &lt;em&gt;Faecalibacterium prausnitzii&lt;/em&gt; and &lt;em&gt;Clostridium&lt;/em&gt; and higher abundance of the genus &lt;em&gt;Streptococcus&lt;/em&gt;. No association was found between the fecal microbiota composition and HLAB27 status, disease activity, function, or medication. Dysbiosis (defined as DI ≥ 3) was found in 87% of AS patients.&lt;/p&gt;&lt;p&gt;Conclusions: Patients with AS have a distinct fecal microbiota signature, which is linked to fecal calprotectin levels, a marker of intestinal inflammation, but not to other clinical parameters. These findings suggest a local interplay between intestinal microbiota and gut inflammation in AS.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Arthritis Research &amp; Therapy</title>
			</titleInfo>
			<identifier type="issn">1478-6354</identifier>
			<identifier type="eissn">1478-6362</identifier>
			<part>
				<detail type="volume">
					<number>21</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1382439/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-03</recordCreationDate>
			<recordChangeDate>2020-01-03</recordChangeDate>
			<recordIdentifier>diva2:1382439</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="heni0023">
			<namePart type="family">Mackay</namePart>
			<namePart type="given">Heather</namePart>
			<namePart type="date">1976-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för geografi</affiliation>
			<description>orcid.org=0000-0001-5516-1109</description>
			<description>diva-portal.org=authority-person:68214</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881251">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för geografi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A feminist geographic analysis of perceptions of food and health in Ugandan cities</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Routledge</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-09T13:13:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158000</identifier>
		<identifier type="doi">10.1080/0966369X.2018.1555148</identifier>
		<identifier type="isi">000470408500001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/0966369X.2018.1555148</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Feminist geography</topic>
		</subject>
		<subject lang="eng">
			<topic>food</topic>
		</subject>
		<subject lang="eng">
			<topic>non-communicable disease</topic>
		</subject>
		<subject lang="eng">
			<topic>nutrition transition</topic>
		</subject>
		<subject lang="eng">
			<topic>obesity</topic>
		</subject>
		<subject lang="eng">
			<topic>Uganda</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30304">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nutrition and Dietetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30304">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Näringslära</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="507">
			<topic>Social Sciences</topic>
			<topic>Social and Economic Geography</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="507">
			<topic>Samhällsvetenskap</topic>
			<topic>Social och ekonomisk geografi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;This article contributes to a feminist geographic analysis of how urban food and health environments and non-communicable disease experience may be being constructed, and contested, by healthcare professionals (local elites) in two secondary Ugandan cities (Mbale and Mbarara). I use thematic and group interaction analysis of focus group data to explore material and discursive representations. Findings make explicit how healthcare professionals had a tendency to prescribe highly classed and gendered assumptions of bodies and behaviours in places and in daily practices. The work supports the discomfort some have felt concerning claims of an African nutrition transition, and is relevant to debates regarding double burden malnutrition. I argue that a feministic analysis, and an intersectional appreciation of people in places, is advantageous to food and health-related research and policy-making. Results uncover and deconstruct a dominant patriarchal tendency towards blaming women for obesity. Yet findings also exemplify the co-constructed and malleable nature of knowledge and understandings, and this offers encouragement.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Gender, Place and Culture</title>
				<subTitle>A Journal of Feminist Geography</subTitle>
			</titleInfo>
			<identifier type="issn">0966-369X</identifier>
			<identifier type="eissn">1360-0524</identifier>
			<part>
				<detail type="volume">
					<number>26</number>
				</detail>
				<detail type="issue">
					<number>11</number>
				</detail>
				<extent>
					<start>1519</start>
					<end>1543</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Forskningsrådet Formas [250-2014-1227]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1303300/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>heni0023</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-09</recordCreationDate>
			<recordChangeDate>2019-10-09</recordChangeDate>
			<recordIdentifier>diva2:1303300</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Sofer</namePart>
			<namePart type="given">Tamar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zheng</namePart>
			<namePart type="given">Xiuwen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gogarten</namePart>
			<namePart type="given">Stephanie M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laurie</namePart>
			<namePart type="given">Cecelia A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Grinde</namePart>
			<namePart type="given">Kelsey</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shaffer</namePart>
			<namePart type="given">John R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="dmsh0003">
			<namePart type="family">Shungin</namePart>
			<namePart type="given">Dmitry</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<affiliation>Broad Institute of Harvard and MIT, Cambridge, Massachusetts</affiliation>
			<description>diva-portal.org=authority-person:63545</description>
		</name>
		<name type="personal">
			<namePart type="family">O'Connell</namePart>
			<namePart type="given">Jeffrey R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Durazo-Arvizo</namePart>
			<namePart type="given">Ramon A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Raffield</namePart>
			<namePart type="given">Laura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lange</namePart>
			<namePart type="given">Leslie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Musani</namePart>
			<namePart type="given">Solomon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vasan</namePart>
			<namePart type="given">Ramachandran S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cupples</namePart>
			<namePart type="given">L. Adrienne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Reiner</namePart>
			<namePart type="given">Alexander P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laurie</namePart>
			<namePart type="given">Cathy C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rice</namePart>
			<namePart type="given">Kenneth M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A fully adjusted two-stage procedure for rank-normalization in genetic association studies</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-09T16:23:35</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157743</identifier>
		<identifier type="doi">10.1002/gepi.22188</identifier>
		<identifier type="pmid">30653739</identifier>
		<identifier type="isi">000461058300003</identifier>
		<identifier type="scopus">2-s2.0-85060217416</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>rank-normalization</topic>
		</subject>
		<subject lang="eng">
			<topic>rare variants</topic>
		</subject>
		<subject lang="eng">
			<topic>whole-genome sequencing</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30107">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Medical Genetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30107">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Medicinsk genetik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;When testing genotype–phenotype associations using linear regression, departure of the trait distribution from normality can impact both Type I error rate control and statistical power, with worse consequences for rarer variants. Because genotypes are expected to have small effects (if any) investigators now routinely use a two‐stage method, in which they first regress the trait on covariates, obtain residuals, rank‐normalize them, and then use the rank‐normalized residuals in association analysis with the genotypes. Potential confounding signals are assumed to be removed at the first stage, so in practice, no further adjustment is done in the second stage. Here, we show that this widely used approach can lead to tests with undesirable statistical properties, due to both combination of a mis‐specified mean–variance relationship and remaining covariate associations between the rank‐normalized residuals and genotypes. We demonstrate these properties theoretically, and also in applications to genome‐wide and whole‐genome sequencing association studies. We further propose and evaluate an alternative fully adjusted two‐stage approach that adjusts for covariates both when residuals are obtained and in the subsequent association test. This method can reduce excess Type I errors and improve statistical power.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Genetic Epidemiology</title>
			</titleInfo>
			<identifier type="issn">0741-0395</identifier>
			<identifier type="eissn">1098-2272</identifier>
			<part>
				<detail type="volume">
					<number>43</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>263</start>
					<end>275</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-09</recordCreationDate>
			<recordChangeDate>2019-04-09</recordChangeDate>
			<recordIdentifier>diva2:1303439</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Schmidt</namePart>
			<namePart type="given">Tobias T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="sush0003">
			<namePart type="family">Sharma</namePart>
			<namePart type="given">Sushma</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:65353</description>
		</name>
		<name type="personal">
			<namePart type="family">Reyes</namePart>
			<namePart type="given">Gloria X.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gries</namePart>
			<namePart type="given">Kerstin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gross</namePart>
			<namePart type="given">Maike</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhao</namePart>
			<namePart type="given">Boyu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yuan</namePart>
			<namePart type="given">Jui-Hung</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wade</namePart>
			<namePart type="given">Rebecca</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anch0002">
			<namePart type="family">Chabes</namePart>
			<namePart type="given">Andrei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Andrei Chabes</affiliation>
			<description>orcid.org=0000-0003-1708-8259</description>
			<description>diva-portal.org=authority-person:64019</description>
		</name>
		<name type="corporate">
			<namePart>Andrei Chabes</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Hombauer</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="791">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk kemi och biofysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A genetic screen pinpoints ribonucleotide reductase residues that sustain dNTP homeostasis and specifies a highly mutagenic type of dNTP imbalance</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-13T10:44:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154182</identifier>
		<identifier type="doi">10.1093/nar/gky1154</identifier>
		<identifier type="pmid">30462295</identifier>
		<identifier type="isi">000462586700025</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1093/nar/gky1154</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30108">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Cell and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30108">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Cell- och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The balance and the overall concentration of intracellular deoxyribonucleoside triphosphates (dNTPs) are important determinants of faithful DNA replication. Despite the established fact that changes in dNTP pools negatively influence DNA replication fidelity, it is not clear why certain dNTP pool alterations are more mutagenic than others. As intracellular dNTP pools are mainly controlled by ribonucleotide reductase (RNR), and given the limited number of eukaryotic &lt;em&gt;RNR&lt;/em&gt; mutations characterized so far, we screened for &lt;em&gt;RNR1&lt;/em&gt; mutations causing mutator phenotypes in &lt;em&gt;Saccharomyces cerevisiae&lt;/em&gt;. We identified 24 &lt;em&gt;rnr1&lt;/em&gt; mutant alleles resulting in diverse mutator phenotypes linked in most cases to imbalanced dNTPs. Among the identified &lt;em&gt;rnr1&lt;/em&gt; alleles the strongest mutators presented a dNTP imbalance in which three out of the four dNTPs were elevated (dCTP, dTTP and dGTP), particularly if dGTP levels were highly increased. These &lt;em&gt;rnr1&lt;/em&gt; alleles caused growth defects/lethality in DNA replication fidelity-compromised backgrounds, and caused strong mutator phenotypes even in the presence of functional DNA polymerases and mismatch repair. In summary, this study pinpoints key residues that contribute to allosteric regulation of RNR’s overall activity or substrate specificity. We propose a model that distinguishes between different dNTP pool alterations and provides a mechanistic explanation why certain dNTP imbalances are particularly detrimental.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Nucleic Acids Research</title>
			</titleInfo>
			<identifier type="issn">0305-1048</identifier>
			<identifier type="eissn">1362-4962</identifier>
			<part>
				<detail type="volume">
					<number>47</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>237</start>
					<end>252</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Cancerfonden</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse</note>
		<note type="funder">Vetenskapsrådet</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1270394/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>anch0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-13</recordCreationDate>
			<recordChangeDate>2019-04-12</recordChangeDate>
			<recordIdentifier>diva2:1270394</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="kalo0015">
			<namePart type="family">Lopatko Lindman</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Geriatrik</affiliation>
			<description>diva-portal.org=authority-person:74777</description>
		</name>
		<name type="personal" authority="umu" xlink:href="bowe0003">
			<namePart type="family">Weidung</namePart>
			<namePart type="given">Bodil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Geriatrik</affiliation>
			<affiliation>Department of Public Health and Caring Sciences, Geriatric Medicine, Uppsala University, Uppsala, Sweden</affiliation>
			<description>diva-portal.org=authority-person:64008</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jaol0001">
			<namePart type="family">Olsson</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för virologi</affiliation>
			<description>orcid.org=0000-0001-9094-319x</description>
			<description>diva-portal.org=authority-person:66622</description>
		</name>
		<name type="personal" authority="umu" xlink:href="majo4198">
			<namePart type="family">Josefsson</namePart>
			<namePart type="given">Maria</namePart>
			<namePart type="date">1979-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Enheten för demografi och åldrandeforskning (CEDAR)</affiliation>
			<description>diva-portal.org=authority-person:63470</description>
		</name>
		<name type="personal">
			<namePart type="family">Kok</namePart>
			<namePart type="given">Eloise</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anjo0002">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Anders</namePart>
			<namePart type="date">1955-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<affiliation>Aa-gruppen</affiliation>
			<description>orcid.org=0000-0002-8069-8263</description>
			<description>diva-portal.org=authority-person:62984</description>
		</name>
		<name type="corporate">
			<namePart>Aa-gruppen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="ster0022">
			<namePart type="family">Eriksson</namePart>
			<namePart type="given">Sture</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Geriatrik</affiliation>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<description>diva-portal.org=authority-person:62558</description>
		</name>
		<name type="personal" authority="umu" xlink:href="goha0001">
			<namePart type="family">Hallmans</namePart>
			<namePart type="given">Göran</namePart>
			<namePart type="date">1947-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<description>orcid.org=0000-0001-9581-3845</description>
			<description>diva-portal.org=authority-person:65436</description>
		</name>
		<name type="personal" authority="umu" xlink:href="frkelh76">
			<namePart type="family">Elgh</namePart>
			<namePart type="given">Fredrik</namePart>
			<namePart type="date">1957-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för virologi</affiliation>
			<description>diva-portal.org=authority-person:63226</description>
		</name>
		<name type="personal" authority="umu" xlink:href="huolom01">
			<namePart type="family">Lövheim</namePart>
			<namePart type="given">Hugo</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Geriatrik</affiliation>
			<affiliation>Umeå universitet, Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)</affiliation>
			<description>orcid.org=0000-0002-5271-4780</description>
			<description>diva-portal.org=authority-person:62947</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="774">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<namePart>Geriatrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881553">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk mikrobiologi</namePart>
			<namePart>Avdelningen för virologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="873307">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Enheten för demografi och åldrandeforskning (CEDAR)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881550">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Avdelningen för hållbar hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="880000">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex-associated Alzheimer's disease</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-13T13:10:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167226</identifier>
		<identifier type="doi">10.1016/j.trci.2019.09.014</identifier>
		<identifier type="pmid">31921962</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.trci.2019.09.014</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>APOEε4</topic>
		</subject>
		<subject lang="eng">
			<topic>Alzheimer's disease</topic>
		</subject>
		<subject lang="eng">
			<topic>Apolipoprotein E4</topic>
		</subject>
		<subject lang="eng">
			<topic>Dementia</topic>
		</subject>
		<subject lang="eng">
			<topic>HSV</topic>
		</subject>
		<subject lang="eng">
			<topic>Herpes simplex</topic>
		</subject>
		<subject lang="eng">
			<topic>Nested case-control study</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="302">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2108">
			<topic>medicinsk virologi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2108">
			<topic>Medical Virology</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Introduction: Herpes simplex virus type 1 (HSV1) in combination with genetic susceptibility has previously been implicated in Alzheimer's disease (AD) pathogenesis.&lt;/p&gt;&lt;p&gt;Methods: Plasma from 360 AD cases, obtained on average 9.6 years before diagnosis, and their age- and sex-matched controls, were analyzed for anti-HSV1 immunoglobulin (Ig) G with enzyme-linked immunosorbent assays (ELISAs). &lt;em&gt;A&lt;/em&gt;&lt;em&gt;POE&lt;/em&gt; genotype and nine other selected risk genes for AD were extracted from a genome-wide association study analysis by deCODE genetics, Reykjavik, Iceland.&lt;/p&gt;&lt;p&gt;Results: The interaction between &lt;em&gt;APOEε&lt;/em&gt;4 heterozygosity (&lt;em&gt;APOEε&lt;/em&gt;2&lt;em&gt;/ε&lt;/em&gt;4 or &lt;em&gt;ε&lt;/em&gt;3/&lt;em&gt;ε&lt;/em&gt;4) and anti-HSV1 IgG carriage increased the risk of AD (OR 4.55, &lt;em&gt;P&lt;/em&gt; = .02). A genetic risk score based on the nine AD risk genes also interacted with anti-HSV1 IgG for the risk of developing AD (OR 2.35, &lt;em&gt;P&lt;/em&gt; = .01).&lt;/p&gt;&lt;p&gt;Discussion: The present findings suggest that the &lt;em&gt;APOEε&lt;/em&gt;4 allele and other AD genetic risk factors might potentiate the risk of HSV1-associated AD.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<extent>
					<start>697</start>
					<end>704</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Alzheimer's &amp; dementia</title>
			</titleInfo>
			<identifier type="issn">1552-5279</identifier>
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<extent>
					<start>697</start>
					<end>704</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1385098/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>anjo0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-13</recordCreationDate>
			<recordChangeDate>2020-01-14</recordChangeDate>
			<recordIdentifier>diva2:1385098</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="maaret01">
			<namePart type="family">Rentoft</namePart>
			<namePart type="given">Matilda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:64075</description>
		</name>
		<name type="personal" authority="umu" xlink:href="dasw0002">
			<namePart type="family">Svensson</namePart>
			<namePart type="given">Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>orcid.org=0000-0002-4476-9255</description>
			<description>diva-portal.org=authority-person:71983</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anssjn96">
			<namePart type="family">Sjödin</namePart>
			<namePart type="given">Andreas</namePart>
			<namePart type="date">1976-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<affiliation>Division of CBRN Security and Defence, FOI–Swedish Defence Research Agency, SE Umeå, Sweden</affiliation>
			<description>diva-portal.org=authority-person:64652</description>
		</name>
		<name type="personal">
			<namePart type="family">Olason</namePart>
			<namePart type="given">Pall I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="olsj0002">
			<namePart type="family">Sjöström</namePart>
			<namePart type="given">Olle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<affiliation>Unit of research, education and development, Region Jämtland Härjedalen, SE Östersund, Sweden</affiliation>
			<description>diva-portal.org=authority-person:68591</description>
		</name>
		<name type="personal">
			<namePart type="family">Nylander</namePart>
			<namePart type="given">Carin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="pios0001">
			<namePart type="family">Osterman</namePart>
			<namePart type="given">Pia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:65721</description>
		</name>
		<name type="personal" authority="umu" xlink:href="risj0005">
			<namePart type="family">Sjögren</namePart>
			<namePart type="given">Rickard</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>orcid.org=0000-0001-7881-0968</description>
			<description>diva-portal.org=authority-person:70000</description>
		</name>
		<name type="personal" authority="umu" xlink:href="sene0006">
			<namePart type="family">Netotea</namePart>
			<namePart type="given">Sergiu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<affiliation>Science for Life Laboratory, Department of Biology and Biological Engineering, Chalmers University of Technology, SE Göteborg, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63059</description>
		</name>
		<name type="personal" authority="umu" xlink:href="caewim02">
			<namePart type="family">Wibom</namePart>
			<namePart type="given">Carl</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<description>diva-portal.org=authority-person:63434</description>
		</name>
		<name type="personal" authority="umu" xlink:href="krce0002">
			<namePart type="family">Cederquist</namePart>
			<namePart type="given">Kristina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Medicinsk och klinisk genetik</affiliation>
			<description>diva-portal.org=authority-person:65788</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anch0002">
			<namePart type="family">Chabes</namePart>
			<namePart type="given">Andrei</namePart>
			<namePart type="termsOfAddress">Professor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>orcid.org=0000-0003-1708-8259</description>
			<description>diva-portal.org=authority-person:64019</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jotr0001">
			<namePart type="family">Trygg</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>orcid.org=0000-0003-3799-6094</description>
			<description>diva-portal.org=authority-person:62586</description>
		</name>
		<name type="personal" authority="umu" xlink:href="bema0010">
			<namePart type="family">Melin</namePart>
			<namePart type="given">Beatrice S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<description>diva-portal.org=authority-person:62992</description>
		</name>
		<name type="personal" authority="umu" xlink:href="erjo0002">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:63203</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="791">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk kemi och biofysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="778">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<namePart>Onkologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="752">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<namePart>Medicinsk och klinisk genetik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Public Library of Science</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-10T14:34:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158021</identifier>
		<identifier type="doi">10.1371/journal.pone.0213350</identifier>
		<identifier type="pmid">30917156</identifier>
		<identifier type="isi">000462465800028</identifier>
		<identifier type="articleId">e0213350</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1371/journal.pone.0213350</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30107">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Medical Genetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30107">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Medicinsk genetik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. However, the vast number of genetic variants observed by this method constitutes a challenge when trying to identify the causal variants. This is often handled by restricting disease studies to the most damaging variants, e.g. those found in coding regions, and overlooking the remaining genetic variation. Such a biased approach explains in part why the genetic causes of many families with dominantly inherited diseases, in spite of being included in whole-genome sequencing studies, are left unsolved today. Here we explore the use of a geographically matched control population to minimize the number of candidate disease-causing variants without excluding variants based on assumptions on genomic position or functional predictions. To exemplify the benefit of the geographically matched control population we apply a typical disease variant filtering strategy in a family with an autosomal dominant form of colorectal cancer. With the use of the geographically matched control population we end up with 26 candidate variants genome wide. This is in contrast to the tens of thousands of candidates left when only making use of available public variant datasets. The effect of the local control population is dual, it (1) reduces the total number of candidate variants shared between affected individuals, and more importantly (2) increases the rate by which the number of candidate variants are reduced as additional affected family members are included in the filtering strategy. We demonstrate that the application of a geographically matched control population effectively limits the number of candidate disease-causing variants and may provide the means by which variants suitable for functional studies are identified genome wide.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>PLoS ONE</title>
			</titleInfo>
			<identifier type="issn">1932-6203</identifier>
			<identifier type="eissn">1932-6203</identifier>
			<part>
				<detail type="volume">
					<number>14</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse [2011.0042]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1303766/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>olsj0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-10</recordCreationDate>
			<recordChangeDate>2019-04-12</recordChangeDate>
			<recordIdentifier>diva2:1303766</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="ahho0002">
			<namePart type="family">Hosseini</namePart>
			<namePart type="given">Ahmad</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för datavetenskap</affiliation>
			<description>diva-portal.org=authority-person:68678</description>
		</name>
		<name type="personal">
			<namePart type="family">Lindroos</namePart>
			<namePart type="given">Ola</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Sveriges lantbruksuniversitet, Swedish University of Agricultural Sciences</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="edwa0002">
			<namePart type="family">Wadbro</namePart>
			<namePart type="given">Eddie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för datavetenskap</affiliation>
			<affiliation>Design Optimization</affiliation>
			<description>diva-portal.org=authority-person:63682</description>
		</name>
		<name type="corporate">
			<namePart>Design Optimization</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="863">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för datavetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A holistic optimization framework for forest machine trail network design accounting for multiple objectives and machines</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-14T16:35:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154287</identifier>
		<identifier type="doi">10.1139/cjfr-2018-0258</identifier>
		<identifier type="isi">000458033400001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="10199">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Other Mathematics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10199">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Annan matematik</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="40104">
			<topic>Agricultural and Veterinary sciences</topic>
			<topic>Agricultural Science, Forestry and Fisheries</topic>
			<topic>Forest Science</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="40104">
			<topic>Lantbruksvetenskap och veterinärmedicin</topic>
			<topic>Lantbruksvetenskap, skogsbruk och fiske</topic>
			<topic>Skogsvetenskap</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Ground-based mechanized forestry requires the traversal of terrain by heavy machines. The routes they take are often called machine trails, and are created by removing trees from the trail and placing the logs outside it. Designing an optimal machine trail network is a complex locational problem that requires understanding how forestry machines can operate on the terrain as well as the trade-offs between various economic and ecological aspects. Machine trail designs are currently created manually based on intuitive decisions about the importance, correlations, and effects of many potentially conflicting aspects. Badly designed machine trail networks could result in costly operations and adverse environmental impacts. Therefore, this study was conducted to develop a holistic optimization framework for machine trail network design. Key economic and ecological objectives involved in designing machine trail networks for mechanized cut-to-length operations are presented, along with strategies for simultaneously addressing multiple objectives while accounting for the physical capabilities of forestry machines, the impact of slope, and operating costs. Ways of quantitatively formulating and combining these different aspects are demonstrated, together with examples showing how the optimal network design changes in response to various inputs.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Canadian Journal of Forest Research</title>
			</titleInfo>
			<identifier type="issn">0045-5067</identifier>
			<identifier type="eissn">1208-6037</identifier>
			<part>
				<detail type="volume">
					<number>49</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
				<extent>
					<start>111</start>
					<end>120</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>edwa0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-14</recordCreationDate>
			<recordChangeDate>2019-02-20</recordChangeDate>
			<recordIdentifier>diva2:1270962</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Kleyko</namePart>
			<namePart type="given">Denis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Osipov</namePart>
			<namePart type="given">Evgeny</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="urwi0001">
			<namePart type="family">Wiklund</namePart>
			<namePart type="given">Urban</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<description>orcid.org=0000-0002-1313-0934</description>
			<description>diva-portal.org=authority-person:9897</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="776">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Hyperdimensional Computing Framework for Analysis of Cardiorespiratory Synchronization During Paced Deep Breathing</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Institute of Electrical and Electronics Engineers (IEEE)</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-08T10:45:01</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158768</identifier>
		<identifier type="doi">10.1109/ACCESS.2019.2904311</identifier>
		<identifier type="isi">000463487400001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Deep breathing test</topic>
		</subject>
		<subject lang="eng">
			<topic>deep breathing index</topic>
		</subject>
		<subject lang="eng">
			<topic>similarity analysis</topic>
		</subject>
		<subject lang="eng">
			<topic>heart rate variability</topic>
		</subject>
		<subject lang="eng">
			<topic>hyperdimensional computing</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20206">
			<topic>Engineering and Technology</topic>
			<topic>Electrical Engineering, Electronic Engineering, Information Engineering</topic>
			<topic>Computer Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20206">
			<topic>Teknik och teknologier</topic>
			<topic>Elektroteknik och elektronik</topic>
			<topic>Datorsystem</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Autonomic function during deep breathing (DB) is normally scored based on the assumption that the heart rate is synchronized with the breathing. We have observed individuals with subtle arrhythmias during DB, where an autonomic function cannot be evaluated. This paper presents a novel method for analyzing cardiorespiratory synchronization: feature-based analysis of the similarity between heart rate and respiration using the principles of hyperdimensional computing. Heart rate and respiration signals were modeled using Fourier series analysis. Three feature variables were derived and mapped to binary vectors in a high-dimensional space. Using both synthesized data and recordings from patients/healthy subjects, the similarity between the feature vectors was assessed using Hamming distance (high-dimensional space), Euclidean distance (original space), and with a coherence-based index. Methods were evaluated via the classification of the similarity indices into three groups. The distance-based methods achieved good separation of signals into classes with different degrees of cardiorespiratory synchronization, also providing identification of patients with low cardiorespiratory synchronization but high values of conventional DB scores. Moreover, binary high-dimensional vectors allowed an additional analysis of the obtained Hamming distance. Feature-based similarity analysis using hyperdimensional computing is capable of identifying signals with low cardiorespiratory synchronization during DB due to arrhythmias. Vector-based similarity analysis could be applied to other types of feature variables than based on spectral analysis. The proposed methods for robustly assessing cardiorespiratory synchronization during DB facilitate the identification of individuals where the evaluation of the autonomic function is problematic or even impossible, thus increasing the correctness of the conventional DB scores.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>IEEE Access</title>
			</titleInfo>
			<identifier type="eissn">2169-3536</identifier>
			<part>
				<detail type="volume">
					<number>7</number>
				</detail>
				<extent>
					<start>34403</start>
					<end>34415</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-08</recordCreationDate>
			<recordChangeDate>2019-05-08</recordChangeDate>
			<recordIdentifier>diva2:1314286</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="made0135">
			<namePart type="family">Deiana</namePart>
			<namePart type="given">Marco</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Sabourilab</affiliation>
			<description>diva-portal.org=authority-person:74005</description>
		</name>
		<name type="corporate">
			<namePart>Sabourilab</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kach0026">
			<namePart type="family">Chand</namePart>
			<namePart type="given">Karam</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:68443</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jaja0034">
			<namePart type="family">Jamroskovic</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Sabourilab</affiliation>
			<description>diva-portal.org=authority-person:62967</description>
		</name>
		<name type="corporate">
			<namePart>Sabourilab</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="ikob0001">
			<namePart type="family">Obi</namePart>
			<namePart type="given">Ikenna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Sabourilab</affiliation>
			<description>diva-portal.org=authority-person:65739</description>
		</name>
		<name type="corporate">
			<namePart>Sabourilab</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="erkchl00">
			<namePart type="family">Chorell</namePart>
			<namePart type="given">Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:62970</description>
		</name>
		<name type="personal" authority="umu" xlink:href="namsai01">
			<namePart type="family">Sabouri</namePart>
			<namePart type="given">Nasim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:62532</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="791">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk kemi och biofysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Light‐up Logic Platform for Selective Recognition of Parallel G‐Quadruplex Structures via Disaggregation‐Induced Emission</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Wiley-VCH Verlagsgesellschaft</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-25T13:48:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164662</identifier>
		<identifier type="doi">10.1002/anie.201912027</identifier>
		<identifier type="pmid">31644837</identifier>
		<identifier type="isi">000497789300001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="1">
			<topic>Natural Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="1">
			<topic>Naturvetenskap</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="3">
			<topic>Medical and Health Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="3">
			<topic>Medicin och hälsovetenskap</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2240">
			<topic>medicinsk biokemi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2240">
			<topic>Medical Biochemistry</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;The design of turn‐on dyes with optical signals sensitive to the formation of supramolecular structures provides fascinating and underexplored opportunities for G‐quadruplex (G4) DNA detection and characterization. Here, we show a new switching mechanism that relies on the recognition‐driven disaggregation (on‐signal) of an ultrabright coumarin‐quinazoline conjugate. The synthesized probe selectively lights‐up parallel G4 DNA structures via the disassembly of its supramolecular state, demonstrating outputs that are easily integrable into a label free molecular logic system. Finally, our molecule preferentially stains the G4‐rich nucleoli of cancer cells.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Angewandte Chemie International Edition</title>
			</titleInfo>
			<identifier type="issn">1433-7851</identifier>
			<identifier type="eissn">1521-3773</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse [KAW2015-0189]</note>
		<note type="funder">Vetenskapsrådet [VR-NT 2017-05235]</note>
		<note type="funder">Vetenskapsrådet [VR-MH 2018-02651]</note>
		<note type="funder">Kempestiftelserna [SMK-1632]</note>
		<recordInfo>
			<recordOrigin>namsai01</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-25</recordCreationDate>
			<recordChangeDate>2019-12-16</recordChangeDate>
			<recordIdentifier>diva2:1365659</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Lindgren</namePart>
			<namePart type="given">Petter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Myrtennäs</namePart>
			<namePart type="given">Kerstin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Forsman</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anjo0135">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Anders</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:63480</description>
		</name>
		<name type="personal" authority="umu" xlink:href="perstg96">
			<namePart type="family">Stenberg</namePart>
			<namePart type="given">Per</namePart>
			<namePart type="date">1974-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<affiliation>Department of Biological Agents, Division of CBRN Defence and Security, Swedish Defence Research Agency (FOI), SE-901 82 Umeå, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63395</description>
		</name>
		<name type="personal">
			<namePart type="family">Nordgaard</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ahlinder</namePart>
			<namePart type="given">Jon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="879">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för ekologi, miljö och geovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A likelihood ratio-based approach for improved source attribution in microbiological forensic investigations</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-09T09:10:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165758</identifier>
		<identifier type="doi">10.1016/j.forsciint.2019.06.027</identifier>
		<identifier type="pmid">31302416</identifier>
		<identifier type="isi">000496801100024</identifier>
		<identifier type="articleId">109869</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.forsciint.2019.06.027</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Microbial source tracking</topic>
		</subject>
		<subject lang="eng">
			<topic>Bayes factor</topic>
		</subject>
		<subject lang="eng">
			<topic>Hypothesis assessment</topic>
		</subject>
		<subject lang="eng">
			<topic>Listeria monocytogenes</topic>
		</subject>
		<subject lang="eng">
			<topic>Francisella tularensis</topic>
		</subject>
		<subject lang="eng">
			<topic>Likelihood ratio</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30501">
			<topic>Medical and Health Sciences</topic>
			<topic>Other Medical Sciences</topic>
			<topic>Forensic Science</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30501">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Annan medicin och hälsovetenskap</topic>
			<topic>Rättsmedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;A common objective in microbial forensic investigations is to identify the origin of a recovered pathogenic bacterium by DNA sequencing. However, there is currently no consensus about how degrees of belief in such origin hypotheses should be quantified, interpreted, and communicated to wider audiences. To fill this gap, we have developed a concept based on calculating probabilistic evidential values for microbial forensic hypotheses. The likelihood-ratio method underpinning this concept is widely used in other forensic fields, such as human DNA matching, where results are readily interpretable and have been successfully communicated in juridical hearings. The concept was applied to two case scenarios of interest in microbial forensics: (1) identifying source cultures among series of very similar cultures generated by parallel serial passage of the Tier 1 pathogen Francisella tularensis, and (2) finding the production facilities of strains isolated in a real disease outbreak caused by the human pathogen Listeria monocytogenes. Evidence values for the studied hypotheses were computed based on signatures derived from whole genome sequencing data, including deep-sequenced low-frequency variants and structural variants such as duplications and deletions acquired during serial passages. In the F. tularensis case study, we were able to correctly assign fictive evidence samples to the correct culture batches of origin on the basis of structural variant data. By setting up relevant hypotheses and using data on cultivated batch sources to define the reference populations under each hypothesis, evidential values could be calculated. The results show that extremely similar strains can be separated on the basis of amplified mutational patterns identified by high-throughput sequencing. In the L. monocytogenes scenario, analyses of whole genome sequence data conclusively assigned the clinical samples to specific sources of origin, and conclusions were formulated to facilitate communication of the findings. Taken together, these findings demonstrate the potential of using bacterial whole genome sequencing data, including data on both low frequency SNP signatures and structural variants, to calculate evidence values that facilitate interpretation and communication of the results. The concept could be applied in diverse scenarios, including both epidemiological and forensic source tracking of bacterial infectious disease outbreaks. &lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Forensic Science International</title>
			</titleInfo>
			<identifier type="issn">0379-0738</identifier>
			<identifier type="eissn">1872-6283</identifier>
			<part>
				<detail type="volume">
					<number>302</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Utrikespolitiska institutet [A4952]</note>
		<note type="funder">Försvarsmakten [A4040]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1376177/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-09</recordCreationDate>
			<recordChangeDate>2019-12-09</recordChangeDate>
			<recordIdentifier>diva2:1376177</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Junkai</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ouyang</namePart>
			<namePart type="given">Feiyi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="liho0001">
			<namePart type="family">Holm</namePart>
			<namePart type="given">Linus</namePart>
			<namePart type="date">1978-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>orcid.org=0000-0001-6105-2929</description>
			<description>diva-portal.org=authority-person:65619</description>
		</name>
		<name type="personal">
			<namePart type="family">Huang</namePart>
			<namePart type="given">Yingyu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gan</namePart>
			<namePart type="given">Lingyu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Liang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chao</namePart>
			<namePart type="given">Huizhen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Mengxue</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Sheng</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Bo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wu</namePart>
			<namePart type="given">Xiang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A mechanism of timing variability underlying the association between the mean and SD of asynchrony</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-28T10:21:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162789</identifier>
		<identifier type="doi">10.1016/j.humov.2019.102500</identifier>
		<identifier type="isi">000494888500003</identifier>
		<identifier type="articleId">102500</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>timing asynchrony motor control</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="5">
			<topic>Social Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="5">
			<topic>Samhällsvetenskap</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2148">
			<topic>Psychology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2148">
			<topic>psykologi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Sensorimotor timing behaviors typically exhibit an elusive phenomenon known as the negative asynchrony. When synchronizing movements (e.g. finger taps) with an external sequence (e.g. a metronome), people’s taps precede event onsets by a few tens of milliseconds. We recently reported that asynchrony is less negative in participants with lower asynchrony variability. This indicates an association between negative asynchrony and variability of timing. Here, in 24 metronome-synchronization data sets, we modeled asynchrony series using a sensorimotor synchronization model that accounts for serial dependence of asynchronies. The results showed that the modeling well captured the negative correlation between the mean and SD of asynchrony. The finding suggests that serial dependence in asynchronies is an essential mechanism of timing variability underlying the association between the mean and SD of asynchrony.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Human Movement Science</title>
			</titleInfo>
			<identifier type="issn">0167-9457</identifier>
			<identifier type="eissn">1872-7646</identifier>
			<part>
				<detail type="volume">
					<number>67</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>liho0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-28</recordCreationDate>
			<recordChangeDate>2019-11-26</recordChangeDate>
			<recordIdentifier>diva2:1346498</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Echim</namePart>
			<namePart type="given">M. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lamy</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Keyser</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maggiolo</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="hegu0051">
			<namePart type="family">Gunell</namePart>
			<namePart type="given">Herbert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<affiliation>Royal Belgian Institute for Space Aeronomy, Brussels, Belgium</affiliation>
			<description>orcid.org=0000-0001-5379-1158</description>
			<description>diva-portal.org=authority-person:67930</description>
		</name>
		<name type="personal">
			<namePart type="family">Wedlund</namePart>
			<namePart type="given">C. L. Simon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="866">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Method to Estimate the Physical Properties of Magnetospheric Generators From Observations of Quiet Discrete Auroral Arcs</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Geophysical Union (AGU)</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-09T13:19:29</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167089</identifier>
		<identifier type="doi">10.1029/2019JA026969</identifier>
		<identifier type="isi">000504543100001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>quiet auroral arcs</topic>
		</subject>
		<subject lang="eng">
			<topic>magnetosphere-ionosphere coupling</topic>
		</subject>
		<subject lang="eng">
			<topic>magnetospheric plasma interfaces</topic>
		</subject>
		<subject lang="eng">
			<topic>field-aligned currents</topic>
		</subject>
		<subject lang="eng">
			<topic>Vlasov equilibrium</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10303">
			<topic>Natural Sciences</topic>
			<topic>Physical Sciences</topic>
			<topic>Fusion, Plasma and Space Physics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10303">
			<topic>Naturvetenskap</topic>
			<topic>Fysik</topic>
			<topic>Fusion, plasma och rymdfysik</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10305">
			<topic>Natural Sciences</topic>
			<topic>Physical Sciences</topic>
			<topic>Astronomy, Astrophysics and Cosmology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10305">
			<topic>Naturvetenskap</topic>
			<topic>Fysik</topic>
			<topic>Astronomi, astrofysik och kosmologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;We discuss a method to estimate the properties of a magnetospheric generator using a quasi-electrostatic magnetosphere-ionosphere coupling model and in situ or remote sensing observations of discrete quiet arcs. We first construct an ensemble of Vlasov equilibrium solutions for generator structures formed at magnetospheric plasma interfaces. For each generator solution, we compute the ionospheric electric potential from the current continuity equation. Thus, we estimate the field-aligned potential drop that allows us to assess several properties of the discrete auroral arc, such as the field-aligned potential difference, the field-aligned current density, the flux of precipitating energy, and the height-integrated Pedersen conductance. A minimization procedure based on comparing the numerical results with observations is defined and applied to find which solution of the current continuity equation and which generator model give auroral arc properties that best fit the observations. The procedure is validated in a case study with observations by DMSP and Cluster and can be generalized to other types of data.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Geophysical Research - Space Physics</title>
			</titleInfo>
			<identifier type="issn">2169-9380</identifier>
			<identifier type="eissn">2169-9402</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-09</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1384158</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="anka0381">
			<namePart type="family">Kawde</namePart>
			<namePart type="given">Anurag</namePart>
			<namePart type="date">1984-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<affiliation>European Synchrotron Radiation Facility (ESRF), Grenoble, France</affiliation>
			<description>orcid.org=0000-0002-5027-9199</description>
			<description>diva-portal.org=authority-person:68366</description>
		</name>
		<name type="personal" authority="umu" xlink:href="alan0060">
			<namePart type="family">Annamalai</namePart>
			<namePart type="given">Alagappan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>orcid.org=0000-0002-5210-2645</description>
			<description>diva-portal.org=authority-person:63637</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anse0001">
			<namePart type="family">Sellstedt</namePart>
			<namePart type="given">Anita</namePart>
			<namePart type="date">1953-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:62529</description>
		</name>
		<name type="personal">
			<namePart type="family">Glatzel</namePart>
			<namePart type="given">Pieter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="thwa0002">
			<namePart type="family">Wågberg</namePart>
			<namePart type="given">Thomas</namePart>
			<namePart type="date">1971-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>orcid.org=0000-0002-5080-8273</description>
			<description>diva-portal.org=authority-person:63788</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jome0007">
			<namePart type="family">Messinger</namePart>
			<namePart type="given">Johannes</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<affiliation>Molecular Biomimetics, Department of Chemistry, Ångström Laboratory, Uppsala University, Sweden</affiliation>
			<description>diva-portal.org=authority-person:62751</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="866">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="867">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysiologisk botanik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="874">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Umeå Plant Science Centre (UPSC)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A microstructured p-Si photocathode outcompetes Pt as a counter electrode to hematite in photoelectrochemical water-splitting</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Royal Society of Chemistry</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-11-20T09:42:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-153415</identifier>
		<identifier type="doi">10.1039/c8dt03653e</identifier>
		<identifier type="pmid">30534760</identifier>
		<identifier type="isi">000459625900002</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1039/c8dt03653e</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="10403">
			<topic>Natural Sciences</topic>
			<topic>Chemical Sciences</topic>
			<topic>Materials Chemistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10403">
			<topic>Naturvetenskap</topic>
			<topic>Kemi</topic>
			<topic>Materialkemi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Herein, we communicate about an Earth-abundant semiconductor photocathode (p-Si/TiO&lt;sub&gt;2&lt;/sub&gt;/NiO&lt;sub&gt;x&lt;/sub&gt;) as an alternative for the rare and expensive Pt as a counter electrode for overall photoelectrochemical water splitting. The proposed photoelectrochemical (PEC) water-splitting device mimics the "Z"-scheme observed in natural photosynthesis by combining two photoelectrodes in a parallelillumination mode. A nearly 60% increase in the photocurrent density (J&lt;sub&gt;ph&lt;/sub&gt;) for pristine α-Fe&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;3 &lt;/sub&gt;and a 77% increase in the applied bias photocurrent efficiency (ABPE) were achieved by replacing the conventionally used Pt cathode with an efficient, cost effective p-Si/TiO&lt;sub&gt;2&lt;/sub&gt;/NiO&lt;sub&gt;x&lt;/sub&gt; photocathode under parallel illumination. The resulting photocurrent density of 1.26 mA cm&lt;sup&gt;−2&lt;/sup&gt; at 1.23V&lt;sub&gt;RHE&lt;/sub&gt; represents a new record performance for hydrothermally grown pristine α-Fe&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;3&lt;/sub&gt; nanorod photoanodes in combination with a photocathode, which opens the prospect for further improvement by doping α-Fe&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;3&lt;/sub&gt; or by its decoration with co-catalysts. Electrochemical impedance spectroscopy measurements suggest that this significant performance increase is due to the enhancement of the space-charge field in α-Fe&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;3. &lt;/sub&gt;&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Dalton Transactions</title>
			</titleInfo>
			<identifier type="issn">1477-9226</identifier>
			<identifier type="eissn">1477-9234</identifier>
			<part>
				<detail type="volume">
					<number>48</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>1166</start>
					<end>1170</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1264349/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-11-20</recordCreationDate>
			<recordChangeDate>2019-03-27</recordChangeDate>
			<recordIdentifier>diva2:1264349</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<genre authority="diva" type="publicationSubTypeCode">letter</genre>
		<name type="personal" authority="umu" xlink:href="miot0002">
			<namePart type="family">Ott</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0003-2393-9750</description>
			<description>diva-portal.org=authority-person:63313</description>
		</name>
		<name type="personal" authority="umu" xlink:href="urwe0002">
			<namePart type="family">Werneke</namePart>
			<namePart type="given">Ursula</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Psykiatri</affiliation>
			<affiliation>Sunderby Research Unit</affiliation>
			<description>orcid.org=0000-0002-5023-3254</description>
			<description>diva-portal.org=authority-person:63314</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="740">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Psykiatri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Lippincott Williams &amp; Wilkins</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-17T10:19:55</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159616</identifier>
		<identifier type="doi">10.1097/PEC.0000000000001830</identifier>
		<identifier type="pmid">30964850</identifier>
		<identifier type="isi">000467740700007</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30221">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Pediatrics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30221">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Pediatrik</topic>
		</subject>
		<relatedItem type="host">
			<titleInfo>
				<title>Pediatric emergency care</title>
			</titleInfo>
			<identifier type="issn">0749-5161</identifier>
			<identifier type="eissn">1535-1815</identifier>
			<part>
				<detail type="volume">
					<number>35</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>E98</start>
					<end>E98</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-17</recordCreationDate>
			<recordChangeDate>2019-06-17</recordChangeDate>
			<recordIdentifier>diva2:1325715</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="gujo0010">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Gudrun M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Fysioterapi</affiliation>
			<description>diva-portal.org=authority-person:62544</description>
		</name>
		<name type="personal" authority="umu" xlink:href="chha0003">
			<namePart type="family">Häger</namePart>
			<namePart type="given">Charlotte K.</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Fysioterapi</affiliation>
			<description>orcid.org=0000-0002-0366-4609</description>
			<description>diva-portal.org=authority-person:62538</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="15650">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<namePart>Fysioterapi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A modified standardized nine hole peg test for valid and reliable kinematic assessment of dexterity post-stroke</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-18T13:44:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155494</identifier>
		<identifier type="doi">10.1186/s12984-019-0479-y</identifier>
		<identifier type="pmid">30642350</identifier>
		<identifier type="isi">000455641600001</identifier>
		<identifier type="articleId">8</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12984-019-0479-y</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Clinical laboratory techniques</topic>
		</subject>
		<subject lang="eng">
			<topic>Outcome assessment</topic>
		</subject>
		<subject lang="eng">
			<topic>Stroke</topic>
		</subject>
		<subject lang="eng">
			<topic>Upper extremity</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30307">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Physiotherapy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30307">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Sjukgymnastik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;&lt;strong&gt;BACKGROUND:&lt;/strong&gt; Impairments in dexterity after stroke are commonly assessed by the Nine Hole Peg Test (NHPT), where the only outcome variable is the time taken to complete the test. We aimed to kinematically quantify and to compare the motor performance of the NHPT in persons post-stroke and controls (discriminant validity), to compare kinematics to clinical assessments of upper extremity function (convergent validity), and to establish the within-session reliability.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;METHODS:&lt;/strong&gt; The NHPT was modified and standardized (S-NHPT) by 1) replacing the original peg container with an additional identical nine hole pegboard, 2) adding a specific order of which peg to pick, and 3) specifying to insert the peg taken from the original pegboard into the corresponding hole of the target pegboard. Eight optical cameras registered upper body kinematics of 30 persons post-stroke and 41 controls during the S-NHPT. Four sequential phases of the task were identified and analyzed for kinematic group differences. Clinical assessments were performed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;RESULTS:&lt;/strong&gt; The stroke group performed the S-NHPT slower (total movement time; mean diff 9.8 s, SE diff 1.4), less smoothly (number of movement units; mean diff 0.4, SE diff 0.1) and less efficiently (path ratio; mean diff 0.05, SE diff 0.02), and used increased scapular/trunk movements (acromion displacement; mean diff 15.7 mm, SE diff 3.5) than controls (P &amp;lt; 0.000, r ≥ 0.32), indicating discriminant validity. The stroke group also spent a significantly longer time grasping and releasing pegs relative to the transfer phases of the task compared to controls. Within the stroke group, kinematics correlated with time to complete the S-NHPT and the Fugl-Meyer Assessment (r&lt;sub&gt;s&lt;/sub&gt; 0.38-0.70), suggesting convergent validity. Within-session reliability for the S-NHPT was generally high to very high for both groups (ICCs 0.71-0.94).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;CONCLUSIONS:&lt;/strong&gt; The S-NHPT shows adequate discriminant validity, convergent validity and within-session reliability. Standardization of the test facilitates kinematic analysis of movement performance, which in turn enables identification of differences in movement control between persons post-stroke and controls that may otherwise not be captured through the traditional time-based NHPT. Future research should ascertain further psychometric properties, e.g. sensitivity, of the S-NHPT.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of NeuroEngineering and Rehabilitation</title>
			</titleInfo>
			<identifier type="issn">1743-0003</identifier>
			<identifier type="eissn">1743-0003</identifier>
			<part>
				<detail type="volume">
					<number>16</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Västerbottens läns landsting</note>
		<note type="funder">Hjärnfonden</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1280305/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>thenin01</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-18</recordCreationDate>
			<recordChangeDate>2019-02-08</recordChangeDate>
			<recordIdentifier>diva2:1280305</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="abla0005">
			<namePart type="family">Lakehal</namePart>
			<namePart type="given">Abdellah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:68627</description>
		</name>
		<name type="personal" authority="umu" xlink:href="sach0010">
			<namePart type="family">Chaabouni</namePart>
			<namePart type="given">Salma</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:66070</description>
		</name>
		<name type="personal" authority="umu" xlink:href="emca0018">
			<namePart type="family">Cavel</namePart>
			<namePart type="given">Emilie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:66069</description>
		</name>
		<name type="personal">
			<namePart type="family">Le Hir</namePart>
			<namePart type="given">Rozenn</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="alra0028">
			<namePart type="family">Ranjan</namePart>
			<namePart type="given">Alok</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:68628</description>
		</name>
		<name type="personal" authority="umu" xlink:href="zara0006">
			<namePart type="family">Rahneshan</namePart>
			<namePart type="given">Zahra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:69744</description>
		</name>
		<name type="personal">
			<namePart type="family">Novák</namePart>
			<namePart type="given">Ondřej</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="dapa0011">
			<namePart type="family">Pacurar</namePart>
			<namePart type="given">Daniel I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:65954</description>
		</name>
		<name type="personal" authority="umu" xlink:href="irpe0004">
			<namePart type="family">Perrone</namePart>
			<namePart type="given">Irene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:66068</description>
		</name>
		<name type="personal">
			<namePart type="family">Jobert</namePart>
			<namePart type="given">François</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gutierrez</namePart>
			<namePart type="given">Laurent</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="laba0001">
			<namePart type="family">Bako</namePart>
			<namePart type="given">Laszlo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>diva-portal.org=authority-person:62705</description>
		</name>
		<name type="personal" authority="umu" xlink:href="cabe0042">
			<namePart type="family">Bellini</namePart>
			<namePart type="given">Catherine</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<description>orcid.org=0000-0003-2985-6649</description>
			<description>diva-portal.org=authority-person:64218</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="867">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysiologisk botanik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="874">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Umeå Plant Science Centre (UPSC)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Molecular Framework for the Control of Adventitious Rooting by TIR1/AFB2-Aux/IAA-Dependent Auxin Signaling in Arabidopsis</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-05T13:42:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164949</identifier>
		<identifier type="doi">10.1016/j.molp.2019.09.001</identifier>
		<identifier type="pmid">31520787</identifier>
		<identifier type="isi">000494946400011</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Arabidopsis</topic>
		</subject>
		<subject lang="eng">
			<topic>AuxIAA</topic>
		</subject>
		<subject lang="eng">
			<topic>TIR1/AFB</topic>
		</subject>
		<subject lang="eng">
			<topic>adventitious roots</topic>
		</subject>
		<subject lang="eng">
			<topic>jasmonate</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10614">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Developmental Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10614">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Utvecklingsbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;In Arabidopsis thaliana, canonical auxin-dependent gene regulation is mediated by 23 transcription factors from the AUXIN RESPONSE FACTOR (ARF) family that interact with auxin/indole acetic acid repressors (Aux/IAAs), which themselves form co-receptor complexes with one of six TRANSPORT INHIBITOR1/AUXIN-SIGNALLING F-BOX (TIR1/AFB) proteins. Different combinations of co-receptors drive specific sensing outputs, allowing auxin to control a myriad of processes. ARF6 and ARF8 are positive regulators of adventitious root initiation upstream of jasmonate, but the exact auxin co-receptor complexes controlling the transcriptional activity of these proteins has remained unknown. Here, using loss-of-function mutants we show that three Aux/IAA genes, IAA6, IAA9, and IAA17, act additively in the control of adventitious root (AR) initiation. These three IAA proteins interact with ARF6 and/or ARF8 and likely repress their activity in AR development. We show that TIR1 and AFB2 are positive regulators of AR formation and TIR1 plays a dual role in the control of jasmonic acid (JA) biosynthesis and conjugation, as several JA biosynthesis genes are up-regulated in the tir1-1 mutant. These results lead us to propose that in the presence of auxin, TIR1 and AFB2 form specific sensing complexes with IAA6, IAA9, and/or IAA17 to modulate JA homeostasis and control AR initiation.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Molecular Plant</title>
			</titleInfo>
			<identifier type="issn">1674-2052</identifier>
			<identifier type="eissn">1752-9867</identifier>
			<part>
				<detail type="volume">
					<number>12</number>
				</detail>
				<detail type="issue">
					<number>11</number>
				</detail>
				<extent>
					<start>1499</start>
					<end>1514</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Vinnova</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse</note>
		<note type="funder">Carl Tryggers stiftelse för vetenskaplig forskning </note>
		<note type="funder">Kempestiftelserna</note>
		<recordInfo>
			<recordOrigin>abla0005</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-05</recordCreationDate>
			<recordChangeDate>2019-11-26</recordChangeDate>
			<recordIdentifier>diva2:1367961</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Mohammadi</namePart>
			<namePart type="given">Marzieh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shafiei</namePart>
			<namePart type="given">Marzieh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Abdolmaleki</namePart>
			<namePart type="given">Amir</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Karimi</namePart>
			<namePart type="given">Keikhosro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jymi0001">
			<namePart type="family">Mikkola</namePart>
			<namePart type="given">Jyri-Pekka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<affiliation>Industrial Chemistry &amp; Reaction Engineering, Johan Gadolin Process Chemistry Centre, Åbo Akademi University, Åbo-Turku, Finland</affiliation>
			<affiliation>Bio4Energy</affiliation>
			<description>diva-portal.org=authority-person:62811</description>
		</name>
		<name type="corporate">
			<namePart>Bio4Energy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Christer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A morpholinium ionic liquid for rice straw pretreatment to enhance ethanol production</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-05T14:09:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161787</identifier>
		<identifier type="doi">10.1016/j.indcrop.2019.111494</identifier>
		<identifier type="isi">000484646900063</identifier>
		<identifier type="scopus">2-s2.0-85067492224</identifier>
		<identifier type="articleId">111494</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Ethanol</topic>
		</subject>
		<subject lang="eng">
			<topic>Hydrolysis</topic>
		</subject>
		<subject lang="eng">
			<topic>Morpholinium ionic liquid</topic>
		</subject>
		<subject lang="eng">
			<topic>Rice straw</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20904">
			<topic>Engineering and Technology</topic>
			<topic>Industrial Biotechnology</topic>
			<topic>Bioenergy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20904">
			<topic>Teknik och teknologier</topic>
			<topic>Industriell bioteknik</topic>
			<topic>Bioenergi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Rice straw was successfully pretreated with a novel and inexpensive morpholinium ionic liquid, 1-H-3-methylmorpholinium chloride ([HMMorph][Cl]). The influence of water (30, 40, 50% w/w) and dimethyl sulfoxide (DMSO) (10, 30% w/w), as co-solvents, pretreatment time (2, 3, 5 h), temperature (90, 105, 120 °C), solid loading (5, 6.7, 10% w/w), and straw particle size (&amp;lt;0.177, 0.177–0.841 mm, and 0.841–2 mm) were investigated for maximum ethanol production. The best results were obtained in 50% water, at 120 °C and 5% (w/w) solid loading for 5 h from 0.177 – 0.841 mm straw particles. The hydrolysis yield was increased from 33.2% to 70.1%, while ethanol production yield was improved from 21.9% to 64% of the theoretical maximum. The performance of the IL was comparable to 1-ethyl-3-methylimidazolium acetate. Simple synthesis process and dilute solution required for the pretreatment with [HMMorph][Cl] offers cost reductions in the use of ILs in biofuel production.&lt;/p&gt;</abstract>
		<note type="project">Bio4Energy</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Industrial crops and products (Print)</title>
			</titleInfo>
			<identifier type="issn">0926-6690</identifier>
			<identifier type="eissn">1872-633X</identifier>
			<part>
				<detail type="volume">
					<number>139</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>sast0019</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-05</recordCreationDate>
			<recordChangeDate>2019-11-13</recordChangeDate>
			<recordIdentifier>diva2:1340465</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="anah0094">
			<namePart type="family">Åhman</namePart>
			<namePart type="given">Annika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Obstetrik och gynekologi</affiliation>
			<description>diva-portal.org=authority-person:62392</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kraedn92">
			<namePart type="family">Edvardsson</namePart>
			<namePart type="given">Kristina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Obstetrik och gynekologi</affiliation>
			<affiliation>Judith Lumley Centre, La Trobe University, Melbourne, Victoria, Australia</affiliation>
			<description>orcid.org=0000-0001-6883-3664</description>
			<description>diva-portal.org=authority-person:62631</description>
		</name>
		<name type="personal">
			<namePart type="family">Fagerli</namePart>
			<namePart type="given">Tove Anita</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Darj</namePart>
			<namePart type="given">Elisabeth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="soahnd04">
			<namePart type="family">Holmlund</namePart>
			<namePart type="given">Sophia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Obstetrik och gynekologi</affiliation>
			<description>orcid.org=0000-0003-3391-2308</description>
			<description>diva-portal.org=authority-person:68086</description>
		</name>
		<name type="personal">
			<namePart type="family">Small</namePart>
			<namePart type="given">Rhonda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="inmo0001">
			<namePart type="family">Mogren</namePart>
			<namePart type="given">Ingrid</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Obstetrik och gynekologi</affiliation>
			<affiliation>Judith Lumley Centre, La Trobe University, Melbourne, Victoria, Australia</affiliation>
			<description>diva-portal.org=authority-person:62393</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="743">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Obstetrik och gynekologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A much valued tool that also brings ethical dilemmas</title>
			<subTitle>a qualitative study of Norwegian midwives' experiences and views on the role of obstetric ultrasound</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-04T10:52:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162773</identifier>
		<identifier type="doi">10.1186/s12884-019-2178-x</identifier>
		<identifier type="pmid">30651083</identifier>
		<identifier type="isi">000455891900001</identifier>
		<identifier type="articleId">33</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12884-019-2178-x</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Pregnancy</topic>
		</subject>
		<subject lang="eng">
			<topic>Ultrasonography</topic>
		</subject>
		<subject lang="eng">
			<topic>Midwives</topic>
		</subject>
		<subject lang="eng">
			<topic>Qualitative research</topic>
		</subject>
		<subject lang="eng">
			<topic>Norway</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30220">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Obstetrics, Gynecology and Reproductive Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30220">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Reproduktionsmedicin och gynekologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Midwives are the main providers of routine antenatal care services including the routine ultrasound examination in Norway. The ultrasound examination can be perceived by expectant parents not only as a medical examination but also as a social event facilitating attachment to their fetus. This study explores Norwegian midwives' experiences and views on the role of ultrasound in clinical management of pregnancy.&lt;/p&gt;&lt;p&gt;Methods: A qualitative study design was applied. Twenty-four midwives who all performed obstetric ultrasound examinations were recruited for focus group discussions and individual interviews. Data collection took place in 2015 in five hospitals in two different regions of Norway. Data were analyzed using qualitative content analysis.&lt;/p&gt;&lt;p&gt;Results: Midwives described obstetric ultrasound examinations as very valuable although doing ultrasounds placed high demands on their operational and counselling skills. Increasing requests for ultrasound from pregnant women were mentioned. Advancements in ultrasound diagnosis were considered to have put the fetus in the position of a patient, and that pregnant women declining ultrasound could be viewed as irresponsible by some health professionals. Ethical concerns were raised regarding the possibility of pregnancy termination when fetal anomalies were detected. Fears were also expressed that prenatal diagnoses including those following ultrasound, might create a society where only perfect' children are valued. However, participants stressed that their intention in performing ultrasound was to optimize pregnancy outcome and thereby assist expectant couples and their unborn children.&lt;/p&gt;&lt;p&gt;Conclusions: Midwives in Norwegian maternity care services describe obstetric ultrasound as very valuable, playing a central role in pregnancy management by optimizing pregnancy outcomes. Although high demands are placed on operators' technical skills and counseling, midwives described performing obstetric ultrasound as very satisfying work. However, midwives believed that expectant parents' approach to the ultrasound examination, both its medical value and the precious images obtained of the fetus, could put extra strain on the midwives performing ultrasounds. The potential of ultrasound to detect fetal anomalies and the possibility that this may lead to termination of pregnancy, seemed to create some ambivalent feelings in midwives towards its use.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>BMC Pregnancy and Childbirth</title>
			</titleInfo>
			<identifier type="issn">1471-2393</identifier>
			<identifier type="eissn">1471-2393</identifier>
			<part>
				<detail type="volume">
					<number>19</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1348390/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-04</recordCreationDate>
			<recordChangeDate>2019-09-04</recordChangeDate>
			<recordIdentifier>diva2:1348390</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Sung</namePart>
			<namePart type="given">Yun Ju</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Las Fuentes</namePart>
			<namePart type="given">Lisa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Winkler</namePart>
			<namePart type="given">Thomas W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chasman</namePart>
			<namePart type="given">Daniel, I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bentley</namePart>
			<namePart type="given">Amy R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kraja</namePart>
			<namePart type="given">Aldi T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ntalla</namePart>
			<namePart type="given">Ioanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Warren</namePart>
			<namePart type="given">Helen R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guo</namePart>
			<namePart type="given">Xiuqing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schwander</namePart>
			<namePart type="given">Karen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Manning</namePart>
			<namePart type="given">Alisa K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brown</namePart>
			<namePart type="given">Michael R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aschard</namePart>
			<namePart type="given">Hugues</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Feitosa</namePart>
			<namePart type="given">Mary F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0933-2410</description>
		</name>
		<name type="personal">
			<namePart type="family">Franceschini</namePart>
			<namePart type="given">Nora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lu</namePart>
			<namePart type="given">Yingchang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cheng</namePart>
			<namePart type="given">Ching-Yu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sim</namePart>
			<namePart type="given">Xueling</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vojinovic</namePart>
			<namePart type="given">Dina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-5744-0232</description>
		</name>
		<name type="personal">
			<namePart type="family">Marten</namePart>
			<namePart type="given">Jonathan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Musani</namePart>
			<namePart type="given">Solomon K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kilpelainen</namePart>
			<namePart type="given">Tuomas O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Richard</namePart>
			<namePart type="given">Melissa A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aslibekyan</namePart>
			<namePart type="given">Stella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bartz</namePart>
			<namePart type="given">Traci M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dorajoo</namePart>
			<namePart type="given">Rajkumar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Li</namePart>
			<namePart type="given">Changwei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liu</namePart>
			<namePart type="given">Yongmei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rankinen</namePart>
			<namePart type="given">Tuomo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Smith</namePart>
			<namePart type="given">Albert Vernon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1942-5845</description>
		</name>
		<name type="personal">
			<namePart type="family">Tajuddin</namePart>
			<namePart type="given">Salman M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-7919-8528</description>
		</name>
		<name type="personal">
			<namePart type="family">Tayo</namePart>
			<namePart type="given">Bamidele O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhao</namePart>
			<namePart type="given">Wei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Yanhua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Matoba</namePart>
			<namePart type="given">Nana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sofer</namePart>
			<namePart type="given">Tamar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-8520-8860</description>
		</name>
		<name type="personal">
			<namePart type="family">Alver</namePart>
			<namePart type="given">Maris</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amini</namePart>
			<namePart type="given">Marzyeh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boissel</namePart>
			<namePart type="given">Mathilde</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-5719-8749</description>
		</name>
		<name type="personal">
			<namePart type="family">Chai</namePart>
			<namePart type="given">Jin Fang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Xu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-7299-3238</description>
		</name>
		<name type="personal">
			<namePart type="family">Divers</namePart>
			<namePart type="given">Jasmin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gandin</namePart>
			<namePart type="given">Ilaria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gao</namePart>
			<namePart type="given">Chuan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giulianini</namePart>
			<namePart type="given">Franco</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goel</namePart>
			<namePart type="given">Anuj</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2307-4021</description>
		</name>
		<name type="personal">
			<namePart type="family">Harris</namePart>
			<namePart type="given">Sarah E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hartwig</namePart>
			<namePart type="given">Fernando P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">He</namePart>
			<namePart type="given">Meian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Horimoto</namePart>
			<namePart type="given">Andrea R. V. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hsu</namePart>
			<namePart type="given">Fang-Chi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jackson</namePart>
			<namePart type="given">Anne U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kammerer</namePart>
			<namePart type="given">Candace M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kasturiratne</namePart>
			<namePart type="given">Anuradhani</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Komulainen</namePart>
			<namePart type="given">Pirjo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuehnel</namePart>
			<namePart type="given">Brigitte</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Leander</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lee</namePart>
			<namePart type="given">Wen-Jane</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lin</namePart>
			<namePart type="given">Keng-Hung</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Luan</namePart>
			<namePart type="given">Jian'an</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lyytikainen</namePart>
			<namePart type="given">Leo-Pekka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">McKenzie</namePart>
			<namePart type="given">Colin A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nelson</namePart>
			<namePart type="given">Christopher P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Noordam</namePart>
			<namePart type="given">Raymond</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scott</namePart>
			<namePart type="given">Robert A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sheu</namePart>
			<namePart type="given">Wayne H. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stancakova</namePart>
			<namePart type="given">Alena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Takeuchi</namePart>
			<namePart type="given">Fumihiko</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Der Most</namePart>
			<namePart type="given">Peter J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Varga</namePart>
			<namePart type="given">Tibor V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-2383-699X</description>
		</name>
		<name type="personal">
			<namePart type="family">Waken</namePart>
			<namePart type="given">Robert J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Heming</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Yajuan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ware</namePart>
			<namePart type="given">Erin B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Weiss</namePart>
			<namePart type="given">Stefan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wen</namePart>
			<namePart type="given">Wanqing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yanek</namePart>
			<namePart type="given">Lisa R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Weihua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhao</namePart>
			<namePart type="given">Jing Hua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Afaq</namePart>
			<namePart type="given">Saima</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Alfred</namePart>
			<namePart type="given">Tamuno</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amin</namePart>
			<namePart type="given">Najaf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arking</namePart>
			<namePart type="given">Dan E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aung</namePart>
			<namePart type="given">Tin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barr</namePart>
			<namePart type="given">R. Graham</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bielak</namePart>
			<namePart type="given">Lawrence F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boerwinkle</namePart>
			<namePart type="given">Eric</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bottinger</namePart>
			<namePart type="given">Erwin P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Braund</namePart>
			<namePart type="given">Peter S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brody</namePart>
			<namePart type="given">Jennifer A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Broeckel</namePart>
			<namePart type="given">Ulrich</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cade</namePart>
			<namePart type="given">Brian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1424-0673</description>
		</name>
		<name type="personal">
			<namePart type="family">Campbell</namePart>
			<namePart type="given">Archie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Canouil</namePart>
			<namePart type="given">Mickael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-3396-4549</description>
		</name>
		<name type="personal">
			<namePart type="family">Chakravarti</namePart>
			<namePart type="given">Aravinda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cocca</namePart>
			<namePart type="given">Massimiliano</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Collins</namePart>
			<namePart type="given">Francis S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Connell</namePart>
			<namePart type="given">John M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Mutsert</namePart>
			<namePart type="given">Renee</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Silva</namePart>
			<namePart type="given">H. Janaka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Doerr</namePart>
			<namePart type="given">Marcus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Duan</namePart>
			<namePart type="given">Qing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Eaton</namePart>
			<namePart type="given">Charles B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ehret</namePart>
			<namePart type="given">Georg</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Evangelou</namePart>
			<namePart type="given">Evangelos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Faul</namePart>
			<namePart type="given">Jessica D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Forouhi</namePart>
			<namePart type="given">Nita G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Franco</namePart>
			<namePart type="given">Oscar H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Friedlander</namePart>
			<namePart type="given">Yechiel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gao</namePart>
			<namePart type="given">He</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gigante</namePart>
			<namePart type="given">Bruna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gu</namePart>
			<namePart type="given">C. Charles</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gupta</namePart>
			<namePart type="given">Preeti</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hagenaars</namePart>
			<namePart type="given">Saskia P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Harris</namePart>
			<namePart type="given">Tamara B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">He</namePart>
			<namePart type="given">Jiang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Heikkinen</namePart>
			<namePart type="given">Sami</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Heng</namePart>
			<namePart type="given">Chew-Kiat</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hofman</namePart>
			<namePart type="given">Albert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Howard</namePart>
			<namePart type="given">Barbara, V</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hunt</namePart>
			<namePart type="given">Steven C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Irvin</namePart>
			<namePart type="given">Marguerite R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jia</namePart>
			<namePart type="given">Yucheng</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Katsuya</namePart>
			<namePart type="given">Tomohiro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaufman</namePart>
			<namePart type="given">Joel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kerrison</namePart>
			<namePart type="given">Nicola D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Khor</namePart>
			<namePart type="given">Chiea Chuen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Koh</namePart>
			<namePart type="given">Woon-Puay</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Koistinen</namePart>
			<namePart type="given">Heikki A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kooperberg</namePart>
			<namePart type="given">Charles B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Krieger</namePart>
			<namePart type="given">Jose E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kubo</namePart>
			<namePart type="given">Michiaki</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kutalik</namePart>
			<namePart type="given">Zoltan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuusisto</namePart>
			<namePart type="given">Johanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lakka</namePart>
			<namePart type="given">Timo A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Langefeld</namePart>
			<namePart type="given">Carl D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Langenberg</namePart>
			<namePart type="given">Claudia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Launer</namePart>
			<namePart type="given">Lenore J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lee</namePart>
			<namePart type="given">Joseph H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lehne</namePart>
			<namePart type="given">Benjamin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Levy</namePart>
			<namePart type="given">Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lewis</namePart>
			<namePart type="given">Cora E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Li</namePart>
			<namePart type="given">Yize</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1074-281X</description>
		</name>
		<name type="personal">
			<namePart type="family">Lim</namePart>
			<namePart type="given">Sing Hui</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liu</namePart>
			<namePart type="given">Ching-Ti</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liu</namePart>
			<namePart type="given">Jianjun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liu</namePart>
			<namePart type="given">Jingmin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liu</namePart>
			<namePart type="given">Yeheng</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Loh</namePart>
			<namePart type="given">Marie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lohman</namePart>
			<namePart type="given">Kurt K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Louie</namePart>
			<namePart type="given">Tin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Magi</namePart>
			<namePart type="given">Reedik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Matsuda</namePart>
			<namePart type="given">Koichi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Meitinger</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Metspalu</namePart>
			<namePart type="given">Andres</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Milani</namePart>
			<namePart type="given">Lili</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Momozawa</namePart>
			<namePart type="given">Yukihide</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mosley</namePart>
			<namePart type="given">Thomas H., Jr.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nalls</namePart>
			<namePart type="given">Mike A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nasri</namePart>
			<namePart type="given">Ubaydah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">O'Connell</namePart>
			<namePart type="given">Jeff R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ogunniyi</namePart>
			<namePart type="given">Adesola</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palmas</namePart>
			<namePart type="given">Walter R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palmer</namePart>
			<namePart type="given">Nicholette D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pankow</namePart>
			<namePart type="given">James S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pedersen</namePart>
			<namePart type="given">Nancy L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peters</namePart>
			<namePart type="given">Annette</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peyser</namePart>
			<namePart type="given">Patricia A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Polasek</namePart>
			<namePart type="given">Ozren</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Porteous</namePart>
			<namePart type="given">David</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Raitakari</namePart>
			<namePart type="given">Olli T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="frre0001">
			<namePart type="family">Renström</namePart>
			<namePart type="given">Frida</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Enheten för biobanksforskning</affiliation>
			<affiliation>Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63373</description>
		</name>
		<name type="personal">
			<namePart type="family">Rice</namePart>
			<namePart type="given">Treva K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ridker</namePart>
			<namePart type="given">Paul M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Robino</namePart>
			<namePart type="given">Antonietta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Robinson</namePart>
			<namePart type="given">Jennifer G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rose</namePart>
			<namePart type="given">Lynda M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rudan</namePart>
			<namePart type="given">Igor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sabanayagam</namePart>
			<namePart type="given">Charumathi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Salako</namePart>
			<namePart type="given">Babatunde L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sandow</namePart>
			<namePart type="given">Kevin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schmidt</namePart>
			<namePart type="given">Carsten O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schreiner</namePart>
			<namePart type="given">Pamela J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scott</namePart>
			<namePart type="given">William R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sever</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sims</namePart>
			<namePart type="given">Mario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sitlani</namePart>
			<namePart type="given">Colleen M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Smith</namePart>
			<namePart type="given">Blair H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-5362-9430</description>
		</name>
		<name type="personal">
			<namePart type="family">Smith</namePart>
			<namePart type="given">Jennifer A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-3575-5468</description>
		</name>
		<name type="personal">
			<namePart type="family">Snieder</namePart>
			<namePart type="given">Harold</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Starr</namePart>
			<namePart type="given">John M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Strauch</namePart>
			<namePart type="given">Konstantin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tang</namePart>
			<namePart type="given">Hua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Taylor</namePart>
			<namePart type="given">Kent D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Teo</namePart>
			<namePart type="given">Yik Ying</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tham</namePart>
			<namePart type="given">Yih Chung</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Uitterlinden</namePart>
			<namePart type="given">Andre G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waldenberger</namePart>
			<namePart type="given">Melanie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Lihua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Ya Xing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wei</namePart>
			<namePart type="given">Wen Bin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wilson</namePart>
			<namePart type="given">Gregory</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wojczynski</namePart>
			<namePart type="given">Mary K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Xiang</namePart>
			<namePart type="given">Yong-Bing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yao</namePart>
			<namePart type="given">Jie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yu</namePart>
			<namePart type="given">Caizheng</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yuan</namePart>
			<namePart type="given">Jian-Min</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zonderman</namePart>
			<namePart type="given">Alan B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Becker</namePart>
			<namePart type="given">Diane M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boehnke</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bowden</namePart>
			<namePart type="given">Donald W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chambers</namePart>
			<namePart type="given">John C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Yii-Der Ida</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Weir</namePart>
			<namePart type="given">David R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Faire</namePart>
			<namePart type="given">Ulf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Deary</namePart>
			<namePart type="given">Ian J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Esko</namePart>
			<namePart type="given">Tonu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Farrall</namePart>
			<namePart type="given">Martin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Forrester</namePart>
			<namePart type="given">Terrence</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Freedman</namePart>
			<namePart type="given">Barry, I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Froguel</namePart>
			<namePart type="given">Philippe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gasparini</namePart>
			<namePart type="given">Paolo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gieger</namePart>
			<namePart type="given">Christian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Horta</namePart>
			<namePart type="given">Bernardo Lessa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hung</namePart>
			<namePart type="given">Yi-Jen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jonas</namePart>
			<namePart type="given">Jost Bruno</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kato</namePart>
			<namePart type="given">Norihiro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kooner</namePart>
			<namePart type="given">Jaspal S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laakso</namePart>
			<namePart type="given">Markku</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lehtimaki</namePart>
			<namePart type="given">Terho</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liang</namePart>
			<namePart type="given">Kae-Woei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Magnusson</namePart>
			<namePart type="given">Patrik K. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Oldehinkel</namePart>
			<namePart type="given">Albertine J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pereira</namePart>
			<namePart type="given">Alexandre C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Perls</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rauramaa</namePart>
			<namePart type="given">Rainer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Redline</namePart>
			<namePart type="given">Susan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rettig</namePart>
			<namePart type="given">Rainer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Samani</namePart>
			<namePart type="given">Nilesh J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scott</namePart>
			<namePart type="given">James</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shu</namePart>
			<namePart type="given">Xiao-Ou</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Der Harst</namePart>
			<namePart type="given">Pim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wagenknecht</namePart>
			<namePart type="given">Lynne E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wareham</namePart>
			<namePart type="given">Nicholas J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Watkins</namePart>
			<namePart type="given">Hugh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wickremasinghe</namePart>
			<namePart type="given">Ananda R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wu</namePart>
			<namePart type="given">Tangchun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kamatani</namePart>
			<namePart type="given">Yoichiro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laurie</namePart>
			<namePart type="given">Cathy C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bouchard</namePart>
			<namePart type="given">Claude</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0048-491X</description>
		</name>
		<name type="personal">
			<namePart type="family">Cooper</namePart>
			<namePart type="given">Richard S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Evans</namePart>
			<namePart type="given">Michele K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gudnason</namePart>
			<namePart type="given">Vilmundur</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hixson</namePart>
			<namePart type="given">James</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kardia</namePart>
			<namePart type="given">Sharon L. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kritchevsky</namePart>
			<namePart type="given">Stephen B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Psaty</namePart>
			<namePart type="given">Bruce M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Dam</namePart>
			<namePart type="given">Rob M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arnett</namePart>
			<namePart type="given">Donna K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mook-Kanamori</namePart>
			<namePart type="given">Dennis O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fornage</namePart>
			<namePart type="given">Myriam</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fox</namePart>
			<namePart type="given">Ervin R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hayward</namePart>
			<namePart type="given">Caroline</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Duijn</namePart>
			<namePart type="given">Cornelia M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tai</namePart>
			<namePart type="given">E. Shyong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wong</namePart>
			<namePart type="given">Tien Yin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Loos</namePart>
			<namePart type="given">Ruth J. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8532-5087</description>
		</name>
		<name type="personal">
			<namePart type="family">Reiner</namePart>
			<namePart type="given">Alex P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rotimi</namePart>
			<namePart type="given">Charles N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bierut</namePart>
			<namePart type="given">Laura J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhu</namePart>
			<namePart type="given">Xiaofeng</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cupples</namePart>
			<namePart type="given">L. Adrienne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Province</namePart>
			<namePart type="given">Michael A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rotter</namePart>
			<namePart type="given">Jerome, I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="pafr0003">
			<namePart type="family">Franks</namePart>
			<namePart type="given">Paul W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden; Harvard T. H. Chan School of Public Health, Department of Nutrition, Harvard University, Boston, MA, USA</affiliation>
			<description>diva-portal.org=authority-person:62479</description>
		</name>
		<name type="personal">
			<namePart type="family">Rice</namePart>
			<namePart type="given">Kenneth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Elliott</namePart>
			<namePart type="given">Paul</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Caulfield</namePart>
			<namePart type="given">Mark J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gauderman</namePart>
			<namePart type="given">W. James</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Munroe</namePart>
			<namePart type="given">Patricia B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rao</namePart>
			<namePart type="given">Dabeeru C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morrison</namePart>
			<namePart type="given">Alanna C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="11400">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Enheten för biobanksforskning</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A multi-ancestry genome-wide study incorporating gene-smoking interactions identifies multiple new loci for pulse pressure and mean arterial pressure</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-16T16:13:41</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166416</identifier>
		<identifier type="doi">10.1093/hmg/ddz070</identifier>
		<identifier type="pmid">31127295</identifier>
		<identifier type="isi">000493061600012</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>smoking</topic>
		</subject>
		<subject lang="eng">
			<topic>hypertension</topic>
		</subject>
		<subject lang="eng">
			<topic>genes</topic>
		</subject>
		<subject lang="eng">
			<topic>genome</topic>
		</subject>
		<subject lang="eng">
			<topic>life style</topic>
		</subject>
		<subject lang="eng">
			<topic>genetics</topic>
		</subject>
		<subject lang="eng">
			<topic>kidney</topic>
		</subject>
		<subject lang="eng">
			<topic>mean arterial pressure</topic>
		</subject>
		<subject lang="eng">
			<topic>blood pressure regulation</topic>
		</subject>
		<subject lang="eng">
			<topic>pulse pressure</topic>
		</subject>
		<subject lang="eng">
			<topic>genome-wide association study</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30107">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Medical Genetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30107">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Medicinsk genetik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Elevated blood pressure (BP), a leading cause of global morbidity and mortality, is influenced by both genetic and lifestyle factors. Cigarette smoking is one such lifestyle factor. Across five ancestries, we performed a genome-wide gene–smoking interaction study of mean arterial pressure (MAP) and pulse pressure (PP) in 129 913 individuals in stage 1 and follow-up analysis in 480 178 additional individuals in stage 2. We report here 136 loci significantly associated with MAP and/or PP. Of these, 61 were previously published through main-effect analysis of BP traits, 37 were recently reported by us for systolic BP and/or diastolic BP through gene–smoking interaction analysis and 38 were newly identified (&lt;em&gt;P&lt;/em&gt; &amp;lt; 5 × 10&lt;sup&gt;−8&lt;/sup&gt;, false discovery rate &amp;lt; 0.05). We also identified nine new signals near known loci. Of the 136 loci, 8 showed significant interaction with smoking status. They include &lt;em&gt;CSMD1&lt;/em&gt; previously reported for insulin resistance and BP in the spontaneously hypertensive rats. Many of the 38 new loci show biologic plausibility for a role in BP regulation. &lt;em&gt;SLC26A7&lt;/em&gt; encodes a chloride/bicarbonate exchanger expressed in the renal outer medullary collecting duct. &lt;em&gt;AVPR1A&lt;/em&gt; is widely expressed, including in vascular smooth muscle cells, kidney, myocardium and brain. &lt;em&gt;FHAD1&lt;/em&gt; is a long non-coding RNA overexpressed in heart failure. &lt;em&gt;TMEM51&lt;/em&gt; was associated with contractile function in cardiomyocytes. &lt;em&gt;CASP9&lt;/em&gt; plays a central role in cardiomyocyte apoptosis. Identified only in African ancestry were 30 novel loci. Our findings highlight the value of multi-ancestry investigations, particularly in studies of interaction with lifestyle factors, where genomic and lifestyle differences may contribute to novel findings.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Human Molecular Genetics</title>
			</titleInfo>
			<identifier type="issn">0964-6906</identifier>
			<identifier type="eissn">1460-2083</identifier>
			<part>
				<detail type="volume">
					<number>28</number>
				</detail>
				<detail type="issue">
					<number>15</number>
				</detail>
				<extent>
					<start>2615</start>
					<end>2633</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-16</recordCreationDate>
			<recordChangeDate>2019-12-16</recordChangeDate>
			<recordIdentifier>diva2:1379266</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Olstrup</namePart>
			<namePart type="given">Henrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation> Atmospheric Science Unit, Department of Environmental Science and Analytical Chemistry, Stockholm University, 11418 Stockholm, Sweden. </affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Christer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Atmospheric Science Unit, Department of Environmental Science and Analytical Chemistry, Stockholm University, 11418 Stockholm, Sweden.  Environment and Health Administration, SLB, Box 8136, 104 20 Stockholm, Sweden.</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="befo0001">
			<namePart type="family">Forsberg</namePart>
			<namePart type="given">Bertil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<description>diva-portal.org=authority-person:62755</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anstoi02">
			<namePart type="family">Tornevi</namePart>
			<namePart type="given">Andreas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<description>diva-portal.org=authority-person:62783</description>
		</name>
		<name type="personal">
			<namePart type="family">Ekebom</namePart>
			<namePart type="given">Agneta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation> Swedish Museum of Natural History, 114 18 Stockholm, Sweden.</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="kame0001">
			<namePart type="family">Meister</namePart>
			<namePart type="given">Kadri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Statistik</affiliation>
			<description>diva-portal.org=authority-person:64589</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="730">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Yrkes- och miljömedicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="11053">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Multi-Pollutant Air Quality Health Index (AQHI) Based on Short-Term Respiratory Effects in Stockholm, Sweden</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-07T11:36:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154982</identifier>
		<identifier type="doi">10.3390/ijerph16010105</identifier>
		<identifier type="pmid">30609753</identifier>
		<identifier type="isi">000459111400105</identifier>
		<identifier type="articleId">105</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/ijerph16010105</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>AQHI</topic>
		</subject>
		<subject lang="eng">
			<topic>NOx</topic>
		</subject>
		<subject lang="eng">
			<topic>PM10</topic>
		</subject>
		<subject lang="eng">
			<topic>asthma</topic>
		</subject>
		<subject lang="eng">
			<topic>birch pollen</topic>
		</subject>
		<subject lang="eng">
			<topic>ozone</topic>
		</subject>
		<subject lang="eng">
			<topic>risk coefficients</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30303">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Occupational Health and Environmental Health</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30303">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Arbetsmedicin och miljömedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;In this study, an Air Quality Health Index (AQHI) for Stockholm is introduced as a tool to capture the combined effects associated with multi-pollutant exposure. Public information regarding the expected health risks associated with current or forecasted concentrations of pollutants and pollen can be very useful for sensitive persons when planning their outdoor activities. For interventions, it can also be important to know the contribution from pollen and the specific air pollutants, judged to cause the risk. The AQHI is based on an epidemiological analysis of asthma emergency department visits (AEDV) and urban background concentrations of NO&lt;sub&gt;x&lt;/sub&gt;, O₃, PM&lt;sub&gt;10&lt;/sub&gt; and birch pollen in Stockholm during 2001⁻2005. This analysis showed per 10 µg·m&lt;sup&gt;⁻3&lt;/sup&gt; increase in the mean of same day and yesterday an increase in AEDV of 0.5% (95% CI: -1.2⁻2.2), 0.3% (95% CI: -1.4⁻2.0) and 2.5% (95% CI: 0.3⁻4.8) for NO&lt;sub&gt;x&lt;/sub&gt;, O₃ and PM&lt;sub&gt;10&lt;/sub&gt;, respectively. For birch pollen, the AEDV increased with 0.26% (95% CI: 0.18⁻0.34) for 10 pollen grains·m&lt;sup&gt;⁻3&lt;/sup&gt;. In comparison with the coefficients in a meta-analysis, the mean values of the coefficients obtained in Stockholm are smaller. The mean value of the risk increase associated with PM&lt;sub&gt;10&lt;/sub&gt; is somewhat smaller than the mean value of the meta-coefficient, while for O₃, it is less than one fifth of the meta-coefficient. We have not found any meta-coefficient using NO&lt;sub&gt;x&lt;/sub&gt; as an indicator of AEDV, but compared to the mean value associated with NO₂, our value of NO&lt;sub&gt;x&lt;/sub&gt; is less than half as large. The AQHI is expressed as the predicted percentage increase in AEDV without any threshold level. When comparing the relative contribution of each pollutant to the total AQHI, based on monthly averages concentrations during the period 2015⁻2017, there is a tangible pattern. The AQHI increase associated with NO&lt;sub&gt;x&lt;/sub&gt; exhibits a relatively even distribution throughout the year, but with a clear decrease during the summer months due to less traffic. O₃ contributes to an increase in AQHI during the spring. For PM&lt;sub&gt;10&lt;/sub&gt;, there is a significant increase during early spring associated with increased suspension of road dust. For birch pollen, there is a remarkable peak during the late spring and early summer during the flowering period. Based on monthly averages, the total AQHI during 2015⁻2017 varies between 4 and 9%, but with a peak value of almost 16% during the birch pollen season in the spring 2016. Based on daily mean values, the most important risk contribution during the study period is from PM&lt;sub&gt;10&lt;/sub&gt; with 3.1%, followed by O₃ with 2.0%.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Environmental Research and Public Health</title>
			</titleInfo>
			<identifier type="issn">1661-7827</identifier>
			<identifier type="eissn">1660-4601</identifier>
			<part>
				<detail type="volume">
					<number>16</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">EU, Horisont 2020</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1275704/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>lrtjon02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-07</recordCreationDate>
			<recordChangeDate>2019-04-15</recordChangeDate>
			<recordIdentifier>diva2:1275704</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Talsi</namePart>
			<namePart type="given">Oskar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Anestesiologi och intensivvård</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Berggren</namePart>
			<namePart type="given">Ritva Kiiski</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Anestesiologi och intensivvård</affiliation>
			<affiliation>Swedish National Quality Registry for Intensive Care (SIR), Karlstad, Sweden</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="gojo0001">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Göran</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Anestesiologi och intensivvård</affiliation>
			<description>orcid.org=0000-0002-5325-2688</description>
			<description>diva-portal.org=authority-person:62646</description>
		</name>
		<name type="personal" authority="umu" xlink:href="olwi0001">
			<namePart type="family">Winsö</namePart>
			<namePart type="given">Ola</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Anestesiologi och intensivvård</affiliation>
			<description>diva-portal.org=authority-person:64787</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="794">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Anestesiologi och intensivvård</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A national survey on routines regarding sedation in Swedish intensive care units</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-17T14:34:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-160299</identifier>
		<identifier type="doi">10.1080/03009734.2019.1616339</identifier>
		<identifier type="pmid">31119971</identifier>
		<identifier type="isi">000469543300001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/03009734.2019.1616339</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Analgesics</topic>
		</subject>
		<subject lang="eng">
			<topic>intensive care</topic>
		</subject>
		<subject lang="eng">
			<topic>mechanical ventilation</topic>
		</subject>
		<subject lang="eng">
			<topic>sedation scale</topic>
		</subject>
		<subject lang="eng">
			<topic>sedatives</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30201">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Anesthesiology and Intensive Care</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30201">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Anestesi och intensivvård</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Previous studies concerning sedation in Swedish intensive care units (ICU) have shown variability in drug choices and strategies. Currently, there are no national guidelines on this topic. As an update to a Nordic survey from 2004, and as a follow-up to a recently introduced quality indicator from the Swedish Intensive Care Registry, we performed a national survey.&lt;/p&gt;&lt;p&gt;Methods: A digital survey was sent to the ICUs in Sweden, asking for sedation routines regarding hypnosedatives, analgosedatives, protocols, sedation scales, etc.&lt;/p&gt;&lt;p&gt;Results: Fifty out of 80 ICUs responded to the survey. All units used sedation scales, and 88% used the RASS scale; 80% used written guidelines for sedation. Propofol and dexmedetomidine were the preferred short-term hypnosedatives. Propofol, dexmedetomidine, and midazolam were preferred for long-term hypnosedation. Remifentanil, morphine, and fentanyl were the most frequently used agents for analgosedation.&lt;/p&gt;&lt;p&gt;Conclusions: All ICUs used a sedation scale, an increase compared with previous studies. Concerning the choice of hypno- and analgosedatives, the use of dexmedetomidine, clonidine, and remifentanil has increased, and the use of benzodiazepines has decreased since the Nordic survey in 2004.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Upsala Journal of Medical Sciences</title>
			</titleInfo>
			<identifier type="issn">0300-9734</identifier>
			<identifier type="eissn">2000-1967</identifier>
			<part>
				<detail type="volume">
					<number>37</number>
				</detail>
				<detail type="issue">
					<number>23</number>
				</detail>
				<extent>
					<start>3088</start>
					<end>3096</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1325960/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-17</recordCreationDate>
			<recordChangeDate>2019-06-17</recordChangeDate>
			<recordIdentifier>diva2:1325960</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Sörelius</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="josv0027">
			<namePart type="family">Svensson</namePart>
			<namePart type="given">Johan</namePart>
			<namePart type="date">1978-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kirurgi</affiliation>
			<affiliation>Umeå universitet, Statistik</affiliation>
			<description>diva-portal.org=authority-person:66345</description>
		</name>
		<name type="personal">
			<namePart type="family">Matthiessen</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jaru0001">
			<namePart type="family">Rutegård</namePart>
			<namePart type="given">Jörgen</namePart>
			<namePart type="date">1948-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kirurgi</affiliation>
			<description>diva-portal.org=authority-person:63771</description>
		</name>
		<name type="personal" authority="umu" xlink:href="maru0039">
			<namePart type="family">Rutegård</namePart>
			<namePart type="given">Martin</namePart>
			<namePart type="date">1982-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kirurgi</affiliation>
			<description>orcid.org=0000-0002-0974-6373</description>
			<description>diva-portal.org=authority-person:63768</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="793">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Kirurgi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="11053">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A nationwide study on the incidence of mesenteric ischaemia after surgery for rectal cancer demonstrates an association with high arterial ligation</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-04T14:47:46</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162667</identifier>
		<identifier type="doi">10.1111/codi.14674</identifier>
		<identifier type="pmid">31062468</identifier>
		<identifier type="isi">000478607100012</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Inferior mesenteric artery</topic>
		</subject>
		<subject lang="eng">
			<topic>high tie</topic>
		</subject>
		<subject lang="eng">
			<topic>low tie</topic>
		</subject>
		<subject lang="eng">
			<topic>stoma necrosis</topic>
		</subject>
		<subject lang="eng">
			<topic>bowel ischaemia</topic>
		</subject>
		<subject lang="eng">
			<topic>central ligation</topic>
		</subject>
		<subject lang="eng">
			<topic>proximal ligation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30213">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Gastroenterology and Hepatology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30213">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Gastroenterologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Aim: The incidence of mesenteric ischaemia after resection for rectal cancer has not been investigated in a population-based setting. The use of high ligation of the inferior mesenteric artery might cause such ischaemia, as the bowel left in situ depends on collateral blood supply after a high tie.&lt;/p&gt;&lt;p&gt;Method: The Swedish Colorectal Cancer Registry was used to identify all patients subjected to an abdominal resection for rectal cancer during the years 2007-2017 inclusive. Mesenteric ischaemia within the first 30 postoperative days was recorded, classified as either stoma necrosis or colonic necrosis. Multivariable logistic regression was used to estimate odds ratios (ORs) with 95% confidence intervals (CIs) for mesenteric ischaemia in relation to high tie, with adjustment for confounding.&lt;/p&gt;&lt;p&gt;Results: Some 14 657 patients were included, of whom 59 (0.40%) had a reoperation for any type of mesenteric ischaemia, divided into 34 and 25 cases of stoma necrosis and colonic necrosis, respectively. Compared with patients who did not require reoperation for mesenteric ischaemia following rectal cancer surgery, the proportion having high tie was greater (54.2% vs 38.5%; P = 0.032). The adjusted OR for reoperation due to any mesenteric ischaemia with high tie was 2.26 (95% CI 1.34-3.79), while the corresponding estimates for stoma and colonic necrosis, respectively, were 1.60 (95% CI 0.81-3.17) and 3.69 (95% CI 1.57-8.66).&lt;/p&gt;&lt;p&gt;Conclusion: The incidence of reoperation for mesenteric ischaemia after abdominal resection for rectal cancer is low, but the use of a high tie might increase the risk of colonic necrosis demanding surgery.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Colorectal Disease</title>
			</titleInfo>
			<identifier type="issn">1462-8910</identifier>
			<identifier type="eissn">1463-1318</identifier>
			<part>
				<detail type="volume">
					<number>21</number>
				</detail>
				<detail type="issue">
					<number>8</number>
				</detail>
				<extent>
					<start>925</start>
					<end>931</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-04</recordCreationDate>
			<recordChangeDate>2019-09-04</recordChangeDate>
			<recordIdentifier>diva2:1348518</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="mihj0001">
			<namePart type="family">Hjerm</namePart>
			<namePart type="given">Mikael</namePart>
			<namePart type="date">1969-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Sociologiska institutionen</affiliation>
			<description>orcid.org=0000-0003-4203-5394</description>
			<description>diva-portal.org=authority-person:62519</description>
		</name>
		<name type="personal" authority="umu" xlink:href="maeg0005">
			<namePart type="family">Eger</namePart>
			<namePart type="given">Maureen A.</namePart>
			<namePart type="termsOfAddress">Dr.</namePart>
			<namePart type="date">1977-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Sociologiska institutionen</affiliation>
			<description>orcid.org=0000-0001-9023-7316</description>
			<description>diva-portal.org=authority-person:63250</description>
		</name>
		<name type="personal" authority="umu" xlink:href="aeabon03">
			<namePart type="family">Bohman</namePart>
			<namePart type="given">Andrea</namePart>
			<namePart type="date">1983-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Sociologiska institutionen</affiliation>
			<description>orcid.org=0000-0001-8335-9235</description>
			<description>diva-portal.org=authority-person:62520</description>
		</name>
		<name type="personal" authority="umu" xlink:href="fipfos01">
			<namePart type="family">Fors Connolly</namePart>
			<namePart type="given">Filip</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Sociologiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:64155</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="850">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Sociologiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A New Approach to the Study of Tolerance</title>
			<subTitle>Conceptualizing and Measuring Acceptance, Respect, and Appreciation of Difference</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-23T14:31:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162606</identifier>
		<identifier type="doi">10.1007/s11205-019-02176-y</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s11205-019-02176-y</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>tolerance</topic>
		</subject>
		<subject lang="eng">
			<topic>prejudice</topic>
		</subject>
		<subject lang="eng">
			<topic>SEM</topic>
		</subject>
		<subject lang="eng">
			<topic>survey</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50401">
			<topic>Social Sciences</topic>
			<topic>Sociology</topic>
			<topic>Sociology (excluding Social Work, Social Psychology and Social Anthropology)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50401">
			<topic>Samhällsvetenskap</topic>
			<topic>Sociologi</topic>
			<topic>Sociologi (exklusive socialt arbete, socialpsykologi och socialantropologi)</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2149">
			<topic>Sociology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2149">
			<topic>sociologi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Previous empirical research on tolerance suffers from a number of shortcomings, the most serious being the conceptual and operational conflation of (in)tolerance and prejudice. We design research to remedy this. First, we contribute to the literature by advancing research that distinguishes analytically between the two phenomena. We conceptualize tolerance as a value orientation towards difference. This definition—which is abstract and does not capture attitudes towards specific out-groups, ideas, or behaviors—allows for the analysis of tolerance within and between societies. Second, we improve the measurement of tolerance by developing survey items that are consistent with this conceptualization. We administer two surveys, one national (Sweden) and one cross-national (Australia, Denmark, Great Britain, Sweden, and the United States). Results from structural equation models show that tolerance is best understood as a three-dimensional concept, which includes acceptance of, respect for, and appreciation of difference. Analyses show that measures of tolerance have metric invariance across countries, and additional tests demonstrate convergent and discriminant validity. We also assess tolerance’s relationship to prejudice and find that only an appreciation of difference has the potential to reduce prejudice. We conclude that it is not only possible to measure tolerance in a way that is distinct from prejudice but also necessary if we are to understand the causes and consequences of tolerance.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Social Indicators Research</title>
			</titleInfo>
			<identifier type="issn">0303-8300</identifier>
			<identifier type="eissn">1573-0921</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<note type="funder">Marianne och Marcus Wallenbergs Stiftelse [2014.0019]</note>
		<note type="funder">Riksbankens Jubileumsfond [P14-0775:1]</note>
		<note type="funder">Forte, Forskningsrådet för hälsa, arbetsliv och välfärd [2016-07177]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1345323/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>maeg0005</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-23</recordCreationDate>
			<recordChangeDate>2019-10-09</recordChangeDate>
			<recordIdentifier>diva2:1345323</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="laal0007">
			<namePart type="family">Alvarez</namePart>
			<namePart type="given">Laura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid- Consejo Superior de Investigaciones Científicas, Madrid, Spain</affiliation>
			<description>diva-portal.org=authority-person:63975</description>
		</name>
		<name type="personal">
			<namePart type="family">Sanchez-Hevia</namePart>
			<namePart type="given">Dione</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sanchez</namePart>
			<namePart type="given">Mercedes</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Berenguer</namePart>
			<namePart type="given">Jose</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-9689-6272</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A new family of nitrate/nitrite transporters involved in denitrification</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer-Verlag New York</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-22T09:47:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162498</identifier>
		<identifier type="doi">10.1007/s10123-018-0023-0</identifier>
		<identifier type="pmid">30810929</identifier>
		<identifier type="isi">000464866200001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s10123-018-0023-0</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Thermus</topic>
		</subject>
		<subject lang="eng">
			<topic>Denitrification</topic>
		</subject>
		<subject lang="eng">
			<topic>Nitrate</topic>
		</subject>
		<subject lang="eng">
			<topic>Nitrite</topic>
		</subject>
		<subject lang="eng">
			<topic>Transport</topic>
		</subject>
		<subject lang="eng">
			<topic>MFS</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10606">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Microbiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10606">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Mikrobiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Denitrifying bacteria carry out nitrate and nitrite respiration inside and outside the cell, respectively. In Thermus thermophilus, nitrate and nitrite transport processes are carried out by major facilitator superfamily (MFS) transporters. The sequence of the nar operon of nitrate-only respiring strains of T. thermophilus includes two tandemly organized MFS transporter genes (narK and narT) of the NarK1 and NarK2 families. Both can function as nitrate/nitrite antiporters, but NarK has been proposed as more specific for nitrate whereas NarT more specific for nitrite. In some nitrate- and nitrite-respiring strains of the same species, a single MFS transporter (NarO) belonging to a different MFS subfamily appears. To analyze the role of this single MFS in the same genetic context, we transferred the two types of nar operon to the aerobic strain HB27, and further included in both of them the ability to respire nitrite. The new denitrifying strains HB27dn, with two MFS, and HB27dp, with a single one, were used to isolate mutants devoid of transporters. Through in trans complementation experiments, we demonstrate that the NarO single MFS works efficiently in the transport of both nitrate and nitrite.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Microbiology</title>
			</titleInfo>
			<identifier type="issn">1139-6709</identifier>
			<identifier type="eissn">1618-1905</identifier>
			<part>
				<detail type="volume">
					<number>22</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>19</start>
					<end>28</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1344809/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-22</recordCreationDate>
			<recordChangeDate>2019-08-22</recordChangeDate>
			<recordIdentifier>diva2:1344809</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="dael0025">
			<namePart type="family">Elfverson</namePart>
			<namePart type="given">Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>orcid.org=0000-0002-1710-8494</description>
			<description>diva-portal.org=authority-person:68083</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mala0002">
			<namePart type="family">Larson</namePart>
			<namePart type="given">Mats G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>orcid.org=0000-0001-5589-4521</description>
			<description>diva-portal.org=authority-person:63088</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kallan02">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Karl</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>UMIT</affiliation>
			<description>orcid.org=0000-0001-7838-1307</description>
			<description>diva-portal.org=authority-person:66327</description>
		</name>
		<name type="corporate">
			<namePart>UMIT</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A new least squares stabilized Nitsche method for cut isogeometric analysis</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-01T07:40:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156840</identifier>
		<identifier type="doi">10.1016/j.cma.2019.02.011</identifier>
		<identifier type="scopus">2-s2.0-85062154279</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Fictitious domain methods</topic>
		</subject>
		<subject lang="eng">
			<topic>Nitsche’s method</topic>
		</subject>
		<subject lang="eng">
			<topic>Least squares stabilization</topic>
		</subject>
		<subject lang="eng">
			<topic>Isogeometric analysis</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10105">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Computational Mathematics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10105">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Beräkningsmatematik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;We derive a new stabilized symmetric Nitsche method for enforcement of Dirichlet boundary conditions for elliptic problems of second order in cut isogeometric analysis (CutIGA). We consider &lt;em&gt;C&lt;/em&gt;&lt;sup&gt;1&lt;/sup&gt; splines and stabilize the standard Nitsche method by adding a certain elementwise least squares terms in the vicinity of the Dirichlet boundary and an additional term on the boundary which involves the tangential gradient. We show coercivity with respect to the energy norm for functions in &lt;em&gt;H&lt;/em&gt;&lt;sup&gt;2&lt;/sup&gt;(Ω) and optimal order a priori error estimates in the energy and &lt;em&gt;L&lt;/em&gt;&lt;sup&gt;2&lt;/sup&gt; norms. To obtain a well posed linear system of equations we combine our formulation with basis function removal which essentially eliminates basis functions with sufficiently small intersection with Ω. The upshot of the formulation is that only elementwise stabilization is added in contrast to standard procedures based on ghost penalty and related techniques and that the stabilization is consistent. In our numerical experiments we see that the method works remarkably well in even extreme cut situations using a Nitsche parameter of moderate size.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Computer Methods in Applied Mechanics and Engineering</title>
			</titleInfo>
			<identifier type="issn">0045-7825</identifier>
			<identifier type="eissn">1879-2138</identifier>
			<part>
				<detail type="volume">
					<number>349</number>
				</detail>
				<extent>
					<start>1</start>
					<end>16</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [2013-4708]</note>
		<note type="funder">Vetenskapsrådet [2017-03911]</note>
		<note type="funder">Stiftelsen för strategisk forskning (SSF) [AM13-0029]</note>
		<note type="funder">eSSENCE - An eScience Collaboration</note>
		<recordInfo>
			<recordOrigin>kallan02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-01</recordCreationDate>
			<recordChangeDate>2019-06-13</recordChangeDate>
			<recordIdentifier>diva2:1292662</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="zhzh0022">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Zhiyong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:67873</description>
		</name>
		<name type="personal" authority="umu" xlink:href="juyu0002">
			<namePart type="family">Yu</namePart>
			<namePart type="given">Jun</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>Mathematical Statistics</affiliation>
			<description>orcid.org=0000-0001-5673-620X</description>
			<description>diva-portal.org=authority-person:63104</description>
		</name>
		<name type="corporate">
			<namePart>Mathematical Statistics</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A New Nonconvex Sparse Recovery Method for Compressive Sensing</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Frontiers Media S.A.</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-15T09:14:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157346</identifier>
		<identifier type="doi">10.3389/fams.2019.00014</identifier>
		<identifier type="articleId">14</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3389/fams.2019.00014</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>compressive sensing</topic>
		</subject>
		<subject lang="eng">
			<topic>nonconvex sparse recovery</topic>
		</subject>
		<subject lang="eng">
			<topic>iteratively reweighted least squares</topic>
		</subject>
		<subject lang="eng">
			<topic>difference of convex functions</topic>
		</subject>
		<subject lang="eng">
			<topic>q-ratio constrained minimal singular values</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20205">
			<topic>Engineering and Technology</topic>
			<topic>Electrical Engineering, Electronic Engineering, Information Engineering</topic>
			<topic>Signal Processing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20205">
			<topic>Teknik och teknologier</topic>
			<topic>Elektroteknik och elektronik</topic>
			<topic>Signalbehandling</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="101">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="101">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2225">
			<topic>Signal Processing</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2225">
			<topic>signalbehandling</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2199">
			<topic>matematisk statistik</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2199">
			<topic>Mathematical Statistics</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;As an extension of the widely used ℓr-minimization with 0 &amp;lt; r ≤ 1, a new non-convex weighted ℓr − ℓ1 minimization method is proposed for compressive sensing. The theoretical recovery results based on restricted isometry property and q-ratio constrained minimal singular values are established. An algorithm that integrates the iteratively reweighted least squares algorithm and the difference of convex functions algorithmis given to approximately solve this non-convex problem. Numerical experiments are presented to illustrate our results.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<extent>
					<start>1</start>
					<end>11</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Frontiers in Applied Mathematics and Statistics</title>
			</titleInfo>
			<identifier type="issn">2297-4687</identifier>
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<extent>
					<start>1</start>
					<end>11</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [340-2013-5342]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1296371/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>juyu0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-15</recordCreationDate>
			<recordChangeDate>2019-03-20</recordChangeDate>
			<recordIdentifier>diva2:1296371</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Clutton</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="alsa0118">
			<namePart type="family">Sandgren</namePart>
			<namePart type="given">Alexander</namePart>
			<namePart type="date">1990-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för idé- och samhällsstudier</affiliation>
			<description>orcid.org=0000-0001-5599-7598</description>
			<description>diva-portal.org=authority-person:71847</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="820">
			<namePart>Umeå universitet</namePart>
			<namePart>Humanistiska fakulteten</namePart>
			<namePart>Institutionen för idé- och samhällsstudier</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A New Puzzle for Phenomenal Intentionality</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Michigan State University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-07-10T14:42:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161552</identifier>
		<identifier type="doi">10.3998/ergo.12405314.0006.012</identifier>
		<identifier type="isi">000472075400001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3998/ergo.12405314.0006.012</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Intentionality</topic>
		</subject>
		<subject lang="eng">
			<topic>intentional identity</topic>
		</subject>
		<subject lang="eng">
			<topic>hooded man paradox</topic>
		</subject>
		<subject lang="eng">
			<topic>phenomenal intentionality</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="60301">
			<topic>Humanities and the Arts</topic>
			<topic>Philosophy, Ethics and Religion</topic>
			<topic>Philosophy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="60301">
			<topic>Humaniora och konst</topic>
			<topic>Filosofi, etik och religion</topic>
			<topic>Filosofi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Phenomenal intentionality theories have recently enjoyed significant attention. According to these theories, the intentionality of a mental representation (what it is about) crucially depends on its phenomenal features. We present a new puzzle for these theories, involving a phenomenon called 'intentional identity', or 'cointentionality'. Co-intentionality is a ubiquitous intentional phenomenon that involves tracking things even when there is no concrete thing being tracked. We suggest that phenomenal intentionality theories need to either develop new uniquely phenomenal resources for handling the puzzle, or restrict their explanatory ambitions.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Ergo - An Open Access Journal of Philosophy</title>
			</titleInfo>
			<identifier type="issn">0014-0171</identifier>
			<identifier type="eissn">2330-4014</identifier>
			<part>
				<detail type="volume">
					<number>6</number>
				</detail>
				<extent>
					<start>335</start>
					<end>355</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-07-10</recordCreationDate>
			<recordChangeDate>2019-09-05</recordChangeDate>
			<recordIdentifier>diva2:1336829</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Vallesi</namePart>
			<namePart type="given">Adriana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-4127-090X</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anssjn96">
			<namePart type="family">Sjödin</namePart>
			<namePart type="given">Andreas</namePart>
			<namePart type="date">1976-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<affiliation>Division of CBRN Defence and Security, Swedish Defence Research Agency, FOI, Umeå, Sweden</affiliation>
			<description>diva-portal.org=authority-person:64652</description>
		</name>
		<name type="personal">
			<namePart type="family">Petrelli</namePart>
			<namePart type="given">Dezemona</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Luporini</namePart>
			<namePart type="given">Pierangelo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Taddei</namePart>
			<namePart type="given">Anna Rita</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thelaus</namePart>
			<namePart type="given">Johanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ohrman</namePart>
			<namePart type="given">Caroline</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-8489-757X</description>
		</name>
		<name type="personal">
			<namePart type="family">Nilsson</namePart>
			<namePart type="given">Elin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Di Giuseppe</namePart>
			<namePart type="given">Graziano</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gutierrez</namePart>
			<namePart type="given">Gabriel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-1354-2883</description>
		</name>
		<name type="personal">
			<namePart type="family">Villalobo</namePart>
			<namePart type="given">Eduardo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0331-115X</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A New Species of the gamma-Proteobacterium &lt;em&gt;Francisella, F. adeliensis&lt;/em&gt; Sp. Nov., Endocytobiont in an Antarctic Marine Ciliate and Potential Evolutionary Forerunner of Pathogenic Species</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-27T14:56:12</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158588</identifier>
		<identifier type="doi">10.1007/s00248-018-1256-3</identifier>
		<identifier type="pmid">30187088</identifier>
		<identifier type="isi">000464747100003</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Endosymbiosis</topic>
		</subject>
		<subject lang="eng">
			<topic>Microbial associations</topic>
		</subject>
		<subject lang="eng">
			<topic>Polar microbiology</topic>
		</subject>
		<subject lang="eng">
			<topic>Environmental Francisella</topic>
		</subject>
		<subject lang="eng">
			<topic>Francisella phylogeny</topic>
		</subject>
		<subject lang="eng">
			<topic>Euplotes</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10606">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Microbiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10606">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Mikrobiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The study of the draft genome of an Antarctic marine ciliate, Euplotes petzi, revealed foreign sequences of bacterial origin belonging to the gamma-proteobacterium Francisella that includes pathogenic and environmental species. TEM and FISH analyses confirmed the presence of a Francisella endocytobiont in E. petzi. This endocytobiont was isolated and found to be a new species, named F. adeliensis sp. nov.. F. adeliensis grows well at wide ranges of temperature, salinity, and carbon dioxide concentrations implying that it may colonize new organisms living in deeply diversified habitats. The F. adeliensis genome includes the igl and pdp gene sets (pdpC and pdpE excepted) of the Francisella pathogenicity island needed for intracellular growth. Consistently with an F. adeliensis ancient symbiotic lifestyle, it also contains a single insertion-sequence element. Instead, it lacks genes for the biosynthesis of essential amino acids such as cysteine, lysine, methionine, and tyrosine. In a genome-based phylogenetic tree, F. adeliensis forms a new early branching clade, basal to the evolution of pathogenic species. The correlations of this clade with the other clades raise doubts about a genuine free-living nature of the environmental Francisella species isolated from natural and man-made environments, and suggest to look at F. adeliensis asa pioneer in the Francisella colonization of eukaryotic organisms.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Microbial Ecology</title>
			</titleInfo>
			<identifier type="issn">0095-3628</identifier>
			<identifier type="eissn">1432-184X</identifier>
			<part>
				<detail type="volume">
					<number>77</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>587</start>
					<end>596</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-27</recordCreationDate>
			<recordChangeDate>2019-05-27</recordChangeDate>
			<recordIdentifier>diva2:1318349</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Helms Jørgensen</namePart>
			<namePart type="given">Christian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Roskilde University</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Järvinen</namePart>
			<namePart type="given">Tero</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>University of Turku</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="lilu0004">
			<namePart type="family">Lundahl</namePart>
			<namePart type="given">Lisbeth</namePart>
			<namePart type="date">1951-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad utbildningsvetenskap</affiliation>
			<affiliation>Utbildningspolicy och ungas övergångar</affiliation>
			<description>diva-portal.org=authority-person:62455</description>
		</name>
		<name type="corporate">
			<namePart>Utbildningspolicy och ungas övergångar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="5301">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad utbildningsvetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Nordic transition regime?</title>
			<subTitle>Policies for school-to-work transitions in Sweden, Denmark and Finland</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-02-26T09:32:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156739</identifier>
		<identifier type="doi">10.1177/1474904119830037</identifier>
		<identifier type="isi">000468194700002</identifier>
		<identifier type="scopus">2-s2.0-85062363736</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>School-to-work transitions</topic>
		</subject>
		<subject lang="eng">
			<topic>transition regimes</topic>
		</subject>
		<subject lang="eng">
			<topic>comparative research</topic>
		</subject>
		<subject lang="eng">
			<topic>Nordic countries</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50304">
			<topic>Social Sciences</topic>
			<topic>Educational Sciences</topic>
			<topic>Pedagogical Work</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50304">
			<topic>Samhällsvetenskap</topic>
			<topic>Utbildningsvetenskap</topic>
			<topic>Pedagogiskt arbete</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="9450">
			<topic>pedagogiskt arbete</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="9450">
			<topic>educational work</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;In recent decades, a range of policy measures to support young people’s school-to-work transitions has been initiated across Europe. However, these transition policies have rarely been studied systematically, particularly from a comparative perspective. Thus, the aim of this article is to compare Swedish, Danish and Finnish policies for supporting young people’s educational and school-to-work transitions. Synthesising and analysing recent research, the article critically draws on Walther’s (2006) classification of transition regimes that recognises a Nordic universalistic regime of youth transitions characterised by emphasis on collective social responsibility, individual motivation and personal development. We conclude that significant policy changes have occurred during the last two decades. Coercive measures have been adopted and social support reduced, making young people more individually responsible for the success of their transitions. Hence, current transition policies diverge in many respects from qualities traditionally ascribed to the Nordic transition regime. We also find significant differences between the three countries’ transition policies, which in some cases indicate policy trade-offs. In addition, we conclude that transition policies are generally weakly coordinated across policy domains, which increases the risk of unintended consequences of these policies.&lt;/p&gt;</abstract>
		<note>&lt;p&gt;Special Issue: SI&lt;/p&gt;</note>
		<note type="project">Justice through education (JustEd)</note>
		<relatedItem type="host">
			<titleInfo>
				<title>European Educational Research Journal (online)</title>
			</titleInfo>
			<identifier type="issn">1474-9041</identifier>
			<identifier type="eissn">1474-9041</identifier>
			<part>
				<detail type="volume">
					<number>18</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>278</start>
					<end>297</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">NordForsk</note>
		<recordInfo>
			<recordOrigin>lilu0004</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-02-26</recordCreationDate>
			<recordChangeDate>2019-06-10</recordChangeDate>
			<recordIdentifier>diva2:1291733</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Giné-Garriga</namePart>
			<namePart type="given">Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-4449-3524</description>
		</name>
		<name type="personal" authority="umu" xlink:href="masa0025">
			<namePart type="family">Sandlund</namePart>
			<namePart type="given">Marlene</namePart>
			<namePart type="date">1972-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för samhällsmedicin och rehabilitering</affiliation>
			<description>orcid.org=0000-0003-4781-862x</description>
			<description>diva-portal.org=authority-person:63849</description>
		</name>
		<name type="personal">
			<namePart type="family">Dall</namePart>
			<namePart type="given">Philippa M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-1958-1517</description>
		</name>
		<name type="personal">
			<namePart type="family">Chastin</namePart>
			<namePart type="given">Sebastien F. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1421-9348</description>
		</name>
		<name type="personal">
			<namePart type="family">Pérez</namePart>
			<namePart type="given">Susana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Skelton</namePart>
			<namePart type="given">Dawn A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-6223-9840</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="770">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Novel Approach to Reduce Sedentary Behaviour in Care Home Residents</title>
			<subTitle>The GET READY Study Utilising Service-Learning and Co-Creation</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-28T16:25:18</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157595</identifier>
		<identifier type="doi">10.3390/ijerph16030418</identifier>
		<identifier type="pmid">30717105</identifier>
		<identifier type="isi">000459113600124</identifier>
		<identifier type="articleId">418</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/ijerph16030418</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Co-creation</topic>
		</subject>
		<subject lang="eng">
			<topic>service-learning</topic>
		</subject>
		<subject lang="eng">
			<topic>care home residents</topic>
		</subject>
		<subject lang="eng">
			<topic>sedentary behaviour</topic>
		</subject>
		<subject lang="eng">
			<topic>physical activity</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The GET READY study aimed to integrate service-learning methodology into University degrees by offering students individual service opportunities with residential care homes, to co-create the best suited intervention to reduce the sedentary behaviour (SB) of residents throughout the day, with researchers, end-users, care staff, family members and policymakers. Eight workshops with care home residents and four workshops with care staff, relatives and policymakers, led by undergraduate students, were audiotaped, transcribed verbatim and analysed with inductive thematic analysis to understand views and preferences for sustainable strategies to reduce SB and increase movement of residents. Perspectives about SB and movement in care homes highlighted four subthemes. Assets for decreasing SB included three subthemes, and suggestions and strategies encapsulated four subthemes. There is a need to include end-users in decision making, and involve care staff and relatives in enhancing strategies to reduce SB among residents if we want sustainable changes in behaviour. A change in the culture at a policymaker and care staff's level could provide opportunities to open care homes to the community with regular activities outside the care home premises, and offer household chores and opportunities to give residents a role in maintaining their home environment.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Environmental Research and Public Health</title>
			</titleInfo>
			<identifier type="issn">1661-7827</identifier>
			<identifier type="eissn">1660-4601</identifier>
			<part>
				<detail type="volume">
					<number>16</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-28</recordCreationDate>
			<recordChangeDate>2019-03-28</recordChangeDate>
			<recordIdentifier>diva2:1300301</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Liu</namePart>
			<namePart type="given">Jianxin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Yueting</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guo</namePart>
			<namePart type="given">Songjie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hou</namePart>
			<namePart type="given">Jiajuan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhao</namePart>
			<namePart type="given">Gang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ma</namePart>
			<namePart type="given">Weiguang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wu</namePart>
			<namePart type="given">Yongqian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dong</namePart>
			<namePart type="given">Lei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Lei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yin</namePart>
			<namePart type="given">Wangbao</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Xiao</namePart>
			<namePart type="given">Liantuan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="ovax0001">
			<namePart type="family">Axner</namePart>
			<namePart type="given">Ove</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>diva-portal.org=authority-person:62928</description>
		</name>
		<name type="personal">
			<namePart type="family">Jia</namePart>
			<namePart type="given">Suotang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="866">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A novel methodology to directly pre-determine the relative wavelength response of DFB laser in wavelength modulation spectroscopy</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Optical Society of America</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-02-20T13:43:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156320</identifier>
		<identifier type="doi">10.1364/OE.27.001249</identifier>
		<identifier type="pmid">30696194</identifier>
		<identifier type="isi">000456326300074</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1364/OE.27.001249</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="10302">
			<topic>Natural Sciences</topic>
			<topic>Physical Sciences</topic>
			<topic>Atom and Molecular Physics and Optics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10302">
			<topic>Naturvetenskap</topic>
			<topic>Fysik</topic>
			<topic>Atom- och molekylfysik och optik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;A novel methodology to directly pre-determine the relative wavelength response (RWR) of a DFB laser, in terms of a combined current linearly scanned wavelength response and current modulated wavelength response (CMWR), in wavelength modulation spectroscopy (WMS) is presented. It is shown that the assessed RWR can be used to mimic the measured response with standard deviation of discriminations that are below 3.4 x 10(-3)cm(-1) under a variety of conditions. It is also shown that its performance supersedes two commonly used assessment models of the CMWR but is slightly worse than that of the third model. however with the benefit of solely using a single fitting parameter (the concentration) instead of more. When the novel method is applied to the assessment of CO2 concentration in a Herriot-type multipass cell by using the technique of calibration-free WMS, the results show that there is virtually no difference compared to that by use of the best of the other methods. It is concluded that the novel method is more robust and simplifies the retrieval process of gas concentration.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Optics Express</title>
			</titleInfo>
			<identifier type="issn">1094-4087</identifier>
			<identifier type="eissn">1094-4087</identifier>
			<part>
				<detail type="volume">
					<number>27</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
				<extent>
					<start>1249</start>
					<end>1261</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1290360/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-02-20</recordCreationDate>
			<recordChangeDate>2019-02-20</recordChangeDate>
			<recordIdentifier>diva2:1290360</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="asar0008">
			<namePart type="family">Arumugam</namePart>
			<namePart type="given">Ashokan</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-6339-9544</description>
			<description>diva-portal.org=authority-person:67935</description>
		</name>
		<name type="personal" authority="umu" xlink:href="joma0043">
			<namePart type="family">Markström</namePart>
			<namePart type="given">Jonas</namePart>
			<namePart type="date">1985-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för fysioterapi</affiliation>
			<description>orcid.org=0000-0002-6339-9544</description>
			<description>diva-portal.org=authority-person:66817</description>
		</name>
		<name type="personal" authority="umu" xlink:href="chha0003">
			<namePart type="family">Häger</namePart>
			<namePart type="given">Charlotte</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för fysioterapi</affiliation>
			<description>orcid.org=0000-0002-0366-4609</description>
			<description>diva-portal.org=authority-person:62538</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881555">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<namePart>Avdelningen för fysioterapi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A novel test reliably captures hip and knee kinematics and kinetics during unanticipated/anticipated diagonal hops in individuals with anterior cruciate ligament reconstruction</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-18T13:14:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165259</identifier>
		<identifier type="doi">10.1016/j.jbiomech.2019.109480</identifier>
		<identifier type="pmid">31727373</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.jbiomech.2019.109480</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Biomechanics</topic>
		</subject>
		<subject lang="eng">
			<topic>Feasibility</topic>
		</subject>
		<subject lang="eng">
			<topic>Injury</topic>
		</subject>
		<subject lang="eng">
			<topic>Kinematics</topic>
		</subject>
		<subject lang="eng">
			<topic>Kinetics</topic>
		</subject>
		<subject lang="eng">
			<topic>Sport</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30307">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Physiotherapy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30307">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Sjukgymnastik</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="23450">
			<topic>biomechanics</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="23450">
			<topic>biomekanik</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Unanticipated land-and-cut maneuvers might emulate lower limb mechanics associated with anterior cruciate ligament (ACL) injury. Reliability studies on landing mechanics of such maneuvers are however lacking. This study investigated feasibility and within-session reliability of landing mechanics of a novel one-leg double-hop test, mimicking a land-and-cut maneuver, in individuals with ACL reconstruction (ACLR). Our test comprised a forward hop followed by a diagonal hop in either of two directions (medial/lateral) under anticipated and unanticipated conditions. Twenty individuals with a unilateral ACLR (aged 24.2 ± 4.2 years, 0.7-10.8 years post-surgery) performed three successful hops/direction per leg. We determined reliability (intraclass correlation coefficient [ICC]) and agreement (standard error of measurement [SEM]) of 3-dimensional hip and knee angles and moments during the deceleration phase of the land-and-cut maneuver (vulnerable for non-contact ACL injuries). Mean success rate for unanticipated hops was 71-77% and for anticipated hops 91-95%. Both limbs demonstrated moderate-excellent reliability (ICC 95% confidence intervals: 0.50-0.99) for almost all hip and knee peak angles and moments in all planes and conditions, with a few exceptions: poor-good reliability for hip and knee frontal and/or transverse plane variables, especially for lateral diagonal hops. The SEMs were ≤5° and ≤0.23 N·m/kg·m for most peak angles and moments, respectively. Our test seems feasible and showed satisfactory reliability for most hip and knee angles and moments; however, low knee abduction and internal rotation angles and moments, and moderate reliability of these moments deserve consideration. The test appears to challenge dynamic knee control and may prove valuable in evaluation during knee rehabilitation.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Biomechanics</title>
			</titleInfo>
			<identifier type="issn">0021-9290</identifier>
			<identifier type="eissn">1873-2380</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1370830/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>joma0043</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-18</recordCreationDate>
			<recordChangeDate>2019-11-19</recordChangeDate>
			<recordIdentifier>diva2:1370830</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Papadimitriou</namePart>
			<namePart type="given">Nikos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Muller</namePart>
			<namePart type="given">David</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van den Brandt</namePart>
			<namePart type="given">Piet A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Geybels</namePart>
			<namePart type="given">Milan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Patel</namePart>
			<namePart type="given">Chirag J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gunter</namePart>
			<namePart type="given">Marc J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lopez</namePart>
			<namePart type="given">David S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Key</namePart>
			<namePart type="given">Timothy J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Perez-Cornago</namePart>
			<namePart type="given">Aurora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ferrari</namePart>
			<namePart type="given">Pietro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vineis</namePart>
			<namePart type="given">Paolo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Weiderpass</namePart>
			<namePart type="given">Elisabete</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boeing</namePart>
			<namePart type="given">Heiner</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Agudo</namePart>
			<namePart type="given">Antonio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sanchez</namePart>
			<namePart type="given">Maria-Jose</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Overvad</namePart>
			<namePart type="given">Kim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-6429-7921</description>
		</name>
		<name type="personal">
			<namePart type="family">Kuehn</namePart>
			<namePart type="given">Tilman</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fortner</namePart>
			<namePart type="given">Renee T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palli</namePart>
			<namePart type="given">Domenico</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Drake</namePart>
			<namePart type="given">Isabel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bjartell</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Santiuste</namePart>
			<namePart type="given">Carmen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bueno-de-Mesquita</namePart>
			<namePart type="given">Bas H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Krogh</namePart>
			<namePart type="given">Vittorio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tjonneland</namePart>
			<namePart type="given">Anne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lauritzen</namePart>
			<namePart type="given">Dorthe Furstrand</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gurrea</namePart>
			<namePart type="given">Aurelio Barricarte</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Quiros</namePart>
			<namePart type="given">Jose Ramon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stattin</namePart>
			<namePart type="given">Par</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Trichopoulou</namePart>
			<namePart type="given">Antonia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Martimianaki</namePart>
			<namePart type="given">Georgia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Karakatsani</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="elnsjn00">
			<namePart type="family">Thysell</namePart>
			<namePart type="given">Elin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<affiliation>Umeå universitet, Enheten för biobanksforskning</affiliation>
			<description>diva-portal.org=authority-person:62562</description>
		</name>
		<name type="personal" authority="umu" xlink:href="injo0003">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Ingegerd</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<affiliation>Umeå universitet, Enheten för biobanksforskning</affiliation>
			<affiliation>Umeå universitet, Kardiologi</affiliation>
			<description>orcid.org=0000-0002-9227-8434</description>
			<description>diva-portal.org=authority-person:63135</description>
		</name>
		<name type="personal">
			<namePart type="family">Ricceri</namePart>
			<namePart type="given">Fulvio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tumino</namePart>
			<namePart type="given">Rosario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larranaga</namePart>
			<namePart type="given">Nerea</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Khaw</namePart>
			<namePart type="given">Kay Tee</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Riboli</namePart>
			<namePart type="given">Elio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tzoulaki</namePart>
			<namePart type="given">Ioanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tsilidis</namePart>
			<namePart type="given">Konstantinos K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="749">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<namePart>Patologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="11400">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Enheten för biobanksforskning</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="9950">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Kardiologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer Berlin/Heidelberg</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-25T10:42:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165358</identifier>
		<identifier type="doi">10.1007/s00394-019-02132-z</identifier>
		<identifier type="pmid">31705265</identifier>
		<identifier type="isi">000495235600001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s00394-019-02132-z</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Diet</topic>
		</subject>
		<subject lang="eng">
			<topic>Nutrition</topic>
		</subject>
		<subject lang="eng">
			<topic>Epidemiology</topic>
		</subject>
		<subject lang="eng">
			<topic>Cohort study</topic>
		</subject>
		<subject lang="eng">
			<topic>Prostate cancer</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30304">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nutrition and Dietetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30304">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Näringslära</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Purpose: The evidence from the literature regarding the association of dietary factors and risk of prostate cancer is inconclusive.&lt;/p&gt;&lt;p&gt;Methods: A nutrient-wide association study was conducted to systematically and comprehensively evaluate the associations between 92 foods or nutrients and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cox proportional hazard regression models adjusted for total energy intake, smoking status, body mass index, physical activity, diabetes and education were used to estimate hazard ratios and 95% confidence intervals for standardized dietary intakes. As in genome-wide association studies, correction for multiple comparisons was applied using the false discovery rate (FDR &amp;lt; 5%) method and suggested results were replicated in an independent cohort, the Netherlands Cohort Study (NLCS).&lt;/p&gt;&lt;p&gt;Results: A total of 5916 and 3842 incident cases of prostate cancer were diagnosed during a mean follow-up of 14 and 20 years in EPIC and NLCS, respectively. None of the dietary factors was associated with the risk of total prostate cancer in EPIC (minimum FDR-corrected &lt;em&gt;P&lt;/em&gt;, 0.37). Null associations were also observed by disease stage, grade and fatality, except for positive associations observed for intake of dry cakes/biscuits with low-grade and butter with aggressive prostate cancer, respectively, out of which the intake of dry cakes/biscuits was replicated in the NLCS.&lt;/p&gt;&lt;p&gt;Conclusions: Our findings provide little support for an association for the majority of the 92 examined dietary factors and risk of prostate cancer. The association of dry cakes/biscuits with low-grade prostate cancer warrants further replication given the scarcity in the literature.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>European Journal of Nutrition</title>
			</titleInfo>
			<identifier type="issn">1436-6207</identifier>
			<identifier type="eissn">1436-6215</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<note type="funder">Cancerfonden</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Region Skåne</note>
		<note type="funder">Västerbottens läns landsting</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1372616/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-25</recordCreationDate>
			<recordChangeDate>2019-11-25</recordChangeDate>
			<recordIdentifier>diva2:1372616</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Bashir</namePart>
			<namePart type="given">Rania Salah Eldien</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="osah0003">
			<namePart type="family">Hassan</namePart>
			<namePart type="given">Osama Ahmed</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för virologi</affiliation>
			<description>diva-portal.org=authority-person:63426</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881553">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk mikrobiologi</namePart>
			<namePart>Avdelningen för virologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A One Health perspective to identify environmental factors that affect Rift Valley fever transmission in Gezira state, Central Sudan</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-18T11:05:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166506</identifier>
		<identifier type="doi">10.1186/s41182-019-0178-1</identifier>
		<identifier type="pmid">31798311</identifier>
		<identifier type="isi">000499863500001</identifier>
		<identifier type="articleId">54</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s41182-019-0178-1</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Rift Valley fever</topic>
		</subject>
		<subject lang="eng">
			<topic>One Health</topic>
		</subject>
		<subject lang="eng">
			<topic>Remote sensing</topic>
		</subject>
		<subject lang="eng">
			<topic>Geographical information system</topic>
		</subject>
		<subject lang="eng">
			<topic>Normalized Difference Vegetation Index</topic>
		</subject>
		<subject lang="eng">
			<topic>Soil type</topic>
		</subject>
		<subject lang="eng">
			<topic>Multilevel logistic regression</topic>
		</subject>
		<subject lang="eng">
			<topic>Gezira state</topic>
		</subject>
		<subject lang="eng">
			<topic>Sudan</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30209">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Infectious Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30209">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Infektionsmedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Rift Valley fever (RVF) is a zoonotic viral vector-borne disease that affects both animals and humans and leads to severe economic consequences. RVF outbreaks are triggered by a favorable environment and flooding, which enable mosquitoes to proliferate and spread the virus further. RVF is endemic to Africa and has spread to Saudi Arabia and Yemen. There is great concern that RVF may spread to previously unaffected geographic regions due to climate change. We aimed to better understand the spatiotemporal pattern of the 2007 RVF outbreak at the human-animal-environment interface and to determine environmental factors that may have effects on RVF occurrence in Gezira state, Sudan.&lt;/p&gt;&lt;p&gt;Materials and methods: We compiled epidemiological, environmental, and spatiotemporal data across time and space using remote sensing and a geographical information system (GIS). The epidemiological data included 430 RVF human cases as well as human and animal population demographic data for each locality. The cases were collected from 41 locations in Gezira state. The environmental data represent classified land cover during 2007, the year of the RVF outbreak, and the average of the Normalized Difference Vegetation Index (NDVI) for 6 months of 2007 is compared with those of 2010 and 2014, when there was no RVF outbreak. To determine the effect of the environmental factors such as NDVI, soil type, and RVF case's location on the Blue Nile riverbank on RVF incidence in Gezira state, a multilevel logistic regression model was carried out.&lt;/p&gt;&lt;p&gt;Results: We found that the outbreak in Gezira state occurred as a result of interaction among animals, humans, and the environment. The multilevel logistic regression model (F = 43,858, df = 3, p = 0.000) explained 23% of the variance in RVF incidence due to the explanatory variables. Notably, soil type (beta = 0.613, t = 11.284, p = 0.000) and NDVI (beta = - 0.165, t = - 3.254, p = 0.001) were the explanatory environmental factors that had significant effects on RVF incidence in 2007 in Gezira state, Sudan.&lt;/p&gt;&lt;p&gt;Conclusions: Precise remote sensing and the GIS technique, which rely on environmental indices such as NDVI and soil type that are satellite-derived, can contribute to establishing an early warning system for RVF in Sudan. Future preparedness and strengthening the capacity of regional laboratories are necessary for early notification of outbreaks in animals and humans.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Tropical Medicine and Health</title>
			</titleInfo>
			<identifier type="issn">1348-8945</identifier>
			<identifier type="eissn">1349-4147</identifier>
			<part>
				<detail type="volume">
					<number>47</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1380132/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-18</recordCreationDate>
			<recordChangeDate>2019-12-18</recordChangeDate>
			<recordIdentifier>diva2:1380132</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Park</namePart>
			<namePart type="given">Saengryeol</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ntoumanis</namePart>
			<namePart type="given">Nikos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fenton</namePart>
			<namePart type="given">Sally A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anslil01">
			<namePart type="family">Stenling</namePart>
			<namePart type="given">Andreas</namePart>
			<namePart type="date">1982-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<affiliation>Department of Psychology, University of Gothenburg, Sweden; Department of Psychology, University of Otago, Dunedin, New Zealand</affiliation>
			<description>diva-portal.org=authority-person:64150</description>
		</name>
		<name type="personal">
			<namePart type="family">van Zanten</namePart>
			<namePart type="given">Jet J. C. S. Veldhuijzen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thogersen-Ntoumani</namePart>
			<namePart type="given">Cecilie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-0255-1263</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Person-Centered Analysis of Motivation for Physical Activity and Perceived Neighborhood Environment in Residents of Assisted Living Facilities</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>SAGE PUBLICATIONS INC</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-22T13:36:03</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164504</identifier>
		<identifier type="doi">10.1177/0091415018784763</identifier>
		<identifier type="pmid">29966431</identifier>
		<identifier type="isi">000483808000002</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>self-determination theory</topic>
		</subject>
		<subject lang="eng">
			<topic>latent profile analysis</topic>
		</subject>
		<subject lang="eng">
			<topic>older adults</topic>
		</subject>
		<subject lang="eng">
			<topic>physical activity</topic>
		</subject>
		<subject lang="eng">
			<topic>perceived ighborhood environment</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50102">
			<topic>Social Sciences</topic>
			<topic>Psychology</topic>
			<topic>Applied Psychology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50102">
			<topic>Samhällsvetenskap</topic>
			<topic>Psykologi</topic>
			<topic>Tillämpad psykologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;This study sought to identify profiles of individual, social, and perceived neighborhood environmental correlates of physical activity (PA) and to explore differences between the identified profiles in PA. Residents of assisted living facilities (N = 87, M age = 77.57 years) were recruited for the cross-sectional study. Participants reported their perceived support from important others for PA, basic psychological need satisfaction and motivation for PA, and perceived neighborhood environment around the assisted living facilities. Engagement in light PA and moderate-to-vigorous PA was measured by accelerometers over 1 week. We identified three profiles using latent profile analysis: 'low self-determined and minimally supported', 'moderately self-determined and supported', and 'highly self-determined and supported'. Results showed participants in the highly self-determined and supported profile engaged in higher levels of light PA and moderate-to-vigorous PA than participants from other profiles. Findings showed perceptions of the neighborhood environment should be taken into account with motivation regarding PA.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>The International Journal of Aging &amp; Human Development</title>
			</titleInfo>
			<identifier type="issn">0091-4150</identifier>
			<identifier type="eissn">1541-3535</identifier>
			<part>
				<detail type="volume">
					<number>89</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>257</start>
					<end>278</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>parsug04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-22</recordCreationDate>
			<recordChangeDate>2019-11-22</recordChangeDate>
			<recordIdentifier>diva2:1372301</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Zhao</namePart>
			<namePart type="given">Guang-Hui</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, Collaborative Innovation Center of Endemic Diseases and Health Promotion in Silk Road Region, School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Lei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, Collaborative Innovation Center of Endemic Diseases and Health Promotion in Silk Road Region, School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China; School of Nursing, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China; School of Nursing, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="mila0077">
			<namePart type="family">Lammi</namePart>
			<namePart type="given">Mikko</namePart>
			<namePart type="date">1961-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för integrativ medicinsk biologi (IMB)</affiliation>
			<affiliation>Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, Collaborative Innovation Center of Endemic Diseases and Health Promotion in Silk Road Region, School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China</affiliation>
			<affiliation>Chondrogenic and Osteogenic Differentiation Group</affiliation>
			<description>orcid.org=0000-0002-6181-9904</description>
			<description>diva-portal.org=authority-person:62693</description>
		</name>
		<name type="corporate">
			<namePart>Chondrogenic and Osteogenic Differentiation Group</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Guo</namePart>
			<namePart type="given">Xiong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, Collaborative Innovation Center of Endemic Diseases and Health Promotion in Silk Road Region, School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="734">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för integrativ medicinsk biologi (IMB)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A preliminary analysis of microRNA profiles in the subchondral bone between Kashin-Beck disease and primary knee osteoarthritis</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-13T12:25:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158867</identifier>
		<identifier type="doi">10.1007/s10067-019-04580-8</identifier>
		<identifier type="pmid">31062252</identifier>
		<identifier type="isi">000483770400039</identifier>
		<identifier type="articleId">31062252</identifier>
		<location>
			<url displayLabel="Publisher's full text">https://link.springer.com/article/10.1007/s10067-019-04580-8</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Kashin-Beck disease</topic>
		</subject>
		<subject lang="eng">
			<topic>MicroRNAs</topic>
		</subject>
		<subject lang="eng">
			<topic>Osteoarthritis</topic>
		</subject>
		<subject lang="eng">
			<topic>Subchondral bone</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30108">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Cell and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30108">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Cell- och molekylärbiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30211">
			<topic>Clinical Medicine</topic>
			<topic>Orthopaedics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30211">
			<topic>Klinisk medicin</topic>
			<topic>Ortopedi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10604">
			<topic>Cell Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10604">
			<topic>Cellbiologi</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2167">
			<topic>Biochemistry</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2167">
			<topic>biokemi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2076">
			<topic>cellforskning</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2076">
			<topic>cell research</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2206">
			<topic>molekylärbiologi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2206">
			<topic>Molecular Biology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2122">
			<topic>Orthopaedics</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2122">
			<topic>ortopedi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;&lt;strong&gt;INTRODUCTION:&lt;/strong&gt; Kashin-Beck disease (KBD) is a chronic osteochondral disorder primarily associated with cartilage degeneration. The bone texture structure in KBD was also changed but it was not identical to primary knee osteoarthritis (OA). This study investigates the differences in microRNA (miRNA) profiles of subchondral bone collected from patients suffering from KBD in comparison with those with primary knee osteoarthritis (OA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;METHODS:&lt;/strong&gt; Subchondral bone tissues were taken from four patients with KBD and four patients with primary knee OA undergoing total knee replacement. The miRNA array profiling was performed using an Affymetrix miRNA 4.0 Array, and then the target gene predictions and function annotations of the predicted targets were performed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;RESULTS:&lt;/strong&gt; Our results showed that 124 miRNAs had lower expression levels in the subchondral bone sampled from KBD patients in comparison with OA patients. Gene ontology (GO) and KEGG pathway analyses of the predicted targets demonstrated numerous significantly enriched GO terms and signal pathways essential for bone development and integrity, such as metabolic processes, PI3K-Akt, and MAPK signaling pathways.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;CONCLUSIONS:&lt;/strong&gt; Our study confirms that a large set of miRNAs are differentially expressed in the subchondral bone of patients with KBD and OA and contributes new insights into potential pathological changes in the subchondral bone of KBD patients.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Clinical Rheumatology</title>
			</titleInfo>
			<identifier type="issn">0770-3198</identifier>
			<identifier type="eissn">1434-9949</identifier>
			<part>
				<detail type="volume">
					<number>38</number>
				</detail>
				<detail type="issue">
					<number>9</number>
				</detail>
				<extent>
					<start>2637</start>
					<end>2645</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>mila0077</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-13</recordCreationDate>
			<recordChangeDate>2019-11-20</recordChangeDate>
			<recordIdentifier>diva2:1315263</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="glsa0001">
			<namePart type="family">Sandström</namePart>
			<namePart type="given">Glenn</namePart>
			<namePart type="date">1971-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för idé- och samhällsstudier</affiliation>
			<affiliation>Umeå universitet, Enheten för demografi och åldrandeforskning (CEDAR)</affiliation>
			<affiliation>Stockholm University Demography Unit (SUDA), Stockholm University, Sweden</affiliation>
			<description>orcid.org=0000-0001-7559-2571</description>
			<description>diva-portal.org=authority-person:62429</description>
		</name>
		<name type="personal" authority="umu" xlink:href="emma0017">
			<namePart type="family">Marklund</namePart>
			<namePart type="given">Emil</namePart>
			<namePart type="date">1985-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för idé- och samhällsstudier</affiliation>
			<affiliation>Umeå universitet, Umeå centrum för genusstudier (UCGS)</affiliation>
			<description>orcid.org=0000-0002-0180-5762</description>
			<description>diva-portal.org=authority-person:62430</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="820">
			<namePart>Umeå universitet</namePart>
			<namePart>Humanistiska fakulteten</namePart>
			<namePart>Institutionen för idé- och samhällsstudier</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="873307">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Enheten för demografi och åldrandeforskning (CEDAR)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="2651">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Umeå centrum för genusstudier (UCGS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A prelude to the dual provider family</title>
			<subTitle>the changing role of female labor force participation and occupational field on fertility outcomes during the baby boom in Sweden 1900–60</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-20T14:54:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154625</identifier>
		<identifier type="doi">10.1080/1081602X.2018.1556721</identifier>
		<identifier type="isi">000462901600007</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/1081602X.2018.1556721</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Fertility</topic>
		</subject>
		<subject lang="eng">
			<topic>baby boom</topic>
		</subject>
		<subject lang="eng">
			<topic>female labor force participation</topic>
		</subject>
		<subject lang="eng">
			<topic>caring professions</topic>
		</subject>
		<subject lang="eng">
			<topic>Sweden</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="60101">
			<topic>Humanities and the Arts</topic>
			<topic>History and Archaeology</topic>
			<topic>History</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="60101">
			<topic>Humaniora och konst</topic>
			<topic>Historia och arkeologi</topic>
			<topic>Historia</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50999">
			<topic>Social Sciences</topic>
			<topic>Other Social Sciences</topic>
			<topic>Other Social Sciences not elsewhere specified</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50999">
			<topic>Samhällsvetenskap</topic>
			<topic>Annan samhällsvetenskap</topic>
			<topic>Övrig annan samhällsvetenskap</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="25950">
			<topic>Historical Demography</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="25950">
			<topic>historisk demografi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2033">
			<topic>History</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2033">
			<topic>historia</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="12350">
			<topic>historia med utbildningsvetenskaplig inriktning</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="12350">
			<topic>history of education</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;By investigating changes in the association between women’s socioeconomic status, labor market activity and fertility outcomes during the Swedish baby boom 1900–60 this study reaches three main conclusions. First, the results show that a convergence of fertility behavior occurred across female socioeconomic strata during the peak baby boom period in the 1940s and 1950s in terms of a strong two child norm. Second, the negative socio-economic gradient of fertility found in Sweden before the baby boom declined sharply among women who came of age during the 1940s and 1950s, as white-collar women increased their fertility more than all the other strata. Third, this was especially the case for women engaged in the so called ‘caring professions’ that exhibit the largest changes in behavior. The pattern found in contemporary Western contexts where women in healthcare and education have a substantially higher fertility was thus formed in Sweden already during the 1940s and 1950s. The empirical finding fit with the interpretation that middle-class women employed in the public sector experienced stronger reductions in constraints to family formation compared to women employed in the private sector. We propose that the pronatalist polices implemented in the 1930s and 1940s, especially the extensive improvements in employment protection implemented for women who got married or became pregnant in the late 1930s in Sweden, is one important factor to consider when we try to understand why especially women employed in the public sector in education and healthcare increased their fertility more than other groups.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>The History of the Family</title>
			</titleInfo>
			<identifier type="issn">1081-602X</identifier>
			<identifier type="eissn">1873-5398</identifier>
			<part>
				<detail type="volume">
					<number>24</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>149</start>
					<end>173</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1273204/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>emma0017</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-20</recordCreationDate>
			<recordChangeDate>2019-05-23</recordChangeDate>
			<recordIdentifier>diva2:1273204</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="anfr0023">
			<namePart type="family">Fredriksson</namePart>
			<namePart type="given">Anneli</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Oftalmiatrik</affiliation>
			<description>diva-portal.org=authority-person:68249</description>
		</name>
		<name type="personal" authority="umu" xlink:href="sona0013">
			<namePart type="family">Näslund</namePart>
			<namePart type="given">Sofie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Oftalmiatrik</affiliation>
			<description>diva-portal.org=authority-person:73060</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anbe0068">
			<namePart type="family">Behndig</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Oftalmiatrik</affiliation>
			<description>diva-portal.org=authority-person:63699</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="744">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Oftalmiatrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A prospective evaluation of photorefractive intrastromal cross-linking for the treatment of low-grade myopia</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-07T15:29:41</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161907</identifier>
		<identifier type="doi">10.1111/aos.14190</identifier>
		<identifier type="pmid">31301105</identifier>
		<identifier type="isi">000476189700001</identifier>
		<identifier type="scopus">2-s2.0-85069900831</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>corneal collagen cross-linking</topic>
		</subject>
		<subject lang="eng">
			<topic>myopia</topic>
		</subject>
		<subject lang="eng">
			<topic>PiXL</topic>
		</subject>
		<subject lang="eng">
			<topic>refractive cross-linking</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30217">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Ophthalmology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30217">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Oftalmologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Purpose: To evaluate photorefractive intrastromal cross‐linking (PiXL) treatment for low‐grade myopia, comparing three treatment protocols.&lt;/p&gt;&lt;p&gt;Methods: Healthy individuals, 25.6 ± 3.6 years of age, with low‐grade myopia underwent epi‐on PiXL with either: 4‐mm zone treated in high oxygen environment (4 mm‐HIGH;&lt;em&gt; n&lt;/em&gt; = 15), 4‐mm/room air (4‐mm LOW; &lt;em&gt;n&lt;/em&gt; = 6), or 6‐mm/high oxygen (6‐mm HIGH;&lt;em&gt; n&lt;/em&gt; = 6). Efficacy was determined by change in uncorrected visual acuity (UCVA), manifest refractive spherical equivalent (MRSE) and corneal curvature (&lt;em&gt;K&lt;/em&gt;&lt;sub&gt;mean&lt;/sub&gt;) over a 12‐month follow‐up. Safety was determined by best spectacle corrected visual acuity (BSCVA), corneal endothelial cell loss and registration of side‐effects.&lt;/p&gt;&lt;p&gt;Results: Twenty‐seven subjects were included. Due to insufficient effect with the 4‐mm LOW treatment and an unacceptable degree of initial light sensitivity/ocular irritation in the 6‐mm HIGH group, the inclusions to these treatments were stopped after inclusion of 6 patients in each group. The 4‐mm HIGH treatment showed a significantly larger improvement in UCVA (−0.45 ± 0.27 LogMAR) and MRSE (+0.99 ± 0.44 D) at 1, 6 and 12 months compared with the 4‐mm LOW treatment (p &amp;lt; 0.05). At 12 months posttreatment, endothelial cell count and BSCVA were unaltered. More initial side‐effects were noted with the 6‐mm HIGH treatment, compared with the 4‐mm HIGH treatment (p &amp;lt; 0.05).&lt;/p&gt;&lt;p&gt;Conclusion: Epi‐on PiXL may become a safe and effective non‐ablative treatment for low‐grade myopia. The effect is augmented by high oxygen environment and remains stable for 12 months. The initial ocular irritation is acceptable with a 4‐mm treatment zone. The present results justify further clinical studies on PiXL, including refinements of the technique and long‐term results.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Acta Ophthalmologica</title>
			</titleInfo>
			<identifier type="issn">1755-375X</identifier>
			<identifier type="eissn">1755-3768</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-07</recordCreationDate>
			<recordChangeDate>2019-08-07</recordChangeDate>
			<recordIdentifier>diva2:1341108</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Tozan</namePart>
			<namePart type="given">Yesim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Headley</namePart>
			<namePart type="given">Tyler Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="maod0017">
			<namePart type="family">Sewe</namePart>
			<namePart type="given">Maquins Odhiambo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:63037</description>
		</name>
		<name type="personal">
			<namePart type="family">Schwartz</namePart>
			<namePart type="given">Eli</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shemesh</namePart>
			<namePart type="given">Tamar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cramer</namePart>
			<namePart type="given">Jakob P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Eberhardt</namePart>
			<namePart type="given">Kirsten A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-1002-0326</description>
		</name>
		<name type="personal">
			<namePart type="family">Ramharter</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Harrison</namePart>
			<namePart type="given">Nicole</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-5971-0662</description>
		</name>
		<name type="personal">
			<namePart type="family">Leder</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Angheben</namePart>
			<namePart type="given">Andrea</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hatz</namePart>
			<namePart type="given">Christoph</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Neumayr</namePart>
			<namePart type="given">Andreas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Lin Hwei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-5684-8436</description>
		</name>
		<name type="personal">
			<namePart type="family">De Pijper</namePart>
			<namePart type="given">Cornelis A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Grobusch</namePart>
			<namePart type="given">Martin P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anwi0099">
			<namePart type="family">Wilder-Smith</namePart>
			<namePart type="given">Annelies</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:63309</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>AMER SOC TROP MED &amp; HYGIENE</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-08T15:15:26</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162029</identifier>
		<identifier type="doi">10.4269/ajtmh.18-0780</identifier>
		<identifier type="pmid">30994088</identifier>
		<identifier type="isi">000476674600034</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Although the costs of dengue illness to patients and households have been extensively studied in endemic populations, international travelers have not been the focus of costing studies. As globalization and humantravel activities intensify, travelers are increasingly at risk for emerging and reemerging infectious diseases, such as dengue. This exploratory study aims to investigate the impact and out-of-pocket costs of dengue illness among travelers. We conducted a prospective study in adult travelers with laboratory-confirmed dengue and recruited patients at travel medicine clinics in eight different countries from December 2013 to December 2015. Using a structured questionnaire, we collected information on patients and their health-care utilization and out-of-pocket expenditures, as well as income and other financial losses they incurred because of dengue illness. A total of 90 patients participated in the study, most of whom traveled for tourism (74%) and visited countries in Asia (82%). Although 22% reported hospitalization and 32% receiving ambulatory care while traveling, these percentages were higher at 39% and 71%, respectively, after returning home. The out-of-pocket direct and indirect costs of dengue illness were US$421 (SD 744) and US$571 (SD 1,913) per episode, respectively, averaging to a total out-of-pocket cost of US$992 (SD 2,052) per episode. The study findings suggest that international travelers incur important direct and indirect costs because of dengue-related illness. This study is the first to date to investigate the impact and out-of-pocket costs of travel-related dengue illness from the patient's perspective and paves the way for future economic burden studies in this population.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>American Journal of Tropical Medicine and Hygiene</title>
			</titleInfo>
			<identifier type="issn">0002-9637</identifier>
			<identifier type="eissn">1476-1645</identifier>
			<part>
				<detail type="volume">
					<number>100</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
				<extent>
					<start>1525</start>
					<end>1533</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-08</recordCreationDate>
			<recordChangeDate>2019-08-08</recordChangeDate>
			<recordIdentifier>diva2:1341428</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="pewe0001">
			<namePart type="family">Westlund</namePart>
			<namePart type="given">Per-Olof</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:62843</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A proton T&lt;sub&gt;1&lt;/sub&gt;-nuclear magnetic resonance dispersion study of water motion in snowflakes and hexagonal ice</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-19T11:46:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154547</identifier>
		<identifier type="doi">10.1080/00268976.2018.1541197</identifier>
		<identifier type="scopus">2-s2.0-85056004434</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/00268976.2018.1541197</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Six-site exchange model</topic>
		</subject>
		<subject lang="eng">
			<topic>water dynamics in hexagonal ice</topic>
		</subject>
		<subject lang="eng">
			<topic>water proton spin–lattice relaxation dispersion</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10407">
			<topic>Natural Sciences</topic>
			<topic>Chemical Sciences</topic>
			<topic>Theoretical Chemistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10407">
			<topic>Naturvetenskap</topic>
			<topic>Kemi</topic>
			<topic>Teoretisk kemi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Snowflakes and ordinary hexagonal ice were studied measuring water proton spin–lattice relaxation rate R1(ωI)-nuclear magnetic resonance dispersion (NMRD) profiles at proton Larmor frequencies ranging from 1 to 30 MHz and at different temperatures ranging from −2◦C to −10◦C. The spin–spin relaxation rate 1/ 1/T2(ωI) was determined at a single Larmor frequency of 16.3 MHz. The high-field wing of the proton R1(ωI)-NMRD profile was characterised by two parameters: a correlation time τc which described the dipole–dipole spectral density, and the relaxation rate at low fields R &lt;sup&gt;max&lt;/sup&gt; &lt;sub&gt;real&lt;/sub&gt; (0) which was determined from T &lt;sub&gt;2&lt;/sub&gt; . The correlation time τc depended on the dynamic model used. A rotation diffusion model yield approximatively 3μs at −3◦C to about 5μs at 10◦C, whereas for a more realistic six-site discrete exchange model, the correlation times decreased slightly to about 80% for the same temperature interval. Proton dipole–dipole interactions were divided into intramolecular and intermolecular contributions where the intermolecular contribution was about 0.4–0.8 × the intramolecular contribution. It was not possible to discriminate between the dynamic models or to detect ice/water interface effects by comparing the NMRD data from snowflakes with ordinary hexagonal ice data.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Molecular Physics</title>
			</titleInfo>
			<identifier type="issn">0026-8976</identifier>
			<identifier type="eissn">1362-3028</identifier>
			<part>
				<detail type="volume">
					<number>117</number>
				</detail>
				<detail type="issue">
					<number>7-8</number>
				</detail>
				<extent>
					<start>960</start>
					<end>967</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1272517/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>clpe0003</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-19</recordCreationDate>
			<recordChangeDate>2019-05-28</recordChangeDate>
			<recordIdentifier>diva2:1272517</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="java0001">
			<namePart type="family">van Dijken</namePart>
			<namePart type="given">Jan W. V.</namePart>
			<namePart type="date">1947-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>diva-portal.org=authority-person:62777</description>
		</name>
		<name type="personal">
			<namePart type="family">Pallesen</namePart>
			<namePart type="given">Ulla</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Benetti</namePart>
			<namePart type="given">Ana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A randomized controlled evaluation of posterior resin restorations of an altered resin modified glass-ionomer cement with claimed bioactivity</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<place>
				<placeTerm>Oxford</placeTerm>
			</place>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-13T08:37:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154178</identifier>
		<identifier type="doi">10.1016/j.dental.2018.11.027</identifier>
		<identifier type="pmid">30527586</identifier>
		<identifier type="isi">000456070900016</identifier>
		<identifier type="scopus">2-s2.0-85057611260</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>bioactive</topic>
		</subject>
		<subject lang="eng">
			<topic>clinical</topic>
		</subject>
		<subject lang="eng">
			<topic>composite resin</topic>
		</subject>
		<subject lang="eng">
			<topic>glass ionomer</topic>
		</subject>
		<subject lang="eng">
			<topic>posterior</topic>
		</subject>
		<subject lang="eng">
			<topic>self etch adhesive</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30216">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Dentistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30216">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Odontologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;&lt;strong&gt;OBJECTIVE:&lt;/strong&gt; The objective of this randomized controlled prospective clinical trial was to evaluate the short time clinical behaviour of an altered resin modified glass-ionomer cement (RMGIC), which is claimed to possess bioactivity, in posterior restorations and to compare it intraindividually with a nanofilled resin composite.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;METHODS:&lt;/strong&gt; Totally 78 pairs Class II and 4 pairs Class I restorations were placed in 29 female and 38 male participants with a mean age of 58.3 years (range 37-86). Each patient received at random at least one pair of, as similar as possible, Class II or Class I restorations. In the first cavity of each pair, the modified flowable RMGIC (ACTIVA Bioactive; AB) was placed after phosphoric acid etching of the cavity and without adhesive, according to the instructions of the manufacturer. In the other cavity a well established nanofilled resin composite (CeramX; RC) with a single step self-etch adhesive (Xeno Select) was placed. The restorations were evaluated using slightly modified USPHS criteria at baseline, 6 and 12 months. Caries risk and parafunctional habits of the participants were estimated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;RESULTS:&lt;/strong&gt; 158 restorations, 8 Class I and 150 Class II, were evaluated at the one year recalls. At baseline two failed restorations were observed (2AB), at 6 months six failures (5AB, 1RC) and at 12 months another thirteen failed restorations were observed (12AB, 1RC). This resulted in annual failure rates of 24.1% for the AB and 2.5% for RC (p&amp;lt;0.0001). The main reasons for failure for AB were lost restorations (5), postoperative symptoms (4) and secondary caries (3). Do to the unacceptable very high one-year failure frequency, the clinical study was stopped and no further evaluation will be performed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;SIGNIFICANCE:&lt;/strong&gt; The use of the AB restorative in Class II cavities, applied as instructed by the manufacturer after a short phosphoric acid pretreatment but without adhesive system, resulted in a non-acceptable very high failure frequency after a one year period. Further studies should be conducted using a bonding agent.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Dental Materials</title>
			</titleInfo>
			<identifier type="issn">0109-5641</identifier>
			<identifier type="eissn">1879-0097</identifier>
			<part>
				<detail type="volume">
					<number>35</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
				<extent>
					<start>335</start>
					<end>343</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>sako0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-13</recordCreationDate>
			<recordChangeDate>2019-03-29</recordChangeDate>
			<recordIdentifier>diva2:1270341</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Hallberg</namePart>
			<namePart type="given">Jonas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaldo</namePart>
			<namePart type="given">Viktor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arver</namePart>
			<namePart type="given">Stefan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dhejne</namePart>
			<namePart type="given">Cecilia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jujo0022">
			<namePart type="family">Jokinen</namePart>
			<namePart type="given">Jussi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Psykiatri</affiliation>
			<description>diva-portal.org=authority-person:68590</description>
		</name>
		<name type="personal">
			<namePart type="family">Oberg</namePart>
			<namePart type="given">Katarina Gorts</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="740">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Psykiatri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Randomized Controlled Study of Group-Administered Cognitive Behavioral Therapy for Hypersexual Disorder in Men</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-17T12:22:54</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-160310</identifier>
		<identifier type="doi">10.1016/j.jsxm.2019.03.005</identifier>
		<identifier type="pmid">30956109</identifier>
		<identifier type="isi">000469936400015</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Male Sexual Desire Disorders</topic>
		</subject>
		<subject lang="eng">
			<topic>Basic science male behavioral</topic>
		</subject>
		<subject lang="eng">
			<topic>Mental Health and Male Sexuality</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50102">
			<topic>Social Sciences</topic>
			<topic>Psychology</topic>
			<topic>Applied Psychology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50102">
			<topic>Samhällsvetenskap</topic>
			<topic>Psykologi</topic>
			<topic>Tillämpad psykologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Hypersexual disorder (HD) is defined as a condition in which the individual loses control over engagement in sexual behaviors, leading to distress and negative effects on key life areas. Cognitive behavioral therapy (CBT) has been proven to reduce symptoms of hypersexual behavior; however, no randomized controlled study of CBT interventions for HD has been reported previously.&lt;/p&gt;&lt;p&gt;Aim: To investigate the efficacy of group-administered CBT for HD.&lt;/p&gt;&lt;p&gt;Methods: Male participants (n = 137) diagnosed with HD, were randomized between 7 weeks of group-administered CBT (n = 70) and a waitlist control receiving the intervention after 8 weeks (n = 67). Measurements were administered at pre-, mid-, and posttreatment, with follow-up after 3 and 6 months.&lt;/p&gt;&lt;p&gt;Outcomes: The primary outcome was the Hypersexual Disorder: Current Assessment Scale (HD:CAS), and secondary outcomes were the Sexual Compulsivity Scale (SCS) and measures of depression (Montgomery–Åsberg Depression Rating Scale (MADRS-S), psychological distress (Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM), and treatment satisfaction (CSQ-8).&lt;/p&gt;&lt;p&gt;Results: A significantly greater decrease in HD symptoms and sexual compulsivity, as well as significantly greater improvements in psychiatric well-being, were found for the treatment condition compared with the waitlist. These effects remained stable at 3 and 6 months after treatment.&lt;/p&gt;&lt;p&gt;Clinical Implications: CBT can ameliorate HD symptoms and psychiatric distress, suggesting that the CBT program may serve as a first-line treatment in clinical settings.&lt;/p&gt;&lt;p&gt;Strengths &amp;amp; Limitations: This is the first randomized controlled study evaluating the efficacy of a CBT program in a rather large sample of HD-specific diagnosed men. The long-term treatment effects are vague due to the low response rate on follow-up measurements, and the efficacy of this program for hypersexual women remains unknown.&lt;/p&gt;&lt;p&gt;Conclusion: This study supports the efficacy of a group-administered CBT program as a treatment option for HD; however, future studies should include women, comprise dismantling analysis of the constituting interventions, and evaluate other treatment formats, for example, administration via the Internet.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Sexual Medicine</title>
			</titleInfo>
			<identifier type="issn">1743-6095</identifier>
			<identifier type="eissn">1743-6109</identifier>
			<part>
				<detail type="volume">
					<number>16</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>733</start>
					<end>745</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-17</recordCreationDate>
			<recordChangeDate>2019-06-17</recordChangeDate>
			<recordIdentifier>diva2:1325831</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Sköldenberg</namePart>
			<namePart type="given">Olof G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rysinska</namePart>
			<namePart type="given">Agata D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chammout</namePart>
			<namePart type="given">Ghaz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Salemyr</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="semu0002">
			<namePart type="family">Mukka</namePart>
			<namePart type="given">Sebastian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för kirurgisk och perioperativ vetenskap</affiliation>
			<description>diva-portal.org=authority-person:63032</description>
		</name>
		<name type="personal">
			<namePart type="family">Bodén</namePart>
			<namePart type="given">Henrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Eisler</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="792">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A randomized double-blind noninferiority trial, evaluating migration of a cemented vitamin E-stabilized highly crosslinked component compared with a standard polyethylene component in reverse hybrid total hip arthroplasty</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>The British Editorial Society of Bone &amp; Joint Surgery</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-07T08:40:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163878</identifier>
		<identifier type="doi">10.1302/0301-620X.101B10.BJJ-2019-0456.R2</identifier>
		<identifier type="pmid">31564144</identifier>
		<identifier type="isi">000488617100005</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Cemented component</topic>
		</subject>
		<subject lang="eng">
			<topic>Highly crosslinked polyethylene</topic>
		</subject>
		<subject lang="eng">
			<topic>Radiostereometry</topic>
		</subject>
		<subject lang="eng">
			<topic>Randomized clinical trial</topic>
		</subject>
		<subject lang="eng">
			<topic>Total hip arthroplasty</topic>
		</subject>
		<subject lang="eng">
			<topic>Vitamin E</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30211">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Orthopaedics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30211">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Ortopedi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;AIMS: Radiostereometric analysis (RSA) studies of vitamin E-doped, highly crosslinked polyethylene (VEPE) liners show low head penetration rates in cementless acetabular components. There is, however, currently no data on cemented VEPE acetabular components in total hip arthroplasty (THA). The aim of this study was to evaluate the safety of a new cemented VEPE component, compared with a conventional polyethylene (PE) component regarding migration, head penetration, and clinical results.&lt;/p&gt;&lt;p&gt;PATIENTS AND METHODS: We enrolled 42 patients (21 male, 21 female) with osteoarthritis and a mean age of 67 years (sd 5), in a double-blinded, noninferiority, randomized controlled trial. The subjects were randomized in a 1:1 ratio to receive a reverse hybrid THA with a cemented component of either argon-gas gamma-sterilized PE component (controls) or VEPE, with identical geometry. The primary endpoint was proximal implant migration of the component at two years postoperatively measured with RSA. Secondary endpoints included total migration of the component, penetration of the femoral head into the component, and patient-reported outcome measurements.&lt;/p&gt;&lt;p&gt;RESULTS: In total, 19 control implants and 18 implants in the VEPE group were analyzed for the primary endpoint. We found a continuous proximal migration of the component in the VEPE group that was significantly higher with a difference at two years of a mean 0.21 mm (95% confidence interval (CI) 0.05 to 0.37; p = 0.013). The total migration was also significantly higher in the VEPE group, but femoral head penetration was lower. We found no difference in clinical outcomes between the groups.&lt;/p&gt;&lt;p&gt;CONCLUSION: At two years, this cemented VEPE component, although having a low head penetration and excellent clinical results, failed to meet noninferiority compared with the conventional implant by a proximal migration above the proposed safety threshold of RSA. The early proximal migration pattern of the VEPE component is a reason for continued monitoring, although a specific threshold for proximal migration and risk for later failure cannot be defined and needs further study.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>The Bone &amp; Joint Journal</title>
			</titleInfo>
			<identifier type="issn">2049-4394</identifier>
			<identifier type="eissn">2049-4408</identifier>
			<part>
				<detail type="volume">
					<number>101-B</number>
				</detail>
				<detail type="issue">
					<number>10</number>
				</detail>
				<extent>
					<start>1192</start>
					<end>1198</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Stockholms läns landsting</note>
		<recordInfo>
			<recordOrigin>anjo0012</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-07</recordCreationDate>
			<recordChangeDate>2019-11-07</recordChangeDate>
			<recordIdentifier>diva2:1358056</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Farias</namePart>
			<namePart type="given">Fabiana H. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dahlqvist</namePart>
			<namePart type="given">Johanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kozyrev</namePart>
			<namePart type="given">Sergey V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Leonard</namePart>
			<namePart type="given">Dag</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wilbe</namePart>
			<namePart type="given">Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Abramov</namePart>
			<namePart type="given">Sergei N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-3174-4363</description>
		</name>
		<name type="personal">
			<namePart type="family">Alexsson</namePart>
			<namePart type="given">Andrei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pielberg</namePart>
			<namePart type="given">Gerli R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hansson-Hamlin</namePart>
			<namePart type="given">Helene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Andersson</namePart>
			<namePart type="given">Goran</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tandre</namePart>
			<namePart type="given">Karolina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bengtsson</namePart>
			<namePart type="given">Anders A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sjöwall</namePart>
			<namePart type="given">Christopher</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-0900-2048</description>
		</name>
		<name type="personal">
			<namePart type="family">Svenungsson</namePart>
			<namePart type="given">Elisabet</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gunnarsson</namePart>
			<namePart type="given">Iva</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="sora0001">
			<namePart type="family">Rantapää-Dahlqvist</namePart>
			<namePart type="given">Solbritt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Reumatologi</affiliation>
			<description>orcid.org=0000-0001-8259-3863</description>
			<description>diva-portal.org=authority-person:62730</description>
		</name>
		<name type="personal">
			<namePart type="family">Syvanen</namePart>
			<namePart type="given">Ann-Christine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sandling</namePart>
			<namePart type="given">Johanna K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Eloranta</namePart>
			<namePart type="given">Maija-Leena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rönnblom</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lindblad-Toh</namePart>
			<namePart type="given">Kerstin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="729">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Reumatologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A rare regulatory variant in the &lt;em&gt;MEF2D&lt;/em&gt; gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Nature Publishing Group</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-12T11:12:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156863</identifier>
		<identifier type="doi">10.1038/s41431-018-0297-x</identifier>
		<identifier type="pmid">30459414</identifier>
		<identifier type="isi">000458626500013</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1038/s41431-018-0297-x</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30107">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Medical Genetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30107">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Medicinsk genetik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Systemic lupus erythematosus (SLE) is an autoimmune disorder with heterogeneous clinical presentation and complex etiology involving the interplay between genetic, epigenetic, environmental and hormonal factors. Many common SNPs identified by genome wide-association studies (GWAS) explain only a small part of the disease heritability suggesting the contribution from rare genetic variants, undetectable in GWAS, and complex epistatic interactions. Using targeted resequencing of coding and conserved regulatory regions within and around 215 candidate genes selected on the basis of their known role in autoimmunity and genes associated with canine immune-mediated diseases, we identified a rare regulatory variant rs200395694:G &amp;gt; T located in intron 4 of the MEF2D gene encoding the myocyte-specific enhancer factor 2D transcription factor and associated with SLE in Swedish cohorts (504 SLE patients and 839 healthy controls, p = 0 .014 , CI = 1.1-10). Fisher's exact test revealed an association between the genetic variant and a triad of disease manifestations including Raynaud, anti-Ul-ribonucleoprotein (anti-RNP), and anti-Smith (anti-Sm) antibodies (p = 0.00037) among the patients. The DNA-binding activity of the allele was further studied by EMSA, reporter assays, and minigenes. The region has properties of an active cell-specific enhancer, differentially affected by the alleles of rs200395694:G &amp;gt; T. In addition, the risk allele exerts an inhibitory effect on the splicing of the alternative tissue-specific isoform, and thus may modify the target gene set regulated by this isoform. These findings emphasize the potential of dissecting traits of complex diseases and correlating them with rare risk alleles with strong biological effects.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>European Journal of Human Genetics</title>
			</titleInfo>
			<identifier type="issn">1018-4813</identifier>
			<identifier type="eissn">1476-5438</identifier>
			<part>
				<detail type="volume">
					<number>27</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>432</start>
					<end>441</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1295620/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-12</recordCreationDate>
			<recordChangeDate>2019-03-12</recordChangeDate>
			<recordIdentifier>diva2:1295620</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Xing</namePart>
			<namePart type="given">Xuanxuan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kane</namePart>
			<namePart type="given">Daniel P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bulock</namePart>
			<namePart type="given">Chelsea R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Moore</namePart>
			<namePart type="given">Elizabeth A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="sush0003">
			<namePart type="family">Sharma</namePart>
			<namePart type="given">Sushma</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Andrei Chabes</affiliation>
			<description>diva-portal.org=authority-person:65353</description>
		</name>
		<name type="corporate">
			<namePart>Andrei Chabes</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anch0002">
			<namePart type="family">Chabes</namePart>
			<namePart type="given">Andrei</namePart>
			<namePart type="termsOfAddress">Professor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>orcid.org=0000-0003-1708-8259</description>
			<description>diva-portal.org=authority-person:64019</description>
		</name>
		<name type="personal">
			<namePart type="family">Shcherbakova</namePart>
			<namePart type="given">Polina V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="791">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk kemi och biofysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Nature Publishing Group</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-28T14:00:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155817</identifier>
		<identifier type="doi">10.1038/s41467-018-08145-2</identifier>
		<identifier type="pmid">30670691</identifier>
		<identifier type="isi">000456286400002</identifier>
		<identifier type="articleId">374</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1038/s41467-018-08145-2</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30108">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Cell and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30108">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Cell- och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Alterations in the exonuclease domain of DNA polymerase ε (Polε) cause ultramutated tumors. Severe mutator effects of the most common variant, Polε-P286R, modeled in yeast suggested that its pathogenicity involves yet unknown mechanisms beyond simple proofreading deficiency. We show that, despite producing a catastrophic amount of replication errors in vivo, the yeast Polε-P286R analog retains partial exonuclease activity and is more accurate than exonuclease-dead Polε. The major consequence of the arginine substitution is a dramatically increased DNA polymerase activity. This is manifested as a superior ability to copy synthetic and natural templates, extend mismatched primer termini, and bypass secondary DNA structures. We discuss a model wherein the cancer-associated substitution limits access of the 3'-terminus to the exonuclease site and promotes binding at the polymerase site, thus stimulating polymerization. We propose that the ultramutator effect results from increased polymerase activity amplifying the contribution of Polε errors to the genomic mutation rate.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Nature Communications</title>
			</titleInfo>
			<identifier type="issn">2041-1723</identifier>
			<identifier type="eissn">2041-1723</identifier>
			<part>
				<detail type="volume">
					<number>10</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">NIH (National Institute of Health) [ES015869]</note>
		<note type="funder">Cancerfonden</note>
		<note type="funder">Vetenskapsrådet</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1283191/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>anch0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-28</recordCreationDate>
			<recordChangeDate>2019-02-26</recordChangeDate>
			<recordIdentifier>diva2:1283191</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="tefr0002">
			<namePart type="family">Bidleman</namePart>
			<namePart type="given">Terry</namePart>
			<namePart type="date">1942-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<affiliation>EcoChange; UMFpub</affiliation>
			<description>orcid.org=0000-0001-7469-0532</description>
		</name>
		<name type="corporate">
			<namePart>EcoChange; UMFpub</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="agan0002">
			<namePart type="family">Andersson</namePart>
			<namePart type="given">Agneta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå marina forskningscentrum (UMF)</affiliation>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<description>diva-portal.org=authority-person:62615</description>
		</name>
		<name type="personal">
			<namePart type="family">Jantunen</namePart>
			<namePart type="given">Liisa M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kucklick</namePart>
			<namePart type="given">John R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kylin</namePart>
			<namePart type="given">Henrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Letcher</namePart>
			<namePart type="given">Robert J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="maty0001">
			<namePart type="family">Tysklind</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:63063</description>
		</name>
		<name type="personal">
			<namePart type="family">Wong</namePart>
			<namePart type="given">Fiona</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="873">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Umeå marina forskningscentrum (UMF)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="879">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för ekologi, miljö och geovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A review of halogenated natural products in Arctic, Subarctic and Nordic ecosystems</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-12T14:43:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157149</identifier>
		<identifier type="doi">10.1016/j.emcon.2019.02.007</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.emcon.2019.02.007</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Halogenated natural products (HNPs)</topic>
		</subject>
		<subject lang="eng">
			<topic>Arctic</topic>
		</subject>
		<subject lang="eng">
			<topic>Scandinavia</topic>
		</subject>
		<subject lang="eng">
			<topic>Baltic Sea</topic>
		</subject>
		<subject lang="eng">
			<topic>Air</topic>
		</subject>
		<subject lang="eng">
			<topic>Water</topic>
		</subject>
		<subject lang="eng">
			<topic>Sediment</topic>
		</subject>
		<subject lang="eng">
			<topic>Biota</topic>
		</subject>
		<subject lang="eng">
			<topic>Physicochemical properties</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10502">
			<topic>Natural Sciences</topic>
			<topic>Earth and Related Environmental Sciences</topic>
			<topic>Environmental Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10502">
			<topic>Naturvetenskap</topic>
			<topic>Geovetenskap och miljövetenskap</topic>
			<topic>Miljövetenskap</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="8103">
			<topic>environmental science</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="8103">
			<topic>miljövetenskap</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Halogenated natural products (HNPs) are organic compounds containing bromine, chlorine, iodine, and rarely fluorine. HNPs comprise many classes of compounds, ranging in complexity from halocarbons to higher molecular weight compounds, which often contain oxygen and/or nitrogen atoms in addition to halogens. Many HNPs are biosynthesized by marine bacteria, macroalgae, phytoplankton, tunicates, corals, worms, sponges and other invertebrates. This paper reviews HNPs in Arctic, Subarctic and Nordic ecosystems and is based on sections of Chapter 2.16 in the Arctic Monitoring and Assessment Program (AMAP) assessment&lt;em&gt; Chemicals of Emerging Arctic Concern &lt;/em&gt;(AMAP, 2017) which deal with the higher molecular weight HNPs. Material is updated and expanded to include more Nordic examples. Much of the chapter is devoted to “bromophenolic” HNPs,&lt;em&gt; viz &lt;/em&gt;bromophenols (BPs) and transformation products bromoanisoles (BAs), hydroxylated and methoxylated bromodiphenyl ethers (OH-BDEs, MeO-BDEs) and polybrominated dibenzo-&lt;em&gt;p&lt;/em&gt;-dioxins (PBDDs), since these HNPs are most frequently reported. Others discussed are 2,2′ -dimethoxy-3,3′ ,5,5′ -tetrabromobiphenyl (2,2′ -dimethoxy-BB80), polyhalogenated 1′- methyl-1,2′-bipyrroles (PMBPs), polyhalogenated 1,1′ -dimethyl-2,2′ -bipyrroles (PDBPs), polyhalogenated &lt;em&gt;N&lt;/em&gt;-methylpyrroles (PMPs), polyhalogenated &lt;em&gt;N&lt;/em&gt;-methylindoles (PMIs), bromoheptyl- and bromooctyl pyrroles, (1R,2S,4R,5R,1′E)-2-bromo-1-bromomethyl-1,4-dichloro-5-(2′-chloroethenyl)-5- methylcyclohexane (mixed halogenated compound MHC-1), polybrominated hexahydroxanthene derivatives (PBHDs) and polyhalogenated carbazoles (PHCs). Aspects of HNPs covered are physicochemical properties, sources and production, transformation processes, concentrations and trends in the physical environment and biota (marine and freshwater). Toxic properties of some HNPs and a discussion of how climate change might affect HNPs production and distribution are also included. The review concludes with a summary of research needs to better understand the role of HNPs as “chemicals of emerging Arctic concern”.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Emerging Contaminants</title>
			</titleInfo>
			<identifier type="issn">2405-6650</identifier>
			<identifier type="eissn">2405-6642</identifier>
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<extent>
					<start>89</start>
					<end>115</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Ecosystem dynamics in the Baltic Sea in a changing climate perspective - ECOCHANGE</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1295711/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>tefr0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-12</recordCreationDate>
			<recordChangeDate>2019-03-15</recordChangeDate>
			<recordIdentifier>diva2:1295711</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="tosp0001">
			<namePart type="family">Sparrman</namePart>
			<namePart type="given">Tobias</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:63267</description>
		</name>
		<name type="personal">
			<namePart type="family">Svenningsson</namePart>
			<namePart type="given">Leo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sahlin-Sjovold</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nordstierna</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Westman</namePart>
			<namePart type="given">Gunnar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bernin</namePart>
			<namePart type="given">Diana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-9611-2263</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A revised solid-state NMR method to assess the crystallinity of cellulose</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-27T09:07:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165331</identifier>
		<identifier type="doi">10.1007/s10570-019-02718-0</identifier>
		<identifier type="isi">000493690800003</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s10570-019-02718-0</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Crystallinity</topic>
		</subject>
		<subject lang="eng">
			<topic>Cellulose</topic>
		</subject>
		<subject lang="eng">
			<topic>MAS</topic>
		</subject>
		<subject lang="eng">
			<topic>C-13 NMR</topic>
		</subject>
		<subject lang="eng">
			<topic>C-13 T-1</topic>
		</subject>
		<subject lang="eng">
			<topic>Cross-polarization</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10402">
			<topic>Natural Sciences</topic>
			<topic>Chemical Sciences</topic>
			<topic>Physical Chemistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10402">
			<topic>Naturvetenskap</topic>
			<topic>Kemi</topic>
			<topic>Fysikalisk kemi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The crystallinity of cellulose has a strong impact on various material properties. Over the years, many methods have become available to estimate the crystallinity. The purpose of this work was to revise existing NMR-based methods and to introduce a complementary NMR method related to the C-13 T-1 relaxation time. The C-13 T-1 differs by an order of magnitude for amorphous and crystalline polymers among them cellulose. We have utilized the signal boost of H-1-C-13 cross polarization and the difference in C-13 T-1 as a filter to calculate the degree of crystallinity. The evaluation of the method is based on the difference in peak integrals, which is fed into a simple equation. The method was applied to five cellulosic samples of different nature and compared the obtained degree of crystallinity with the degree estimated from deconvoluted X-ray scattering patterns. Furthermore, an attempt has been made to give a basic understanding on the origin of CP enhancement in order to validate various proposed NMR methods. With the recent progress of NMR equipment, the presented method can be automatized and applied to a series of samples using a sample changer.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Cellulose (London)</title>
			</titleInfo>
			<identifier type="issn">0969-0239</identifier>
			<identifier type="eissn">1572-882X</identifier>
			<part>
				<detail type="volume">
					<number>26</number>
				</detail>
				<detail type="issue">
					<number>17</number>
				</detail>
				<extent>
					<start>8993</start>
					<end>9003</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1373371/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-27</recordCreationDate>
			<recordChangeDate>2019-11-27</recordChangeDate>
			<recordIdentifier>diva2:1373371</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Doyle</namePart>
			<namePart type="given">Siamsa M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-4889-3496</description>
		</name>
		<name type="personal">
			<namePart type="family">Rigal</namePart>
			<namePart type="given">Adeline</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Grones</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-4132-4151</description>
		</name>
		<name type="personal">
			<namePart type="family">Karady</namePart>
			<namePart type="given">Michal</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-5603-706X</description>
		</name>
		<name type="personal" authority="umu" xlink:href="deba0006">
			<namePart type="family">Barange</namePart>
			<namePart type="given">Deepak Kumar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:68756</description>
		</name>
		<name type="personal">
			<namePart type="family">Majda</namePart>
			<namePart type="given">Mateusz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-3405-2901</description>
		</name>
		<name type="personal">
			<namePart type="family">Parizkova</namePart>
			<namePart type="given">Barbora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8125-2271</description>
		</name>
		<name type="personal">
			<namePart type="family">Karampelias</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zwiewka</namePart>
			<namePart type="given">Marta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pencik</namePart>
			<namePart type="given">Ales</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Almqvist</namePart>
			<namePart type="given">Fredrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ljung</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="onno0001">
			<namePart type="family">Novak</namePart>
			<namePart type="given">Ondrej</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:73197</description>
		</name>
		<name type="personal">
			<namePart type="family">Robert</namePart>
			<namePart type="given">Stephanie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A role for the auxin precursor anthranilic acid in root gravitropism via regulation of PIN‐FORMED protein polarity and relocalisation in &lt;em&gt;Arabidopsis&lt;/em&gt;</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-19T12:21:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162321</identifier>
		<identifier type="doi">10.1111/nph.15877</identifier>
		<identifier type="pmid">31038751</identifier>
		<identifier type="isi">000475918000032</identifier>
		<identifier type="scopus">2-s2.0-85068258314</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1111/nph.15877</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>anthranilic acid (AA)</topic>
		</subject>
		<subject lang="eng">
			<topic>Arabidopsis thaliana</topic>
		</subject>
		<subject lang="eng">
			<topic>auxin transport</topic>
		</subject>
		<subject lang="eng">
			<topic>PIN polarity</topic>
		</subject>
		<subject lang="eng">
			<topic>PIN-FORMED proteins</topic>
		</subject>
		<subject lang="eng">
			<topic>root gravitropism</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10607">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Botany</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10607">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Botanik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Distribution of auxin within plant tissues is of great importance for developmental plasticity, including root gravitropic growth. Auxin flow is directed by the subcellular polar distribution and dynamic relocalisation of auxin transporters such as the PIN‐FORMED (PIN) efflux carriers, which can be influenced by the main natural plant auxin indole‐3‐acetic acid (IAA). Anthranilic acid (AA) is an important early precursor of IAA and previously published studies with AA analogues have suggested that AA may also regulate PIN localisation.&lt;/p&gt;&lt;p&gt;Using &lt;em&gt;Arabidopsis thaliana&lt;/em&gt; as a model species, we studied an AA‐deficient mutant displaying agravitropic root growth, treated seedlings with AA and AA analogues and transformed lines to over‐produce AA while inhibiting its conversion to downstream IAA precursors.&lt;/p&gt;&lt;p&gt;We showed that AA rescues root gravitropic growth in the AA‐deficient mutant at concentrations that do not rescue IAA levels. Overproduction of AA affects root gravitropism without affecting IAA levels. Treatments with, or deficiency in, AA result in defects in PIN polarity and gravistimulus‐induced PIN relocalisation in root cells.&lt;/p&gt;&lt;p&gt;Our results revealed a previously unknown role for AA in the regulation of PIN subcellular localisation and dynamics involved in root gravitropism, which is independent of its better known role in IAA biosynthesis.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>New Phytologist</title>
			</titleInfo>
			<identifier type="issn">0028-646X</identifier>
			<identifier type="eissn">1469-8137</identifier>
			<part>
				<detail type="volume">
					<number>223</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>1420</start>
					<end>1432</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1343758/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-19</recordCreationDate>
			<recordChangeDate>2019-08-20</recordChangeDate>
			<recordIdentifier>diva2:1343758</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="vika0044">
			<namePart type="family">Kasari</namePart>
			<namePart type="given">Villu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>orcid.org=0000-0002-2970-2001</description>
			<description>diva-portal.org=authority-person:68731</description>
		</name>
		<name type="personal">
			<namePart type="family">Pochopien</namePart>
			<namePart type="given">Agnieszka A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="toma0068">
			<namePart type="family">Margus</namePart>
			<namePart type="given">Tonu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>orcid.org=0000-0003-4966-1291</description>
			<description>diva-portal.org=authority-person:71790</description>
		</name>
		<name type="personal" authority="umu" xlink:href="vimu0008">
			<namePart type="family">Murina</namePart>
			<namePart type="given">Victoriia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:67911</description>
		</name>
		<name type="personal" authority="umu" xlink:href="katu0016">
			<namePart type="family">Turnbull</namePart>
			<namePart type="given">Kathryn Jane</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:73934</description>
		</name>
		<name type="personal" authority="umu" xlink:href="yazh0011">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Yang</namePart>
			<namePart type="date">1986-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:66402</description>
		</name>
		<name type="personal">
			<namePart type="family">Nissan</namePart>
			<namePart type="given">Tracy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Graf</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Novacek</namePart>
			<namePart type="given">Jiri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="geat0002">
			<namePart type="family">Atkinson</namePart>
			<namePart type="given">Gemma C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:64417</description>
		</name>
		<name type="personal" authority="umu" xlink:href="majo0274">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Marcus J. O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:66404</description>
		</name>
		<name type="personal">
			<namePart type="family">Wilson</namePart>
			<namePart type="given">Daniel N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="vaha0006">
			<namePart type="family">Hauryliuk</namePart>
			<namePart type="given">Vasili</namePart>
			<namePart type="date">1980-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>University of Tartu, Institute of Technology, 50411 Tartu, Estonia</affiliation>
			<description>diva-portal.org=authority-person:62741</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A role for the Saccharomyces cerevisiae ABCF protein New1 in translation termination/recycling</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-05T10:37:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164896</identifier>
		<identifier type="doi">10.1093/nar/gkz600</identifier>
		<identifier type="pmid">31299085</identifier>
		<identifier type="isi">000490576900040</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1093/nar/gkz600</url>
		</location>
		<location>
			<url displayLabel="URL" note="free">https://academic.oup.com/nar/article/47/16/8807/5531767</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Translation is controlled by numerous accessory proteins and translation factors. In the yeast &lt;em&gt;Saccharomyces cerevisiae&lt;/em&gt;, translation elongation requires an essential elongation factor, the ABCF ATPase eEF3. A closely related protein, New1, is encoded by a non-essential gene with cold sensitivity and ribosome assembly defect knock-out phenotypes. Since the exact molecular function of New1 is unknown, it is unclear if the ribosome assembly defect is direct, i.e. New1 is a &lt;em&gt;bona fide&lt;/em&gt; assembly factor, or indirect, for instance due to a defect in protein synthesis. To investigate this, we employed yeast genetics, cryo-electron microscopy (cryo-EM) and ribosome profiling (Ribo-Seq) to interrogate the molecular function of New1. Overexpression of New1 rescues the inviability of a yeast strain lacking the otherwise strictly essential translation factor eEF3. The structure of the ATPase-deficient (EQ&lt;sub&gt;2&lt;/sub&gt;) New1 mutant locked on the 80S ribosome reveals that New1 binds analogously to the ribosome as eEF3. Finally, Ribo-Seq analysis revealed that loss of New1 leads to ribosome queuing upstream of 3′-terminal lysine and arginine codons, including those genes encoding proteins of the cytoplasmic translational machinery. Our results suggest that New1 is a translation factor that fine-tunes the efficiency of translation termination or ribosome recycling.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Nucleic Acids Research</title>
			</titleInfo>
			<identifier type="issn">0305-1048</identifier>
			<identifier type="eissn">1362-4962</identifier>
			<part>
				<detail type="volume">
					<number>47</number>
				</detail>
				<detail type="issue">
					<number>16</number>
				</detail>
				<extent>
					<start>8807</start>
					<end>8820</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [2017-03783]</note>
		<note type="funder">Vetenskapsrådet [201504746]</note>
		<note type="funder">Vetenskapsrådet [2017-04663]</note>
		<note type="funder">Ragnar Söderbergs stiftelse</note>
		<note type="funder">Kempestiftelserna [JCK1627]</note>
		<note type="funder">Kempestiftelserna [SMK-1349]</note>
		<note type="funder">Magnus Bergvalls Stiftelse [2017-02098]</note>
		<note type="funder">Åke Wibergs Stiftelse [M14-0207]</note>
		<note type="funder">EU, Horisont 2020 [2643]</note>
		<note type="funder">Vetenskapsrådet [2017-03783]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1367802/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-05</recordCreationDate>
			<recordChangeDate>2019-12-09</recordChangeDate>
			<recordIdentifier>diva2:1367802</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Odsæter</namePart>
			<namePart type="given">Lars H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kvamsdal</namePart>
			<namePart type="given">Trond</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mala0002">
			<namePart type="family">Larson</namePart>
			<namePart type="given">Mats G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:63088</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A simple embedded discrete fracture-matrix model for a coupled flow and transport problem in porous media</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-11-12T15:32:48</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-153110</identifier>
		<identifier type="doi">10.1016/j.cma.2018.09.003</identifier>
		<identifier type="isi">000447411100026</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Discrete fracture-matrix model</topic>
		</subject>
		<subject lang="eng">
			<topic>Embedded interface</topic>
		</subject>
		<subject lang="eng">
			<topic>Finite element method</topic>
		</subject>
		<subject lang="eng">
			<topic>Finite volume method</topic>
		</subject>
		<subject lang="eng">
			<topic>Porous media flow</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10105">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Computational Mathematics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10105">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Beräkningsmatematik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Accurate simulation of fluid flow and transport in fractured porous media is a key challenge in subsurface reservoir engineering. Due to the high ratio between its length and width, fractures can be modeled as lower dimensional interfaces embedded in the porous rock. We apply a recently developed embedded finite element method (EFEM) for the Darcy problem. This method allows for general fracture geometry, and the fractures may cut the finite element mesh arbitrarily. We present here a velocity model for EFEM and couple the Darcy problem to a transport problem for a passive solute. The main novelties of this work are a locally conservative velocity approximation derived from the EFEM solution, and the development of a lowest order upwind finite volume method for the transport problem. This numerical model is compatible with EFEM in the sense that the same computational mesh may be applied, so that we retain the same flexibility with respect to fracture geometry and meshing. Hence, our coupled solution strategy represents a simple approach in terms of formulation, implementation and meshing. We demonstrate our model by some numerical examples on both synthetic and realistic problems, including a benchmark study for single-phase flow. Despite the simplicity of the method, the results are promising.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Computer Methods in Applied Mechanics and Engineering</title>
			</titleInfo>
			<identifier type="issn">0045-7825</identifier>
			<identifier type="eissn">1879-2138</identifier>
			<part>
				<detail type="volume">
					<number>343</number>
				</detail>
				<extent>
					<start>572</start>
					<end>601</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-11-12</recordCreationDate>
			<recordChangeDate>2018-11-12</recordChangeDate>
			<recordIdentifier>diva2:1262695</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Burman</namePart>
			<namePart type="given">Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hansbo</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mala0002">
			<namePart type="family">Larson</namePart>
			<namePart type="given">Mats G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:63088</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A simple finite element method for elliptic bulk problems with embedded surfaces</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-28T17:07:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157594</identifier>
		<identifier type="doi">10.1007/s10596-018-9792-y</identifier>
		<identifier type="isi">000459423400010</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s10596-018-9792-y</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Darcy equation</topic>
		</subject>
		<subject lang="eng">
			<topic>Fracture</topic>
		</subject>
		<subject lang="eng">
			<topic>Embedded layer</topic>
		</subject>
		<subject lang="eng">
			<topic>Cut finite element methods</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10201">
			<topic>Natural Sciences</topic>
			<topic>Computer and Information Sciences</topic>
			<topic>Computer Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10201">
			<topic>Naturvetenskap</topic>
			<topic>Data- och informationsvetenskap</topic>
			<topic>Datavetenskap (datalogi)</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10106">
			<topic>Mathematics</topic>
			<topic>Probability Theory and Statistics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10106">
			<topic>Matematik</topic>
			<topic>Sannolikhetsteori och statistik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;In this paper, we develop a simple finite element method for simulation of embedded layers of high permeability in a matrix of lower permeability using a basic model of Darcy flow in embedded cracks. The cracks are allowed to cut through the mesh in arbitrary fashion and we take the flow in the crack into account by superposition. The fact that we use continuous elements leads to suboptimal convergence due to the loss of regularity across the crack. We therefore refine the mesh in the vicinity of the crack in order to recover optimal order convergence in terms of the global mesh parameter. The proper degree of refinement is determined based on an a priori error estimate and can thus be performed before the actual finite element computation is started. Numerical examples showing this effect and confirming the theoretical results are provided. The approach is easy to implement and beneficial for rapid assessment of the effect of crack orientation and may for example be used in an optimization loop.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Computational Geosciences</title>
			</titleInfo>
			<identifier type="issn">1420-0597</identifier>
			<identifier type="eissn">1573-1499</identifier>
			<part>
				<detail type="volume">
					<number>23</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>189</start>
					<end>199</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1300550/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-28</recordCreationDate>
			<recordChangeDate>2019-03-28</recordChangeDate>
			<recordIdentifier>diva2:1300550</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="pefr0038">
			<namePart type="family">Fransson</namePart>
			<namePart type="given">Peter</namePart>
			<namePart type="date">1988-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:71423</description>
		</name>
		<name type="personal">
			<namePart type="family">Franklin</namePart>
			<namePart type="given">Oskar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Ecosystems Services and Management Program, International Institute for Applied Systems Analysis</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Lindroos</namePart>
			<namePart type="given">Ola</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Forest Biomaterials and Technology, Swedish University of Agricultural Sciences</affiliation>
			<description>orcid.org=0000-0002-0376-4140</description>
		</name>
		<name type="personal">
			<namePart type="family">Nilsson</namePart>
			<namePart type="given">Urban</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Southern Swedish Forest Research Centre, Swedish University of Agricultural Sciences</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="akebrm97">
			<namePart type="family">Brännström</namePart>
			<namePart type="given">Åke</namePart>
			<namePart type="date">1975-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>Evolution and Ecology Program, International Institute for Applied Systems Analysis, Laxenburg, Austria</affiliation>
			<description>orcid.org=0000-0001-9862-816x</description>
			<description>diva-portal.org=authority-person:62929</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A simulation-based approach to a near optimal thinning strategy</title>
			<subTitle>allowing for individual harvesting times for individual trees</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-02-26T09:14:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156740</identifier>
		<identifier type="doi">10.1139/cjfr-2019-0053</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="40104">
			<topic>Agricultural and Veterinary sciences</topic>
			<topic>Agricultural Science, Forestry and Fisheries</topic>
			<topic>Forest Science</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="40104">
			<topic>Lantbruksvetenskap och veterinärmedicin</topic>
			<topic>Lantbruksvetenskap, skogsbruk och fiske</topic>
			<topic>Skogsvetenskap</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;As various methods for precision inventories, such as LiDAR, are becoming increasingly common in forestry, individual-tree level planning is becoming more viable. Here, we present a method for finding the optimal thinning times for individual trees from an economic perspective. The method utilizes an individual tree-based forest growth model that has been fitted to Norway spruce (&lt;em&gt;Picea abies&lt;/em&gt; (L.) Karst.) stands in northern Sweden. We find that the optimal management strategy is to thin from above, i.e. harvesting trees that are larger than average. We compare our optimal strategy with a conventional management strategy and find that it results in approximately 20% higher land expectation value. Furthermore, we find that increasing the discount rate will, for the optimal strategy, reduce the final harvest age and increase the basal area reduction. Decreasing the cost to initiate a thinning (e.g., machinery-related transportation costs) increases the number of thinnings and delays the first thinning.&lt;/p&gt;</abstract>
		<note>&lt;p&gt;Originally included in thesis in manuscript form &lt;/p&gt;</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Canadian Journal of Forest Research</title>
			</titleInfo>
			<identifier type="issn">0045-5067</identifier>
			<identifier type="eissn">1208-6037</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<note type="funder">Forskningsrådet Formas [2012-1008]</note>
		<location>
			<url displayLabel="fulltext:postprint" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1291719/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>pefr0038</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-02-26</recordCreationDate>
			<recordChangeDate>2019-12-11</recordChangeDate>
			<recordIdentifier>diva2:1291719</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Laera</namePart>
			<namePart type="given">Andreina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-3373-1689</description>
		</name>
		<name type="personal">
			<namePart type="family">Yekta</namePart>
			<namePart type="given">Sepehr Shakeri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mashem96">
			<namePart type="family">Hedenström</namePart>
			<namePart type="given">Mattias</namePart>
			<namePart type="date">1976-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:63998</description>
		</name>
		<name type="personal">
			<namePart type="family">Buzier</namePart>
			<namePart type="given">Remy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guibaud</namePart>
			<namePart type="given">Gilles</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dario</namePart>
			<namePart type="given">Mårten</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Esposito</namePart>
			<namePart type="given">Giovanni</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Hullebusch</namePart>
			<namePart type="given">Eric D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A simultaneous assessment of organic matter and trace elements bio-accessibility in substrate and digestate from an anaerobic digestion plant</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-07-12T11:38:45</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161497</identifier>
		<identifier type="doi">10.1016/j.biortech.2019.121587</identifier>
		<identifier type="pmid">31200348</identifier>
		<identifier type="isi">000472018100008</identifier>
		<identifier type="articleId">121587</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Sequential chemical extraction</topic>
		</subject>
		<subject lang="eng">
			<topic>Organic matter fractionation</topic>
		</subject>
		<subject lang="eng">
			<topic>Trace elements fractionation</topic>
		</subject>
		<subject lang="eng">
			<topic>NMR spectroscopy</topic>
		</subject>
		<subject lang="eng">
			<topic>Anaerobic co-digestion</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;This study evaluates a simultaneous assessment of organic matter (OM) and trace elements (TE) bio-accessibility in substrate and digestate from a full-scale anaerobic digester by a sequential OM extraction method. Simultaneous release of TE was determined along with the extraction of different OM fractions and the effects of extracting reagents on characteristics of OM were evaluated by nuclear magnetic resonance (NMR) spectroscopy. The reagents used for sequential extraction of OM were not enough selective. However, proteins were particularly removed by 0.1 M NaOH, while 72% H2SO4 mainly extracted hemicellulose and cellulose. The OM fractionation allowed for simultaneous extraction of &amp;gt; 60% of total As, Cd, Co, Fe, Mn, Ni and Zn, while the extraction was limited for Al, Cr, Cu, Mo, and Pb. In substrate, &amp;gt; 50% of total As, Co, Mn and Ni and &amp;lt; 40% of total Fe, Zn and Mo were identified in bio-accessible fractions. In digestate, all elements demonstrated poor bio-accessibility except for As.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Bioresource Technology</title>
			</titleInfo>
			<identifier type="issn">0960-8524</identifier>
			<identifier type="eissn">1873-2976</identifier>
			<part>
				<detail type="volume">
					<number>288</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-07-12</recordCreationDate>
			<recordChangeDate>2019-07-12</recordChangeDate>
			<recordIdentifier>diva2:1337257</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Karakostis</namePart>
			<namePart type="given">Konstantinos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gnanasundram</namePart>
			<namePart type="given">Sivakumar Vadivel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lopez</namePart>
			<namePart type="given">Ignacio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thermou</namePart>
			<namePart type="given">Aikaterini</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="liwa0014">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Lixiao</namePart>
			<namePart type="date">1975-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>diva-portal.org=authority-person:67306</description>
		</name>
		<name type="personal">
			<namePart type="family">Nylander</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Olivares-Illana</namePart>
			<namePart type="given">Vanesa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="rofa0013">
			<namePart type="family">Fåhraeus</namePart>
			<namePart type="given">Robin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<affiliation>1 E´quipe Labellise´e Ligue Contre le Cancer, Universite´ Paris 7, 27 Rue Juliette Dodu, Paris, France; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, Czech Republic</affiliation>
			<description>diva-portal.org=authority-person:62979</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="747">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A single synonymous mutation determines the phosphorylation and stability of the nascent protein</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-12T11:52:17</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159634</identifier>
		<identifier type="doi">10.1093/jmcb/mjy049</identifier>
		<identifier type="pmid">30252118</identifier>
		<identifier type="isi">000467903600002</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>synonymous mutations</topic>
		</subject>
		<subject lang="eng">
			<topic>intrinsically disordered proteins</topic>
		</subject>
		<subject lang="eng">
			<topic>cell signaling</topic>
		</subject>
		<subject lang="eng">
			<topic>MDM2</topic>
		</subject>
		<subject lang="eng">
			<topic>p53 messenger RNA</topic>
		</subject>
		<subject lang="eng">
			<topic>ATM kinase</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;p53 is an intrinsically disordered protein with a large number of post-translational modifications and interacting partners. The hierarchical order and subcellular location of these events are still poorly understood. The activation of p53 during the DNA damage response (DDR) requires a switch in the activity of the E3 ubiquitin ligase MDM2 from a negative to a positive regulator of p53. This is mediated by the ATM kinase that regulates the binding of MDM2 to the p53 mRNA facilitating an increase in p53 synthesis. Here we show that the binding of MDM2 to the p53 mRNA brings ATM to the p53 polysome where it phosphorylates the nascent p53 at serine 15 and prevents MDM2-mediated degradation of p53. A single synonymous mutation in p53 codon 22 (L22L) prevents the phosphorylation of the nascent p53 protein and the stabilization of p53 following genotoxic stress. The ATM trafficking from the nucleus to the p53 polysome is mediated by MDM2, which requires its interaction with the ribosomal proteins RPL5 and RPL11. These results show how the ATM kinase phosphorylates the p53 protein while it is being synthesized and offer a novel mechanism whereby a single synonymous mutation controls the stability and activity of the encoded protein.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Molecular Cell Biology</title>
			</titleInfo>
			<identifier type="issn">1674-2788</identifier>
			<identifier type="eissn">1759-4685</identifier>
			<part>
				<detail type="volume">
					<number>11</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>187</start>
					<end>199</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-12</recordCreationDate>
			<recordChangeDate>2019-06-12</recordChangeDate>
			<recordIdentifier>diva2:1323475</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Alexandersson</namePart>
			<namePart type="given">Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Eugen Yuhui</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="ster0001">
			<namePart type="family">Eriksson</namePart>
			<namePart type="given">Staffan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för fysioterapi</affiliation>
			<affiliation>Centre for Clinical Research Sörmland, Uppsala University, Kungsgatan 41, 631 88 Eskilstuna, Sweden; Department of Neuroscience, Physiotherapy, Uppsala University, Box 593, 751 24 Uppsala, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63616</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881555">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<namePart>Avdelningen för fysioterapi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A small difference in recovery between total knee arthroplasty with and without tourniquet use the first 3 months after surgery</title>
			<subTitle>a randomized controlled study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-15T09:53:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158086</identifier>
		<identifier type="doi">10.1007/s00167-018-5196-8</identifier>
		<identifier type="pmid">30328495</identifier>
		<identifier type="isi">000462637500005</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s00167-018-5196-8</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Total knee arthroplasty</topic>
		</subject>
		<subject lang="eng">
			<topic>Tourniquet</topic>
		</subject>
		<subject lang="eng">
			<topic>Rehabilitation</topic>
		</subject>
		<subject lang="eng">
			<topic>Surgery</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30212">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Surgery</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30212">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kirurgi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30211">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Orthopaedics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30211">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Ortopedi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Purpose: When a tourniquet is used during surgery on the extremities, the pressure applied to the muscles, nerves and blood vessels can cause neuromuscular damage that contributes to postoperative weakness. The hypothesis was that the rehabilitation-related results would be improved if total knee arthroplasty (TKA) is performed without the use of a tourniquet.&lt;/p&gt;&lt;p&gt;Methods: 81 patients with osteoarthritis of the knee who underwent TKA surgery were randomized to surgery with or without tourniquet. Active flexion and extension of the knee, pain by visual analog scale (VAS), swelling by knee circumference, quadriceps function by straight leg raise, and timed up and go (TUG) test results were measured before and up to 3 months after surgery.&lt;/p&gt;&lt;p&gt;Results: ANCOVA revealed no between-groups effect for flexion of the knee at day 3 postsurgery. Compared with the tourniquet group, the nontourniquet group experienced elevated pain at 24 h, with a mean difference of 16.6 mm, &lt;em&gt;p&lt;/em&gt; = 0.005. The effect on mobility (TUG test) at 3 months was better in the nontourniquet group, with a mean difference of -1.1 s, &lt;em&gt;p&lt;/em&gt; = 0.029.&lt;/p&gt;&lt;p&gt;Conclusions: The hypothesis that the rehabilitation-related results would be improved without a tourniquet is not supported by the results. When the results in this study for surgery performed with and without tourniquet are compared, no clear benefit for either procedure was observed, as the more pain exhibited by the nontourniquet group was only evident for a short period and the improved mobility in this group was not at a clinically relevant level.&lt;/p&gt;&lt;p&gt;Level of evidence: Inconsistent results, Level II.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Knee Surgery, Sports Traumatology, Arthroscopy</title>
			</titleInfo>
			<identifier type="issn">0942-2056</identifier>
			<identifier type="eissn">1433-7347</identifier>
			<part>
				<detail type="volume">
					<number>27</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>1035</start>
					<end>1042</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1304889/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-15</recordCreationDate>
			<recordChangeDate>2019-04-15</recordChangeDate>
			<recordIdentifier>diva2:1304889</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Fox</namePart>
			<namePart type="given">Adam T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wopereis</namePart>
			<namePart type="given">Harm</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Van Ampting</namePart>
			<namePart type="given">Marleen T. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nijhuis</namePart>
			<namePart type="given">Manon M. Oude</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Butt</namePart>
			<namePart type="given">Assad M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peroni</namePart>
			<namePart type="given">Diego G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vandenplas</namePart>
			<namePart type="given">Yvan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Candy</namePart>
			<namePart type="given">David C. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shah</namePart>
			<namePart type="given">Neil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="chwe0024">
			<namePart type="family">West</namePart>
			<namePart type="given">Christina E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:62734</description>
		</name>
		<name type="personal">
			<namePart type="family">Garssen</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Harthoorn</namePart>
			<namePart type="given">Lucien F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Knol</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Michaelis</namePart>
			<namePart type="given">Louise J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Smets</namePart>
			<namePart type="given">Francoise</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mullier</namePart>
			<namePart type="given">Sandra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Noimark</namePart>
			<namePart type="given">Lee</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Muraro</namePart>
			<namePart type="given">Antonella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="739">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Pediatrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A specific synbiotic-containing amino acid-based formula in dietary management of cow's milk allergy</title>
			<subTitle>a randomized controlled trial</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-28T13:15:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155758</identifier>
		<identifier type="doi">10.1186/s13601-019-0241-3</identifier>
		<identifier type="pmid">30651972</identifier>
		<identifier type="isi">000455597600001</identifier>
		<identifier type="articleId">5</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s13601-019-0241-3</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Bifidobacterium breve M-16V</topic>
		</subject>
		<subject lang="eng">
			<topic>Gut microbiota</topic>
		</subject>
		<subject lang="eng">
			<topic>Prebiotic</topic>
		</subject>
		<subject lang="eng">
			<topic>Probiotic</topic>
		</subject>
		<subject lang="eng">
			<topic>Cow's milk allergy</topic>
		</subject>
		<subject lang="eng">
			<topic>Symptoms</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30213">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Gastroenterology and Hepatology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30213">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Gastroenterologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Here we report follow-up data from a double-blind, randomized, controlled multicenter trial, which investigated fecal microbiota changes with a new amino acid-based formula (AAF) including synbiotics in infants with non-immunoglobulin E (IgE)-mediated cow’s milk allergy (CMA).&lt;/p&gt;&lt;p&gt;Methods: Subjects were randomized to receive test product (AAF including fructo-oligosaccharides and &lt;em&gt;Bifidobacterium breve&lt;/em&gt; M-16V) or control product (AAF) for 8 weeks, after which infants could continue study product until 26 weeks. Fecal percentages of bifidobacteria and &lt;em&gt;Eubacterium rectale&lt;/em&gt;/&lt;em&gt;Clostridium coccoides&lt;/em&gt;group (&lt;em&gt;ER/CC&lt;/em&gt;) were assessed at 0, 8, 12, and 26 weeks. Additional endpoints included stool markers of gut immune status, clinical symptoms, and safety assessments including adverse events and medication use.&lt;/p&gt;&lt;p&gt;Results: The trial included 35 test subjects, 36 controls, and 51 in the healthy reference group. Study product was continued by 86% and 92% of test and control subjects between week 8–12, and by 71% and 80%, respectively until week 26. At week 26 median percentages of bifidobacteria were significantly higher in test than control [47.0% vs. 11.8% (&lt;em&gt;p&lt;/em&gt; &amp;lt; 0.001)], whereas percentages of &lt;em&gt;ER/CC&lt;/em&gt; were significantly lower [(13.7% vs. 23.6% (&lt;em&gt;p&lt;/em&gt; = 0.003)]. Safety parameters were similar between groups. Interestingly use of dermatological medication and reported ear infections were lower in test versus control, &lt;em&gt;p&lt;/em&gt; = 0.019 and 0.011, respectively. Baseline clinical symptoms and stool markers were mild (but persistent) and low, respectively. Symptoms reduced towards lowest score in both groups.&lt;/p&gt;&lt;p&gt;Conclusion: Beneficial effects of this AAF including specific synbiotics on microbiota composition were observed over 26 weeks, and shown suitable for dietary management of infants with non-IgE-mediated CMA.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Clinical and Translational Allergy</title>
			</titleInfo>
			<identifier type="issn">2045-7022</identifier>
			<identifier type="eissn">2045-7022</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1283170/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-28</recordCreationDate>
			<recordChangeDate>2019-09-05</recordChangeDate>
			<recordIdentifier>diva2:1283170</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Wopereis</namePart>
			<namePart type="given">Harm</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Ampting</namePart>
			<namePart type="given">Marleen T. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cetinyurek-Yavuz</namePart>
			<namePart type="given">Aysun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Slump</namePart>
			<namePart type="given">Rob</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Candy</namePart>
			<namePart type="given">David C. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Butt</namePart>
			<namePart type="given">Assad M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peroni</namePart>
			<namePart type="given">Diego G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vandenplas</namePart>
			<namePart type="given">Yvan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fox</namePart>
			<namePart type="given">Adam T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shah</namePart>
			<namePart type="given">Neil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Roeselers</namePart>
			<namePart type="given">Guus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Harthoorn</namePart>
			<namePart type="given">Lucien F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Michaelis</namePart>
			<namePart type="given">Louise J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Knol</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="chwe0024">
			<namePart type="family">West</namePart>
			<namePart type="given">Christina E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:62734</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="739">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Pediatrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A specific synbiotic-containing amino acid-based formula restores gut microbiota in non-IgE mediated cow's milk allergic infants</title>
			<subTitle>a randomized controlled trial</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BMC</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-24T10:54:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-160608</identifier>
		<identifier type="doi">10.1186/s13601-019-0267-6</identifier>
		<identifier type="pmid">31164972</identifier>
		<identifier type="isi">000469809400001</identifier>
		<identifier type="articleId">27</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s13601-019-0267-6</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Cow's milk allergy</topic>
		</subject>
		<subject lang="eng">
			<topic>Pediatrics</topic>
		</subject>
		<subject lang="eng">
			<topic>Gut microbiota</topic>
		</subject>
		<subject lang="eng">
			<topic>Prebiotics</topic>
		</subject>
		<subject lang="eng">
			<topic>Probiotics</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30304">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nutrition and Dietetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30304">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Näringslära</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Altered gut microbiota is implicated in cow’s milk allergy (CMA) and differs markedly from healthy, breastfed infants. Infants who suffer from severe CMA often rely on cow’s milk protein avoidance and, when breastfeeding is not possible, on specialised infant formulas such as amino-acid based formulas (AAF). Herein, we report the effects of an AAF including specific synbiotics on oral and gastrointestinal microbiota of infants with non-IgE mediated CMA with reference to healthy, breastfed infants.&lt;/p&gt;&lt;p&gt;Methods: In this prospective, randomized, double-blind controlled study, infants with suspected non-IgE mediated CMA received test or control formula. Test formula was AAF with synbiotics (prebiotic fructo-oligosaccharides and probiotic &lt;em&gt;Bifidobacterium breve&lt;/em&gt; M-16V). Control formula was AAF without synbiotics. Healthy, breastfed infants were used as a separate reference group (HBR). Bacterial compositions of faecal and salivary samples were analysed by 16S rRNA-gene sequencing. Faecal analysis was complemented with the analysis of pH, short-chain fatty acids (SCFAs) and lactic acids.&lt;/p&gt;&lt;p&gt;Results: The trial included 35 test subjects, 36 controls, and 51 HBR. The 16S rRNA-gene sequencing revealed moderate effects of test formula on oral microbiota. In contrast, the gut microbiota was substantially affected across time comparing test with control. In both groups bacterial diversity increased over time but was characterised by a more gradual increment in test compared to control. Compositionally this reflected an enhancement of &lt;em&gt;Bifidobacterium&lt;/em&gt; spp. and &lt;em&gt;Veillonella&lt;/em&gt; sp. in the test group. In contrast, the control-fed infants showed increased abundance of adult-like species, mainly within the &lt;em&gt;Lachnospiraceae&lt;/em&gt;family, as well as within the &lt;em&gt;Ruminococcus&lt;/em&gt; and &lt;em&gt;Alistipes&lt;/em&gt; genus. The effects on &lt;em&gt;Bifidobacterium&lt;/em&gt; spp. and &lt;em&gt;Lachnospiraceae&lt;/em&gt; spp. were previously confirmed through enumeration by fluorescent in situ hybridization and were shown for test to approximate the proportions observed in the HBR. Additionally, microbial activity was affected as evidenced by an increase of l-lactate, a decrease of valerate, and reduced concentrations of branched-chain SCFAs in test versus control.&lt;/p&gt;&lt;p&gt;Conclusions: The AAF including specific synbiotics effectively modulates the gut microbiota and its metabolic activity in non-IgE mediated CMA infants bringing it close to a healthy breastfed profile.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Clinical and Translational Allergy</title>
			</titleInfo>
			<identifier type="issn">2045-7022</identifier>
			<identifier type="eissn">2045-7022</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1329021/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-24</recordCreationDate>
			<recordChangeDate>2019-09-05</recordChangeDate>
			<recordIdentifier>diva2:1329021</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Jacquier</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-1974-8161</description>
		</name>
		<name type="personal" authority="umu" xlink:href="akya0002">
			<namePart type="family">Yadav</namePart>
			<namePart type="given">Akhilesh K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:68723</description>
		</name>
		<name type="personal">
			<namePart type="family">Pillonel</namePart>
			<namePart type="given">Trestan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Viollier</namePart>
			<namePart type="given">Patrick H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="feca0003">
			<namePart type="family">Cava</namePart>
			<namePart type="given">Felipe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:62587</description>
		</name>
		<name type="personal">
			<namePart type="family">Greub</namePart>
			<namePart type="given">Gilbert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A SpoIID Homolog Cleaves Glycan Strands at the Chlamydial Division Septum</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Society for Microbiology (ASM)</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-04T08:55:15</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162887</identifier>
		<identifier type="doi">10.1128/mBio.01128-19</identifier>
		<identifier type="pmid">31311880</identifier>
		<identifier type="isi">000481617000036</identifier>
		<identifier type="articleId">e01128-19</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Chlamydiales</topic>
		</subject>
		<subject lang="eng">
			<topic>Waddlia chondrophila</topic>
		</subject>
		<subject lang="eng">
			<topic>cell division</topic>
		</subject>
		<subject lang="eng">
			<topic>peptidoglycan</topic>
		</subject>
		<subject lang="eng">
			<topic>sporulation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30109">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Microbiology in the medical area</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30109">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Mikrobiologi inom det medicinska området</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Chlamydiales species are obligate intracellular bacteria lacking a classical peptidoglycan sacculus but relying on peptidoglycan synthesis for cytokinesis. While septal peptidoglycan biosynthesis seems to be regulated by MreB actin and its membrane anchor RodZ rather than FtsZ tubulin in Chlamydiales, the mechanism of peptidoglycan remodeling is poorly understood. An amidase conserved in Chlamydiales is able to cleave peptide stems in peptidoglycan, but it is not clear how peptidoglycan glycan strands are cleaved since no classical lytic transglycosylase is encoded in chlamydial genomes. However, a protein containing a SpoIID domain, known to possess transglycosylase activity in Bacillus subtilis, is conserved in Chiamydiales. We show here that the SpoIID homologue of the Chlamydia-related pathogen Waddlia chondrophila is a septal peptidoglycan-binding protein. Moreover, we demonstrate that SpoIID acts as a lytic transglycosylase on peptidoglycan and as a muramidase on denuded glycan strands in vitro. As SpoIID-like proteins are widespread in nonsporulating bacteria, SpoIID might commonly be a septal peptidoglycan remodeling protein in bacteria, including obligate intracellular pathogens, and thus might represent a promising drug target. IMPORTANCE Chlamydiales species are obligate intracellular bacteria and important human pathogens that have a minimal division machinery lacking the proteins that are essential for bacterial division in other species, such as FtsZ. Chlamydial division requires synthesis of peptidoglycan, which forms a ring at the division septum and is rapidly turned over. However, little is known of peptidoglycan degradation, because many peptidoglycan-degrading enzymes are not encoded by chlamydial genomes. Here we show that an homologue of SpoIID, a peptidoglycan-degrading enzyme involved in sporulation of bacteria such as Bacillus subtilis, is expressed in Chlamydiales, localizes at the division septum, and degrades peptidoglycan in vitro, indicating that SpoIID is not only involved in sporulation but also likely implicated in division of some bacteria.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>mBio</title>
			</titleInfo>
			<identifier type="issn">2161-2129</identifier>
			<identifier type="eissn">2150-7511</identifier>
			<part>
				<detail type="volume">
					<number>10</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-04</recordCreationDate>
			<recordChangeDate>2019-09-04</recordChangeDate>
			<recordIdentifier>diva2:1348327</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="cegr4904">
			<namePart type="family">Gürkan</namePart>
			<namePart type="given">Ceren</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:71989</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anma0561">
			<namePart type="family">Massing</namePart>
			<namePart type="given">André</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>Department of Mathematical Sciences, Norwegian University of Science and Technology, NO 7491, Trondheim, Norway</affiliation>
			<description>diva-portal.org=authority-person:71991</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A stabilized cut discontinuous Galerkin framework for elliptic boundary value and interface problems</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-15T13:16:33</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158064</identifier>
		<identifier type="doi">10.1016/j.cma.2018.12.041</identifier>
		<identifier type="isi">000462472400019</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Elliptic problems</topic>
		</subject>
		<subject lang="eng">
			<topic>Discontinuous Galerkin</topic>
		</subject>
		<subject lang="eng">
			<topic>Cut finite element method</topic>
		</subject>
		<subject lang="eng">
			<topic>Stabilization</topic>
		</subject>
		<subject lang="eng">
			<topic>Condition number</topic>
		</subject>
		<subject lang="eng">
			<topic>A priori error estimates</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10105">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Computational Mathematics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10105">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Beräkningsmatematik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;We develop a stabilized cut discontinuous Galerkin framework for the numerical solution of elliptic boundary value and interface problems on complicated domains. The domain of interest is embedded in a structured, unfitted background mesh in R d , so that the boundary or interface can cut through it in an arbitrary fashion. The method is based on an unfitted variant of the classical symmetric interior penalty method using piecewise discontinuous polynomials defined on the background mesh. Instead of the cell agglomeration technique commonly used in previously introduced unfitted discontinuous Galerkin methods, we employ and extend ghost penalty techniques from recently developed continuous cut finite element methods, which allows for a minimal extension of existing fitted discontinuous Galerkin software to handle unfitted geometries. Identifying four abstract assumptions on the ghost penalty, we derive geometrically robust a priori error and condition number estimates for the Poisson boundary value problem which hold irrespective of the particular cut configuration. Possible realizations of suitable ghost penalties are discussed. We also demonstrate how the framework can be elegantly applied to discretize high contrast interface problems. The theoretical results are illustrated by a number of numerical experiments for various approximation orders and for two and three-dimensional test problems. (C) 2018 Published by Elsevier B.V.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Computer Methods in Applied Mechanics and Engineering</title>
			</titleInfo>
			<identifier type="issn">0045-7825</identifier>
			<identifier type="eissn">1879-2138</identifier>
			<part>
				<detail type="volume">
					<number>348</number>
				</detail>
				<extent>
					<start>466</start>
					<end>499</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Kempestiftelserna [JCK-1612]</note>
		<note type="funder">Vetenskapsrådet [2017-05038]</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-15</recordCreationDate>
			<recordChangeDate>2019-04-15</recordChangeDate>
			<recordIdentifier>diva2:1305016</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="ancl0002">
			<namePart type="family">Claeson</namePart>
			<namePart type="given">Anna-Sara</namePart>
			<namePart type="date">1974-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>orcid.org=0000-0001-5026-4934</description>
			<description>diva-portal.org=authority-person:63418</description>
		</name>
		<name type="personal" authority="umu" xlink:href="sago0010">
			<namePart type="family">Gouveia-Figueira</namePart>
			<namePart type="given">Sandra C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Swedish Metabolomics Centre (SMC), Umeå, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63378</description>
		</name>
		<name type="personal">
			<namePart type="family">Stenlund</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Swedish Metabolomics Centre (SMC), Umeå, Sweden</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Annika I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Swedish Metabolomics Centre (SMC), Umeå, Sweden</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A standardized protocol for comparable analysis of GSH/GSSG by UHPLC-ESI-MSMS for human plasma</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-02-20T13:32:17</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156612</identifier>
		<identifier type="doi">10.1016/j.jchromb.2018.11.007</identifier>
		<identifier type="pmid">30445289</identifier>
		<identifier type="isi">000456890000008</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>GIutathione</topic>
		</subject>
		<subject lang="eng">
			<topic>GSH</topic>
		</subject>
		<subject lang="eng">
			<topic>GSSG</topic>
		</subject>
		<subject lang="eng">
			<topic>Plasma</topic>
		</subject>
		<subject lang="eng">
			<topic>Sample pre-processing</topic>
		</subject>
		<subject lang="eng">
			<topic>UHPLC-ESI-MS</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10401">
			<topic>Natural Sciences</topic>
			<topic>Chemical Sciences</topic>
			<topic>Analytical Chemistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10401">
			<topic>Naturvetenskap</topic>
			<topic>Kemi</topic>
			<topic>Analytisk kemi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Variability in the levels of GSH and GSSG in plasma is suggested to derive from inadequate pre-processing methods. The aim of this study was to develop a protocol for comparable and reliable measurements of GSH/GSSG. Venous blood from 8 healthy individuals were collected and divided into 7 different pre-processing procedures. For three of the samples an extraction mixture was added after 0 (baseline), 4 and 8 min and for three of the samples the extraction mixture was added at different times during defrost. A worst case scenario where a sample was left in a cool box during 6 h was also included. The samples were analyzed with UHPLC-ESIMSMS. A large difference in the levels of GSH and GSSG were identified and it was clearly associated with the sample handling procedures. A sample left untreated for 4 min will have significantly reduced amount of GSH. Stability tests showed that the level of GSH was reduced after 3 months in -80 degrees C.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of chromatography. B</title>
			</titleInfo>
			<identifier type="issn">1570-0232</identifier>
			<identifier type="eissn">1873-376X</identifier>
			<part>
				<detail type="volume">
					<number>1104</number>
				</detail>
				<extent>
					<start>67</start>
					<end>72</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Forskningsrådet Formas [2014-1229]</note>
		<note type="funder">Forskningsrådet Formas [2016-1110]</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-02-20</recordCreationDate>
			<recordChangeDate>2019-02-20</recordChangeDate>
			<recordIdentifier>diva2:1290348</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="than0001">
			<namePart type="family">Bjärstig</namePart>
			<namePart type="given">Therese</namePart>
			<namePart type="termsOfAddress">Docent</namePart>
			<namePart type="date">1978-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Statsvetenskapliga institutionen</affiliation>
			<description>orcid.org=0000-0002-6845-5525</description>
			<description>diva-portal.org=authority-person:64521</description>
		</name>
		<name type="personal" authority="umu" xlink:href="casa0004">
			<namePart type="family">Sandström</namePart>
			<namePart type="given">Camilla</namePart>
			<namePart type="termsOfAddress">Professor</namePart>
			<namePart type="date">1967-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Statsvetenskapliga institutionen</affiliation>
			<description>orcid.org=0000-0002-7674-6197</description>
			<description>diva-portal.org=authority-person:62422</description>
		</name>
		<name type="personal">
			<namePart type="family">Sjögren</namePart>
			<namePart type="given">Jörgen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Wildlife, Fish and Environmental Studies, Swedish University of Agricultural Sciences (SLU), Umeå, Sweden</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Sonesson</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Forestry Management, Forestry Research Institute of Sweden (Skogsforsk), Uppsala</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Nordin</namePart>
			<namePart type="given">Annika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences (SLU), Umeå, Sweden</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="852">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Statsvetenskapliga institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A struggling collaborative process</title>
			<subTitle>revisiting the woodland key habitat concept in Swedish forests</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis Group</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-01T10:23:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163501</identifier>
		<identifier type="doi">10.1080/02827581.2019.1674916</identifier>
		<identifier type="isi">000506918500001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/02827581.2019.1674916</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>evaluation</topic>
		</subject>
		<subject lang="eng">
			<topic>collaboration</topic>
		</subject>
		<subject lang="eng">
			<topic>woodland key habitat</topic>
		</subject>
		<subject lang="eng">
			<topic>inventories</topic>
		</subject>
		<subject lang="eng">
			<topic>forest</topic>
		</subject>
		<subject lang="eng">
			<topic>Sweden</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50901">
			<topic>Social Sciences</topic>
			<topic>Other Social Sciences</topic>
			<topic>Social Sciences Interdisciplinary</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50901">
			<topic>Samhällsvetenskap</topic>
			<topic>Annan samhällsvetenskap</topic>
			<topic>Tvärvetenskapliga studier inom samhällsvetenskap</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50401">
			<topic>Sociology</topic>
			<topic>Sociology (excluding Social Work, Social Psychology and Social Anthropology)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50401">
			<topic>Sociologi</topic>
			<topic>Sociologi (exklusive socialt arbete, socialpsykologi och socialantropologi)</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50701">
			<topic>Social and Economic Geography</topic>
			<topic>Human Geography</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50701">
			<topic>Social och ekonomisk geografi</topic>
			<topic>Kulturgeografi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The term woodland key habitat (WKH) was launched in Sweden in 1990. Definitions for the concept have changed over the years, and today the WKH concept and its application are issues of debate in Sweden. Consequently, the Swedish Forestry Agency (SFA) initiated a collaborative process including forest stakeholders with the purpose to clarify the application and develop the inventory methodology of WKH. We have studied, by means of interviews and observations, participant perceptions of how endogenous and exogenous factors affect the collaborative process. During our research, we identified three game changers: the pause in WKH registration in northwestern Sweden that caused several participants to drop out of the process; budget allocations for new nationwide WKH inventories that put the process on hold; and formal instructions from the government that came nine months later and essentially re-initiated the collaborative process. Altogether, this not only affected the participants’ abilities, understanding and willingness to participate, but also the overall legitimacy of the process – indicating the difficulty of conducting policy development in collaborative form, especially when it is highly politicized since it impact on the participants’ anticipation of the process and its end results.&lt;/p&gt;</abstract>
		<note type="project">Future Forests</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Scandinavian Journal of Forest Research</title>
			</titleInfo>
			<identifier type="issn">0282-7581</identifier>
			<identifier type="eissn">1651-1891</identifier>
			<part>
				<detail type="volume">
					<number>34</number>
				</detail>
				<detail type="issue">
					<number>8</number>
				</detail>
				<extent>
					<start>699</start>
					<end>708</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1356213/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>than0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-01</recordCreationDate>
			<recordChangeDate>2020-02-04</recordChangeDate>
			<recordIdentifier>diva2:1356213</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Gjesdal</namePart>
			<namePart type="given">Siv</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anslil01">
			<namePart type="family">Stenling</namePart>
			<namePart type="given">Andreas</namePart>
			<namePart type="date">1982-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<affiliation>Department of Psychology, University of  Gothenburg, Gothenburg, Sweden; Department of Psychology, University of Otago, Dunedin, New Zealand</affiliation>
			<description>diva-portal.org=authority-person:64150</description>
		</name>
		<name type="personal">
			<namePart type="family">Solstad</namePart>
			<namePart type="given">Bård E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ommundsen</namePart>
			<namePart type="given">Yngvar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A study of coach-team perceptual distance concerning the coach-created motivational climate in youth sport</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-29T12:38:02</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159425</identifier>
		<identifier type="doi">10.1111/sms.13306</identifier>
		<identifier type="pmid">30230049</identifier>
		<identifier type="isi">000467371900014</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>coach behavior</topic>
		</subject>
		<subject lang="eng">
			<topic>Motivation</topic>
		</subject>
		<subject lang="eng">
			<topic>youth sport</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30308">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Sport and Fitness Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30308">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Idrottsvetenskap</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The purpose of this study was to examine whether coach-team perceptual distance regarding the coach-created motivational climate related to achievement goal orientations and affective responses. To this end, we used polynomial regression analysis with response surface methodology. The sample consisted of 1359 youth soccer players (57.8% male; M-age = 11.81 years, SD = 1.18), belonging to 87 different teams (M-size = 16.47), and 87 coaches (94.6% male, M-age = 42 years, SD = 5.67). Results showed that team perceptions of a coach-created mastery climate were positively related to team-rated task goal orientation and enjoyment, whereas team perceptions of a coach-created performance climate were positively related to team-rated ego goal orientation and anxiety, and negatively related to team-rated enjoyment. When the coach and the team were in perceptual agreement, the outcomes increased as both coach and team perceptions of the climate increased. In situations of perceptual disagreement, the most negative effects were seen when the coach held a more favorable perception of the motivational climate compared to the team. The findings highlight the importance of perceptual agreement between the coach and his/her team, contributing to the literature focusing on the effects of the coach-created motivational climate.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Scandinavian Journal of Medicine and Science in Sports</title>
			</titleInfo>
			<identifier type="issn">0905-7188</identifier>
			<identifier type="eissn">1600-0838</identifier>
			<part>
				<detail type="volume">
					<number>29</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>132</start>
					<end>143</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-29</recordCreationDate>
			<recordChangeDate>2019-05-29</recordChangeDate>
			<recordIdentifier>diva2:1319033</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="anol0004">
			<namePart type="family">Olofsson</namePart>
			<namePart type="given">Anders D.</namePart>
			<namePart type="date">1973-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad utbildningsvetenskap</affiliation>
			<description>orcid.org=0000-0001-8409-0557</description>
			<description>diva-portal.org=authority-person:10247</description>
		</name>
		<name type="personal">
			<namePart type="family">Fransson</namePart>
			<namePart type="given">Göran</namePart>
			<namePart type="date">1968-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Högskolan i Gävle</affiliation>
			<description>orcid.org=0000-0002-5592-2964</description>
		</name>
		<name type="personal" authority="umu" xlink:href="olli0036">
			<namePart type="family">Lindberg</namePart>
			<namePart type="given">J. Ola</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pedagogiska institutionen</affiliation>
			<description>orcid.org=0000-0002-0941-9364</description>
			<description>diva-portal.org=authority-person:54131</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="5301">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad utbildningsvetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="845">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Pedagogiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A study of the use of digital technology and its conditions with a view to understanding what 'adequate digital competence' may mean in a national policy initiative</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Routledge</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-15T10:20:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162147</identifier>
		<identifier type="doi">10.1080/03055698.2019.1651694</identifier>
		<identifier type="isi">000481124500001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/03055698.2019.1651694</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Digital competence</topic>
		</subject>
		<subject lang="eng">
			<topic>teacher</topic>
		</subject>
		<subject lang="eng">
			<topic>national policy strategy</topic>
		</subject>
		<subject lang="eng">
			<topic>upper secondary school</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50304">
			<topic>Social Sciences</topic>
			<topic>Educational Sciences</topic>
			<topic>Pedagogical Work</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50304">
			<topic>Samhällsvetenskap</topic>
			<topic>Utbildningsvetenskap</topic>
			<topic>Pedagogiskt arbete</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="9450">
			<topic>pedagogiskt arbete</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="9450">
			<topic>educational work</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;In Sweden, adequate digital competence has been put in the spotlight due to the Swedish 2017 national strategy for the digitalisation of the K-12 school system. Based on both policy and practice, the aim is to explore teachers' enacted digital competence in three upper secondary schools in Sweden and thereby provide an empirical account of what the notion 'adequate' means in practice. The data consists of interviews with teachers and classroom observations. At an aggregated analytical level, the results are presented as four narrative sub-case descriptions. It is concluded that teachers' adequate digital competence is flexible in meaning, determined by local contextual conditions and enacted in activities and decisions that are based on the teachers' own value frameworks. The understanding of 'adequate' in this study does not appear to be clarified in the formulations used in the national strategy.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Educational studies (Dorchester-on-Thames)</title>
			</titleInfo>
			<identifier type="issn">0305-5698</identifier>
			<identifier type="eissn">1465-3400</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<note type="funder">Vetenskapsrådet [2014-1762]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1342984/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>anol0004</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-15</recordCreationDate>
			<recordChangeDate>2020-01-22</recordChangeDate>
			<recordIdentifier>diva2:1342984</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Nilsson</namePart>
			<namePart type="given">Christina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="wosp0001">
			<namePart type="family">Sperker</namePart>
			<namePart type="given">Wolfgang</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:74173</description>
		</name>
		<name type="personal" authority="umu" xlink:href="clsc0014">
			<namePart type="family">Schien</namePart>
			<namePart type="given">Claudia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:74172</description>
		</name>
		<name type="personal">
			<namePart type="family">Isaksson</namePart>
			<namePart type="given">Malin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="best0006">
			<namePart type="family">Stegmayr</namePart>
			<namePart type="given">Bernd</namePart>
			<namePart type="date">1949-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Medicinkliniken, Norrlands Universitetssjukhus, Umeå, Sweden</affiliation>
			<description>orcid.org=0000-0003-2694-7035</description>
			<description>diva-portal.org=authority-person:62791</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A surgical girdle postoperatively may prevent pain and tunnel infections of peritoneal dialysis patients</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-13T16:05:29</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165106</identifier>
		<identifier type="doi">10.1177/0391398819882439</identifier>
		<identifier type="pmid">31648577</identifier>
		<identifier type="isi">000492623700001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Peritoneal dialysis</topic>
		</subject>
		<subject lang="eng">
			<topic>insertion technique</topic>
		</subject>
		<subject lang="eng">
			<topic>wound healing</topic>
		</subject>
		<subject lang="eng">
			<topic>leakage</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30214">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Urology and Nephrology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30214">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Urologi och njurmedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Aim: When performing acute onset dialysis after insertion of catheters for peritoneal dialysis, pain exists and tunnel infections may develop. This study investigated whether patients benefit from the use of a surgical girdle and specific dressing postoperatively to prevent pain and tunnel infections.&lt;/p&gt;&lt;p&gt;Materials and Methods: In 85 consecutive patients, the development of tunnel infections was followed. The patients used a surgical girdle when they were in supine position from day 1 to day 3. The peritoneal dialysis catheter was fixed in a curvature avoiding stretch in the exit. A total of 53 patients participated in a retrospective questionnaire to evaluate abdominal pain within the first 3 days after surgery either with or without girdle. A visual analogue scale from 0 to 10 was used.&lt;/p&gt;&lt;p&gt;Results: In 23 patients, data on pain both with and without the girdle could be recorded. Pain was relieved more when using the girdle versus no girdle (median day 1 3.0 vs 4.0, p &amp;lt; 0.001, n = 30, Wilcoxon paired). The development of tunnel infections during the latest 7-year period (exposure period 1487 months) showed a total of three episodes (one every 495 months) of which one caused a subsequent peritonitis, while the other two resolved after antibiotic therapy. Peritonitis episodes appeared at a mean of 37-month interval.&lt;/p&gt;&lt;p&gt;Conclusion: The use a surgical girdle for 3 days postoperatively and a fixation of the peritoneal dialysis catheter in a curved loop relieves the pain and results in few tunnel infections and subsequent episodes of peritonitis.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Artificial Organs</title>
			</titleInfo>
			<identifier type="issn">0391-3988</identifier>
			<identifier type="eissn">1724-6040</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-13</recordCreationDate>
			<recordChangeDate>2019-11-13</recordChangeDate>
			<recordIdentifier>diva2:1370010</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Byskov</namePart>
			<namePart type="given">Jens</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>University of Zambia</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Maluka</namePart>
			<namePart type="given">Stephen A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>University of Dar Es Salaam, Tanzania</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Marchal</namePart>
			<namePart type="given">Bruno</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Shayo</namePart>
			<namePart type="given">Elizabeth H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>National Institute for Medical Research (NIMR), Dar Es Salaam, Tanzania</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Blystad</namePart>
			<namePart type="given">Astrid</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Global Health and Primary Care, University of Bergen, Norway</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Bukachi</namePart>
			<namePart type="given">Salome</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Institute of Anthropology, Gender and African Studies University of Nairobi, Nairobi, Kenya</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Zulu</namePart>
			<namePart type="given">Joseph M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>School of Public Health, Ridgeway Campus, University of Zambia, Lusaka, Zambia</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Michelo</namePart>
			<namePart type="given">Charles</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>School of Public Health, Ridgeway Campus, University of Zambia, Lusaka, Zambia</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="anhu0001">
			<namePart type="family">Hurtig</namePart>
			<namePart type="given">Anna-Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0001-7087-1467</description>
			<description>diva-portal.org=authority-person:62484</description>
		</name>
		<name type="personal">
			<namePart type="family">Bloch</namePart>
			<namePart type="given">Paul</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Steno Diabetes Center Copenhagen, Niels Steensens Vej 6, Gentofte, Denmark</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A systems perspective on the importance of global health strategy developments for accomplishing today’s Sustainable Development Goals</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-20T14:41:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162434</identifier>
		<identifier type="doi">10.1093/heapol/czz042</identifier>
		<identifier type="pmid">31363736</identifier>
		<identifier type="scopus">2-s2.0-85075814243</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1093/heapol/czz042</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Accountability</topic>
		</subject>
		<subject lang="eng">
			<topic>democracy</topic>
		</subject>
		<subject lang="eng">
			<topic>determinants</topic>
		</subject>
		<subject lang="eng">
			<topic>developing countries</topic>
		</subject>
		<subject lang="eng">
			<topic>ethics</topic>
		</subject>
		<subject lang="eng">
			<topic>health systems</topic>
		</subject>
		<subject lang="eng">
			<topic>organizational change</topic>
		</subject>
		<subject lang="eng">
			<topic>outcomes</topic>
		</subject>
		<subject lang="eng">
			<topic>participation</topic>
		</subject>
		<subject lang="eng">
			<topic>priority setting</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30301">
			<topic>Health Care Service and Management, Health Policy and Services and Health Economy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30301">
			<topic>Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Priority setting within health systems has not led to accountable, fair and sustainable solutions to improving population health. Providers, users and other stakeholders each have their own health and service priorities based on selected evidence, own values, expertise and preferences. Based on a historical account, this article analyses if contemporary health systems are appropriate to optimize population health within the framework of cross cutting targets of the Sustainable Development Goals (SDGs). We applied a scoping review approach to identify and review literature of scientific databases and other programmatic web and library-based documents on historical and contemporary health systems policies and strategies at the global level. Early literature supported the 1977 launching of the global target of Health for All by the year 2000. Reviewed literature was used to provide a historical overview of systems components of global health strategies through describing the conceptualizations of health determinants, user involvement and mechanisms of priority setting over time, and analysing the importance of historical developments on barriers and opportunities to accomplish the SDGs. Definitions, scope and application of health systems-associated priority setting fluctuated and main health determinants and user influence on global health systems and priority setting remained limited. In exploring reasons for the identified lack of SDG-associated health systems and priority setting processes, we discuss issues of accountability, vested interests, ethics and democratic legitimacy as conditional for future sustainability of population health. To accomplish the SDGs health systems must engage beyond their own sector boundary. New approaches to Health in All Policies and One Health may be conducive for scaling up more democratic and inclusive priority setting processes based on proper process guidelines from successful pilots. Sustainable development depends on population preferences supported by technical and managerial expertise.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Health Policy and Planning</title>
			</titleInfo>
			<identifier type="issn">0268-1080</identifier>
			<identifier type="eissn">1460-2237</identifier>
			<part>
				<detail type="volume">
					<number>34</number>
				</detail>
				<detail type="issue">
					<number>9</number>
				</detail>
				<extent>
					<start>635</start>
					<end>645</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1344248/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>ulja0023</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-20</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1344248</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Wästberg</namePart>
			<namePart type="given">Birgitta A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sandström</namePart>
			<namePart type="given">Boel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="papo0013">
			<namePart type="family">Pooremamali</namePart>
			<namePart type="given">Parvin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för samhällsmedicin och rehabilitering</affiliation>
			<description>diva-portal.org=authority-person:68453</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="770">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Turning Point Towards Recovery</title>
			<subTitle>An Interview Study with Participants in the Culture and Health Programme for Clients with Long-Term Mental Health Disorders in Sweden</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-03T13:44:21</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162895</identifier>
		<identifier type="doi">10.1080/01612840.2018.1553002</identifier>
		<identifier type="pmid">30943065</identifier>
		<identifier type="isi">000480543500002</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30305">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nursing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30305">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Omvårdnad</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The study aimed to explore participants' perceptions and experiences of the Culture and Health programme in Sweden for clients with long-term mental health disorders. A qualitative approach with interviews was applied. Grounded Theory guided the analysis and selection of informants. A total of 15 informants were interviewed. A core category 'A turning point in dealing with everyday life beyond the mental illness' with three categories: inner life, social life and occupational life emerged. A theory indicating the importance of asking clients about their expectations, was formulated. Further studies are warranted, including studies of effects.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Issues in Mental Health Nursing</title>
			</titleInfo>
			<identifier type="issn">0161-2840</identifier>
			<identifier type="eissn">1096-4673</identifier>
			<part>
				<detail type="volume">
					<number>40</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>373</start>
					<end>381</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-03</recordCreationDate>
			<recordChangeDate>2019-09-03</recordChangeDate>
			<recordIdentifier>diva2:1348111</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Xingchen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Leahy</namePart>
			<namePart type="given">Darren</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Van Haeften</namePart>
			<namePart type="given">Jessica</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hartfield</namePart>
			<namePart type="given">Perry</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Prentis</namePart>
			<namePart type="given">Peter J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-6587-8875</description>
		</name>
		<name type="personal">
			<namePart type="family">van der Burg</namePart>
			<namePart type="given">Chloe A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Surm</namePart>
			<namePart type="given">Joachim M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pavasovic</namePart>
			<namePart type="given">Ana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Madio</namePart>
			<namePart type="given">Bruno</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hamilton</namePart>
			<namePart type="given">Brett R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">King</namePart>
			<namePart type="given">Glenn F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Undheim</namePart>
			<namePart type="given">Eivind A. B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mabr0003">
			<namePart type="family">Brattsand</namePart>
			<namePart type="given">Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>orcid.org=0000-0001-7175-1336</description>
			<description>diva-portal.org=authority-person:64921</description>
		</name>
		<name type="personal">
			<namePart type="family">Harris</namePart>
			<namePart type="given">Jonathan M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="747">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Versatile and Robust Serine Protease Inhibitor Scaffold from &lt;em&gt;Actinia tenebrosa&lt;/em&gt;</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-02-03T14:04:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167642</identifier>
		<identifier type="doi">10.3390/md17120701</identifier>
		<identifier type="pmid">31842369</identifier>
		<identifier type="isi">000507340000053</identifier>
		<identifier type="scopus">2-s2.0-85076293427</identifier>
		<identifier type="articleId">701</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/md17120701</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Actinia tenebrosa</topic>
		</subject>
		<subject lang="eng">
			<topic>kallikrein-related peptidases</topic>
		</subject>
		<subject lang="eng">
			<topic>Kunitz inhibitor</topic>
		</subject>
		<subject lang="eng">
			<topic>serine protease</topic>
		</subject>
		<subject lang="eng">
			<topic>mass spectrometry imaging</topic>
		</subject>
		<subject lang="eng">
			<topic>molecular dynamics simulation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Serine proteases play pivotal roles in normal physiology and a spectrum of patho-physiological processes. Accordingly, there is considerable interest in the discovery and design of potent serine protease inhibitors for therapeutic applications. This led to concerted efforts to discover versatile and robust molecular scaffolds for inhibitor design. This investigation is a bioprospecting study that aims to isolate and identify protease inhibitors from the cnidarian &lt;em&gt;Actinia tenebrosa&lt;/em&gt;. The study isolated two Kunitz-type protease inhibitors with very similar sequences but quite divergent inhibitory potencies when assayed against bovine trypsin, chymostrypsin, and a selection of human sequence-related peptidases. Homology modeling and molecular dynamics simulations of these inhibitors in complex with their targets were carried out and, collectively, these methodologies enabled the definition of a versatile scaffold for inhibitor design. Thermal denaturation studies showed that the inhibitors were remarkably robust. To gain a fine-grained map of the residues responsible for this stability, we conducted in silico alanine scanning and quantified individual residue contributions to the inhibitor’s stability. Sequences of these inhibitors were then used to search for Kunitz homologs in an &lt;em&gt;A. tenebrosa&lt;/em&gt; transcriptome library, resulting in the discovery of a further 14 related sequences. Consensus analysis of these variants identified a rich molecular diversity of Kunitz domains and expanded the palette of potential residue substitutions for rational inhibitor design using this domain.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Marine Drugs</title>
			</titleInfo>
			<identifier type="issn">1660-3397</identifier>
			<identifier type="eissn">1660-3397</identifier>
			<part>
				<detail type="volume">
					<number>17</number>
				</detail>
				<detail type="issue">
					<number>12</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1390927/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-02-03</recordCreationDate>
			<recordChangeDate>2020-02-03</recordChangeDate>
			<recordIdentifier>diva2:1390927</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Fleurie</namePart>
			<namePart type="given">Aurore</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zoued</namePart>
			<namePart type="given">Abdelrahim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Alvarez</namePart>
			<namePart type="given">Laura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hines</namePart>
			<namePart type="given">Kelly M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="feca0003">
			<namePart type="family">Cava</namePart>
			<namePart type="given">Felipe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<description>diva-portal.org=authority-person:62587</description>
		</name>
		<name type="personal">
			<namePart type="family">Xu</namePart>
			<namePart type="given">Libin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Davis</namePart>
			<namePart type="given">Brigid M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waldor</namePart>
			<namePart type="given">Matthew K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5051">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå Centre for Microbial Research (UCMR)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>A Vibrio cholerae BolA-Like Protein Is Required for Proper Cell Shape and Cell Envelope Integrity</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Society for Microbiology (ASM)</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-03T14:22:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162888</identifier>
		<identifier type="doi">10.1128/mBio.00790-19</identifier>
		<identifier type="pmid">31289173</identifier>
		<identifier type="isi">000481617000011</identifier>
		<identifier type="articleId">e00790-19</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>BolA</topic>
		</subject>
		<subject lang="eng">
			<topic>IbaG</topic>
		</subject>
		<subject lang="eng">
			<topic>Vibrio cholerae</topic>
		</subject>
		<subject lang="eng">
			<topic>cell envelope</topic>
		</subject>
		<subject lang="eng">
			<topic>cell shape</topic>
		</subject>
		<subject lang="eng">
			<topic>iron-sulfur cluster</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30109">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Microbiology in the medical area</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30109">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Mikrobiologi inom det medicinska området</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;BolA family proteins are conserved in Gram-negative bacteria and many eukaryotes. While diverse cellular phenotypes have been linked to this protein family, the molecular pathways through which these proteins mediate their effects are not well described. Here, we investigated the roles of BolA family proteins in Vibrio cholerae, the cholera pathogen. Like Escherichia coli, V. cholerae encodes two BolA proteins, BolA and IbaG. However, in marked contrast to E. coli, where bolA is linked to cell shape and ibaG is not, in V. cholerae, bolA mutants lack morphological defects, whereas ibaG proved critical for the generation and/or maintenance of the pathogen's morphology. Notably, the bizarre-shaped, multipolar, elongated, and wide cells that predominated in exponential-phase Delta ibaG V. cholerae cultures were not observed in stationary-phase cultures. The V. cholerae Delta ibaG mutant exhibited increased sensitivity to cell envelope stressors, including cell wall-acting antibiotics and bile, and was defective in intestinal colonization. Delta ibaG V. cholerae had reduced peptidoglycan and lipid II and altered outer membrane lipids, likely contributing to the mutant's morphological defects and sensitivity to envelope stressors. Transposon insertion sequencing analysis of ibaG's genetic interactions suggested that ibaG is involved in several processes involved in the generation and homeostasis of the cell envelope. Furthermore, copurification studies revealed that IbaG interacts with proteins containing iron-sulfur clusters or involved in their assembly. Collectively, our findings suggest that V. cholerae IbaG controls cell morphology and cell envelope integrity through its role in biogenesis or trafficking of iron-sulfur cluster proteins. IMPORTANCE BolA-like proteins are conserved across prokaryotes and eukaryotes. These proteins have been linked to a variety of phenotypes, but the pathways and mechanisms through which they act have not been extensively characterized. Here, we unraveled the role of the BolA-like protein IbaG in the cholera pathogen Vibrio cholerae. The absence of IbaG was associated with dramatic changes in cell morphology, sensitivity to envelope stressors, and intestinal colonization defects. IbaG was found to be required for biogenesis of several components of the V. cholerae cell envelope and to interact with numerous iron-sulfur cluster-containing proteins and factors involved in their assembly. Thus, our findings suggest that IbaG governs V. cholerae cell shape and cell envelope homeostasis through its effects on iron-sulfur proteins and associated pathways. The diversity of processes involving ironsulfur-containing proteins is likely a factor underlying the range of phenotypes associated with BolA family proteins.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>mBio</title>
			</titleInfo>
			<identifier type="issn">2161-2129</identifier>
			<identifier type="eissn">2150-7511</identifier>
			<part>
				<detail type="volume">
					<number>10</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-03</recordCreationDate>
			<recordChangeDate>2019-09-03</recordChangeDate>
			<recordIdentifier>diva2:1348143</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="vimu0008">
			<namePart type="family">Murina</namePart>
			<namePart type="given">Victoriia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:67911</description>
		</name>
		<name type="personal" authority="umu" xlink:href="maka0502">
			<namePart type="family">Kasari</namePart>
			<namePart type="given">Marje</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:67912</description>
		</name>
		<name type="personal" authority="umu" xlink:href="hita0003">
			<namePart type="family">Takada</namePart>
			<namePart type="given">Hiraku</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:69746</description>
		</name>
		<name type="personal">
			<namePart type="family">Hinnu</namePart>
			<namePart type="given">Mariliis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-6096-0658</description>
		</name>
		<name type="personal" authority="umu" xlink:href="chku0014">
			<namePart type="family">Kumar Saha</namePart>
			<namePart type="given">Chayan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:73996</description>
		</name>
		<name type="personal">
			<namePart type="family">Grimshaw</namePart>
			<namePart type="given">James W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Seki</namePart>
			<namePart type="given">Takahiro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Reith</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Putrins</namePart>
			<namePart type="given">Marta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1492-2826</description>
		</name>
		<name type="personal">
			<namePart type="family">Tenson</namePart>
			<namePart type="given">Tanel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Strahl</namePart>
			<namePart type="given">Henrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-4416-2178</description>
		</name>
		<name type="personal" authority="umu" xlink:href="vaha0006">
			<namePart type="family">Hauryliuk</namePart>
			<namePart type="given">Vasili</namePart>
			<namePart type="date">1980-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>University of Tartu, Institute of Technology, Tartu, Estonia</affiliation>
			<description>orcid.org=0000-0003-2389-5057</description>
			<description>diva-portal.org=authority-person:62741</description>
		</name>
		<name type="personal" authority="umu" xlink:href="geat0002">
			<namePart type="family">Atkinson</namePart>
			<namePart type="given">Gemma Catherine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:64417</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>ABCF ATPases Involved in Protein Synthesis, Ribosome Assembly and Antibiotic Resistance</title>
			<subTitle>Structural and Functional Diversification across the Tree of Life</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-25T14:49:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164649</identifier>
		<identifier type="doi">10.1016/j.jmb.2018.12.013</identifier>
		<identifier type="pmid">30597160</identifier>
		<identifier type="isi">000484872800012</identifier>
		<identifier type="scopus">2-s2.0-85060093624</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.jmb.2018.12.013</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>ribosome</topic>
		</subject>
		<subject lang="eng">
			<topic>translation</topic>
		</subject>
		<subject lang="eng">
			<topic>antibiotic resistance</topic>
		</subject>
		<subject lang="eng">
			<topic>ABCF</topic>
		</subject>
		<subject lang="eng">
			<topic>ARE</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Within the larger ABC superfamily of ATPases, ABCF family members eEF3 in &lt;em&gt;Saccharomyces cerevisiae&lt;/em&gt; and EttA in &lt;em&gt;Escherichia coli&lt;/em&gt; have been found to function as ribosomal translation factors. Several other ABCFs including biochemically characterized VgaA, LsaA and MsrE confer resistance to antibiotics that target the peptidyl transferase center and exit tunnel of the ribosome. However, the diversity of ABCF subfamilies, the relationships among subfamilies and the evolution of antibiotic resistance (ARE) factors from other ABCFs have not been explored. To address this, we analyzed the presence of ABCFs and their domain architectures in 4505 genomes across the tree of life. We find 45 distinct subfamilies of ABCFs that are widespread across bacterial and eukaryotic phyla, suggesting that they were present in the last common ancestor of both. Surprisingly, currently known ARE ABCFs are not confined to a distinct lineage of the ABCF family tree, suggesting that ARE can readily evolve from other ABCF functions. Our data suggest that there are a number of previously unidentified ARE ABCFs in antibiotic producers and important human pathogens. We also find that ATPase-deficient mutants of all four &lt;em&gt;E. coli&lt;/em&gt; ABCFs (EttA, YbiT, YheS and Uup) inhibit protein synthesis, indicative of their ribosomal function, and demonstrate a genetic interaction of ABCFs Uup and YheS with translational GTPase BipA involved in assembly of the 50S ribosome subunit. Finally, we show that the ribosome-binding resistance factor VmlR from &lt;em&gt;Bacillus subtilis&lt;/em&gt; is localized to the cytoplasm, ruling out a role in antibiotic efflux.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Molecular Biology</title>
			</titleInfo>
			<identifier type="issn">0022-2836</identifier>
			<identifier type="eissn">1089-8638</identifier>
			<part>
				<detail type="volume">
					<number>431</number>
				</detail>
				<detail type="issue">
					<number>18</number>
				</detail>
				<extent>
					<start>3568</start>
					<end>3590</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1365772/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-25</recordCreationDate>
			<recordChangeDate>2019-10-25</recordChangeDate>
			<recordIdentifier>diva2:1365772</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Lei</namePart>
			<namePart type="given">Jian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yan</namePart>
			<namePart type="given">Siqi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Yuan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Liyun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Jinghua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guo</namePart>
			<namePart type="given">Xiong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mila0077">
			<namePart type="family">Lammi</namePart>
			<namePart type="given">Mikko</namePart>
			<namePart type="date">1961-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för integrativ medicinsk biologi (IMB)</affiliation>
			<affiliation>School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, P. R. China</affiliation>
			<affiliation>Chondrogenic and Osteogenic Differentiation</affiliation>
			<description>orcid.org=0000-0002-6181-9904</description>
			<description>diva-portal.org=authority-person:62693</description>
		</name>
		<name type="corporate">
			<namePart>Chondrogenic and Osteogenic Differentiation</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Han</namePart>
			<namePart type="given">Jing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="chqu0007">
			<namePart type="family">Qu</namePart>
			<namePart type="given">Chengjuan</namePart>
			<namePart type="date">1967-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för integrativ medicinsk biologi (IMB)</affiliation>
			<affiliation>Chondrogenic and Osteogenic Differentiation</affiliation>
			<description>orcid.org=0000-0002-1710-7715</description>
		</name>
		<name type="corporate">
			<namePart>Chondrogenic and Osteogenic Differentiation</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="734">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för integrativ medicinsk biologi (IMB)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Abnormal expression of chondroitin sulfate sulfotransferases in the articular cartilage of pediatric patients with Kashin-Beck disease.</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-19T14:02:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166647</identifier>
		<identifier type="doi">10.1007/s00418-019-01833-0</identifier>
		<identifier type="pmid">31845005</identifier>
		<location>
			<url displayLabel="Publisher's full text">https://link.springer.com/article/10.1007%2Fs00418-019-01833-0</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Children’s cartilage</topic>
		</subject>
		<subject lang="eng">
			<topic>Chondroitin sulfate</topic>
		</subject>
		<subject lang="eng">
			<topic>Kashin–Beck disease</topic>
		</subject>
		<subject lang="eng">
			<topic>Selenium deficiency</topic>
		</subject>
		<subject lang="eng">
			<topic>Sulfation</topic>
		</subject>
		<subject lang="eng">
			<topic>Sulfotransferases</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30210">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Rheumatology and Autoimmunity</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30210">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Reumatologi och inflammation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30108">
			<topic>Basic Medicine</topic>
			<topic>Cell and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30108">
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Cell- och molekylärbiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2112">
			<topic>molecular medicine (medical sciences)</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2112">
			<topic>molekylär medicin (medicinska vetenskaper)</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="11100">
			<topic>reumatologi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="11100">
			<topic>rheumatology</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;The objective of this study is to investigate the expression of enzymes involved in the sulfation of articular cartilage from proximal metacarpophalangeal (PMC) joint cartilage and distal metacarpophalangeal (DMC) joint cartilage in children with Kashin-Beck disease (KBD). The finger cartilage samples of PMC and DMC were collected from KBD and normal children aged 5-14 years old. Hematoxylin and eosin staining as well as immunohistochemical staining were used to observe the morphology and quantitate the expression of carbohydrate sulfotransferase 3 (CHST-3), carbohydrate sulfotransferase 12 (CHST-12), carbohydrate sulfotransferase 13 (CHST-13), uronyl 2-O-sulfotransferase (UST), and aggrecan. In the results, the numbers of chondrocyte decreased in all three zones of PMC and DMC in the KBD group. Less positive staining cells for CHST-3, CHST-12, CHST-13, UST, and aggrecan were observed in almost all three zones of PMC and DMC in KBD. The positive staining cell rates of CHST-12 were higher in superficial and middle zones of PMC and DMC in KBD, and a significantly higher rate of CHST-13 was observed only in superficial zone of PMC in KBD. In conclusion, the abnormal expression of chondroitin sulfate sulfotransferases in chondrocytes of KBD children may provide an explanation for the cartilage damage, and provide therapeutic targets for the treatment.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Histochemistry and Cell Biology</title>
			</titleInfo>
			<identifier type="issn">0948-6143</identifier>
			<identifier type="eissn">1432-119X</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>mila0077</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-19</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1380832</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="nizl0002">
			<namePart type="family">Zlatkov</namePart>
			<namePart type="given">Nikola</namePart>
			<namePart type="date">1985-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<description>orcid.org=0000-0003-3318-9084</description>
			<description>diva-portal.org=authority-person:65907</description>
		</name>
		<name type="personal" authority="umu" xlink:href="beuh0001">
			<namePart type="family">Uhlin</namePart>
			<namePart type="given">Bernt Eric</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>orcid.org=0000-0002-2991-8072</description>
			<description>diva-portal.org=authority-person:63242</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5051">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå Centre for Microbial Research (UCMR)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Absence of Global Stress Regulation in &lt;em&gt;Escherichia coli&lt;/em&gt; Promotes Pathoadaptation and Novel c-di-GMP-dependent Metabolic Capability</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Nature Publishing Group</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-29T08:22:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155827</identifier>
		<identifier type="doi">10.1038/s41598-019-39580-w</identifier>
		<identifier type="pmid">30796316</identifier>
		<identifier type="isi">000459399400069</identifier>
		<identifier type="articleId">2600</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1038/s41598-019-39580-w</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30401">
			<topic>Medical and Health Sciences</topic>
			<topic>Medical Biotechnology</topic>
			<topic>Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30401">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinsk bioteknologi</topic>
			<topic>Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;athoadaptive mutations linked to c-di-GMP signalling were investigated in neonatal meningitis-causing &lt;em&gt;Escherichia coli&lt;/em&gt; (NMEC). The results indicated that NMEC strains deficient in RpoS (the global stress regulator) maintained remarkably low levels of c-di-GMP, a major bacterial sessility-motility switch. Deletion of &lt;em&gt;ycgG2&lt;/em&gt;, shown here to encode a YcgG allozyme with c-di-GMP phosphodiesterase activity, and the restoration of RpoS led to a decrease in S-fimbriae, robustly produced in artificial urine, hinting that the urinary tract could serve as a habitat for NMEC. We showed that NMEC were skilled in aerobic citrate utilization in the presence of glucose, a property that normally does not exist in &lt;em&gt;E. coli&lt;/em&gt;. Our data suggest that this metabolic novelty is a property of extraintestinal pathogenic &lt;em&gt;E. coli&lt;/em&gt; since we reconstituted this ability in &lt;em&gt;E. coli&lt;/em&gt; UTI89 (a cystitis isolate) &lt;em&gt;via&lt;/em&gt; deactivation &lt;em&gt;rpoS&lt;/em&gt;; additionally, a set of pyelonephritis &lt;em&gt;E. coli&lt;/em&gt; isolates were shown here to aerobically use citrate in the presence of glucose. We found that the main reason for this metabolic capability is RpoS inactivation leading to the production of the citrate transporter CitT, exploited by NMEC for ferric citrate uptake dependent on YcgG2 (an allozyme with c-di-GMP phosphodiesterase activity).&lt;/p&gt;</abstract>
		<note>&lt;p&gt;Originally included in thesis in manuscript form.&lt;/p&gt;</note>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Scientific Reports</title>
			</titleInfo>
			<identifier type="issn">2045-2322</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1283328/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-29</recordCreationDate>
			<recordChangeDate>2019-05-22</recordChangeDate>
			<recordIdentifier>diva2:1283328</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="krha0011">
			<namePart type="family">Hansson</namePart>
			<namePart type="given">Kristina</namePart>
			<namePart type="date">1956-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för estetiska ämnen i lärarutbildningen</affiliation>
			<affiliation>Kampen för läraryrkets kunskap – möjliga vägar för lärares professionalism?</affiliation>
			<description>orcid.org=0000-0002-0183-3069</description>
			<description>diva-portal.org=authority-person:65800</description>
		</name>
		<name type="corporate">
			<namePart>Kampen för läraryrkets kunskap – möjliga vägar för lärares professionalism?</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="peer0004">
			<namePart type="family">Erixon</namePart>
			<namePart type="given">Per-Olof</namePart>
			<namePart type="date">1954-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för estetiska ämnen i lärarutbildningen</affiliation>
			<affiliation>Kampen för läraryrkets kunskap – möjliga vägar för lärares professionalism?</affiliation>
			<description>orcid.org=0000-0001-8444-4132</description>
			<description>diva-portal.org=authority-person:64789</description>
		</name>
		<name type="corporate">
			<namePart>Kampen för läraryrkets kunskap – möjliga vägar för lärares professionalism?</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="4950">
			<namePart>Umeå universitet</namePart>
			<namePart>Humanistiska fakulteten</namePart>
			<namePart>Institutionen för estetiska ämnen i lärarutbildningen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Academisation and teachers’ dilemmas</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-09T15:49:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163165</identifier>
		<identifier type="doi">10.1177/1474904119872935</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Academic drift</topic>
		</subject>
		<subject lang="eng">
			<topic>activity theory</topic>
		</subject>
		<subject lang="eng">
			<topic>scientific school</topic>
		</subject>
		<subject lang="eng">
			<topic>dilemma</topic>
		</subject>
		<subject lang="eng">
			<topic>PIUF</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50304">
			<topic>Social Sciences</topic>
			<topic>Educational Sciences</topic>
			<topic>Pedagogical Work</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50304">
			<topic>Samhällsvetenskap</topic>
			<topic>Utbildningsvetenskap</topic>
			<topic>Pedagogiskt arbete</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="9450">
			<topic>pedagogiskt arbete</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="9450">
			<topic>educational work</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;In 2010, the Swedish Education Act introduced new provisions stating that education at all levels should ‘rest on scientific grounds and proven experience’. These requirements led to greater policy activities at the state level and enhanced the cooperation emerging between the municipality and higher education as well as between teachers and researchers at both the middle and micro levels. This study was conducted in a Swedish municipality that adopted a local strategy to meet the Education Act’s scientific requirements for teaching. As part of this strategy, together with a university the municipality designed a postgraduate programme, corresponding to a one-year master’s level under the Bologna Agreement, made up of four years of part-time studies and with a focus on practical research and school development. This article examines how a sample of 15 teachers participating in this postgraduate programme, and their school leaders, perceive this policy (namely, education being based on scientific grounds) within the development of the teaching profession’s practice and which dilemmas they face while trying to interpret and handle the Education Act’s provisions in their schools. Our overall theoretical perspectives are those of policy enactment, academic drift and activity theory. The results indicate that the teachers’ participation in the postgraduate course has caused tension among their colleagues. Moreover, the teachers expressed a feeling of being ‘isolated cogs’ in an organisation and lacking supporting structures. For some, their participation is a step in a more individualised project that contributes primarily to their own professional development; for others, it is more of a collective project with which one can ‘lift’ one’s school and colleagues.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>European Educational Research Journal (online)</title>
			</titleInfo>
			<identifier type="issn">1474-9041</identifier>
			<identifier type="eissn">1474-9041</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>peer0004</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-09</recordCreationDate>
			<recordChangeDate>2020-02-05</recordChangeDate>
			<recordIdentifier>diva2:1349618</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Banda</namePart>
			<namePart type="given">Emmanuel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Svanemyr</namePart>
			<namePart type="given">Joar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sandoy</namePart>
			<namePart type="given">Ingvild Fossgard</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="isgo0005">
			<namePart type="family">Goicolea</namePart>
			<namePart type="given">Isabel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0002-8114-4705</description>
			<description>diva-portal.org=authority-person:62482</description>
		</name>
		<name type="personal">
			<namePart type="family">Zulu</namePart>
			<namePart type="given">Joseph Mumba</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Acceptability of an economic support component to reduce early pregnancy and school dropout in Zambia</title>
			<subTitle>a qualitative case study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-06T11:59:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165761</identifier>
		<identifier type="doi">10.1080/16549716.2019.1685808</identifier>
		<identifier type="pmid">31735121</identifier>
		<identifier type="isi">000495144000001</identifier>
		<identifier type="articleId">1685808</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/16549716.2019.1685808</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Acceptability</topic>
		</subject>
		<subject lang="eng">
			<topic>Cash transfer</topic>
		</subject>
		<subject lang="eng">
			<topic>adolescent health</topic>
		</subject>
		<subject lang="eng">
			<topic>Zambia</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Cash Transfer (CT) schemes have become popular poverty reducing measures in many low and middle-income countries. Research indicates that when provided to girls in resource poor settings, cash transfers can increase education and postpone marriage and pregnancy. However, a few studies indicate that they can also have negative effects which can affect their acceptability, such as generating intra-community tensions.&lt;/p&gt;&lt;p&gt;Objective: Conceptually informed by Rogers’ diffusion of innovation theory, this paper explores factors affecting the acceptability of economic support in a randomized controlled trial in rural Monze and Pemba Districts of Southern Province in Zambia.&lt;/p&gt;&lt;p&gt;Methods: Qualitative data were collected through five focus group discussions and six in-depth, semi-structured interviews and analysed using thematic analysis. This study was done in the combined arm of a trial where girls received both economic support and participated in youth clubs offering sexuality and life-skills education.&lt;/p&gt;&lt;p&gt;Results: In the study communities, acceptability was encouraging by the belief that economic support provided benefits beyond beneficiaries and that it improved access to education, and reduced teen pregnancies, marriages and school drop-out. However, provision of economic support only to selected girls and their parents and fear among some that the support was linked to satanic practices negatively affected acceptability. These fears were mitigated through community sensitisations.&lt;/p&gt;&lt;p&gt;Conclusion: The study demonstrated that relative advantage, observability, simplicity and compatibility were key factors in influencing acceptability of the economic support. However, to enhance acceptability of cash transfer schemes aimed at addressing early marriage and pregnancy, it is important to explore socio-cultural factors that create suspicions and negative perceptions and to provide schemes that are perceived as relatively better than available similar schemes, understood, compatible and viable beyond the immediate beneficiary.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Global Health Action</title>
			</titleInfo>
			<identifier type="issn">1654-9716</identifier>
			<identifier type="eissn">1654-9880</identifier>
			<part>
				<detail type="volume">
					<number>12</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [2016-05830]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1375885/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-06</recordCreationDate>
			<recordChangeDate>2019-12-06</recordChangeDate>
			<recordIdentifier>diva2:1375885</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Pahnke</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hirvikoski</namePart>
			<namePart type="given">Tatja</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bjureberg</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bölte</namePart>
			<namePart type="given">Sven</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jujo0022">
			<namePart type="family">Jokinen</namePart>
			<namePart type="given">Jussi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Psykiatri</affiliation>
			<description>orcid.org=0000-0001-6766-7983</description>
			<description>diva-portal.org=authority-person:68590</description>
		</name>
		<name type="personal">
			<namePart type="family">Bohman</namePart>
			<namePart type="given">Benjamin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lundgren</namePart>
			<namePart type="given">Tobias</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="740">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Psykiatri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Acceptance and commitment therapy for autistic adults</title>
			<subTitle>An open pilot study in a psychiatric outpatient context</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-23T14:48:57</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164547</identifier>
		<identifier type="doi">10.1016/j.jcbs.2019.04.002</identifier>
		<identifier type="isi">000483320600005</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Highlights:&lt;/p&gt;&lt;p&gt;Feasibility and credibility of the NeuroACT protocol was high.&lt;/p&gt;&lt;p&gt;Symptoms of stress and depression were significantly reduced.&lt;/p&gt;&lt;p&gt;Cognitive defusion and psychological flexibility significantly increased.&lt;/p&gt;&lt;p&gt;Quality of life and social functioning were significantly improved.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Contextual Behavioral Science</title>
			</titleInfo>
			<identifier type="issn">2212-1447</identifier>
			<part>
				<detail type="volume">
					<number>13</number>
				</detail>
				<extent>
					<start>34</start>
					<end>41</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>parsug04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-23</recordCreationDate>
			<recordChangeDate>2019-10-23</recordChangeDate>
			<recordIdentifier>diva2:1365118</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Wagenius</namePart>
			<namePart type="given">Cecilia M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Epidemiologi och global hälsa</affiliation>
			<affiliation>Norrbotten County Council, Public Health Centre, Sweden</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="misa0002">
			<namePart type="family">San Sebastian</namePart>
			<namePart type="given">Miguel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0001-7234-3510</description>
			<description>diva-portal.org=authority-person:62485</description>
		</name>
		<name type="personal" authority="umu" xlink:href="pegu0008">
			<namePart type="family">Gustafsson</namePart>
			<namePart type="given">Per E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Epidemiologi och global hälsa</affiliation>
			<description>diva-portal.org=authority-person:63368</description>
		</name>
		<name type="personal" authority="umu" xlink:href="isgo0005">
			<namePart type="family">Goicolea</namePart>
			<namePart type="given">Isabel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0002-8114-4705</description>
			<description>diva-portal.org=authority-person:62482</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="5303">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Access for all?</title>
			<subTitle>Assessing vertical and horizontal inequities in healthcare utilization among young people in northern Sweden</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-08-13T11:09:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-150573</identifier>
		<identifier type="doi">10.1177/1403494818774965</identifier>
		<identifier type="pmid">29779450</identifier>
		<identifier type="isi">000458888900001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Inequity</topic>
		</subject>
		<subject lang="eng">
			<topic>Sweden</topic>
		</subject>
		<subject lang="eng">
			<topic>access to healthcare</topic>
		</subject>
		<subject lang="eng">
			<topic>youth</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;BACKGROUND: Previous studies in Sweden have detected socioeconomic inequities in access to healthcare services. However, there is limited information regarding access in younger populations. The aim of this study was to explore vertical and horizontal inequities in access to healthcare services in young adults in the north of Sweden.&lt;/p&gt;&lt;p&gt;METHODS: The study used data from the Health on Equal Terms survey (age group 16-24 years, n = 2726) for the health and healthcare variables and from national registers for the sociodemographic characteristics. Self-rated healthcare utilization was measured as visits to general practitioners, youth clinics and nurses. Crude and multivariable binomial regression analysis, stratified by sex, was used to assess vertical equity, adjusting for sociodemographic characteristics, and horizontal equity, adjusting for need variables.&lt;/p&gt;&lt;p&gt;RESULTS: Vertical inequity was detected for all three healthcare services (youth clinics, general practitioners and nurses), with variations for men and women. Horizontal inequities were also found for both men and women in relation to all three healthcare services.&lt;/p&gt;&lt;p&gt;CONCLUSIONS: These findings suggest that both vertical and horizontal inequities in access exist for young people in northern Sweden and that the associations between sociodemographic characteristics and healthcare utilization are complex and need further investigation.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Scandinavian Journal of Public Health</title>
			</titleInfo>
			<identifier type="issn">1403-4948</identifier>
			<identifier type="eissn">1651-1905</identifier>
			<part>
				<detail type="volume">
					<number>47</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>lemu0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-08-13</recordCreationDate>
			<recordChangeDate>2019-04-16</recordChangeDate>
			<recordIdentifier>diva2:1238242</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="raga0013">
			<namePart type="family">Gaitonde</namePart>
			<namePart type="given">Rakhal</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Department of Humanities and Social Sciences, Indian Institute of Technology Madras, Chennai, India</affiliation>
			<description>diva-portal.org=authority-person:64775</description>
		</name>
		<name type="personal">
			<namePart type="family">Muraleedharan</namePart>
			<namePart type="given">V. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="misa0002">
			<namePart type="family">San Sebastian</namePart>
			<namePart type="given">Miguel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0001-7234-3510</description>
			<description>diva-portal.org=authority-person:62485</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anhu0001">
			<namePart type="family">Hurtig</namePart>
			<namePart type="given">Anna-Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0001-7087-1467</description>
			<description>diva-portal.org=authority-person:62484</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Accountability in the health system of Tamil Nadu, India</title>
			<subTitle>exploring its multiple meanings</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BMC</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-21T13:42:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159067</identifier>
		<identifier type="doi">10.1186/s12961-019-0448-8</identifier>
		<identifier type="pmid">31029173</identifier>
		<identifier type="isi">000466190800001</identifier>
		<identifier type="articleId">44</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12961-019-0448-8</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Accountability</topic>
		</subject>
		<subject lang="eng">
			<topic>Community-based accountability</topic>
		</subject>
		<subject lang="eng">
			<topic>National Rural Health Mission</topic>
		</subject>
		<subject lang="eng">
			<topic>Belief structures</topic>
		</subject>
		<subject lang="eng">
			<topic>problematisation</topic>
		</subject>
		<subject lang="eng">
			<topic>Policy implementation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30301">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Health Care Service and Management, Health Policy and Services and Health Economy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30301">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Accountability is increasingly being demanded of public services and is a core aspect of most recent frameworks of health system strengthening. Community-based accountability is an increasingly used strategy, and wasa core aspect of India's flagship National Rural Health Mission (NRHM; 2005-2014). Research on policy implementation has called for policy analysts to go beyond the superficial articulation of a particular policy intervention to study the underlying meaning this has for policy-makers and other actors of the implementation process and to the way in which problems sought to be addressed by the policy have been identified and problematised'.&lt;/p&gt;&lt;p&gt;Methods: This research, focused on state level officials and health NGO leaders, explores the meanings attached to the concept of accountability among a number of key actors during the implementation of the NRHM in the south Indian state of Tamil Nadu. The overall research was guided by an interpretive approach to policy analysis and the problematisation lens. Through in-depth interviews we draw on the interviewees' perspectives on accountability.&lt;/p&gt;&lt;p&gt;Results: The research identifies three distinct perspectives on accountability among the key actors involved in the implementation of the NRHM. One perspective views accountability as the achievement of pre-set targets, the other as efficiency in achieving these targets, and the final one as a transformative process that equalises power differentials between communities and the public health system. We also present the ways in which these differences in perspectives are associated with different programme designs.&lt;/p&gt;&lt;p&gt;Conclusions: This research underlines the importance of going beyond the statements of policy to exploring the underlying beliefs and perspectives in order to more comprehensively understand the dynamics of policy implementation; it further points to the impacts of these perspectives on the design of initiatives in response to the policy.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Health Research Policy and Systems</title>
			</titleInfo>
			<identifier type="issn">1478-4505</identifier>
			<identifier type="eissn">1478-4505</identifier>
			<part>
				<detail type="volume">
					<number>17</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1316921/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-21</recordCreationDate>
			<recordChangeDate>2020-01-31</recordChangeDate>
			<recordIdentifier>diva2:1316921</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="nata0012">
			<namePart type="family">Taheri</namePart>
			<namePart type="given">Nayyer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:68800</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mafa0002">
			<namePart type="family">Fällman</namePart>
			<namePart type="given">Maria</namePart>
			<namePart type="date">1960-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:62573</description>
		</name>
		<name type="personal" authority="umu" xlink:href="suwa0005">
			<namePart type="family">Wai</namePart>
			<namePart type="given">Sun Nyunt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:62883</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anfa0005">
			<namePart type="family">Fahlgren</namePart>
			<namePart type="given">Anna</namePart>
			<namePart type="date">1972-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:62572</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="5051">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå Centre for Microbial Research (UCMR)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Accumulation of virulence-associated proteins in &lt;em&gt;Campylobacter jejuni&lt;/em&gt; Outer Membrane Vesicles at human body temperature</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-18T15:58:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155499</identifier>
		<identifier type="doi">10.1016/j.jprot.2019.01.005</identifier>
		<identifier type="pmid">30641234</identifier>
		<identifier type="isi">000459366000004</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Campylobacter jejuni</topic>
		</subject>
		<subject lang="eng">
			<topic>OMVs</topic>
		</subject>
		<subject lang="eng">
			<topic>Proteomics</topic>
		</subject>
		<subject lang="eng">
			<topic>Temperature</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10606">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Microbiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10606">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Mikrobiologi</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2204">
			<topic>mikrobiologi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2204">
			<topic>Microbiology</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;&lt;em&gt;Campylobacter jejuni&lt;/em&gt; is the major cause of bacterial gastroenteritis in humans. In contrast, colonization in avian hosts is asymptomatic. Body temperature differs between human (37 °C) and avian (42 °C) hosts, and bacterial growth in 37 °C is therefore a potential cue for higher virulence properties during human infection. The proteome of the bacteria was previously shown to be altered by temperature. Here we investigated whether temperature has an effect on the &lt;em&gt;C. jejuni&lt;/em&gt; outer membrane vesicle (OMV) proteome, as OMVs are considered to be bacterial vehicles for protein delivery and might play a role during infection. OMVs isolated from &lt;em&gt;C. jejuni&lt;/em&gt; strain 81-176 grown at 37 °C and 42 °C were analyzed by LC-ESI-MS/MS. 181 proteins were detected in both sample groups, one protein was exclusively present, and three were absent in OMVs from 37 °C. Of the 181 proteins, 59 were differentially expressed; 30 proteins were detected with higher abundance, and 29 proteins with lower abundance at 37 °C. Among the more highly abundant proteins, significantly more proteins were predicted to be associated with virulence. These data show that temperature has an impact on the property of the OMVs, and this might affect the outcome of colonization/infection by &lt;em&gt;C. jejuni&lt;/em&gt; in different hosts.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Proteomics</title>
			</titleInfo>
			<identifier type="issn">1874-3919</identifier>
			<identifier type="eissn">1876-7737</identifier>
			<part>
				<detail type="volume">
					<number>195</number>
				</detail>
				<extent>
					<start>33</start>
					<end>40</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>nata0012</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-18</recordCreationDate>
			<recordChangeDate>2019-04-16</recordChangeDate>
			<recordIdentifier>diva2:1280435</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="todu0001">
			<namePart type="family">Dunås</namePart>
			<namePart type="given">Tora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<description>orcid.org=0000-0002-5911-9511</description>
			<description>diva-portal.org=authority-person:64151</description>
		</name>
		<name type="personal" authority="umu" xlink:href="maho0149">
			<namePart type="family">Holmgren</namePart>
			<namePart type="given">Madelene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<description>diva-portal.org=authority-person:67986</description>
		</name>
		<name type="personal" authority="umu" xlink:href="arswan02">
			<namePart type="family">Wåhlin</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<affiliation>Umeå universitet, Umeå centrum för funktionell hjärnavbildning (UFBI)</affiliation>
			<description>diva-portal.org=authority-person:64152</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jama0002">
			<namePart type="family">Malm</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Klinisk neurovetenskap</affiliation>
			<description>orcid.org=0000-0001-6451-1940</description>
			<description>diva-portal.org=authority-person:63098</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anek0025">
			<namePart type="family">Eklund</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<affiliation>Umeå universitet, Umeå centrum för funktionell hjärnavbildning (UFBI)</affiliation>
			<description>diva-portal.org=authority-person:63097</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="776">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5752">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå centrum för funktionell hjärnavbildning (UFBI)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="10950">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för farmakologi och klinisk neurovetenskap</namePart>
			<namePart>Klinisk neurovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Accuracy of blood flow assessment in cerebral arteries with 4D flow MRI</title>
			<subTitle>Evaluation with three segmentation methods</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-04-30T11:11:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-147255</identifier>
		<identifier type="doi">10.1002/jmri.26641</identifier>
		<identifier type="pmid">30637846</identifier>
		<identifier type="isi">000475681600017</identifier>
		<identifier type="scopus">2-s2.0-85059966858</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1002/jmri.26641</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>magnetic resonance imaging</topic>
		</subject>
		<subject lang="eng">
			<topic>cerebral arteries</topic>
		</subject>
		<subject lang="eng">
			<topic>phase‐contrast MRI</topic>
		</subject>
		<subject lang="eng">
			<topic>4D flow MRI</topic>
		</subject>
		<subject lang="eng">
			<topic>cerebral blood flow</topic>
		</subject>
		<subject lang="eng">
			<topic>Circle of Willis</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20603">
			<topic>Engineering and Technology</topic>
			<topic>Medical Engineering</topic>
			<topic>Medical Image Processing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20603">
			<topic>Teknik och teknologier</topic>
			<topic>Medicinteknik</topic>
			<topic>Medicinsk bildbehandling</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Accelerated 4D flow MRI allows for high‐resolution velocity measurements with whole‐brain coverage. Such scans are increasingly used to calculate flow rates of individual arteries in the vascular tree, but detailed information about the accuracy and precision in relation to different postprocessing options is lacking.&lt;/p&gt;&lt;p&gt;Purpose: To evaluate and optimize three proposed segmentation methods and determine the accuracy of in vivo 4D flow MRI blood flow rate assessments in major cerebral arteries, with high‐resolution 2D PCMRI as a reference.&lt;/p&gt;&lt;p&gt;Study Type: Prospective.&lt;/p&gt;&lt;p&gt;Subjects: Thirty‐five subjects (20 women, 79 ± 5 years, range 70–91 years).&lt;/p&gt;&lt;p&gt;Field Strength/Sequence: 4D flow MRI with PC‐VIPR and 2D PCMRI acquired with a 3 T scanner.&lt;/p&gt;&lt;p&gt;Assessment: We compared blood flow rates measured with 4D flow MRI, to the reference, in nine main cerebral arteries. Lumen segmentation in the 4D flow MRI was performed with k‐means clustering using four different input datasets, and with two types of thresholding methods. The threshold was defined as a percentage of the maximum intensity value in the complex difference image. Local and global thresholding approaches were used, with evaluated thresholds from 6–26%.&lt;/p&gt;&lt;p&gt;Statistical Tests: Paired &lt;em&gt;t&lt;/em&gt;‐test, F‐test, linear correlation (&lt;em&gt;P&lt;/em&gt; &amp;lt; 0.05 was considered significant) along with intraclass correlation (ICC).&lt;/p&gt;&lt;p&gt;Results: With the thresholding methods, the lowest average flow difference was obtained for 20% local (0.02 ± 15.0 ml/min, ICC = 0.97, &lt;em&gt;n&lt;/em&gt; = 310) or 10% global (0.08 ± 17.3 ml/min, ICC = 0.97, &lt;em&gt;n&lt;/em&gt; = 310) thresholding with a significant lower standard deviation for local (F‐test, &lt;em&gt;P&lt;/em&gt; = 0.01). For all clustering methods, we found a large systematic underestimation of flow compared with 2D PCMRI (16.1–22.3 ml/min).&lt;/p&gt;&lt;p&gt;Data Conclusion: A locally adapted threshold value gives a more stable result compared with a globally fixed threshold. 4D flow with the proposed segmentation method has the potential to become a useful reliable clinical tool for assessment of blood flow in the major cerebral arteries.&lt;/p&gt;&lt;p&gt;Level of Evidence: 2&lt;/p&gt;&lt;p&gt;Technical Efficacy: Stage 2&lt;/p&gt;</abstract>
		<note>&lt;p&gt;Originally included in thesis in manuscript form with title "Blood flow assessment in cerebral arteries with 4D flow MRI, concordance with 2D PCMRI"&lt;/p&gt;</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Magnetic Resonance Imaging</title>
			</titleInfo>
			<identifier type="issn">1053-1807</identifier>
			<identifier type="eissn">1522-2586</identifier>
			<part>
				<detail type="volume">
					<number>50</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
				<extent>
					<start>511</start>
					<end>518</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [2015–05616; 2017-04949]</note>
		<note type="funder">Hjärt-Lungfonden [20140592]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1202720/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>todu0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-04-30</recordCreationDate>
			<recordChangeDate>2019-11-19</recordChangeDate>
			<recordIdentifier>diva2:1202720</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="sako0013">
			<namePart type="family">Kollberg</namePart>
			<namePart type="given">Sandra E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för omvårdnad</affiliation>
			<description>diva-portal.org=authority-person:73341</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anha0123">
			<namePart type="family">Häggström</namePart>
			<namePart type="given">Ann-Cristin E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:73365</description>
		</name>
		<name type="personal" authority="umu" xlink:href="healll00">
			<namePart type="family">Claesson Lingehall</namePart>
			<namePart type="given">Helena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för omvårdnad</affiliation>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0002-0549-8544</description>
			<description>diva-portal.org=authority-person:64240</description>
		</name>
		<name type="personal" authority="umu" xlink:href="biaoln00">
			<namePart type="family">Olofsson</namePart>
			<namePart type="given">Birgitta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för omvårdnad</affiliation>
			<description>orcid.org=0000-0002-3754-5026</description>
			<description>diva-portal.org=authority-person:63028</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="769">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för omvårdnad</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Accuracy of Visually Estimated Blood Loss in Surgical Sponges by Members of the Surgical Team</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Association of Nurse Anesthetists</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-30T10:13:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162902</identifier>
		<location>
			<url displayLabel="URL">https://www.aana.com/docs/default-source/aana-journal-web-documents-1/accuracy-of-visually-estimated-blood-loss-in-surgical-sponges-by-members-of-the-surgical-team-august-2019.pdf</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Blood loss</topic>
		</subject>
		<subject lang="eng">
			<topic>surgery</topic>
		</subject>
		<subject lang="eng">
			<topic>surgical sponges</topic>
		</subject>
		<subject lang="eng">
			<topic>visual estimation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30305">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nursing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30305">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Omvårdnad</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;It is important that operating room personnel monitor the correct amount of blood loss during surgery in order to properly replace lost volume. The aim of this study was to investigate the accuracy of operating room personnel in visually estimating blood loss in surgical sponges. We performed an observational study with comparative descriptive design at a university hospital including all members of the surgical team. In total, 163 observations were completed. The participants estimated the amount of blood in surgical sponges in 4 stations with varying amounts of blood and/or numbers of sponges. Data were analyzed using the Wilcoxon signed rank, Kruskal-Wallis, and Mann-Whitney tests. Both overestimations and underestimations occurred. Underestimations dominated and tended to increase with major amounts of blood. Operating room personnel miscalculated the amount of blood by a median value of 30% regardless of profession, years of experience, and self-assessed ability about visual estimation. This study highlights that assessments of patients’ conditions can be partially based on methods often demonstrated to be inaccurate. Inaccurate visual estimation of blood loss might endanger patient safety.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>87</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>277</start>
					<end>284</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>AANA Journal</title>
			</titleInfo>
			<identifier type="issn">0094-6354</identifier>
			<part>
				<detail type="volume">
					<number>87</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>277</start>
					<end>284</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>leri0010</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-30</recordCreationDate>
			<recordChangeDate>2019-09-02</recordChangeDate>
			<recordIdentifier>diva2:1347114</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Wallin</namePart>
			<namePart type="given">Stina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för fysioterapi</affiliation>
			<affiliation>Faculty of Education and Welfare Studies, Health Sciences, Åbo Akademi University, Vaasa, Finland</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="anfj0005">
			<namePart type="family">Fjellman-Wiklund</namePart>
			<namePart type="given">Anncristine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för fysioterapi</affiliation>
			<description>diva-portal.org=authority-person:62860</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881555">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<namePart>Avdelningen för fysioterapi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Act with respect</title>
			<subTitle>Views of supportive actions for older workers after completion of comprehensive vocational rehabilitation services</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>IOS Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-10T10:17:30</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159888</identifier>
		<identifier type="doi">10.3233/WOR-192896</identifier>
		<identifier type="pmid">31104047</identifier>
		<identifier type="isi">000468318200007</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Work ability</topic>
		</subject>
		<subject lang="eng">
			<topic>occupational health</topic>
		</subject>
		<subject lang="eng">
			<topic>aging</topic>
		</subject>
		<subject lang="eng">
			<topic>gender</topic>
		</subject>
		<subject lang="eng">
			<topic>support</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30303">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Occupational Health and Environmental Health</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30303">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Arbetsmedicin och miljömedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;BACKGROUND: The number of older workers will expand during the next decades. Older workers have more long-term health problems and related limitations.&lt;/p&gt;&lt;p&gt;OBJECTIVE: This study examined supportive actions provided in occupational healthcare services to older workers after vocational rehabilitation. An additional purpose was to explore occupational healthcare professionals' views on how to realize and improve adequate support activities.&lt;/p&gt;&lt;p&gt;METHODS: Qualitative and quantitative methods were used, including a postal questionnaire and focus group discussions. Sixty-seven occupational healthcare service units participated in the postal questionnaire. Eight occupational healthcare professionals participated in two focus group discussions. The qualitative data was analyzed using qualitative content analysis.&lt;/p&gt;&lt;p&gt;RESULTS: The qualitative analysis resulted in one theme (Act with respect), and four categories (Need for cooperation, Collaborative resources of involved stakeholders, Individual needs for support, and Gender as homogenous and separate groups). Quantitative results revealed that the workers' initiative strongly influenced the support carried out. Recommendations from the rehabilitation clinic were almost always considered when deciding on supportive actions. Focus group discussions brought up gender differences especially highlighted in the category Gender as homogenous and separate groups.&lt;/p&gt;&lt;p&gt;CONCLUSIONS: Appropriate support of older workers requires cooperation between involved stakeholders, including occupational healthcare services. Provided support should be based on individual needs, but a mutual practice of determining needed support is requested.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Work</title>
				<subTitle>A journal of Prevention, Assessment and rehabilitation</subTitle>
			</titleInfo>
			<identifier type="issn">1051-9815</identifier>
			<identifier type="eissn">1875-9270</identifier>
			<part>
				<detail type="volume">
					<number>62</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>585</start>
					<end>598</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-10</recordCreationDate>
			<recordChangeDate>2019-06-10</recordChangeDate>
			<recordIdentifier>diva2:1321846</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="aria0002">
			<namePart type="family">Iakunkov</namePart>
			<namePart type="given">Artem</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>orcid.org=0000-0002-1535-9476</description>
			<description>diva-portal.org=authority-person:69579</description>
		</name>
		<name type="personal" authority="umu" xlink:href="vask0001">
			<namePart type="family">Skrypnychuk</namePart>
			<namePart type="given">Vasyl</namePart>
			<namePart type="date">1986-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>diva-portal.org=authority-person:63635</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anno0223">
			<namePart type="family">Nordenström</namePart>
			<namePart type="given">Andreas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>diva-portal.org=authority-person:73126</description>
		</name>
		<name type="personal">
			<namePart type="family">Shilayeva</namePart>
			<namePart type="given">Elizaveta A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Korobov</namePart>
			<namePart type="given">Mikhail</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Prodana</namePart>
			<namePart type="given">Mariana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Enachescu</namePart>
			<namePart type="given">Marius</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Sylvia H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="alta0001">
			<namePart type="family">Talyzin</namePart>
			<namePart type="given">Aleksandr V.</namePart>
			<namePart type="date">1969-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>orcid.org=0000-0002-3320-8487</description>
			<description>diva-portal.org=authority-person:63742</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="866">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Activated graphene as a material for supercapacitor electrodes</title>
			<subTitle>effects of surface area, pore size distribution and hydrophilicity</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>RSC Publishing</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-13T14:40:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162087</identifier>
		<identifier type="doi">10.1039/c9cp03327k</identifier>
		<identifier type="pmid">31380541</identifier>
		<identifier type="isi">000481777100040</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1039/c9cp03327k</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>graphene</topic>
		</subject>
		<subject lang="eng">
			<topic>energy storage</topic>
		</subject>
		<subject lang="eng">
			<topic>supercapacitors</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10304">
			<topic>Natural Sciences</topic>
			<topic>Physical Sciences</topic>
			<topic>Condensed Matter Physics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10304">
			<topic>Naturvetenskap</topic>
			<topic>Fysik</topic>
			<topic>Den kondenserade materiens fysik</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2181">
			<topic>Physical Chemistry</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2181">
			<topic>fysikalisk kemi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Activated reduced graphene oxide (a-rGO) is a material with a rigid 3D porous structure and high specific surface area (SSA). Using variation of activation parameters and post-synthesis mechanical treatment we prepared two sets of materials with a broad range of BET (N&lt;sub&gt;2&lt;/sub&gt;) SSA ∼1000–3000 m&lt;sup&gt;2&lt;/sup&gt; g&lt;sup&gt;−1&lt;/sup&gt;, and significant differences in pore size distribution and oxygen content. The performance of activated graphene as an electrode in a supercapacitor with KOH electrolyte was correlated with the structural parameters of the materials and water sorption properties. a-rGO is a hydrophobic material as evidenced by the negligibly small BET (H&lt;sub&gt;2&lt;/sub&gt;O) SSA determined using analysis of water vapor sorption isotherms. However, the total pore volume determined using water vapor sorption and sorption of liquid water is almost the same as the one found by analysis of nitrogen sorption isotherms. Ball milling is found to provide an improved bulk density of activated graphene and collapse of all pores except the smallest ones (&amp;lt;2 nm). A decrease in the activation temperature from 850 °C to 550 °C is found to result in materials with a narrow micropore size distribution and increased oxygen content. Elimination of mesopores using ball milling or a lower activation temperature provided materials with better specific capacitance despite a significant decrease (by ∼30%) of the BET (N&lt;sub&gt;2&lt;/sub&gt;) SSA. The best gravimetric and volumetric capacitances in KOH electrolyte were achieved not for samples with the highest value of the BET (N&lt;sub&gt;2&lt;/sub&gt;) SSA but for materials with 80–90% of the total pore volume in micropores and an increased BET (H&lt;sub&gt;2&lt;/sub&gt;O) SSA. Comparing the performance of electrodes prepared using rGO and a-rGO shows that a more hydrophilic surface is favorable for charge storage in supercapacitors with KOH electrolyte.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Physical Chemistry, Chemical Physics - PCCP</title>
			</titleInfo>
			<identifier type="issn">1463-9076</identifier>
			<identifier type="eissn">1463-9084</identifier>
			<part>
				<detail type="volume">
					<number>21</number>
				</detail>
				<detail type="issue">
					<number>32</number>
				</detail>
				<extent>
					<start>17901</start>
					<end>17912</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1342445/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-13</recordCreationDate>
			<recordChangeDate>2019-10-21</recordChangeDate>
			<recordIdentifier>diva2:1342445</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="empe0001">
			<namePart type="family">Persson</namePart>
			<namePart type="given">Emma</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>diva-portal.org=authority-person:65569</description>
		</name>
		<name type="personal">
			<namePart type="family">Souza</namePart>
			<namePart type="given">Pedro P. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Floriano-Marcelino</namePart>
			<namePart type="given">Thais</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Conaway</namePart>
			<namePart type="given">Howard Herschel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Henning</namePart>
			<namePart type="given">Petra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="ulle0001">
			<namePart type="family">Lerner</namePart>
			<namePart type="given">Ulf H.</namePart>
			<namePart type="date">1946-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<affiliation>Department of Internal Medicine and Clinical Nutrition, Centre for Bone and Arthritis Research, Institute for Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63094</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Frontiers Media S.A.</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-11T14:27:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159851</identifier>
		<identifier type="doi">10.3389/fimmu.2019.01164</identifier>
		<identifier type="isi">000469268500001</identifier>
		<identifier type="articleId">1164</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3389/fimmu.2019.01164</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>OSM</topic>
		</subject>
		<subject lang="eng">
			<topic>LIF</topic>
		</subject>
		<subject lang="eng">
			<topic>RANKL</topic>
		</subject>
		<subject lang="eng">
			<topic>Shc1</topic>
		</subject>
		<subject lang="eng">
			<topic>osteoclast</topic>
		</subject>
		<subject lang="eng">
			<topic>bone resorption</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="106">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="106">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background and Purpose: The gp130 family of cytokines signals through receptors dimerizing with the gp130 subunit. Downstream signaling typically activates STAT3 but also SHP2/Ras/MAPK pathways. Oncostatin M (OSM) is a unique cytokine in this family since the receptor (OSMR) activates a non-redundant signaling pathway by recruitment of the adapter Shc1. We have studied the functional relevance of Shc1 for OSM-induced bone resorption.&lt;/p&gt;&lt;p&gt;Experimental Approach: Osteoblasts were stimulated with OSM and STAT3 and Shc1 activations were studied using real-time PCR and Western blots. The role of STAT3 and Shc1 for OSM-induced RANKL expression and osteoclast formation was studied by silencing their mRNA expressions. Effects of OSM were compared to those of the closely related cytokine leukemia inhibitory factor (LIF).&lt;/p&gt;&lt;p&gt;Key Results: OSM, but not LIF, induced the mRNA and protein expression of Shc1 and activated phosphorylation of Shc1 in the osteoblasts. Silencing of Shc1 decreased OSM-induced activation of STAT3 and RANKL expression. Silencing of STAT3 had no effect on activation of Shc1, but prevented the OSM-mediated increase of RANKL expression. Silencing of either Shc1 or STAT3 in osteoblasts decreased formation of osteoclasts in OSM-stimulated co-cultures of osteoblasts and macrophages. In agreement with these observations, OSM was a more potent and robust stimulator than LIF of RANKL formation and bone resorption in mouse calvariae and osteoclast formation in bone marrow cultures.&lt;/p&gt;&lt;p&gt;Conclusions and Implications: Activation of the Shc1-dependent STAT3 signaling is crucial for OSM-induced osteoclast formation. Inhibition of Shc1 is a potential mechanism to specifically inhibit OSM-induced bone resorption.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Frontiers in Immunology</title>
			</titleInfo>
			<identifier type="issn">1664-3224</identifier>
			<identifier type="eissn">1664-3224</identifier>
			<part>
				<detail type="volume">
					<number>10</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Reumatikerförbundet</note>
		<note type="funder">Konung Gustaf V:s Jubileumsfond</note>
		<note type="funder">Västerbottens läns landsting</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1322981/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-11</recordCreationDate>
			<recordChangeDate>2019-06-11</recordChangeDate>
			<recordIdentifier>diva2:1322981</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Souza</namePart>
			<namePart type="given">Pedro P. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="pelu0004">
			<namePart type="family">Lundberg</namePart>
			<namePart type="given">Pernilla</namePart>
			<namePart type="date">1965-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>orcid.org=0000-0002-8244-5200</description>
			<description>diva-portal.org=authority-person:64956</description>
		</name>
		<name type="personal" authority="umu" xlink:href="inlu0001">
			<namePart type="family">Lundgren</namePart>
			<namePart type="given">Inger</namePart>
			<namePart type="date">1950-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>diva-portal.org=authority-person:66879</description>
		</name>
		<name type="personal">
			<namePart type="family">Magalhäes</namePart>
			<namePart type="given">Fernando A. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Costa-Neto</namePart>
			<namePart type="given">Claudio M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="ulle0001">
			<namePart type="family">Lerner</namePart>
			<namePart type="given">Ulf H.</namePart>
			<namePart type="date">1946-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<affiliation>Centre for Bone and Arthritis Research at Department of Internal Medicine and Clinical Nutrition, Institute for Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63094</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Activation of Toll-like receptor 2 induces B1 and B2 kinin receptors in human gingival fibroblasts and in mouse gingiva</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Nature Publishing Group</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-01T12:33:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157584</identifier>
		<identifier type="doi">10.1038/s41598-018-37777-z</identifier>
		<identifier type="pmid">30814538</identifier>
		<identifier type="isi">000459799800122</identifier>
		<identifier type="articleId">2973</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1038/s41598-018-37777-z</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30108">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Cell and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30108">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Cell- och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p data-test="article-identifier"&gt;The regulation of the kallikrein-kinin system is an important mechanism controlling vasodilation and promoting inflammation. We aimed to investigate the role of Toll-like receptor 2 (TLR2) in regulating kinin B&lt;sub&gt;1&lt;/sub&gt; and B&lt;sub&gt;2&lt;/sub&gt; receptor expression in human gingival fibroblasts and in mouse gingiva. Both &lt;em&gt;P. gingivalis&lt;/em&gt; LPS and the synthetic TLR2 agonist Pam&lt;sub&gt;2&lt;/sub&gt;CSK&lt;sub&gt;4&lt;/sub&gt; increased kinin receptor transcripts. Silencing of TLR2, but not of TLR4, inhibited the induction of kinin receptor transcripts by both &lt;em&gt;P. gingivalis&lt;/em&gt; LPS and Pam&lt;sub&gt;2&lt;/sub&gt;CSK&lt;sub&gt;4&lt;/sub&gt;. Human gingival fibroblasts (HGF) exposed to Pam&lt;sub&gt;2&lt;/sub&gt;CSK&lt;sub&gt;4&lt;/sub&gt; increased binding sites for bradykinin (BK, B&lt;sub&gt;2&lt;/sub&gt;receptor agonist) and des-Arg&lt;sup&gt;10&lt;/sup&gt;-Lys-bradykinin (DALBK, B&lt;sub&gt;1&lt;/sub&gt; receptor agonist). Pre-treatment of HGF for 24 h with Pam&lt;sub&gt;2&lt;/sub&gt;CSK&lt;sub&gt;4&lt;/sub&gt; resulted in increased PGE&lt;sub&gt;2&lt;/sub&gt; release in response to BK and DALBK. The increase of B1 and B2 receptor transcripts by &lt;em&gt;P. gingivalis&lt;/em&gt; LPS was not blocked by IL-1β neutralizing antibody; TNF-α blocking antibody did not affect B&lt;sub&gt;1 &lt;/sub&gt;receptor up-regulation, but partially blocked increase of B&lt;sub&gt;2&lt;/sub&gt; receptor mRNA. Injection of &lt;em&gt;P. gingivalis&lt;/em&gt; LPS in mouse gingiva induced an increase of B&lt;sub&gt;1&lt;/sub&gt; and B&lt;sub&gt;2&lt;/sub&gt; receptor mRNA. These data show that activation of TLR2 in human gingival fibroblasts as well as in mouse gingival tissue leads to increase of B&lt;sub&gt;1&lt;/sub&gt; and B&lt;sub&gt;2&lt;/sub&gt; receptor mRNA and protein.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Scientific Reports</title>
			</titleInfo>
			<identifier type="issn">2045-2322</identifier>
			<identifier type="eissn">2045-2322</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1301175/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-01</recordCreationDate>
			<recordChangeDate>2019-04-01</recordChangeDate>
			<recordIdentifier>diva2:1301175</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Zuo</namePart>
			<namePart type="given">Nianming</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="alsa0014">
			<namePart type="family">Salami</namePart>
			<namePart type="given">Alireza</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå centrum för funktionell hjärnavbildning (UFBI)</affiliation>
			<affiliation>Umeå universitet, Institutionen för integrativ medicinsk biologi (IMB)</affiliation>
			<affiliation>Umeå universitet, Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)</affiliation>
			<affiliation>Aging Research Center, Karolinska Institute and Stockholm University, Stockholm, Sweden</affiliation>
			<description>diva-portal.org=authority-person:64316</description>
		</name>
		<name type="personal">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Yihong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Zhengyi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sui</namePart>
			<namePart type="given">Jing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jian</namePart>
			<namePart type="given">Tianzi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5752">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå centrum för funktionell hjärnavbildning (UFBI)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="734">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för integrativ medicinsk biologi (IMB)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="880000">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Activation-based association profiles differentiate network roles across cognitive loads</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-18T10:25:02</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159585</identifier>
		<identifier type="doi">10.1002/hbm.24561</identifier>
		<identifier type="pmid">30854745</identifier>
		<identifier type="isi">000467570300018</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>association</topic>
		</subject>
		<subject lang="eng">
			<topic>cognitive performance</topic>
		</subject>
		<subject lang="eng">
			<topic>functional activation</topic>
		</subject>
		<subject lang="eng">
			<topic>functional magnetic resonance imaging MRI)</topic>
		</subject>
		<subject lang="eng">
			<topic>working memory</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30105">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Neurosciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30105">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Neurovetenskaper</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Working memory (WM) is a complex and pivotal cognitive system underlying the performance of many cognitive behaviors. Although individual differences in WM performance have previously been linked to the blood oxygenation level-dependent (BOLD) response across several large-scale brain networks, the unique and shared contributions of each large-scale brain network to efficient WM processes across different cognitive loads remain elusive. Using a WM paradigm and functional magnetic resonance imaging (fMRI) from the Human Connectome Project, we proposed a framework to assess the association and shared-association strength between imaging biomarkers and behavioral scales. Association strength is the capability of individual brain regions to modulate WM performance and shared-association strength measures how different regions share the capability of modulating performance. Under higher cognitive load (2-back), the frontoparietal executive control network (FPN), dorsal attention network (DAN), and salience network showed significant positive activation and positive associations, whereas the default mode network (DMN) showed the opposite pattern, namely, significant deactivation and negative associations. Comparing the different cognitive loads, the DMN and FPN showed predominant associations and globally shared-associations. When investigating the differences in association from lower to higher cognitive loads, the DAN demonstrated enhanced association strength and globally shared-associations, which were significantly greater than those of the other networks. This study characterized how brain regions individually and collaboratively support different cognitive loads.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Human Brain Mapping</title>
			</titleInfo>
			<identifier type="issn">1065-9471</identifier>
			<identifier type="eissn">1097-0193</identifier>
			<part>
				<detail type="volume">
					<number>40</number>
				</detail>
				<detail type="issue">
					<number>9</number>
				</detail>
				<extent>
					<start>2800</start>
					<end>2812</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-18</recordCreationDate>
			<recordChangeDate>2019-06-18</recordChangeDate>
			<recordIdentifier>diva2:1326406</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Nyqvist</namePart>
			<namePart type="given">Fredrica</namePart>
			<namePart type="date">1972-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Åbo Akademi</affiliation>
			<description>orcid.org=0000-0001-6554-8040</description>
		</name>
		<name type="personal">
			<namePart type="family">Nygård</namePart>
			<namePart type="given">Mikael</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Åbo Akademi</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="frsn0001">
			<namePart type="family">Snellman</namePart>
			<namePart type="given">Fredrik</namePart>
			<namePart type="date">1975-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för socialt arbete</affiliation>
			<affiliation>GERDA research group (Gerontological Regional Database), Age, Ageing and Social Welfare</affiliation>
			<description>orcid.org=0000-0003-3452-3953</description>
		</name>
		<name type="corporate">
			<namePart>GERDA research group (Gerontological Regional Database), Age, Ageing and Social Welfare</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="849">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för socialt arbete</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Active ageing</title>
			<subTitle>Results from Western Finland</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<place>
				<placeTerm>Turku</placeTerm>
			</place>
			<publisher>Society of Social and Economic Research in the Universities of Turku</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-10T14:27:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167182</identifier>
		<location>
			<url displayLabel="URL" note="free">http://www.finnresearch.fi/RFS2019_Nyqvist_etal.pdf</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>active aging</topic>
		</subject>
		<subject lang="eng">
			<topic>linguistic groups</topic>
		</subject>
		<subject lang="eng">
			<topic>gender</topic>
		</subject>
		<subject lang="eng">
			<topic>municipality</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50402">
			<topic>Social Sciences</topic>
			<topic>Sociology</topic>
			<topic>Social Work</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50402">
			<topic>Samhällsvetenskap</topic>
			<topic>Sociologi</topic>
			<topic>Socialt arbete</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2149">
			<topic>Sociology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2149">
			<topic>sociologi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;The Active Ageing Index (AAI) can be applied across countries to compare active aging outcomes, evaluate the current situation regarding ageing, and identify the most desired directions for policy action. While the AAI-EU is addressed on a national level, it can also be used for assessing active ageing policies on the municipal level, which is the case in this study. The aim of this article was to assess active ageing amongst older people in western parts of Finland by adapting the methodology used for the AAI-EU. We used GERDA data (n=5,011) collected from people aged 66, 71, 76, 81 and 86 for our descriptive analyses. The results showed that the municipalities differed in their active ageing outcomes, and that men and Swedish speakers generally scored higher on the index, which is something that warrants further investigation. Based on the results, we argue that AAI could potentially be used as a tool to monitor various dimensions of active ageing on a regional level and that gender and ethno-linguistic characteristics should be a central concern for a discussion on ageing in our study region.&lt;/p&gt;</abstract>
		<abstract lang="fin">&lt;p&gt;Aktiivisen ikääntymisen indeksiä (AAI) voidaan soveltaa kaikissa maissa aktiivisen ikääntymisen tulosten vertailemiseksi, ikääntymisen nykytilan arvioimiseksi sekä politiikkatoimien tavoitteiden tunnistamiseksi. Vaikka AAI-EU on suunnattu kansalliselle tasolle, sitä voidaan käyttää myös aktiivisen ikääntymisen politiikan tarkasteluun kuntatasolla, kuten tässä tutkimuksessa. Tämän artikkelin tarkoituksena oli arvioida aktiivista ikääntymistä Länsi-Suomessa AAI-EU:n avulla. Kuvailevassa analyysissä käytimme 66-, 71-, 76-, 81- ja 86-vuotiailta kerättyä GERDA-aineistoa (n = 5011). Tutkimuksemme osoitti, että aktiivisen ikääntymisen tulokset eroavat kuntatasolla ja että miehet ja ruotsinkieliset sijoittuivat indeksissä yleisesti korkeammalle, mikä kaipaa lisätutkimusta. Tulosten perusteella voidaan todeta, että AAI on soveltuva työkalu aktiivisen ikääntymisen seurannassa alueellisella tasolla ja että sukupuolen sekä kieliryhmien ominaispiirteet tulisi huomioida ikäntymistä koskevassa keskustelussa tutkimusalueellamme.&lt;/p&gt;</abstract>
		<abstract lang="swe">&lt;p&gt;Ett index för det aktiva åldrandet (AAI) används för att jämföra hur olika länder hanterar en åldrande befolkning och lyfter fram var behoven för olika policyinsatser är som störst. Emedan AAI-EU används för att jämföra situationen i europeiska länder, så kan indexet även användas för att jämföra kommuner, vilket är något som vi gjorde i den här studien. Syftet med studien var således att undersöka det aktiva åldrandet bland äldre i västra Finland genom att använda metodologin som använts för AAI-EU. Vi använde GERDA-data (n=5011) insamlat bland 66-, 71-, 76-, 81-, och 86-åringar för våra deskriptiva analyser. Resultaten visade att det fanns skillnader i det aktiva åldrandet mellan kommunerna. Resultaten visade även att fanns skillnader mellan svensk- och finskspråkiga så att svenskspråkiga placerade sig högre på indexet. Baserat på resultaten från studien så konkluderar vi att ett regionalt AAI kunde användas för att följa upp det aktiva åldrandet på kommunnivå och att skillnader mellan män och kvinnor samt skillnader mellan etnolingvistiska grupper borde lyftas fram i diskussioner om det aktiva åldrandet i vår region.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>12</number>
				</detail>
				<extent>
					<start>55</start>
					<end>66</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Research on Finnish Society</title>
			</titleInfo>
			<identifier type="issn">1796-8739</identifier>
			<identifier type="eissn">2490-0958</identifier>
			<part>
				<detail type="volume">
					<number>12</number>
				</detail>
				<extent>
					<start>55</start>
					<end>66</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1384728/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>frsn0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-10</recordCreationDate>
			<recordChangeDate>2020-01-10</recordChangeDate>
			<recordIdentifier>diva2:1384728</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="maasps77">
			<namePart type="family">Sperens</namePart>
			<namePart type="given">Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för samhällsmedicin och rehabilitering</affiliation>
			<description>orcid.org=0000-0002-8417-1768</description>
			<description>diva-portal.org=authority-person:67098</description>
		</name>
		<name type="personal" authority="umu" xlink:href="dege0007">
			<namePart type="family">Georgiev</namePart>
			<namePart type="given">Dejan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia; Faculty of Computer Sciences and Informatics, University of Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia</affiliation>
			<description>orcid.org=0000-0003-1832-3441</description>
			<description>diva-portal.org=authority-person:68445</description>
		</name>
		<name type="personal" authority="umu" xlink:href="maaeon98">
			<namePart type="family">Domellöf</namePart>
			<namePart type="given">Magdalena E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>orcid.org=0000-0002-2348-1164</description>
			<description>diva-portal.org=authority-person:64745</description>
		</name>
		<name type="personal" authority="umu" xlink:href="lafo0001">
			<namePart type="family">Forsgren</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för farmakologi och klinisk neurovetenskap</affiliation>
			<description>diva-portal.org=authority-person:62555</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kaha0002">
			<namePart type="family">Hamberg</namePart>
			<namePart type="given">Katarina</namePart>
			<namePart type="date">1952-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Allmänmedicin</affiliation>
			<description>diva-portal.org=authority-person:63220</description>
		</name>
		<name type="personal" authority="umu" xlink:href="guha0001">
			<namePart type="family">Hariz</namePart>
			<namePart type="given">Gun-Marie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för samhällsmedicin och rehabilitering</affiliation>
			<affiliation>Umeå universitet, Institutionen för farmakologi och klinisk neurovetenskap</affiliation>
			<description>diva-portal.org=authority-person:63219</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="770">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="717">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för farmakologi och klinisk neurovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="724">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Allmänmedicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Activities of daily living in Parkinson's disease</title>
			<subTitle>Time/gender perspective</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-19T10:41:39</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166577</identifier>
		<identifier type="doi">10.1111/ane.13189</identifier>
		<identifier type="pmid">31693751</identifier>
		<identifier type="isi">000497350700001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>activities of daily living</topic>
		</subject>
		<subject lang="eng">
			<topic>gender differences</topic>
		</subject>
		<subject lang="eng">
			<topic>longitudinal study</topic>
		</subject>
		<subject lang="eng">
			<topic>Parkinson's disease</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30207">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Neurology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30207">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Neurologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Objective: The objectives of this study were to explore the changes in the activities of daily living (ADL) in persons with Parkinson's disease (pwPD) over time and to investigate possible differences in ADL performance between men and women with PD.&lt;/p&gt;&lt;p&gt;Materials &amp;amp; Methods: One hundred twenty‐nine persons (76 men) with a clinically established PD self‐assessed their ADL performance from the time of diagnosis up to 8 years follow‐up using the ADL taxonomy. Other demographic and clinical data (motor state, cognition, depression) were also collected and subjected to further analysis.&lt;/p&gt;&lt;p&gt;Results: Nine of 12 domains in the ADL taxonomy showed a change over time (Eating and Drinking [&lt;em&gt;P&lt;/em&gt; = .009], Mobility [&lt;em&gt;P&lt;/em&gt; &amp;lt; .001], Toilet activities [&lt;em&gt;P&lt;/em&gt; = .031], Dressing [&lt;em&gt;P&lt;/em&gt; &amp;lt; .001], Personal hygiene [&lt;em&gt;P&lt;/em&gt; &amp;lt; .001], Communication [&lt;em&gt;P&lt;/em&gt; &amp;lt; .001], Cooking [&lt;em&gt;P&lt;/em&gt; = .001], Shopping [&lt;em&gt;P&lt;/em&gt; &amp;lt; .001] and Cleaning [&lt;em&gt;P&lt;/em&gt; &amp;lt; .001]). In addition to time, two domains, (Shopping [&lt;em&gt;P&lt;/em&gt; = .007] and Cleaning [&lt;em&gt;P&lt;/em&gt; = .027]) also showed an effect of gender with worse scores in women. The nine ADL domains showing effect of time, showed temporary improvement at 12 months follow‐up, most probably due to dopaminergic medication. All nine domains deteriorated at later follow‐up.&lt;/p&gt;&lt;p&gt;Conclusions: As expected, there was deterioration in self‐assessed performance in the majority od ADL domains over time. Women assessed their ADLs worse in two domains (Shopping and Cleaning) probably reflecting a general gender‐related activity pattern rather than being a PD‐specific finding.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Acta Neurologica Scandinavica</title>
			</titleInfo>
			<identifier type="issn">0001-6314</identifier>
			<identifier type="eissn">1600-0404</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>bonnym04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-19</recordCreationDate>
			<recordChangeDate>2019-12-19</recordChangeDate>
			<recordIdentifier>diva2:1380634</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Antoniewicz</namePart>
			<namePart type="given">Lukasz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="ambr0007">
			<namePart type="family">Brynedal</namePart>
			<namePart type="given">Amelie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:72209</description>
		</name>
		<name type="personal" authority="umu" xlink:href="evli0029">
			<namePart type="family">Hedman</namePart>
			<namePart type="given">Linnea</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<affiliation>Division of Nursing, Department of Health Science, Luleå University of Technology, Luleå, Sweden.</affiliation>
			<affiliation>The OLIN Unit</affiliation>
			<description>orcid.org=0000-0002-1630-3167</description>
			<description>diva-portal.org=authority-person:62779</description>
		</name>
		<name type="corporate">
			<namePart>The OLIN Unit</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Lundbäck</namePart>
			<namePart type="given">Magnus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jebo0004">
			<namePart type="family">Bosson</namePart>
			<namePart type="given">Jenny A.</namePart>
			<namePart type="date">1975-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:63294</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="730">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Yrkes- och miljömedicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Acute Effects of Electronic Cigarette Inhalation on the Vasculature and the Conducting Airways</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-09T13:30:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158824</identifier>
		<identifier type="doi">10.1007/s12012-019-09516-x</identifier>
		<identifier type="pmid">30963443</identifier>
		<identifier type="isi">000486337400006</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1007/s12012-019-09516-x</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Arterial stiffness</topic>
		</subject>
		<subject lang="eng">
			<topic>Augmentation index</topic>
		</subject>
		<subject lang="eng">
			<topic>ENDS</topic>
		</subject>
		<subject lang="eng">
			<topic>Electronic cigarettes</topic>
		</subject>
		<subject lang="eng">
			<topic>IOS</topic>
		</subject>
		<subject lang="eng">
			<topic>Pulse wave velocity</topic>
		</subject>
		<subject lang="eng">
			<topic>e-Cig</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30303">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Occupational Health and Environmental Health</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30303">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Arbetsmedicin och miljömedicin</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The use of electronic cigarettes has increased exponentially since its introduction onto the global market in 2006. However, short- and long-term health effects remain largely unknown due to the novelty of this product. The present study examines the acute effects of e-cigarette aerosol inhalation, with and without nicotine, on vascular and pulmonary function in healthy volunteers. Seventeen healthy subjects inhaled electronic cigarette aerosol with and without nicotine on two separate occasions in a double-blinded crossover fashion. Blood pressure, heart rate, and arterial stiffness measured by pulse wave velocity and pulse wave analysis were assessed at baseline, and then at 0 h, 2 h, and 4 h following exposure. Dynamic spirometry and impulse oscillometry were measured following vascular assessments at these time points, as well as at 6 h following exposure. e-Cigarette aerosol with nicotine caused a significant increase in heart rate and arterial stiffness. Furthermore, e-cigarette aerosol-containing nicotine caused a sudden increase in flow resistance as measured by impulse oscillometry, indicating obstruction of the conducting airways. Both aerosols caused an increase in blood pressure. The present study indicates that inhaled e-cigarette aerosol with nicotine has an acute impact on vascular and pulmonary function. Thus, chronic usage may lead to long-term adverse health effects. Further investigation is warranted.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Cardiovascular Toxicology</title>
			</titleInfo>
			<identifier type="issn">1530-7905</identifier>
			<identifier type="eissn">1559-0259</identifier>
			<part>
				<detail type="volume">
					<number>19</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>441</start>
					<end>450</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1314646/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>lrtjon02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-09</recordCreationDate>
			<recordChangeDate>2019-11-11</recordChangeDate>
			<recordIdentifier>diva2:1314646</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Cameli</namePart>
			<namePart type="given">Matteo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-3872-8964</description>
		</name>
		<name type="personal">
			<namePart type="family">Pastore</namePart>
			<namePart type="given">Maria Concetta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-7223-141X</description>
		</name>
		<name type="personal">
			<namePart type="family">De Carli</namePart>
			<namePart type="given">Giuseppe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mihe0015">
			<namePart type="family">Henein</namePart>
			<namePart type="given">Michael Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>St George London &amp; Brunel Universities, UK</affiliation>
			<description>orcid.org=0000-0002-6089-5614</description>
			<description>diva-portal.org=authority-person:62840</description>
		</name>
		<name type="personal">
			<namePart type="family">Mandoli</namePart>
			<namePart type="given">Giulia Elena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lisi</namePart>
			<namePart type="given">Edoardo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cameli</namePart>
			<namePart type="given">Paolo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-8639-2882</description>
		</name>
		<name type="personal">
			<namePart type="family">Lunghetti</namePart>
			<namePart type="given">Stefano</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">D'Ascenzi</namePart>
			<namePart type="given">Flavio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nannelli</namePart>
			<namePart type="given">Chiara</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rizzo</namePart>
			<namePart type="given">Luisa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valente</namePart>
			<namePart type="given">Serafina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mondillo</namePart>
			<namePart type="given">Sergio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>ACUTE HF score, a multiparametric prognostic tool for acute heart failure</title>
			<subTitle>A real-life study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-05T09:34:51</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165665</identifier>
		<identifier type="doi">10.1016/j.ijcard.2019.07.015</identifier>
		<identifier type="pmid">31324396</identifier>
		<identifier type="isi">000488960200024</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Acute heart failure</topic>
		</subject>
		<subject lang="eng">
			<topic>Prognosis</topic>
		</subject>
		<subject lang="eng">
			<topic>Coronary care unit</topic>
		</subject>
		<subject lang="eng">
			<topic>Score</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Acute heart failure (AHF) is the first cause of hospitalization for over-65 individuals, associated with high mortality and readmission rate. The aim of this study was to assess the prognostic value of a multiparametric score combining clinical, biochemical and echocardiographic indexes in AHF for clinical practice.&lt;/p&gt;&lt;p&gt;Methods: 830 patients hospitalized for AHF were enrolled. Exclusion criteria were: active neoplasms; previous heart transplantation or left ventricular assist device implantation. Different variables were analyzed: etiology of AHF, clinical and biochemical data, lung congestion on chest-X ray, echocardiographic parameters and administered therapy. The endpoints were: all-cause mortality at 30 days, 6 months and 5 years and the duration of hospitalization.&lt;/p&gt;&lt;p&gt;Results: 771 patients met eligibility criteria. Using the univariate and multivariate analysis the indexes with the best correlation with outcome were discretized and used to create the ACUTE HF score, computed as: 1.4*[serum creatinine&amp;gt;2 mg/dl] + 0.8*[ejection fraction&amp;lt;30] + 0.7*[age &amp;gt; 76] + 0.7*[prior hospitalization for AHF] + 0.9*[prior stroke/transient ischemic attack] + 0.5*[more than moderate mitral regurgitation] + 0.8*[use of non-invasive ventilation] and used to divide patients into 3 groups according to the risk of 6-months mortality. With the receiver operating curves and Kaplan-Meier analysis, this score proved to have a high predictive power for mortality at 30 days, 6 months and 5 years from hospitalization, and for event-free survival rates, providing a risk stratification capability superior to that of single variables.&lt;/p&gt;&lt;p&gt;Conclusions: The ACUTE HF score could be a complete and useful tool for assessing prognosis of AHF patients. It could represent a step in the long standardization pathway of prognostic protocols for AHF.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Cardiology</title>
			</titleInfo>
			<identifier type="issn">0167-5273</identifier>
			<identifier type="eissn">1874-1754</identifier>
			<part>
				<detail type="volume">
					<number>296</number>
				</detail>
				<extent>
					<start>103</start>
					<end>108</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>bonnym04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-05</recordCreationDate>
			<recordChangeDate>2019-12-05</recordChangeDate>
			<recordIdentifier>diva2:1375453</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Carlsson</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lundälv</namePart>
			<namePart type="given">Jörgen</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för kirurgisk och perioperativ vetenskap</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="792">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Acute Injuries Resulting from Accidents Involving Powered Mobility Devices (PMDs) – Development and Outcomes of PMD Related Accidents in Sweden</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-27T20:39:35</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158432</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>acute injuries</topic>
		</subject>
		<subject lang="eng">
			<topic>accidents</topic>
		</subject>
		<subject lang="eng">
			<topic>Powered Mobility Devices</topic>
		</subject>
		<subject lang="eng">
			<topic>PMD</topic>
		</subject>
		<subject lang="eng">
			<topic>Outcomes</topic>
		</subject>
		<subject lang="eng">
			<topic>Sweden</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30212">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Surgery</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30212">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kirurgi</topic>
		</subject>
		<relatedItem type="host">
			<titleInfo>
				<title>Traffic Injury Prevention</title>
			</titleInfo>
			<identifier type="issn">1538-9588</identifier>
			<identifier type="eissn">1538-957X</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Accepted</note>
		<recordInfo>
			<recordOrigin>jalu0004</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-27</recordCreationDate>
			<recordChangeDate>2019-04-27</recordChangeDate>
			<recordIdentifier>diva2:1307511</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Carlsson</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Chalmersa Commercial R&amp;D, Chalmers Industrial Technology, Gothenburg, Sweden</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="jalu0004">
			<namePart type="family">Lundälv</namePart>
			<namePart type="given">Jörgen</namePart>
			<namePart type="termsOfAddress">Docent i trafikmedicin</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kirurgi</affiliation>
			<affiliation>Department of Social Work, University of Gothenburg, Gothenburg, Sweden</affiliation>
			<affiliation>traffic medicine</affiliation>
			<description>orcid.org=0000-0003-0552-886X</description>
			<description>diva-portal.org=authority-person:62762</description>
		</name>
		<name type="corporate">
			<namePart>traffic medicine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="793">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Kirurgi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Acute injuries resulting from accidents involving powered mobility devices (PMDs)</title>
			<subTitle>Development and outcomes of PMD-related accidents in Sweden</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-11T06:39:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159937</identifier>
		<identifier type="doi">10.1080/15389588.2019.1606910</identifier>
		<identifier type="isi">000474308200006</identifier>
		<identifier type="scopus">2-s2.0-85067574126</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/15389588.2019.1606910</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>powered mobility devices</topic>
		</subject>
		<subject lang="eng">
			<topic>acute injuries</topic>
		</subject>
		<subject lang="eng">
			<topic>PMD-related accident</topic>
		</subject>
		<subject lang="eng">
			<topic>disabled persons</topic>
		</subject>
		<subject lang="eng">
			<topic>traffic environment</topic>
		</subject>
		<subject lang="eng">
			<topic>vulnerable road users</topic>
		</subject>
		<subject lang="eng">
			<topic>STRADA</topic>
		</subject>
		<subject lang="eng">
			<topic>Sweden</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30212">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Surgery</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30212">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kirurgi</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2087">
			<topic>Surgery</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2087">
			<topic>kirurgi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Objective: Powered mobility devices (PMDs) are commonly used as aids for older people andpeople with disabilities, subgroups of vulnarable road users (VRUs) who are rarely noted in trafficsafety contexts. However, the problem of accidents involving PMD drivers has been reported inmany countries where these vehicles have become increasingly popular.The aim of this study is to extract and analyze national PMD-related accident and injury datareported to the Swedish Traffic Accident Data Acquisition (STRADA) database. The results will providevaluable insight into the risks and obstacles that PMD drivers are exposed to in the trafficenvironment and may contribute to improving the mobility of this group in the long term.&lt;/p&gt;&lt;p&gt;Methods: The current study is based on data from 743 accidents and 998 persons. An analysiswas performed on a subset of data (N¼301) in order to investigate the development of accidentsover a period of 10 years. Thereafter, each accident in the whole data set was registered as eithersingle (N¼427) or collision (N¼315).&lt;/p&gt;&lt;p&gt;Results: The results show that there was a 3-fold increase in the number of PMD-related accidentsreported to STRADA during the period 2007–2016.With regard to single accidents, collisions, as well as fatalities, the injury statistics were dominatedby males. Single accidents were more common than collisions (N¼427 and N¼316, respectively)and the level of injury sustained in each type of accident is on par.The vast majority of single accidents resulted in the PMD driver impacting the ground (87%), dueto either PMD turnover (71%) or the driver falling out of the PMD (16%). The reason for many ofthe single accidents was a difference in ground level (34%, typically a curb).Cars, trucks, or buses were involved in 67% of collision events; these occured predominantly atjunctions or intersections (70%).Abbreviated Injury Scale (AIS) 3þ injuries were dominated by hip and head injuries in both singleaccidents and collision events.&lt;/p&gt;&lt;p&gt;Conclusions: The present study shows that further research on PMD accidents is required, withregard to both single accidents and collision events. To ensure that appropriate decisions aremade, future work should follow up on injury trends and further improve the quality of PDMrelatedaccident data. Improved vehicle stability and design, increased usage of safety equipment,proper training programs, effective maintenance services, and development of a supporting infrastructurewould contribute to increased safety for PMD drivers.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Traffic Injury Prevention</title>
			</titleInfo>
			<identifier type="issn">1538-9588</identifier>
			<identifier type="eissn">1538-957X</identifier>
			<part>
				<detail type="volume">
					<number>20</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>484</start>
					<end>491</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1322576/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>jalu0004</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-11</recordCreationDate>
			<recordChangeDate>2019-09-06</recordChangeDate>
			<recordIdentifier>diva2:1322576</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="fele0003">
			<namePart type="family">Bayisa</namePart>
			<namePart type="given">Fekadu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:67872</description>
		</name>
		<name type="personal" authority="umu" xlink:href="zhzh0022">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Zhiyong</namePart>
			<namePart type="date">1989-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:67873</description>
		</name>
		<name type="personal" authority="umu" xlink:href="otcr0001">
			<namePart type="family">Cronie</namePart>
			<namePart type="given">Ottmar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>Mathematical Statistics</affiliation>
			<description>diva-portal.org=authority-person:62742</description>
		</name>
		<name type="corporate">
			<namePart>Mathematical Statistics</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="juyu0002">
			<namePart type="family">Yu</namePart>
			<namePart type="given">Jun</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>Mathematical Statistics</affiliation>
			<description>orcid.org=0000-0001-5673-620X</description>
			<description>diva-portal.org=authority-person:63104</description>
		</name>
		<name type="corporate">
			<namePart>Mathematical Statistics</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adaptive algorithm for sparse signal recovery</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-04-07T15:37:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-146386</identifier>
		<identifier type="doi">10.1016/j.dsp.2019.01.002</identifier>
		<identifier type="isi">000461266700002</identifier>
		<identifier type="scopus">2-s2.0-85060542792</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>sparsity</topic>
		</subject>
		<subject lang="eng">
			<topic>adaptive algorithm</topic>
		</subject>
		<subject lang="eng">
			<topic>sparse signal recovery</topic>
		</subject>
		<subject lang="eng">
			<topic>spike and slab priors</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10106">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Probability Theory and Statistics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10106">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Sannolikhetsteori och statistik</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20205">
			<topic>Engineering and Technology</topic>
			<topic>Electrical Engineering, Electronic Engineering, Information Engineering</topic>
			<topic>Signal Processing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20205">
			<topic>Teknik och teknologier</topic>
			<topic>Elektroteknik och elektronik</topic>
			<topic>Signalbehandling</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20603">
			<topic>Engineering and Technology</topic>
			<topic>Medical Engineering</topic>
			<topic>Medical Image Processing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20603">
			<topic>Teknik och teknologier</topic>
			<topic>Medicinteknik</topic>
			<topic>Medicinsk bildbehandling</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2199">
			<topic>matematisk statistik</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2199">
			<topic>Mathematical Statistics</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2225">
			<topic>Signal Processing</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2225">
			<topic>signalbehandling</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;The development of compressive sensing in recent years has given much attention to sparse signal recovery. In sparse signal recovery, spike and slab priors are playing a key role in inducing sparsity. The use of such priors, however, results in non-convex and mixed integer programming problems. Most of the existing algorithms to solve non-convex and mixed integer programming problems involve either simplifying assumptions, relaxations or high computational expenses. In this paper, we propose a new adaptive alternating direction method of multipliers (AADMM) algorithm to directly solve the suggested non-convex and mixed integer programming problem. The algorithm is based on the one-to-one mapping property of the support and non-zero element of the signal. At each step of the algorithm, we update the support by either adding an index to it or removing an index from it and use the alternating direction method of multipliers to recover the signal corresponding to the updated support. Moreover, as opposed to the competing “adaptive sparsity matching pursuit” and “alternating direction method of multipliers” methods our algorithm can solve non-convex problems directly. Experiments on synthetic data and real-world images demonstrated that the proposed AADMM algorithm provides superior performance and is computationally cheaper than the recently developed iterative convex refinement (ICR) and adaptive matching pursuit (AMP) algorithms.&lt;/p&gt;</abstract>
		<note>&lt;p&gt;Originally included in thesis in manuscript form&lt;/p&gt;</note>
		<note type="project">Statistical modelling and intelligent data sampling in MRI and PET measurements for cancer therapy assessment</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Digital signal processing (Print)</title>
			</titleInfo>
			<identifier type="issn">1051-2004</identifier>
			<identifier type="eissn">1095-4333</identifier>
			<part>
				<detail type="volume">
					<number>87</number>
				</detail>
				<extent>
					<start>10</start>
					<end>18</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [340-2013-534]</note>
		<recordInfo>
			<recordOrigin>juyu0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-04-07</recordCreationDate>
			<recordChangeDate>2019-04-04</recordChangeDate>
			<recordIdentifier>diva2:1195952</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="zhzh0022">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Zhiyong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:67873</description>
		</name>
		<name type="personal" authority="umu" xlink:href="juyu0002">
			<namePart type="family">Yu</namePart>
			<namePart type="given">Jun</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>Mathematical Statistics</affiliation>
			<description>orcid.org=0000-0001-5673-620X</description>
			<description>diva-portal.org=authority-person:63104</description>
		</name>
		<name type="corporate">
			<namePart>Mathematical Statistics</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adaptive estimation for varying coefficient modelswith nonstationary covariates</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-30T13:52:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154754</identifier>
		<identifier type="doi">10.1080/03610926.2018.1484483</identifier>
		<identifier type="isi">000473519800007</identifier>
		<identifier type="scopus">2-s2.0-85059303429</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/03610926.2018.1484483</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Varying coefficient model</topic>
		</subject>
		<subject lang="eng">
			<topic>adaptive estimation</topic>
		</subject>
		<subject lang="eng">
			<topic>local linear fitting</topic>
		</subject>
		<subject lang="eng">
			<topic>non stationary covariates</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10106">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Probability Theory and Statistics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10106">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Sannolikhetsteori och statistik</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2199">
			<topic>matematisk statistik</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2199">
			<topic>Mathematical Statistics</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;In this paper, the adaptive estimation for varying coefficient models proposed by Chen, Wang, and Yao (2015) is extended to allowing for nonstationary covariates. The asymptotic properties of the estimator are obtained, showing different convergence rates for the integrated covariates and stationary covariates. The nonparametric estimator of the functional coefficient with integrated covariates has a faster convergence rate than the estimator with stationary covariates, and its asymptotic distribution is mixed normal. Moreover, the adaptive estimation is more efficient than the least square estimation for non normal errors. A simulation study is conducted to illustrate our theoretical results.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Communications in Statistics - Theory and Methods</title>
			</titleInfo>
			<identifier type="issn">0361-0926</identifier>
			<identifier type="eissn">1532-415X</identifier>
			<part>
				<detail type="volume">
					<number>48</number>
				</detail>
				<detail type="issue">
					<number>16</number>
				</detail>
				<extent>
					<start>4034</start>
					<end>4050</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [340-2013-534]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1274392/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>juyu0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-30</recordCreationDate>
			<recordChangeDate>2019-08-06</recordChangeDate>
			<recordIdentifier>diva2:1274392</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Frøkedal</namePart>
			<namePart type="given">Hilde</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sorensen</namePart>
			<namePart type="given">Torgeir</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ruud</namePart>
			<namePart type="given">Torleif</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="vade0006">
			<namePart type="family">DeMarinis</namePart>
			<namePart type="given">Valerie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Innlandet Hospital Trust, Norway; Uppsala University, Sweden</affiliation>
			<description>diva-portal.org=authority-person:62940</description>
		</name>
		<name type="personal">
			<namePart type="family">Stifoss-Hanssen</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Addressing the existential dimension in treatment settings</title>
			<subTitle>Mental health professionals' and healthcare chaplains' attitudes, practices, understanding and perceptions of value</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-09T12:47:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165752</identifier>
		<identifier type="doi">10.1177/0084672419883345</identifier>
		<identifier type="isi">000496575800001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Existential</topic>
		</subject>
		<subject lang="eng">
			<topic>existential dimension</topic>
		</subject>
		<subject lang="eng">
			<topic>existential group practice</topic>
		</subject>
		<subject lang="eng">
			<topic>healthcare chaplains</topic>
		</subject>
		<subject lang="eng">
			<topic>mental health</topic>
		</subject>
		<subject lang="eng">
			<topic>mental health professionals</topic>
		</subject>
		<subject lang="eng">
			<topic>religious and spiritual struggles</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30305">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nursing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30305">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Omvårdnad</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="60303">
			<topic>Humanities and the Arts</topic>
			<topic>Philosophy, Ethics and Religion</topic>
			<topic>Religious Studies</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="60303">
			<topic>Humaniora och konst</topic>
			<topic>Filosofi, etik och religion</topic>
			<topic>Religionsvetenskap</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Research has shown that addressing and integrating the existential dimension in treatment settings reduce symptoms like anxiety, depression and substance abuse. Healthcare chaplains are key personnel in this practice. A nationwide, cross-sectional survey influenced by a mixed-methods approach was used to examine the attitudes, practices, understanding and perceptions of mental health professionals, including healthcare chaplains, regarding the value of addressing the existential dimension in treatment programmes. The existential group practice was led by the healthcare chaplains as an integrated part of specialist mental health services. A positive and open attitude towards addressing the existential dimension was identified among the informants. Despite this, a small gap between attitude and practice was reported. Existential, religious and spiritual concerns are reported as part of the existential dimension and as relevant topics to be discussed in specialist mental health services. The findings indicate that the existential group practice could have a positive influence on the co-leaders' competence to address existential, religious and spiritual concerns; however, this should be further investigated.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Archive for the Psychology of Religion/ Archiv für Religionspsychologie</title>
			</titleInfo>
			<identifier type="issn">0084-6724</identifier>
			<identifier type="eissn">1573-6121</identifier>
			<part>
				<detail type="volume">
					<number>41</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>253</start>
					<end>276</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-09</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1376322</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="alfi0002">
			<namePart type="family">Fischer</namePart>
			<namePart type="given">Alexandra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för medicin</affiliation>
			<description>diva-portal.org=authority-person:73428</description>
		</name>
		<name type="personal" authority="umu" xlink:href="injo0003">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Ingegerd</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>orcid.org=0000-0002-9227-8434</description>
			<description>diva-portal.org=authority-person:63135</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anbl0001">
			<namePart type="family">Blomberg</namePart>
			<namePart type="given">Anders</namePart>
			<namePart type="date">1961-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för medicin</affiliation>
			<description>diva-portal.org=authority-person:63000</description>
		</name>
		<name type="personal" authority="umu" xlink:href="bjnsum99">
			<namePart type="family">Sundström</namePart>
			<namePart type="given">Björn</namePart>
			<namePart type="date">1968-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för medicin</affiliation>
			<description>orcid.org=0000-0001-7226-0969</description>
			<description>diva-portal.org=authority-person:63334</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881551">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Avdelningen för medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adherence to a Mediterranean-like Diet as a Protective Factor Against COPD</title>
			<subTitle>A Nested Case-Control Study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-06T15:14:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162857</identifier>
		<identifier type="doi">10.1080/15412555.2019.1634039</identifier>
		<identifier type="pmid">31405301</identifier>
		<identifier type="isi">000481171500001</identifier>
		<identifier type="scopus">2-s2.0-85070930883</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/15412555.2019.1634039</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>COPD</topic>
		</subject>
		<subject lang="eng">
			<topic>dietary habit</topic>
		</subject>
		<subject lang="eng">
			<topic>Mediterranean diet</topic>
		</subject>
		<subject lang="eng">
			<topic>nutrients</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30219">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Respiratory Medicine and Allergy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30219">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Lungmedicin och allergi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;A diet rich in nutrients has been suggested to have protective effects against the development of chronic obstructive pulmonary disease (COPD). Since the traditional Mediterranean diet is high in nutrients, including antioxidants, vitamins, and minerals, it is of interest to study as a protective factor against COPD. Our aim was therefore to study its associations with development of COPD using population-based prospective data from the Vasterbotten Intervention Programme (VIP) cohort. Data on diet from 370 individuals, who later visited the Department of Medicine at the University Hospital, Umea, Sweden, with a diagnosis of COPD, were compared to 1432 controls. Adherence to a Mediterranean diet was assessed by a modified version of the Mediterranean diet score (MDS). Cases were diagnosed with COPD 11.1 years (mean) (standard deviation [SD] 4.5 years) after first stating their dietary habits in the VIP at a mean age of 55.5 years (SD 6.6 years). Higher MDS was associated with a higher level of education and not living alone. After adjustment for co-habiting and education level, individuals with an intermediate MDS and those with the highest MDS had a lower odds of developing COPD (odds ratio [OR] 0.73, 95% confidence interval [CI] 0.56-0.95; OR 0.56, 95% CI 0.37-0.86, respectively). These results remained also after adjustment for smoking intensity, i.e., numbers of cigarettes smoked per day (OR 0.73, 95% CI 0.53-0.99; OR 0.59, 95% CI 0.35-0.97), respectively). To conclude, adherence to a Mediterranean-like diet seems to be inversely associated with the development of COPD.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>COPD</title>
				<subTitle> Journal of Chronic Obstructive Pulmonary Disease</subTitle>
			</titleInfo>
			<identifier type="issn">1541-2555</identifier>
			<identifier type="eissn">1541-2563</identifier>
			<part>
				<detail type="volume">
					<number>16</number>
				</detail>
				<detail type="issue">
					<number>3–4</number>
				</detail>
				<extent>
					<start>272</start>
					<end>277</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1349156/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-06</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1349156</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Solans</namePart>
			<namePart type="given">Marta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-2397-0435</description>
		</name>
		<name type="personal">
			<namePart type="family">Benavente</namePart>
			<namePart type="given">Yolanda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Saez</namePart>
			<namePart type="given">Marc</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Agudo</namePart>
			<namePart type="given">Antonio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Naudin</namePart>
			<namePart type="given">Sabine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hosnijeh</namePart>
			<namePart type="given">Fatemeh Saberi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Noh</namePart>
			<namePart type="given">Hwayoung</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Freisling</namePart>
			<namePart type="given">Heinz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ferrari</namePart>
			<namePart type="given">Pietro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Besson</namePart>
			<namePart type="given">Caroline</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mahamat-Saleh</namePart>
			<namePart type="given">Yahya</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boutron-Ruault</namePart>
			<namePart type="given">Marie-Christine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-5956-5693</description>
		</name>
		<name type="personal">
			<namePart type="family">Kühn</namePart>
			<namePart type="given">Tilman</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaaks</namePart>
			<namePart type="given">Rudolf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boeing</namePart>
			<namePart type="given">Heiner</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lasheras</namePart>
			<namePart type="given">Cristina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodríguez-Barranco</namePart>
			<namePart type="given">Miguel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amiano</namePart>
			<namePart type="given">Pilar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maria Huerta</namePart>
			<namePart type="given">Jose</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-9637-3869</description>
		</name>
		<name type="personal">
			<namePart type="family">Barricarte</namePart>
			<namePart type="given">Aurelio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schmidt</namePart>
			<namePart type="given">Julie A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vineis</namePart>
			<namePart type="given">Paolo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Riboli</namePart>
			<namePart type="given">Elio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Trichopoulou</namePart>
			<namePart type="given">Antonia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bamia</namePart>
			<namePart type="given">Christina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peppa</namePart>
			<namePart type="given">Eleni</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Masala</namePart>
			<namePart type="given">Giovanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Agnoli</namePart>
			<namePart type="given">Claudia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tumino</namePart>
			<namePart type="given">Rosario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sacerdote</namePart>
			<namePart type="given">Carlotta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panico</namePart>
			<namePart type="given">Salvatore</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Skeie</namePart>
			<namePart type="given">Guri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Weiderpass</namePart>
			<namePart type="given">Elisabete</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jerkeman</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ericson</namePart>
			<namePart type="given">Ulrika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="flsp0001">
			<namePart type="family">Späth</namePart>
			<namePart type="given">Florentin</namePart>
			<namePart type="date">1980-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<description>orcid.org=0000-0002-0711-0830</description>
			<description>diva-portal.org=authority-person:64438</description>
		</name>
		<name type="personal" authority="umu" xlink:href="leni0002">
			<namePart type="family">Nilsson</namePart>
			<namePart type="given">Lena Maria</namePart>
			<namePart type="date">1965-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Arktiskt centrum vid Umeå universitet (Arcum)</affiliation>
			<affiliation>Umeå universitet, Näringsforskning</affiliation>
			<description>diva-portal.org=authority-person:62441</description>
		</name>
		<name type="personal">
			<namePart type="family">Dahm</namePart>
			<namePart type="given">Christina C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-0481-2893</description>
		</name>
		<name type="personal">
			<namePart type="family">Overvad</namePart>
			<namePart type="given">Kim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bolvig</namePart>
			<namePart type="given">Anne Katrine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tjønneland</namePart>
			<namePart type="given">Anne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Sanjose</namePart>
			<namePart type="given">Silvia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Buckland</namePart>
			<namePart type="given">Genevieve</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vermeulen</namePart>
			<namePart type="given">Roel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nieters</namePart>
			<namePart type="given">Alexandra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Casabonne</namePart>
			<namePart type="given">Delphine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="778">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<namePart>Onkologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="12000">
			<namePart>Umeå universitet</namePart>
			<namePart>Arktiskt centrum vid Umeå universitet (Arcum)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="731">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Näringsforskning</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adherence to the mediterranean diet and lymphoma risk in the european prospective investigation into cancer and nutrition</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-22T09:14:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159047</identifier>
		<identifier type="doi">10.1002/ijc.32091</identifier>
		<identifier type="pmid">30588620</identifier>
		<identifier type="isi">000466175500012</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>lymphoma</topic>
		</subject>
		<subject lang="eng">
			<topic>Mediterranean diet</topic>
		</subject>
		<subject lang="eng">
			<topic>Europe</topic>
		</subject>
		<subject lang="eng">
			<topic>prospective studies</topic>
		</subject>
		<subject lang="eng">
			<topic>risk</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;There is a growing evidence of the protective role of the Mediterranean diet (MD) on cancer. However, no prospective study has yet investigated its influence on lymphoma. We evaluated the association between adherence to the MD and risk of lymphoma and its subtypes in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. The analysis included 476,160 participants, recruited from 10 European countries between 1991 and 2001. Adherence to the MD was estimated through the adapted relative MD (arMED) score excluding alcohol. Cox proportional hazards regression models were used while adjusting for potential confounders. During an average follow-up of 13.9 years, 3,136 lymphomas (135 Hodgkin lymphoma [HL], 2,606 non-HL and 395 lymphoma not otherwise specified) were identified. Overall, a 1-unit increase in the arMED score was associated with a 2% lower risk of lymphoma (95% CI: 0.97; 1.00, p-trend = 0.03) while a statistically nonsignificant inverse association between a high versus low arMED score and risk of lymphoma was observed (hazard ratio [HR]: 0.91 [95% CI 0.80; 1.03], p-trend = 0.12). Analyses by lymphoma subtype did not reveal any statistically significant associations. Albeit with small numbers of cases (N = 135), a suggestive inverse association was found for HL (HR 1-unit increase = 0.93 [95% CI: 0.86; 1.01], p-trend = 0.07). However, the study may have lacked statistical power to detect small effect sizes for lymphoma subtype. Our findings suggest that an increasing arMED score was inversely related to the risk of overall lymphoma in EPIC but not by subtypes. Further large prospective studies are warranted to confirm these findings.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Cancer</title>
			</titleInfo>
			<identifier type="issn">0020-7136</identifier>
			<identifier type="eissn">1097-0215</identifier>
			<part>
				<detail type="volume">
					<number>145</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>122</start>
					<end>131</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-22</recordCreationDate>
			<recordChangeDate>2019-05-22</recordChangeDate>
			<recordIdentifier>diva2:1317184</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Menditto</namePart>
			<namePart type="given">Enrica</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Costa</namePart>
			<namePart type="given">Elisio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1158-1480</description>
		</name>
		<name type="personal">
			<namePart type="family">Midao</namePart>
			<namePart type="given">Luis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1981-2554</description>
		</name>
		<name type="personal">
			<namePart type="family">Bosnic-Anticevich</namePart>
			<namePart type="given">Sinthia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Novellino</namePart>
			<namePart type="given">Ettore</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bialek</namePart>
			<namePart type="given">Slawomir</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Briedis</namePart>
			<namePart type="given">Vitalis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mair</namePart>
			<namePart type="given">Alpana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rajabian-Soderlund</namePart>
			<namePart type="given">Rojin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arnavielhe</namePart>
			<namePart type="given">Sylvie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bedbrook</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Czarlewski</namePart>
			<namePart type="given">Wienczyslawa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Annesi-Maesano</namePart>
			<namePart type="given">Isabella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Anto</namePart>
			<namePart type="given">Josep M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Devillier</namePart>
			<namePart type="given">Philippe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Vries</namePart>
			<namePart type="given">Govert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keil</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sheikh</namePart>
			<namePart type="given">Aziz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Orlando</namePart>
			<namePart type="given">Valentina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larenas-Linnemann</namePart>
			<namePart type="given">Desiree</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cecchi</namePart>
			<namePart type="given">Lorenzo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0658-2449</description>
		</name>
		<name type="personal">
			<namePart type="family">De Feo</namePart>
			<namePart type="given">Giulia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Illario</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stellato</namePart>
			<namePart type="given">Cristiana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fonseca</namePart>
			<namePart type="given">Joao</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0887-8796</description>
		</name>
		<name type="personal">
			<namePart type="family">Malva</namePart>
			<namePart type="given">Joao</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morais-Almeida</namePart>
			<namePart type="given">Mario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pereira</namePart>
			<namePart type="given">Ana Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Todo-Bom</namePart>
			<namePart type="given">Ana Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kvedariene</namePart>
			<namePart type="given">Violeta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valiulis</namePart>
			<namePart type="given">Arunas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bergmann</namePart>
			<namePart type="given">Karl Christian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klimek</namePart>
			<namePart type="given">Ludger</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Moesges</namePart>
			<namePart type="given">Ralph</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pfaar</namePart>
			<namePart type="given">Oliver</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zuberbier</namePart>
			<namePart type="given">Torsten</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cardona</namePart>
			<namePart type="given">Vicky</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mullol</namePart>
			<namePart type="given">Joaquim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Papadopoulos</namePart>
			<namePart type="given">Nikos G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Prokopakis</namePart>
			<namePart type="given">Emmanuel P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bewick</namePart>
			<namePart type="given">Mike</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ryan</namePart>
			<namePart type="given">Dermot</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Roller-Wirnsberger</namePart>
			<namePart type="given">Regina E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tomazic</namePart>
			<namePart type="given">Peter Valentin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cruz</namePart>
			<namePart type="given">Alvaro A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuna</namePart>
			<namePart type="given">Piotr</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Samolinski</namePart>
			<namePart type="given">Boleslaw</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fokkens</namePart>
			<namePart type="given">Wytske J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Reitsma</namePart>
			<namePart type="given">Sietze</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bosse</namePart>
			<namePart type="given">Isabelle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fontaine</namePart>
			<namePart type="given">Jean-Francois</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laune</namePart>
			<namePart type="given">Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Haahtela</namePart>
			<namePart type="given">Tari</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Toppila-Salmi</namePart>
			<namePart type="given">Sanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-0890-6686</description>
		</name>
		<name type="personal">
			<namePart type="family">Bachert</namePart>
			<namePart type="given">Claus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hellings</namePart>
			<namePart type="given">Peter W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Melen</namePart>
			<namePart type="given">Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wickman</namePart>
			<namePart type="given">Magnus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bindslev-Jensen</namePart>
			<namePart type="given">Carsten</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8940-038X</description>
		</name>
		<name type="personal">
			<namePart type="family">Eller</namePart>
			<namePart type="given">Esben</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">O'Hehir</namePart>
			<namePart type="given">Robyn E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cingi</namePart>
			<namePart type="given">Cemal</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gemicioglu</namePart>
			<namePart type="given">Bilun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kalayci</namePart>
			<namePart type="given">Omer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ivancevich</namePart>
			<namePart type="given">Juan Carlos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bousquet</namePart>
			<namePart type="given">Jean</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bousquet</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hellings</namePart>
			<namePart type="given">P. W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aberer</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Agache</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Akdis</namePart>
			<namePart type="given">C. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Akdis</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aliberti</namePart>
			<namePart type="given">M. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Almeida</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amat</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Angles</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Annesi-Maesano</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ansotegui</namePart>
			<namePart type="given">I. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Anto</namePart>
			<namePart type="given">J. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arnavielle</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Asayag</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Asarnoj</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arshad</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Avolio</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bacci</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bachert</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Baiar-Dini</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barbara</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barbagallo</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Baroni</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barreto</namePart>
			<namePart type="given">B. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Basagana</namePart>
			<namePart type="given">X.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bateman</namePart>
			<namePart type="given">E. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bedolla-Barajas</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bedbrook</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bewick</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beghe</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bel</namePart>
			<namePart type="given">E. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bergmann</namePart>
			<namePart type="given">K. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bennoor</namePart>
			<namePart type="given">K. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Benson</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bertorello</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bialoszewski</namePart>
			<namePart type="given">A. Z.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bieber</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bialek</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bindslev-Jensen</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bjermer</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blain</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blasi</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blua</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marciniak</namePart>
			<namePart type="given">M. Bochenska</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bogus-Buczynska</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boner</namePart>
			<namePart type="given">A. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bonini</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bonini</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bosnic-Anticevich</namePart>
			<namePart type="given">C. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bosse</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bouchard</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boulet</namePart>
			<namePart type="given">L. P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bourret</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bousquet</namePart>
			<namePart type="given">Pj</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Braido</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Briedis</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brightling</namePart>
			<namePart type="given">C. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brozek</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bucca</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Buhl</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Buonaiuto</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panaitescu</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cabanas</namePart>
			<namePart type="given">M. T. Burguete</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Burte</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bush</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Caballero-Fonseca</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Caillaud</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Caimmi</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Calderon</namePart>
			<namePart type="given">M. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Camargos</namePart>
			<namePart type="given">P. A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Camuzat</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Canfora</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Canonica</namePart>
			<namePart type="given">G. W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cardona</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carlsen</namePart>
			<namePart type="given">K. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carreiro-Martins</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carriazo</namePart>
			<namePart type="given">A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carr</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cartier</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Casale</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Castellano</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cecchi</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cepeda</namePart>
			<namePart type="given">A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chavannes</namePart>
			<namePart type="given">N. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chiron</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chivato</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chkhartishvili</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chuchalin</namePart>
			<namePart type="given">A. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chung</namePart>
			<namePart type="given">K. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ciaravolo</namePart>
			<namePart type="given">M. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ciceran</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cingi</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ciprandi</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Coehlo</namePart>
			<namePart type="given">A. C. Carvalho</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Colas</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Colgan</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Coll</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Conforti</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Sousa</namePart>
			<namePart type="given">J. Correia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cortes-Grimaldo</namePart>
			<namePart type="given">R. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Corti</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Costa</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Costa-Dominguez</namePart>
			<namePart type="given">Mc</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Al Courbis</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cox</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Crescenzo</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cruz</namePart>
			<namePart type="given">A. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Custovic</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Czarlewski</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dahlen</namePart>
			<namePart type="given">S. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">D'Amato</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dario</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">da Silva</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dauvilliers</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Darsow</namePart>
			<namePart type="given">U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Blay</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Carlo</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dedeu</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Emerson</namePart>
			<namePart type="given">M. De Fatima</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Feo</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Vries</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Martino</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rubina</namePart>
			<namePart type="given">N. P. Motta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Deleanu</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Demoly</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Denburg</namePart>
			<namePart type="given">Ja</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Devillier</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ercolano</namePart>
			<namePart type="given">S. Di Capua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Di Carluccio</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Didier</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dokic</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dominguez-Silva</namePart>
			<namePart type="given">M. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Douagui</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dray</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dubakiene</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Durham</namePart>
			<namePart type="given">S. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Du Toit</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dykewicz</namePart>
			<namePart type="given">M. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">El-Gamal</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="paek0001">
			<namePart type="family">Eklund</namePart>
			<namePart type="given">Patrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för datavetenskap</affiliation>
			<description>diva-portal.org=authority-person:62859</description>
		</name>
		<name type="personal">
			<namePart type="family">Eller</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Emuzyte</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Farrell</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Farsi</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Mello</namePart>
			<namePart type="given">J. Ferreira, Jr.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ferrero</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fink-Wagner</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fiocchi</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fok-Kens</namePart>
			<namePart type="given">W. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fonseca</namePart>
			<namePart type="given">Ja</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fontaine</namePart>
			<namePart type="given">J. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Forti</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fuentes-Perez</namePart>
			<namePart type="given">J. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Galvez-Romero</namePart>
			<namePart type="given">J. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gamkrelidze</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Aymerich</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Cobas</namePart>
			<namePart type="given">C. Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Cruz</namePart>
			<namePart type="given">M. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gemicioglu</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Genova</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Christoff</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gereda</namePart>
			<namePart type="given">J. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Van Wijk</namePart>
			<namePart type="given">R. Gerth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gomez</namePart>
			<namePart type="given">R. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gomez-Vera</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Diaz</namePart>
			<namePart type="given">S. Gonzalez</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gotua</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Grisle</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guidacci</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guldemond</namePart>
			<namePart type="given">Na</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gutter</namePart>
			<namePart type="given">Z.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guzman</namePart>
			<namePart type="given">Ma</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Haahtela</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hajjam</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hernandez</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Houri-Hane</namePart>
			<namePart type="given">J O ' B</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Huerta-Villalobos</namePart>
			<namePart type="given">Y. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Humbert</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Iaccarino</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ispayeva</namePart>
			<namePart type="given">Z.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ivancevich</namePart>
			<namePart type="given">J. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jares</namePart>
			<namePart type="given">Ej</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jassem</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Johnston</namePart>
			<namePart type="given">S. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Joos</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jung</namePart>
			<namePart type="given">K. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Just</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jutel</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaidashev</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kalayci</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kalyoncu</namePart>
			<namePart type="given">A. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Karjalainen</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kardas</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keil</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keith</namePart>
			<namePart type="given">P. K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Khaitov</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Khaltaev</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kleine-Tebbe</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klimek</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kowalski</namePart>
			<namePart type="given">M. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuitunen</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kull</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuna</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kupczyk</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kvedariene</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Krzych-Falta</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lacwik</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larenas-Linnemann</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laune</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lauri</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lavrut</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Le</namePart>
			<namePart type="given">L. T. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lessa</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Levato</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Li</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lieberman</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liplec</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lipworth</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carlsen</namePart>
			<namePart type="given">K. C. Lodrup</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Louis</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lourenco</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Luna-Pech</namePart>
			<namePart type="given">J. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Magnan</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mahboub</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maier</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mair</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Majer</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Malva</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mandajieva</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Manning</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keenoy</namePart>
			<namePart type="given">E. De Manuel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marshall</namePart>
			<namePart type="given">G. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Masjedi</namePart>
			<namePart type="given">M. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maspero</namePart>
			<namePart type="given">J. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mathieu-Dupas</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Campos</namePart>
			<namePart type="given">J. J. Matta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Matos</namePart>
			<namePart type="given">Al</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maurer</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mavale-Manuel</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mayora</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Medina-Avalos</namePart>
			<namePart type="given">M. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Melen</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Melo-Gomes</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Meltzer</namePart>
			<namePart type="given">Eo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Menditto</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mercier</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Miculinic</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mihaltan</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Milenkovic</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Moda</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mogica-Martinez</namePart>
			<namePart type="given">M. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mohammad</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Momas</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Monte-Fort</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Monti</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bogado</namePart>
			<namePart type="given">D. Mora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morais-Almeida</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morato-Castro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mosges</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mota-Pinto</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Santo</namePart>
			<namePart type="given">P. Moura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mullol</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Munter</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Muraro</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Murray</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Naclerio</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nadif</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nalin</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Napoli</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Namazova-Baranova</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Neffen</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Niedeberger</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nekam</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Neou</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nieto</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nogueira-Silva</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nogues</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Novellino</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nyembue</namePart>
			<namePart type="given">Td</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">O'Hehir</namePart>
			<namePart type="given">Re</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Odzhakova</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ohta</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Okamoto</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Okubo</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Onorato</namePart>
			<namePart type="given">G. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cisneros</namePart>
			<namePart type="given">M. Ortega</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ouedraogo</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pali-Scholl</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palkonen</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panzner</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Papadopoulos</namePart>
			<namePart type="given">N. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Park</namePart>
			<namePart type="given">H. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Papi</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Passalacqua</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Paulino</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pawankar</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pedersen</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pepin</namePart>
			<namePart type="given">J. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pereira</namePart>
			<namePart type="given">A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Persico</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pfaar</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Phillips</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Picard</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pigearias</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pin</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pitsios</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Plavec</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pohl</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Popov</namePart>
			<namePart type="given">T. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Portejoie</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Potter</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pozzi</namePart>
			<namePart type="given">A. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Price</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Prokopakis</namePart>
			<namePart type="given">E. P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Puy</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pugin</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ross</namePart>
			<namePart type="given">R. E. Pulido</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Przemecka</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rabe</namePart>
			<namePart type="given">K. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Raciborski</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Raja-Bian-Soderlund</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Reitsma</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ribeirinho</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rimmer</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Riv-Ero-Yeverino</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rizzo</namePart>
			<namePart type="given">J. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rizzo</namePart>
			<namePart type="given">M. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Robalo-Cordeiro</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodenas</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodo</namePart>
			<namePart type="given">X.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gonzalez</namePart>
			<namePart type="given">M. Rodriguez</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodriguez-Manas</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rolland</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valle</namePart>
			<namePart type="given">S. Rodrigues</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodriguez</namePart>
			<namePart type="given">M. Roman</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Romano</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodriguez-Zagal</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rolla</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Roller-Wirnsberger</namePart>
			<namePart type="given">R. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Romano</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rosado-Pinto</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rosario</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rottem</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ryan</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sagara</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Salimaki</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Samolinski</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sanchez-Borges</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sastre-Dominguez</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scadding</namePart>
			<namePart type="given">G. K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schunemann</namePart>
			<namePart type="given">H. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scichilone</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schmid-Grendelmeier</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Serpa</namePart>
			<namePart type="given">F. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shamai</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sheikh</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sierra</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Simons</namePart>
			<namePart type="given">F. E. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sir-Oux</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sisul</namePart>
			<namePart type="given">J. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Skrindo</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sole</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Somekh</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sonder-Mann</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sooronbaev</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sova</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sorensen</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sorlini</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Spranger</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stellato</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stelmach</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stukas</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sunyer</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Strozek</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Szylling</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tebyrica</namePart>
			<namePart type="given">Jn</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thibaudon</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">To</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Todo-Bom</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tomazic</namePart>
			<namePart type="given">P. V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Toppila-Salmi</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Trama</namePart>
			<namePart type="given">U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Triggiani</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ulrik</namePart>
			<namePart type="given">C. Suppli</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Urrutia-Pereira</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valenta</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valero</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valiulis</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valovirta</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Van Eerd</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Van Ganse</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Van Hague</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vandenplas</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ventura</namePart>
			<namePart type="given">M. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vezzani</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vasankari</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vatrella</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Verissimo</namePart>
			<namePart type="given">M. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Viart</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Viegi</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vicheva</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vontetsianos</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wagenmann</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Walker</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wallace</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">D. Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waserman</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Werfel</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Westman</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wickman</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Williams</namePart>
			<namePart type="given">D. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Williams</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wilson</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wright</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wroczynski</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yakovliev</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yawn</namePart>
			<namePart type="given">B. P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yiallouros</namePart>
			<namePart type="given">P. K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yorgancioglu</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yusuf</namePart>
			<namePart type="given">O. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zar</namePart>
			<namePart type="given">H. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhong</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zernotti</namePart>
			<namePart type="given">M. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhanat</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zidarn</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zuberbier</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zubrinich</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zurkuhlen</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="863">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för datavetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adherence to treatment in allergic rhinitis using mobile technology</title>
			<subTitle>The MASK Study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>WILEY</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-21T11:00:52</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162486</identifier>
		<identifier type="doi">10.1111/cea.13333</identifier>
		<identifier type="pmid">30597673</identifier>
		<identifier type="isi">000463761700007</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>adherence</topic>
		</subject>
		<subject lang="eng">
			<topic>mHealth</topic>
		</subject>
		<subject lang="eng">
			<topic>mobile technology</topic>
		</subject>
		<subject lang="eng">
			<topic>observational study</topic>
		</subject>
		<subject lang="eng">
			<topic>rhinitis</topic>
		</subject>
		<subject lang="eng">
			<topic>treatment</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30104">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Social and Clinical Pharmacy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30104">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Samhällsfarmaci och klinisk farmaci</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12143 users were registered. A total of 6949 users reported at least one VAS data recording. Among them, 1887 users reported &amp;gt;= 7 VAS data. About 1195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR &amp;gt;= 70% and PDC &amp;lt;= 1.25), 51 (4.23%) were partly adherent (MPR &amp;gt;= 70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR &amp;lt;70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Clinical and Experimental Allergy</title>
			</titleInfo>
			<identifier type="issn">0954-7894</identifier>
			<identifier type="eissn">1365-2222</identifier>
			<part>
				<detail type="volume">
					<number>49</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>442</start>
					<end>460</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-21</recordCreationDate>
			<recordChangeDate>2019-08-21</recordChangeDate>
			<recordIdentifier>diva2:1344515</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Benetti</namePart>
			<namePart type="given">Ana Raquel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Michou</namePart>
			<namePart type="given">Stavroula</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larsen</namePart>
			<namePart type="given">Liselotte</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peutzfeldt</namePart>
			<namePart type="given">Anne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palllesen</namePart>
			<namePart type="given">Ulla</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="java0001">
			<namePart type="family">van Dijken</namePart>
			<namePart type="given">Jan Willem Viator</namePart>
			<namePart type="date">1947-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Tandläkarutbildning</affiliation>
			<description>diva-portal.org=authority-person:62777</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="12250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<namePart>Tandläkarutbildning</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adhesion and marginal adaptation of a claimed bioactive, restorative material</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-16T07:52:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166375</identifier>
		<identifier type="doi">10.1080/26415275.2019.1696202</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/26415275.2019.1696202</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Composite resins</topic>
		</subject>
		<subject lang="eng">
			<topic>glass ionomer cements</topic>
		</subject>
		<subject lang="eng">
			<topic>dental bonding</topic>
		</subject>
		<subject lang="eng">
			<topic>dental marginal adaptation</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30216">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Dentistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30216">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Odontologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;&lt;strong&gt;Objectives:&lt;/strong&gt; Adhesion and marginal adaptation of a claimed bioactive restorative material (ACTIVA BioACTIVE Restorative) to human teeth were compared with those of a resin-modified glass ionomer cement (Fuji II LC) and a control resin composite (Ceram X Mono).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Material and Methods:&lt;/strong&gt; Shear bond strength and marginal adaptation to enamel and dentine were assessed after no pretreatment of the hard tissues or after etching with phosphoric acid (ACTIVA BioACTIVE Restorative and Ceram X Mono) or polyacrylic acid (Fuji II LC). For ACTIVA BioACTIVE Restorative, the effect of applying a self-etch adhesive (Xeno Select, Dentsply Sirona) was also investigated. Data were analyzed using non-parametric tests (&lt;em&gt;α&lt;/em&gt; = 0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Bond strength and marginal adaptation in enamel and dentine were significantly different among the investigated materials (&lt;em&gt;p&lt;/em&gt;&amp;lt;.05). Due to loss of restorations, it was not possible to measure bond strength of ACTIVA BioACTIVE Restorative if no pretreatment was performed or if dentine was etched; however, use of the self-etch adhesive resulted in similar bond strength as Ceram X Mono. Etching improved adhesion of Fuji II LC to enamel and dentine. Regarding marginal adaptation, ACTIVA BioACTIVE Restorative showed the highest wall-to-wall contraction to enamel in all pretreatment groups and the overall highest wall-to-wall contraction to dentine after etching. Due to loss of restorations, no marginal assessment was possible on cavities with margins in dentine when no pretreatment was used. The use of a self-etch adhesive with ACTIVA BioACTIVE Restorative resulted in similar adaptation to dentine compared to the other materials.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; The self-adhesive property of ACTIVA BioACTIVE Restorative is nonexistent.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>6</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>90</start>
					<end>98</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Biomaterial investigations in dentistry</title>
			</titleInfo>
			<identifier type="issn">2641-5275</identifier>
			<part>
				<detail type="volume">
					<number>6</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>90</start>
					<end>98</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1378894/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>sako0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-16</recordCreationDate>
			<recordChangeDate>2019-12-18</recordChangeDate>
			<recordIdentifier>diva2:1378894</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Mtintsilana</namePart>
			<namePart type="given">Asanda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Micklesfield</namePart>
			<namePart type="given">Lisa K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-4994-0779</description>
		</name>
		<name type="personal" authority="umu" xlink:href="elnpon01">
			<namePart type="family">Chorell</namePart>
			<namePart type="given">Elin</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:64036</description>
		</name>
		<name type="personal" authority="umu" xlink:href="tool0003">
			<namePart type="family">Olsson</namePart>
			<namePart type="given">Tommy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0001-7768-1076</description>
			<description>diva-portal.org=authority-person:62478</description>
		</name>
		<name type="personal">
			<namePart type="family">Shivappa</namePart>
			<namePart type="given">Nitin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hebert</namePart>
			<namePart type="given">James R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0677-2672</description>
		</name>
		<name type="personal">
			<namePart type="family">Kengne</namePart>
			<namePart type="given">Andre P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goedecke</namePart>
			<namePart type="given">Julia H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adiposity Mediates the Association between the Dietary Inflammatory Index and Markers of Type 2 Diabetes Risk in Middle-Aged Black South African Women</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-06T11:49:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161928</identifier>
		<identifier type="doi">10.3390/nu11061246</identifier>
		<identifier type="pmid">31159253</identifier>
		<identifier type="isi">000474936700052</identifier>
		<identifier type="scopus">2-s2.0-85067181094</identifier>
		<identifier type="articleId">1246</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/nu11061246</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>DII</topic>
		</subject>
		<subject lang="eng">
			<topic>diet-induced inflammation</topic>
		</subject>
		<subject lang="eng">
			<topic>obesity</topic>
		</subject>
		<subject lang="eng">
			<topic>VAT</topic>
		</subject>
		<subject lang="eng">
			<topic>mediation</topic>
		</subject>
		<subject lang="eng">
			<topic>T2D risk</topic>
		</subject>
		<subject lang="eng">
			<topic>South African women</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30304">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nutrition and Dietetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30304">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Näringslära</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The dietary inflammatory index (DII&lt;sup&gt;®&lt;/sup&gt;), a validated tool used to measure the inflammatory potential of the diet, has been associated with metabolic disorders in various settings, but not in African populations. The aim of this study was to investigate whether the DII is associated with markers of type 2 diabetes (T2D) risk, and if this association is mediated by adiposity and/or low-grade inflammation, in black South Africa women. Energy-adjusted-DII (E-DII) scores were calculated in 190 women (median age, 53 years) from the Birth-to-Twenty plus cohort using a validated food frequency questionnaire. Fasting glucose, insulin, HbA1c, and inflammatory cytokines were measured, and an oral glucose tolerance test performed. Basic anthropometry and dual-energy x-ray absorptiometry-derived body fat, including estimate of visceral adipose tissue (VAT) area, were measured. E-DII scores were associated with all markers of T2D risk, namely, fasting glucose and insulin, HbA1c, HOMA2-IR, two-hour glucose and Matsuda index (all p &amp;lt; 0.05). After adjusting for age, measures of adiposity, but not inflammatory cytokines, mediated the association between E-DII and markers of T2D risk (p &amp;lt; 0.05). Measures of central obesity had proportionally higher (range: 23.5–100%) mediation effects than total obesity (range: 10–60%). The E-DII is associated with T2D risk through obesity, in particular central obesity, among black middle-aged South African women.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Nutrients</title>
			</titleInfo>
			<identifier type="issn">2072-6643</identifier>
			<identifier type="eissn">2072-6643</identifier>
			<part>
				<detail type="volume">
					<number>11</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1340751/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-06</recordCreationDate>
			<recordChangeDate>2019-08-06</recordChangeDate>
			<recordIdentifier>diva2:1340751</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<genre authority="diva" type="publicationSubTypeCode">letter</genre>
		<name type="personal" authority="umu" xlink:href="kosi0001">
			<namePart type="family">Sjödin</namePart>
			<namePart type="given">Kotryna Simonyte</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:62731</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mado0002">
			<namePart type="family">Domellöf</namePart>
			<namePart type="given">Magnus</namePart>
			<namePart type="date">1963-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:63141</description>
		</name>
		<name type="personal" authority="umu" xlink:href="cala0025">
			<namePart type="family">Lagerqvist</namePart>
			<namePart type="given">Carina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:64210</description>
		</name>
		<name type="personal" authority="umu" xlink:href="olhe0002">
			<namePart type="family">Hernell</namePart>
			<namePart type="given">Olle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:63197</description>
		</name>
		<name type="personal">
			<namePart type="family">Lönnerdal</namePart>
			<namePart type="given">Bo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Szymlek-Gay</namePart>
			<namePart type="given">Ewa A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sjödin</namePart>
			<namePart type="given">Andreas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="chwe0024">
			<namePart type="family">West</namePart>
			<namePart type="given">Christina E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:62734</description>
		</name>
		<name type="personal" authority="umu" xlink:href="toli0008">
			<namePart type="family">Lind</namePart>
			<namePart type="given">Torbjörn</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>orcid.org=0000-0001-6328-1098</description>
			<description>diva-portal.org=authority-person:63407</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="739">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Pediatrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Administration of ferrous sulfate drops has significant effects on the gut microbiota of iron-sufficient infants</title>
			<subTitle>a randomised controlled study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BMJ Publishing Group Ltd</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-09T07:51:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167039</identifier>
		<identifier type="doi">10.1136/gutjnl-2018-316988</identifier>
		<identifier type="pmid">30343273</identifier>
		<identifier type="isi">000497817400023</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1136/gutjnl-2018-316988</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30213">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Gastroenterology and Hepatology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30213">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Gastroenterologi</topic>
		</subject>
		<relatedItem type="host">
			<titleInfo>
				<title>Gut</title>
			</titleInfo>
			<identifier type="issn">0017-5749</identifier>
			<identifier type="eissn">1468-3288</identifier>
			<part>
				<detail type="volume">
					<number>68</number>
				</detail>
				<detail type="issue">
					<number>11</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Västerbottens läns landsting</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1383910/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-09</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1383910</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Stenbacka</namePart>
			<namePart type="given">Marlene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Moberg</namePart>
			<namePart type="given">Tomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jujo0022">
			<namePart type="family">Jokinen</namePart>
			<namePart type="given">Jussi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Psykiatri</affiliation>
			<affiliation>Department of Clinical Neuroscience/Psychiatry, Karolinska Institutet,Stockholm, Sweden</affiliation>
			<description>diva-portal.org=authority-person:68590</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="740">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Psykiatri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adolescent criminality</title>
			<subTitle>multiple adverse health outcomes and mortality pattern in Swedish men</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-27T16:01:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158573</identifier>
		<identifier type="doi">10.1186/s12889-019-6662-z</identifier>
		<identifier type="pmid">30975117</identifier>
		<identifier type="isi">000464880000011</identifier>
		<identifier type="articleId">400</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12889-019-6662-z</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Alcohol</topic>
		</subject>
		<subject lang="eng">
			<topic>Criminality</topic>
		</subject>
		<subject lang="eng">
			<topic>Violence</topic>
		</subject>
		<subject lang="eng">
			<topic>Substance use</topic>
		</subject>
		<subject lang="eng">
			<topic>Mortality</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: To investigate the impact of adolescent violent and non-violent criminality and subsequent risk of morbidity and mortality in adulthood in a large Swedish cohort of young men conscripted for military service in 1969/70.&lt;/p&gt;&lt;p&gt;Methods: The cohort consisted of 49,398 18-year-old Swedish conscripts followed up for morbidity and mortality up to the age of 55 years in Swedish national registers. Information about convictions for crime before conscription was obtained from national crime registers. Data from a survey at conscription were scrutinized to get information on potential confounders.&lt;/p&gt;&lt;p&gt;Results: Hospitalization due to alcohol and drug related diagnoses and attempted suicide were significantly more evident in the violent group compared to non-violent criminals and non-criminals. More than one fifth (21.13%) of the young violent offenders, 12.90% of the non-violent offenders and 4.96% of the non-criminals had died during the follow-up period. In Cox proportional multivariate analyses, young violent offenders had twice the hazard (HR = 4.29) of all-cause mortality than the non-violent offenders (HR = 2.16) during the follow-up period. Alcohol and drug related mortality, suicide and fatal accidents were most evident in both violent and non-violent offenders.&lt;/p&gt;&lt;p&gt;Conclusions: Men with adolescent criminality received more inpatient care due to alcohol and drug related diagnoses and attempted suicide as adults. Mortality due to unnatural causes, alcohol, and drug related diagnoses, suicide and accidents was most evident in violent offenders, while these causes of death were much lower in non-criminals. Men with adolescent criminality are a high-risk group for multiple adverse health outcomes and for early death. Efforts for detection of substance use and psychiatric disorders in this group is important for the prevention work in both local- and community levels as well as national prevention programs.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>BMC Public Health</title>
			</titleInfo>
			<identifier type="issn">1471-2458</identifier>
			<identifier type="eissn">1471-2458</identifier>
			<part>
				<detail type="volume">
					<number>19</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1318426/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-27</recordCreationDate>
			<recordChangeDate>2019-05-27</recordChangeDate>
			<recordIdentifier>diva2:1318426</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Bjureberg</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2747-9990</description>
		</name>
		<name type="personal">
			<namePart type="family">Ohlis</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ljotsson</namePart>
			<namePart type="given">Brjann</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">D'Onofrio</namePart>
			<namePart type="given">Brian M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hedman-Lagerlöf</namePart>
			<namePart type="given">Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jujo0022">
			<namePart type="family">Jokinen</namePart>
			<namePart type="given">Jussi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för klinisk vetenskap</affiliation>
			<affiliation>Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden</affiliation>
			<description>diva-portal.org=authority-person:68590</description>
		</name>
		<name type="personal">
			<namePart type="family">Sahlin</namePart>
			<namePart type="given">Hanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-6353-024X</description>
		</name>
		<name type="personal">
			<namePart type="family">Lichtenstein</namePart>
			<namePart type="given">Paul</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cederlöf</namePart>
			<namePart type="given">Martin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hellner</namePart>
			<namePart type="given">Clara</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="738">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adolescent self-harm with and without suicidality</title>
			<subTitle>cross-sectional and longitudinal analyses of a Swedish regional register</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-08T16:42:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157201</identifier>
		<identifier type="doi">10.1111/jcpp.12967</identifier>
		<identifier type="pmid">30207392</identifier>
		<identifier type="isi">000459224900008</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1111/jcpp.12967</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Self-harm</topic>
		</subject>
		<subject lang="eng">
			<topic>self-injurious behavior</topic>
		</subject>
		<subject lang="eng">
			<topic>suicidal ideation</topic>
		</subject>
		<subject lang="eng">
			<topic>epidemiology</topic>
		</subject>
		<subject lang="eng">
			<topic>cohort study</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Self-harm is common and there is a need for studies that investigate the relevance of this behavior in clinical samples to inform risk assessment and treatment. The objectives in the current studies were to compare clinical and psychosocial correlates and subsequent adverse outcomes in youth who present to child and adolescent mental health services (CAMHS) with self-harm only (SH), self-harm with suicidality (SH+SU), with those without any indication of SH or SH+SU.&lt;/p&gt;&lt;p&gt;Methods: We conducted a case-control study and a longitudinal cohort study using data from a regional clinical care register, and Swedish national registers. The case-control study included all patients (5-17 years) between 2011 and 2015 (N = 25,161). SH and SH+SU cases were compared with controls (patients without SH) regarding a range of correlates. The longitudinal study included former CAMHS patients (N = 6,120) who were followed for a median time of 2.8 years after termination of CAMHS contact regarding outcomes such as clinical care consumption, social welfare recipiency, and crime conviction.&lt;/p&gt;&lt;p&gt;Results: In the case-control study, both the SH and SH+SU groups received more clinical care, had lower global functioning, and higher odds of having mental disorders compared to controls. In most comparisons, the SH+SU group had more problems than the SH group. In the longitudinal study, the same pattern emerged for most outcomes; for example, the adjusted hazard ratio for recurrent care due to self-harm was 23.1 (95% confidence interval [CI], 17.0-31.4) in the SH+SU group compared to 3.9 (95% CI, 2.3-6.7) in the SH group.&lt;/p&gt;&lt;p&gt;Conclusions: Adolescent patients presenting with self-harm have higher risks for adverse outcomes than patients without self-harm. Suicidality in addition to self-harm is associated with more severe outcomes, importantly recurrent episodes of care for self-harm.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Child Psychology and Psychiatry and Allied Disciplines</title>
			</titleInfo>
			<identifier type="issn">0021-9630</identifier>
			<identifier type="eissn">1469-7610</identifier>
			<part>
				<detail type="volume">
					<number>60</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>295</start>
					<end>304</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1303114/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-08</recordCreationDate>
			<recordChangeDate>2019-04-08</recordChangeDate>
			<recordIdentifier>diva2:1303114</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="lealon03">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Lena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:71585</description>
		</name>
		<name type="personal" authority="umu" xlink:href="bejo0003">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Bengt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:62870</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kawa0013">
			<namePart type="family">Wadell</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för fysioterapi</affiliation>
			<description>orcid.org=0000-0001-7334-8698</description>
			<description>diva-portal.org=authority-person:63140</description>
		</name>
		<name type="personal">
			<namePart type="family">Thilen</namePart>
			<namePart type="given">Ulf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="caahom90">
			<namePart type="family">Sandberg</namePart>
			<namePart type="given">Camilla</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Umeå universitet, Avdelningen för fysioterapi</affiliation>
			<description>orcid.org=0000-0002-4043-7130</description>
			<description>diva-portal.org=authority-person:64671</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881555">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<namePart>Avdelningen för fysioterapi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adults with congenital heart disease overestimate their physical activity level</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-12T13:09:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158111</identifier>
		<identifier type="doi">10.1016/j.ijcha.2018.11.005</identifier>
		<identifier type="pmid">30480085</identifier>
		<identifier type="isi">000462184100003</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.ijcha.2018.11.005</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Adult congenital heart disease</topic>
		</subject>
		<subject lang="eng">
			<topic>Physical activity level</topic>
		</subject>
		<subject lang="eng">
			<topic>IPAQ</topic>
		</subject>
		<subject lang="eng">
			<topic>Actiheart</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Physical activity reduces the risk of acquired cardiovascular disease, which is of great importance in patients with congenital heart disease (CHD). There are diverging data whether physical activity level (PAL) differs between patients with CHD and controls. Furthermore, it is unknown if PAL can be reliably assessed in patients with CHD using self-reported instruments.&lt;/p&gt;&lt;p&gt;Methods: Seventy-five patients with CHD (mean age 37.5 ± 15.5 years, women n = 29 [38.7%]) and 42 age and sex matched controls completed the International Physical Activity Questionnaire (IPAQ) and carried the activity monitor Actiheart over 4 days. Time spent at ≥3 METS ≥21.4 min/day, i.e. reaching the WHO recommendation for PAL to promote health, was used as the outcome measure. Data on PAL obtained from IPAQ were compared with Actiheart.&lt;/p&gt;&lt;p&gt;Results: The proportion of individuals reaching target PAL according to IPAQ was similar in patients with CHD and controls (70.7%vs.76.2%, p = 0.52) as well as between patients with simple and complex lesions. There was an overall difference between IPAQ and Actiheart in detecting recommended PAL (72.6%vs.51.3%, p b 0.001). In a subgroup analysis, this difference was also detected in patients but was borderline for controls. The negative predictive value for IPAQ in detecting insufficient PAL was higher in patients than in controls (73%vs.40%).&lt;/p&gt;&lt;p&gt;Conclusions: The proportion of persons reaching sufficient PAL to promote health was similar in patients and controls. The self-reported instrument overestimated PAL in relation to objective measurements. However, with a high negative predictive value, IPAQ is a potentially useful tool for detecting patients with insufficient PAL.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>22</number>
				</detail>
				<extent>
					<start>13</start>
					<end>17</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>IJC Heart &amp; Vasculature</title>
			</titleInfo>
			<identifier type="issn">2352-9067</identifier>
			<part>
				<detail type="volume">
					<number>22</number>
				</detail>
				<extent>
					<start>13</start>
					<end>17</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Hjärt-Lungfonden [20130472]</note>
		<note type="funder">Hjärt-Lungfonden [20150579]</note>
		<note type="funder">Västerbottens läns landsting</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1304488/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-12</recordCreationDate>
			<recordChangeDate>2019-04-12</recordChangeDate>
			<recordIdentifier>diva2:1304488</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="kash0017">
			<namePart type="family">Shanmugam</namePart>
			<namePart type="given">Kavitha</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:67963</description>
		</name>
		<name type="personal">
			<namePart type="family">Gadhamshetty</namePart>
			<namePart type="given">Venkataramana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yadav</namePart>
			<namePart type="given">Pooja</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Athanassiadis</namePart>
			<namePart type="given">Dimitris</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="maty0001">
			<namePart type="family">Tysklind</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:63063</description>
		</name>
		<name type="personal" authority="umu" xlink:href="krup0001">
			<namePart type="family">Upadhyayula</namePart>
			<namePart type="given">Venkata K.K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:67964</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Advanced High-Strength Steel and Carbon Fiber Reinforced Polymer Composite Body in White for Passenger Cars</title>
			<subTitle>Environmental Performance and Sustainable Return on Investment under Different Propulsion Modes</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>AMER CHEMICAL SOC</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-05T09:12:22</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157515</identifier>
		<identifier type="doi">10.1021/acssuschemeng.8b05588</identifier>
		<identifier type="isi">000460600500042</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Carbon fiber reinforced polymer composites (CFRP)</topic>
		</subject>
		<subject lang="eng">
			<topic>Advanced high strength steel (AHSS)</topic>
		</subject>
		<subject lang="eng">
			<topic>Automotive dy in white</topic>
		</subject>
		<subject lang="eng">
			<topic>Automotive lightweighting Environmental performance</topic>
		</subject>
		<subject lang="eng">
			<topic>Sustainable return on vestment</topic>
		</subject>
		<subject lang="eng">
			<topic>Woody or corn bioethanol</topic>
		</subject>
		<subject lang="eng">
			<topic>Battery electric vehicle (BEV)</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20304">
			<topic>Engineering and Technology</topic>
			<topic>Mechanical Engineering</topic>
			<topic>Energy Engineering</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20304">
			<topic>Teknik och teknologier</topic>
			<topic>Maskinteknik</topic>
			<topic>Energiteknik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Vehicle lightweighting strategies must deliver sustainable returns to customers and society. This work evaluates the sustainable return on investment (SROI) of lightweighted advanced high strength steel (AHSS) and carbon fiber reinforced polymer (CFRP)-intensive multimaterial bodies in white (BIWs) for automobiles. The SROI depends on the lightweighted BIW's manufacturing cost and the difference in sustainable cost between a baseline (mild steel) BIW and the lightweighted alternative. The sustainable cost is the sum of the customer's lifetime fuel (or electricity) costs and the costs of environmental externalities. A cradle-to-grave life cycle assessment (LCA) was conducted to quantify the environmental impacts of CFRP and AHSS BIWs in gasoline-fueled cars, bioethanol (E85)-fueled cars, and battery electric vehicles (BEVs) driven for a lifetime distance of 200 000 km. For cars fueled with gasoline- or corn-based bioethanol, the CFRP BIW yielded the lowest SROI; the AHSS BIW performed best for BEVs and cars fueled with wood bioethanol. However, the commercial availability of recycled carbon fiber should increase the SROI of the CFRP BIW in the future. Additionally, the SROI of CFRP BIWs is maximized when carbon fiber production is done using energy from a low carbon-intensity electric grid or decentralized sources such as waste-to-energy incineration plants.&lt;/p&gt;</abstract>
		<note type="project">Bio4Energy</note>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>7</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>4951</start>
					<end>4963</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>ACS SUSTAINABLE CHEMISTRY &amp; ENGINEERING</title>
			</titleInfo>
			<identifier type="issn">2168-0485</identifier>
			<part>
				<detail type="volume">
					<number>7</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>4951</start>
					<end>4963</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-05</recordCreationDate>
			<recordChangeDate>2019-09-06</recordChangeDate>
			<recordIdentifier>diva2:1302560</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="dadlut99">
			<namePart type="family">Edvardsson</namePart>
			<namePart type="given">David</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för omvårdnad</affiliation>
			<affiliation>La Trobe University, Victoria, Australia</affiliation>
			<description>orcid.org=0000-0001-8787-2327</description>
			<description>diva-portal.org=authority-person:62597</description>
		</name>
		<name type="personal" authority="umu" xlink:href="reba0013">
			<namePart type="family">Baxter</namePart>
			<namePart type="given">Rebecca</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för omvårdnad</affiliation>
			<description>orcid.org=0000-0001-6595-6298</description>
			<description>diva-portal.org=authority-person:67874</description>
		</name>
		<name type="personal" authority="umu" xlink:href="laba0025">
			<namePart type="family">Corneliusson</namePart>
			<namePart type="given">Laura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för omvårdnad</affiliation>
			<description>orcid.org=0000-0001-5005-5024</description>
			<description>diva-portal.org=authority-person:71542</description>
		</name>
		<name type="personal">
			<namePart type="family">Anderson</namePart>
			<namePart type="given">Ruth A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beeber</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boas</namePart>
			<namePart type="given">Paulo Villas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Corazzini</namePart>
			<namePart type="given">Kirsten</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gordon</namePart>
			<namePart type="given">Adam L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hanratty</namePart>
			<namePart type="given">Barbara</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jacinto</namePart>
			<namePart type="given">Alessandro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lepore</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-7117-4919</description>
		</name>
		<name type="personal">
			<namePart type="family">Leung</namePart>
			<namePart type="given">Angela Y. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">McGilton</namePart>
			<namePart type="given">Katherine S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Meyer</namePart>
			<namePart type="given">Julienne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schols</namePart>
			<namePart type="given">Jos M. G. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schwartz</namePart>
			<namePart type="given">Lindsay</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shepherd</namePart>
			<namePart type="given">Victoria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Skoldunger</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thompson</namePart>
			<namePart type="given">Roy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Toles</namePart>
			<namePart type="given">Mark</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wachholz</namePart>
			<namePart type="given">Patrick</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Jing</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wu</namePart>
			<namePart type="given">Bei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zuniga</namePart>
			<namePart type="given">Franziska</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="769">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för omvårdnad</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Advancing Long-Term Care Science Through Using Common Data Elements</title>
			<subTitle>Candidate Measures for Care Outcomes of Personhood, Well-Being, and Quality of Life</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-06T15:39:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161865</identifier>
		<identifier type="doi">10.1177/2333721419842672</identifier>
		<identifier type="pmid">31106240</identifier>
		<identifier type="isi">000475377200001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1177/2333721419842672</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>long-term care</topic>
		</subject>
		<subject lang="eng">
			<topic>care homes</topic>
		</subject>
		<subject lang="eng">
			<topic>measurement</topic>
		</subject>
		<subject lang="eng">
			<topic>personhood</topic>
		</subject>
		<subject lang="eng">
			<topic>quality of life</topic>
		</subject>
		<subject lang="eng">
			<topic>well-being</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30502">
			<topic>Medical and Health Sciences</topic>
			<topic>Other Medical Sciences</topic>
			<topic>Gerontology, specialising in Medical and Health Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30502">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Annan medicin och hälsovetenskap</topic>
			<topic>Gerontologi, medicinsk/hälsovetenskaplig inriktning</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30305">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nursing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30305">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Omvårdnad</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;To support the development of internationally comparable common data elements (CDEs) that can be used to measure essential aspects of long-term care (LTC) across low-, middle-, and high-income countries, a group of researchers in medicine, nursing, behavioral, and social sciences from 21 different countries have joined forces and launched the Worldwide Elements to Harmonize Research in LTC Living Environments (WE-THRIVE) initiative. This initiative aims to develop a common data infrastructure for international use across the domains of organizational context, workforce and staffing, person-centered care, and care outcomes, as these are critical to LTC quality, experiences, and outcomes. This article reports measurement recommendations for the care outcomes domain, focusing on previously prioritized care outcomes concepts of well-being, quality of life (QoL), and personhood for residents in LTC. Through literature review and expert ranking, we recommend nine measures of well-being, QoL, and personhood, as a basis for developing CDEs for long-term care outcomes across countries. Data in LTC have often included deficit-oriented measures; while important, reductions do not necessarily mean that residents are concurrently experiencing well-being. Enhancing measurement efforts with the inclusion of these positive LTC outcomes across countries would facilitate international LTC research and align with global shifts toward healthy aging and person-centered LTC models.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Gerontology and geriatric medicine</title>
			</titleInfo>
			<identifier type="eissn">2333-7214</identifier>
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1340868/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-06</recordCreationDate>
			<recordChangeDate>2019-12-11</recordChangeDate>
			<recordIdentifier>diva2:1340868</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="guta0011">
			<namePart type="family">Tanghöj</namePart>
			<namePart type="given">Gustaf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>orcid.org=0000-0002-8785-3318</description>
			<description>diva-portal.org=authority-person:68693</description>
		</name>
		<name type="personal">
			<namePart type="family">Liuba</namePart>
			<namePart type="given">Petru</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sjöberg</namePart>
			<namePart type="given">Gunnar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anry0014">
			<namePart type="family">Rydberg</namePart>
			<namePart type="given">Annika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:64207</description>
		</name>
		<name type="personal" authority="umu" xlink:href="esna0003">
			<namePart type="family">Naumburg</namePart>
			<namePart type="given">Estelle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pediatrik</affiliation>
			<description>diva-portal.org=authority-person:63391</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="739">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Pediatrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Adverse events within 1 year after surgical and percutaneous closure of atrial septal defects in preterm children</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Cambridge University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-07-12T14:00:22</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161607</identifier>
		<identifier type="doi">10.1017/S1047951119000350</identifier>
		<identifier type="pmid">31159892</identifier>
		<identifier type="isi">000472634800012</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Child</topic>
		</subject>
		<subject lang="eng">
			<topic>atrial septal defect</topic>
		</subject>
		<subject lang="eng">
			<topic>percutaneous closure</topic>
		</subject>
		<subject lang="eng">
			<topic>surgical closure</topic>
		</subject>
		<subject lang="eng">
			<topic>complications</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30221">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Pediatrics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30221">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Pediatrik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Introduction: Atrial septal defect is the third most common CHD. A hemodynamically significant atrial septal defect causes volume overload of the right side of the heart. Preterm children may suffer from both pulmonary and cardiac comorbidities, including altered myocardial function. The aim of this study was to compare the rate of adverse events following atrial septal defect closure in preterm- and term-born children.&lt;/p&gt;&lt;p&gt;Method: We performed a retrospective cohort study including children born in Sweden, who had a surgical or percutaneous atrial septal defect closure at the children’s hospitals in Lund and Stockholm, between 2000 and 2014, assessing time to the first event within 1 month or 1 year. We analysed differences in the number of and the time to events between the preterm and term cohort using the Kaplan–Meier survival curve, a generalised model applying zero-inflated Poisson distribution and Gary-Anderson’s method.&lt;/p&gt;&lt;p&gt;Results: Overall, 413 children were included in the study. Of these, 93 (22.5%) were born prematurely. The total number of adverse events was 178 (110 minor and 68 major). There was no difference between the cohorts in the number of events, whether within 1 month or within a year, between major (p = 0.69) and minor (p = 0.84) events or frequencies of multiple events (p = 0.92).&lt;/p&gt;&lt;p&gt;Conclusion: Despite earlier procedural age, larger atrial septal defects, and higher comorbidity than term children, preterm children appear to have comparable risk for complications during the first year after surgical or percutaneous closure.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Cardiology in the Young</title>
			</titleInfo>
			<identifier type="issn">1047-9511</identifier>
			<identifier type="eissn">1467-1107</identifier>
			<part>
				<detail type="volume">
					<number>29</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>626</start>
					<end>636</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-07-12</recordCreationDate>
			<recordChangeDate>2019-07-12</recordChangeDate>
			<recordIdentifier>diva2:1337291</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="lealon03">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Lena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:71585</description>
		</name>
		<name type="personal" authority="umu" xlink:href="delrim02">
			<namePart type="family">Rinnström</namePart>
			<namePart type="given">Daniel</namePart>
			<namePart type="date">1982-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:62868</description>
		</name>
		<name type="personal" authority="umu" xlink:href="caahom90">
			<namePart type="family">Sandberg</namePart>
			<namePart type="given">Camilla</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0002-4043-7130</description>
			<description>diva-portal.org=authority-person:64671</description>
		</name>
		<name type="personal" authority="umu" xlink:href="gaha0004">
			<namePart type="family">Högström</namePart>
			<namePart type="given">Gabriel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för samhällsmedicin och rehabilitering</affiliation>
			<description>diva-portal.org=authority-person:63660</description>
		</name>
		<name type="personal">
			<namePart type="family">Thilen</namePart>
			<namePart type="given">Ulf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="peno0014">
			<namePart type="family">Nordström</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för samhällsmedicin och rehabilitering</affiliation>
			<description>diva-portal.org=authority-person:62480</description>
		</name>
		<name type="personal" authority="umu" xlink:href="bejo0003">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Bengt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:62870</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="770">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för samhällsmedicin och rehabilitering</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Aerobic capacity in adolescence is associated with time to intervention in adult men with atrial septal defects</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-13T16:02:47</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156856</identifier>
		<identifier type="doi">10.1016/j.ijcard.2018.12.073</identifier>
		<identifier type="pmid">30651192</identifier>
		<identifier type="isi">000458491600013</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Congenital heart disease</topic>
		</subject>
		<subject lang="eng">
			<topic>Atrial septal defect</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Atrial septal defect (ASD) is a congenital heart lesion that often remains undiagnosed until adulthood. The reasons for this may be multifactorial. It is, however, known that closure of a hemodynamically significant ASD improves exercise capacity. This study aimed to explore whether the aerobic capacity in late adolescence is associated with time to diagnosis and intervention in adult men with late diagnosis of an atrial shunt.&lt;/p&gt;&lt;p&gt;Methods: The Swedish Military Conscription Service Register contains data on exercise tests performed in late adolescence. By linking these data with the National Patient Register, 254 men with a later intervention for an ASD were identified.&lt;/p&gt;&lt;p&gt;Results: Interventions were performed at a mean of 26.5 +/- 7.9 years after the initial exercise tests. The mean absolute workload among those with a later diagnosed ASD was similar to those without a later diagnosed ASD (274 +/- 51W vs. 276 +/- 52 W, p = 0.49). Men with a higher exercise capacity (&amp;gt;= 1 SD) had their intervention earlier (21.9 +/- 8.6 years vs. 27.5 +/- 7.4 years, p &amp;lt; 0.001).&lt;/p&gt;&lt;p&gt;Conclusions: The aerobic exercise capacity was similar in adolescent men with later interventions for ASD compared to the reference population. Furthermore, those with high exercise capacity appeared to be diagnosed earlier. Thus, low exercise capacity may not be a feature of ASD during adolescence, but rather develop later in life as a natural progression of the disease.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Cardiology</title>
			</titleInfo>
			<identifier type="issn">0167-5273</identifier>
			<identifier type="eissn">1874-1754</identifier>
			<part>
				<detail type="volume">
					<number>280</number>
				</detail>
				<extent>
					<start>57</start>
					<end>60</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-13</recordCreationDate>
			<recordChangeDate>2019-03-13</recordChangeDate>
			<recordIdentifier>diva2:1296061</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Ruotsalainen</namePart>
			<namePart type="given">Ilona</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Psychology, Centre for Interdisciplinary Brain Research, University of Jyväskylä</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Renvall</namePart>
			<namePart type="given">Ville</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Neuroscience and Biomedical Engineering, Aalto University</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="gote0002">
			<namePart type="family">Gorbach</namePart>
			<namePart type="given">Tetiana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Statistik</affiliation>
			<affiliation>Department of Mathematics and Statistics, University of Jyväskylä, Jyväskylä, Finland</affiliation>
			<affiliation>Stat4Reg</affiliation>
			<description>orcid.org=0000-0003-2135-9963</description>
		</name>
		<name type="corporate">
			<namePart>Stat4Reg</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Syväoja</namePart>
			<namePart type="given">Heidi J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>LIKES Research Centre for Physical Activity and Health, Jyväskylä, Finland</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Tammelin</namePart>
			<namePart type="given">Tuija H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>LIKES Research Centre for Physical Activity and Health, Jyväskylä, Finland</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Karvanen</namePart>
			<namePart type="given">Juha</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Mathematics and Statistics, University of Jyväskylä</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Parviainen</namePart>
			<namePart type="given">Tiina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Psychology, Centre for Interdisciplinary Brain Research, University of Jyväskylä,</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="11053">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Aerobic fitness, but not physical activity, is associated with grey matter volume in adolescents</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-16T22:20:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155465</identifier>
		<identifier type="doi">10.1016/j.bbr.2018.12.041</identifier>
		<identifier type="pmid">30639508</identifier>
		<identifier type="isi">000458941500016</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Physical activity</topic>
		</subject>
		<subject lang="eng">
			<topic>Cardiorespiratory fitness</topic>
		</subject>
		<subject lang="eng">
			<topic>Magnetic resonance imaging</topic>
		</subject>
		<subject lang="eng">
			<topic>Accelerometer</topic>
		</subject>
		<subject lang="eng">
			<topic>Adolescence</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30105">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Neurosciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30105">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Neurovetenskaper</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10106">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Probability Theory and Statistics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10106">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Sannolikhetsteori och statistik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Higher levels of aerobic fitness and physical activity are linked to beneficial effects on brain health, especially in older adults. The generalizability of these earlier results to young individuals is not straightforward, because physiological responses (such as cardiovascular responses) to exercise may depend on age. Earlier studies have mostly focused on the effects of either physical activity or aerobic fitness on the brain. Yet, while physical activity indicates the amount of activity, aerobic fitness is an adaptive state or attribute that an individual has or achieves. Here, by measuring both physical activity and aerobic fitness in the same study, we aimed to differentiate the association between these two measures and grey matter volume specifically. Magnetic resonance imaging scans were used to study volumes of 30 regions of interest located in the frontal, motor and subcortical areas of 60 adolescents (12.7–16.2 years old). Moderate-to-vigorous intensity physical activity (MVPA) was measured with hip-worn accelerometers and aerobic fitness was assessed with a 20-m shuttle run. Multiple regression analyses revealed a negative association between aerobic fitness and left superior frontal cortex volume and a positive association between aerobic fitness and the left pallidum volume. No associations were found between MVPA and any brain region of interest. These results demonstrate unequal contribution of physical activity and aerobic fitness on grey matter volumes, with inherent or achieved capacity (aerobic fitness) showing clearer associations than physical activity.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Behavioural Brain Research</title>
			</titleInfo>
			<identifier type="issn">0166-4328</identifier>
			<identifier type="eissn">1872-7549</identifier>
			<part>
				<detail type="volume">
					<number>362</number>
				</detail>
				<extent>
					<start>122</start>
					<end>130</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>gote0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-16</recordCreationDate>
			<recordChangeDate>2019-04-26</recordChangeDate>
			<recordIdentifier>diva2:1279579</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Kübler</namePart>
			<namePart type="given">Isabella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Independent Scholar</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="kari0040">
			<namePart type="family">Richter</namePart>
			<namePart type="given">Kai-Florian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för datavetenskap</affiliation>
			<description>orcid.org=0000-0001-5629-0981</description>
			<description>diva-portal.org=authority-person:68209</description>
		</name>
		<name type="personal">
			<namePart type="family">Fabrikant</namePart>
			<namePart type="given">Sara Irina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Geography and Digital Society Initiative, University of Z€urich</affiliation>
			<description>orcid.org=0000-0003-1263-8792</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="863">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för datavetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Against All Odds</title>
			<subTitle>Multicriteria Decision Making with Hazard Prediction Maps Depicting Uncertainty</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Routledge</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-23T19:03:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163502</identifier>
		<identifier type="doi">10.1080/24694452.2019.1644992</identifier>
		<identifier type="isi">000487430900001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/24694452.2019.1644992</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>experiment</topic>
		</subject>
		<subject lang="eng">
			<topic>risk maps</topic>
		</subject>
		<subject lang="eng">
			<topic>risk perception</topic>
		</subject>
		<subject lang="eng">
			<topic>uncertainty</topic>
		</subject>
		<subject lang="eng">
			<topic>visualization</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50102">
			<topic>Social Sciences</topic>
			<topic>Psychology</topic>
			<topic>Applied Psychology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50102">
			<topic>Samhällsvetenskap</topic>
			<topic>Psykologi</topic>
			<topic>Tillämpad psykologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10204">
			<topic>Natural Sciences</topic>
			<topic>Computer and Information Sciences</topic>
			<topic>Human Computer Interaction</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10204">
			<topic>Naturvetenskap</topic>
			<topic>Data- och informationsvetenskap</topic>
			<topic>Människa-datorinteraktion (interaktionsdesign)</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10202">
			<topic>Information Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10202">
			<topic>Systemvetenskap, informationssystem och informatik</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="507">
			<topic>Social Sciences</topic>
			<topic>Social and Economic Geography</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="507">
			<topic>Samhällsvetenskap</topic>
			<topic>Social och ekonomisk geografi</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2202">
			<topic>human-computer interaction</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2202">
			<topic>människa-datorinteraktion</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;We report on a multicriteria decision-making study where participants were asked to purchase a house shown on maps that include hazard prediction information. We find that participants decided to buy different houses, depending on whether uncertainty is shown on the map display and on the type of uncertainty visualization (i.e., varying color value, focus, or texture). We also find that participants’ individual differences with respect to their assessed risk-taking behavior influences their spatial decision making with maps. Risk-takers seem to underestimate the dangers of natural hazards when prediction uncertainties are depicted. We are thus able to shed additional light on how people use visualized uncertainty information to make complex map-based decisions. We can demonstrate that not only are design characteristics relevant for map-based reasoning and decision-making outcomes but so are the decision makers’ individual background and the map-based decision-making context.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Annals of the Association of American Geographers</title>
			</titleInfo>
			<identifier type="issn">0004-5608</identifier>
			<identifier type="eissn">1467-8306</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1353702/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>kari0040</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-23</recordCreationDate>
			<recordChangeDate>2019-10-15</recordChangeDate>
			<recordIdentifier>diva2:1353702</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Honkamaki</namePart>
			<namePart type="given">Jasmin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hisinger-Molkanen</namePart>
			<namePart type="given">Hanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2293-0279</description>
		</name>
		<name type="personal">
			<namePart type="family">Ilmarinen</namePart>
			<namePart type="given">Pinja</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8758-2431</description>
		</name>
		<name type="personal">
			<namePart type="family">Piirila</namePart>
			<namePart type="given">Paivi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tuomisto</namePart>
			<namePart type="given">Leena E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Andersen</namePart>
			<namePart type="given">Heidi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Huhtala</namePart>
			<namePart type="given">Heini</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sovijarvi</namePart>
			<namePart type="given">Anssi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="heaban01">
			<namePart type="family">Backman</namePart>
			<namePart type="given">Helena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<description>orcid.org=0000-0002-0553-8067</description>
			<description>diva-portal.org=authority-person:63595</description>
		</name>
		<name type="personal">
			<namePart type="family">Lundbäck</namePart>
			<namePart type="given">Bo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="evra0004">
			<namePart type="family">Rönmark</namePart>
			<namePart type="given">Eva</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<description>diva-portal.org=authority-person:62778</description>
		</name>
		<name type="personal">
			<namePart type="family">Lehtimaki</namePart>
			<namePart type="given">Lauri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kankaanranta</namePart>
			<namePart type="given">Hannu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="730">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Yrkes- och miljömedicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-08T14:49:07</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161842</identifier>
		<identifier type="doi">10.1016/j.rmed.2019.06.003</identifier>
		<identifier type="pmid">31212122</identifier>
		<identifier type="isi">000474821800009</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Asthma</topic>
		</subject>
		<subject lang="eng">
			<topic>Incidence</topic>
		</subject>
		<subject lang="eng">
			<topic>Prevalence</topic>
		</subject>
		<subject lang="eng">
			<topic>Gender</topic>
		</subject>
		<subject lang="eng">
			<topic>Adult</topic>
		</subject>
		<subject lang="eng">
			<topic>Phenotype</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30219">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Respiratory Medicine and Allergy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30219">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Lungmedicin och allergi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Asthma is currently divided into different phenotypes, with age at onset as a relevant differentiating factor. In addition, asthma with onset in adulthood seems to have a poorer prognosis, but studies investigating age-specific incidence of asthma with a wide age span are scarce.&lt;/p&gt;&lt;p&gt;Objective: To evaluate incidence of asthma diagnosis at different ages and differences between child- and adult-diagnosed asthma in a large population-based study, with gender-specific analyzes included.&lt;/p&gt;&lt;p&gt;Methods: In 2016, a respiratory questionnaire was sent to 8000 randomly selected subjects aged 20-69 years in western Finland. After two reminders, 4173 (52.3%) subjects responded. Incidence rate of asthma was retrospectively estimated based on the reported age of asthma onset. Adult-diagnosed asthma was defined as a physician-diagnosis of asthma made at &amp;gt;= 18 years of age.&lt;/p&gt;&lt;p&gt;Results: Among those with physician-diagnosed asthma, altogether, 63.7% of subjects, 58.4% of men and 67.8% of women, reported adult-diagnosed asthma. Incidence of asthma diagnosis was calculated in 10-year age groups and it peaked in young boys (0-9 years) and middle-aged women (40-49 years) and the average incidence rate during the examined period between 1946 and 2015 was 2.2/1000/year. Adult-diagnosed asthma became the dominant phenotype among those with physician-diagnosed asthma by age of 50 years and 38 years in men and women, respectively.&lt;/p&gt;&lt;p&gt;Conclusions: Asthma is mainly diagnosed during adulthood and the incidence of asthma diagnosis peaks in middle-aged women. Asthma diagnosed in adulthood should be considered more in clinical practice and management guidelines.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Respiratory Medicine</title>
			</titleInfo>
			<identifier type="issn">0954-6111</identifier>
			<identifier type="eissn">1532-3064</identifier>
			<part>
				<detail type="volume">
					<number>154</number>
				</detail>
				<extent>
					<start>56</start>
					<end>62</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-08</recordCreationDate>
			<recordChangeDate>2019-08-08</recordChangeDate>
			<recordIdentifier>diva2:1341405</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Stoner</namePart>
			<namePart type="given">Marie C. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nguyen</namePart>
			<namePart type="given">Nadia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kilburn</namePart>
			<namePart type="given">Kelly</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gómez-Olivé</namePart>
			<namePart type="given">F. Xavier</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Edwards</namePart>
			<namePart type="given">Jessie K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Selin</namePart>
			<namePart type="given">Amanda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hughes</namePart>
			<namePart type="given">James P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Agyei</namePart>
			<namePart type="given">Yaw</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Macphail</namePart>
			<namePart type="given">Catherine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="kaka0045">
			<namePart type="family">Kahn</namePart>
			<namePart type="given">Kathleen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Epidemiologi och global hälsa</affiliation>
			<affiliation>MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; eINDEPTH Network, Accra, Ghana</affiliation>
			<description>diva-portal.org=authority-person:62930</description>
		</name>
		<name type="personal">
			<namePart type="family">Pettifor</namePart>
			<namePart type="given">Audrey</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5303">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Wolters Kluwer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-03T10:36:58</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157792</identifier>
		<identifier type="doi">10.1097/QAD.0000000000002037</identifier>
		<identifier type="pmid">30289813</identifier>
		<identifier type="isi">000460936300009</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>adolescent and young women</topic>
		</subject>
		<subject lang="eng">
			<topic>age-disparate partnerships</topic>
		</subject>
		<subject lang="eng">
			<topic>HIV</topic>
		</subject>
		<subject lang="eng">
			<topic>South Africa</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Objective: Adolescent girls and young women (AGYW) have a much higher risk of HIV infection than young men of the same age. One hypothesis for this disparity is AGYW are more likely to be in sexual partnerships with older men with HIV; however, evidence has been inconclusive.&lt;/p&gt;&lt;p&gt;Design: We used longitudinal data from a randomized trial in South Africa (HPTN 068) to determined whether partner age difference is associated with incident HIV infection in AGYW.&lt;/p&gt;&lt;p&gt;Methods: Age difference was examined continuously and dichotomously (≥5 years). We examined inverse probability of exposure weighted survival curves and calculated time-specific risk differences and risk ratios over 5.5 years of follow-up. We also used a marginal structural Cox model to estimate hazard ratios over the entire study period.&lt;/p&gt;&lt;p&gt;Results: Risk of HIV was higher in AGYW with an age-disparate partnership versus not and the risk difference was largest at later time points. At 5.5 years, AGYW with an age-disparate partnership had a 12.6% (95% confidence interval 1.9–23.3) higher risk than AGYW with no age-disparate partnerships. The weighted hazard ratio was 1.91 (95% confidence interval 1.33–2.74), an association that remained after weighting for either transactional or condomless sex, and after examining continuous age-differences.&lt;/p&gt;&lt;p&gt;Conclusion: Age-disparate partnerships increased risk of HIV infection, even after accounting for transactional sex and condomless sex. The relationship between age-disparate partnerships and HIV infection may be explained by increased exposure to infection from men in a higher HIV prevalence pool rather than differences in sexual behaviour within these partnerships.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>AIDS (London)</title>
			</titleInfo>
			<identifier type="issn">0269-9370</identifier>
			<identifier type="eissn">1473-5571</identifier>
			<part>
				<detail type="volume">
					<number>33</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>83</start>
					<end>91</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-03</recordCreationDate>
			<recordChangeDate>2019-04-03</recordChangeDate>
			<recordIdentifier>diva2:1301882</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Granbom</namePart>
			<namePart type="given">Marianne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-7456-2039</description>
		</name>
		<name type="personal">
			<namePart type="family">Szanton</namePart>
			<namePart type="given">Sarah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gitlin</namePart>
			<namePart type="given">Laura N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Paulsson</namePart>
			<namePart type="given">Ulrika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="maszik90">
			<namePart type="family">Zingmark</namePart>
			<namePart type="given">Magnus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0002-1087-8656</description>
			<description>diva-portal.org=authority-person:64046</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Ageing in the right place</title>
			<subTitle>a prototype of a web-based housing counselling intervention for later life</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>TAYLOR &amp; FRANCIS LTD</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-27T13:19:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162332</identifier>
		<identifier type="doi">10.1080/11038128.2019.1634756</identifier>
		<identifier type="pmid">31305191</identifier>
		<identifier type="isi">000478533900001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Relocation</topic>
		</subject>
		<subject lang="eng">
			<topic>home modifications</topic>
		</subject>
		<subject lang="eng">
			<topic>decision-making</topic>
		</subject>
		<subject lang="eng">
			<topic>housing preferences</topic>
		</subject>
		<subject lang="eng">
			<topic>community-living</topic>
		</subject>
		<subject lang="eng">
			<topic>assisted ving facilities</topic>
		</subject>
		<subject lang="eng">
			<topic>nursing home</topic>
		</subject>
		<subject lang="eng">
			<topic>user-centred</topic>
		</subject>
		<subject lang="eng">
			<topic>research circle methodology</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="60406">
			<topic>Humanities and the Arts</topic>
			<topic>Arts</topic>
			<topic>Design</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="60406">
			<topic>Humaniora och konst</topic>
			<topic>Konst</topic>
			<topic>Design</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Despite a strong desire among most older adults to age in place, there are few widely available services to support planning and preparing for one's future housing needs. Objective: To develop a prototype of a web-based housing counselling intervention for use in later life, by employing a user-centred design. Material and Methods: As the first step in intervention development, we employed a development process based on research circle methodology. Nine older adults participated in three sessions. Findings from literature reviews, a meeting with a technology and design panel (n = 6) and interviews with representatives of nonprofit organizations, companies, and municipalities (n = 7) served as discussion points. Result: An on-paper prototype was derived, composed of the THINK, LEARN and ACT module reflecting different stages of the decision-making process. Each module addressed preferences, health, home and social and financial resources. Key design features and theoretical underpinnings were included.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Scandinavian Journal of Occupational Therapy</title>
			</titleInfo>
			<identifier type="issn">1103-8128</identifier>
			<identifier type="eissn">1651-2014</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1346184/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-27</recordCreationDate>
			<recordChangeDate>2019-08-27</recordChangeDate>
			<recordIdentifier>diva2:1346184</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Hedman</namePart>
			<namePart type="given">Ragnhild</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="asno0002">
			<namePart type="family">Norberg</namePart>
			<namePart type="given">Astrid</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för omvårdnad</affiliation>
			<affiliation>Department of Health Care Sciences, Ersta Sköndal Bräcke University, Sweden; The Palliative Research Centre, Ersta Sköndal University College, Sweden</affiliation>
			<description>diva-portal.org=authority-person:64355</description>
		</name>
		<name type="personal">
			<namePart type="family">Hellström</namePart>
			<namePart type="given">Ingrid</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="769">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för omvårdnad</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agency and communion in people with Alzheimer’s disease, as described by themselves and their spousal carers</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2017-05-30T08:36:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-135499</identifier>
		<identifier type="doi">10.1177/1471301217706268</identifier>
		<identifier type="pmid">28440706</identifier>
		<identifier type="isi">000469352700008</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>agency</topic>
		</subject>
		<subject lang="eng">
			<topic>Alzheimer’s disease</topic>
		</subject>
		<subject lang="eng">
			<topic>communion</topic>
		</subject>
		<subject lang="eng">
			<topic>self</topic>
		</subject>
		<subject lang="eng">
			<topic>spousal relationships</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30305">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nursing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30305">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Omvårdnad</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Agency (individuality) and communion (togetherness) are vital to a positive sense of self. People with Alzheimer’s disease are at risk of experiencing diminished agency and decreased communion. Their family members’, especially their partner’s, view on their agency and communion is also likely to influence their sense of agency, communion, and self. In the present study, individual interviews with 10 people with Alzheimer’s disease and their spousal carers were qualitatively analysed to describe how in each couple the two spouses viewed the agency and communion of the person with Alzheimer’s disease from an individual perspective. The findings show that the carers generally described the agency of the person with Alzheimer’s disease as slightly weaker compared with the persons with Alzheimer’s disease themselves. The carers also appeared to have poor knowledge of what supported and threatened the sense of communion of the person with Alzheimer’s disease.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Dementia</title>
			</titleInfo>
			<identifier type="issn">1471-3012</identifier>
			<identifier type="eissn">1741-2684</identifier>
			<part>
				<detail type="volume">
					<number>8</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>leri0010</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2017-05-30</recordCreationDate>
			<recordChangeDate>2019-06-17</recordChangeDate>
			<recordIdentifier>diva2:1102652</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="anra0075">
			<namePart type="family">Rantala</namePart>
			<namePart type="given">Anna</namePart>
			<namePart type="date">1974-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad utbildningsvetenskap</affiliation>
			<affiliation>Anna Rantala</affiliation>
			<description>orcid.org=000-0003-3006-17200000-0003-3006-1720</description>
			<description>diva-portal.org=authority-person:62408</description>
		</name>
		<name type="corporate">
			<namePart>Anna Rantala</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Heikkilä</namePart>
			<namePart type="given">Mia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Åbo Akademi</affiliation>
			<description>orcid.org=0000-0003-3361-348X</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="5301">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad utbildningsvetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agency, guidance and gender</title>
			<subTitle>interrelated aspects of early childhood education settings</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-02-07T08:40:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167939</identifier>
		<identifier type="doi">10.1080/03004279.2019.1620305</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/03004279.2019.1620305</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>preschool</topic>
		</subject>
		<subject lang="eng">
			<topic>guidance</topic>
		</subject>
		<subject lang="eng">
			<topic>children’s agency</topic>
		</subject>
		<subject lang="eng">
			<topic>ethnography</topic>
		</subject>
		<subject lang="eng">
			<topic>gender</topic>
		</subject>
		<subject lang="eng">
			<topic>early childhood education</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="5">
			<topic>Social Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="5">
			<topic>Samhällsvetenskap</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50304">
			<topic>Social Sciences</topic>
			<topic>Educational Sciences</topic>
			<topic>Pedagogical Work</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50304">
			<topic>Samhällsvetenskap</topic>
			<topic>Utbildningsvetenskap</topic>
			<topic>Pedagogiskt arbete</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="9450">
			<topic>pedagogiskt arbete</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="9450">
			<topic>educational work</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Social interaction is one of the many things what preschool life is about, and how social life is constituted is of importance to understand. In early childhood education settings, children are guided and fostered by teachers and by each other in different directions. The overall aim of the article is to make a contribution to a deeper understanding of how children’s agency is performed as a constantly gendered social activity and how this is affected by the guidance they receive from teachers. The relationship between agency, gender and guidance is scrutinised. By using Foucault’s concepts discipline and power in combination with understandings of childhood and gender order this is explored. The empirical material consists of ethnographic observations in two preschools, and the results show how agency, gender and guidance need to be understood as relational processes when highlighting aspects of children’s social life in ECE.&lt;/p&gt;</abstract>
		<note>&lt;p&gt;epub ahead of print. granskad så långt det är möjligt - lägg till volym, sidor och ny pdf / PSu&lt;/p&gt;</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Education 3-13</title>
			</titleInfo>
			<identifier type="issn">0300-4279</identifier>
			<identifier type="eissn">1475-7575</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1392291/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>anra0075</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-02-07</recordCreationDate>
			<recordChangeDate>2020-02-07</recordChangeDate>
			<recordIdentifier>diva2:1392291</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="aska0001">
			<namePart type="family">Karlsson Sjögren</namePart>
			<namePart type="given">Åsa</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för idé- och samhällsstudier</affiliation>
			<description>orcid.org=0000-0001-8077-6578</description>
			<description>diva-portal.org=authority-person:63081</description>
		</name>
		<name type="personal">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Esbjörn</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rimm</namePart>
			<namePart type="given">Stefan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="820">
			<namePart>Umeå universitet</namePart>
			<namePart>Humanistiska fakulteten</namePart>
			<namePart>Institutionen för idé- och samhällsstudier</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agents and Subjects</title>
			<subTitle>schooling and Conceptions of Citizenship in Nineteenth-Century Sweden</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Routledge</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-11-23T16:37:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-153612</identifier>
		<identifier type="doi">10.1080/0046760X.2018.1541482</identifier>
		<identifier type="isi">000461870600002</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/0046760X.2018.1541482</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Citizenship</topic>
		</subject>
		<subject lang="eng">
			<topic>Gender</topic>
		</subject>
		<subject lang="eng">
			<topic>Class</topic>
		</subject>
		<subject lang="eng">
			<topic>School system</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="60101">
			<topic>Humanities and the Arts</topic>
			<topic>History and Archaeology</topic>
			<topic>History</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="60101">
			<topic>Humaniora och konst</topic>
			<topic>Historia och arkeologi</topic>
			<topic>Historia</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50301">
			<topic>Social Sciences</topic>
			<topic>Educational Sciences</topic>
			<topic>Pedagogy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50301">
			<topic>Samhällsvetenskap</topic>
			<topic>Utbildningsvetenskap</topic>
			<topic>Pedagogik</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2033">
			<topic>History</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2033">
			<topic>historia</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="12350">
			<topic>historia med utbildningsvetenskaplig inriktning</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="12350">
			<topic>history of education</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;This article aims to analyse how the emerging Swedish school system in the early nineteenth century can be understood within the context of a gradual break-up of the estate society and its replacement with a class society in which citizenship was an important foundation. This is done through the discussion of the conceptions of citizenship on two levels. The first is the national level, focusing the national debate on education, and the second is the local level, investigating the local schools and the school setting. The main result is that the conceptions of citizenship in the school context were formed along two major lines: an inclusive social and civil citizenship and an exclusive, active and political citizenship. Consequently, the emerging Swedish school system simultaneously fostered these two citizenship conceptions, which coexisted in an educational system that was able to cast pupils as either subjects (comprehensive citizenship) or agents (designated citizenship).&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>History of Education</title>
			</titleInfo>
			<identifier type="issn">0046-760X</identifier>
			<identifier type="eissn">1464-5130</identifier>
			<part>
				<detail type="volume">
					<number>48</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>297</start>
					<end>316</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [721-2013-1228]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1265513/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>aska0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-11-23</recordCreationDate>
			<recordChangeDate>2019-04-23</recordChangeDate>
			<recordIdentifier>diva2:1265513</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Kano</namePart>
			<namePart type="given">Izabella Szakalne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lengyel</namePart>
			<namePart type="given">Balazs</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="zoel0001">
			<namePart type="family">Elekes</namePart>
			<namePart type="given">Zoltán</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för geografi</affiliation>
			<affiliation>Faculty of Economics and Business Administration, University of Szeged, Szeged, Hungary; Agglomeration and Social Networks Lendület Research Group, Centre for Economic and Regional Studies, Hungarian Academy of Sciences, Budapest, Hungary</affiliation>
			<description>orcid.org=0000-0002-7437-5791</description>
			<description>diva-portal.org=authority-person:72904</description>
		</name>
		<name type="personal">
			<namePart type="family">Lengyel</namePart>
			<namePart type="given">Imre</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881251">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för geografi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agglomeration, foreign firms and firm exit in regions under transition</title>
			<subTitle>the increasing importance of related variety in Hungary</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Routledge</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-07-09T12:36:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161476</identifier>
		<identifier type="doi">10.1080/09654313.2019.1606897</identifier>
		<identifier type="isi">000471473500001</identifier>
		<identifier type="scopus">2-s2.0-85064641184</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/09654313.2019.1606897</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Agglomeration economies</topic>
		</subject>
		<subject lang="eng">
			<topic>related variety</topic>
		</subject>
		<subject lang="eng">
			<topic>firm exit</topic>
		</subject>
		<subject lang="eng">
			<topic>foreign-owned firms</topic>
		</subject>
		<subject lang="eng">
			<topic>dual economy</topic>
		</subject>
		<subject lang="eng">
			<topic>transition</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50702">
			<topic>Social Sciences</topic>
			<topic>Social and Economic Geography</topic>
			<topic>Economic Geography</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50702">
			<topic>Samhällsvetenskap</topic>
			<topic>Social och ekonomisk geografi</topic>
			<topic>Ekonomisk geografi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Related variety of economic activities is widely recognized to induce regional development; however, it is not clear how this mechanism takes place in regions that go through major structural and institutional transformation. Furthermore, foreign direct investment (FDI) is typically a major source of structural change in these areas; and we still need a better understanding on how foreign-owned (foreign) firms affect the dynamics of domestic-owned (domestic) companies. For these reasons we analyse firm-level exit in Hungarian city regions between 1996 and 2011, over the late post-socialist transition in manufacturing industries, focusing on the difference between foreign and domestic firms. Introducing ownership into the related variety calculation, we estimate the probability of firm exit with the region-level related variety calculated separately for foreign and domestic firms. Our results suggest that related variety of foreign firms decreases the probability of domestic firm exit earlier during the economic transition compared to the related variety of domestic firms. This finding supports the idea that FDI plays a formative role in regions under transition, and shows that domestic firms benefit from being in agglomerations where foreign firms are technologically related to each other.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>European Planning Studies</title>
			</titleInfo>
			<identifier type="issn">0965-4313</identifier>
			<identifier type="eissn">1469-5944</identifier>
			<part>
				<detail type="volume">
					<number>27</number>
				</detail>
				<detail type="issue">
					<number>11</number>
				</detail>
				<extent>
					<start>2099</start>
					<end>2122</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1336285/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-07-09</recordCreationDate>
			<recordChangeDate>2020-01-08</recordChangeDate>
			<recordIdentifier>diva2:1336285</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Ahlstrand</namePart>
			<namePart type="given">Tuuli</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kovesjoki</namePart>
			<namePart type="given">Laura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maula</namePart>
			<namePart type="given">Terhi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jaos0004">
			<namePart type="family">Oscarsson</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>diva-portal.org=authority-person:64967</description>
		</name>
		<name type="personal">
			<namePart type="family">Ihalin</namePart>
			<namePart type="given">Riikka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Aggregatibacter actinomycetemcomitans LPS binds human interleukin-8</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>TAYLOR &amp; FRANCIS LTD</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-18T12:16:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154325</identifier>
		<identifier type="doi">10.1080/20002297.2018.1549931</identifier>
		<identifier type="isi">000451666300001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/20002297.2018.1549931</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Lipopolysaccharides</topic>
		</subject>
		<subject lang="eng">
			<topic>host-pathogen interactions</topic>
		</subject>
		<subject lang="eng">
			<topic>chemokines</topic>
		</subject>
		<subject lang="eng">
			<topic>periodontal pathogen</topic>
		</subject>
		<subject lang="eng">
			<topic>bacterial rulence</topic>
		</subject>
		<subject lang="eng">
			<topic>outer membrane vesicles</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30216">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Dentistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30216">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Odontologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Various gram-negative species sequester host cytokines using outer membrane proteins or surface modulation by sulfated polysaccharides. An outer membrane lipoprotein (BilRI) of the periodontal pathogen Aggregatibacter actinomycetemcomitans binds several cytokines, including interleukin (IL)-8. Because IL-8 is positively charged at physiological pH, we aimed to determine whether IL-8 interacts with negatively charged lipopolysaccharide (LPS). Binding was investigated using electrophoretic mobility shift assays and microwell-based time-resolved fluorometric immunoassay. LPS from each tested strain of A. actinomycetemcomitans (N = 13), Pseudomonas aeruginosa (N = 1) and Escherichia coli (N = 1) bound IL-8. The K-d value of the A. actinomycetemcomitans LPS-IL-8 interaction varied between 1.2-17 mu M irrespective of the serotype and the amount of phosphorus in LPS and was significantly lower than that of the BilRI-IL-8 interaction. Moreover, IL-8 interacted with whole A. actinomycetemcomitans cells and outer membrane vesicles. Hence, LPS might be involved in binding of IL-8 to the outer membrane of A. actinomycetemcomitans. This raises an interesting question regarding whether other gram-negative periodontal pathogens use LPS for IL-8 sequestering in vivo.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Oral Microbiology</title>
			</titleInfo>
			<identifier type="issn">2000-2297</identifier>
			<identifier type="eissn">2000-2297</identifier>
			<part>
				<detail type="volume">
					<number>11</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1271904/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-18</recordCreationDate>
			<recordChangeDate>2018-12-18</recordChangeDate>
			<recordIdentifier>diva2:1271904</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Walsh</namePart>
			<namePart type="given">Naomi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Han</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hyland</namePart>
			<namePart type="given">Paula L</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Qi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mocci</namePart>
			<namePart type="given">Evelina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Mingfeng</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Childs</namePart>
			<namePart type="given">Erica J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Collins</namePart>
			<namePart type="given">Irene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Zhaoming</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arslan</namePart>
			<namePart type="given">Alan A</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beane-Freeman</namePart>
			<namePart type="given">Laura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bracci</namePart>
			<namePart type="given">Paige M</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brennan</namePart>
			<namePart type="given">Paul</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Canzian</namePart>
			<namePart type="given">Federico</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Duell</namePart>
			<namePart type="given">Eric J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gallinger</namePart>
			<namePart type="given">Steven</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giles</namePart>
			<namePart type="given">Graham G</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goggins</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goodman</namePart>
			<namePart type="given">Gary E</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goodman</namePart>
			<namePart type="given">Phyllis J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hung</namePart>
			<namePart type="given">Rayjean J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kooperberg</namePart>
			<namePart type="given">Charles</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kurtz</namePart>
			<namePart type="given">Robert C</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Malats</namePart>
			<namePart type="given">Núria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">LeMarchand</namePart>
			<namePart type="given">Loic</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Neale</namePart>
			<namePart type="given">Rachel E</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Olson</namePart>
			<namePart type="given">Sara H</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scelo</namePart>
			<namePart type="given">Ghislaine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shu</namePart>
			<namePart type="given">Xiao O</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Van Den Eeden</namePart>
			<namePart type="given">Stephen K</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Visvanathan</namePart>
			<namePart type="given">Kala</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">White</namePart>
			<namePart type="given">Emily</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zheng</namePart>
			<namePart type="given">Wei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Albanes</namePart>
			<namePart type="given">Demetrius</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Andreotti</namePart>
			<namePart type="given">Gabriella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Babic</namePart>
			<namePart type="given">Ana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bamlet</namePart>
			<namePart type="given">William R</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Berndt</namePart>
			<namePart type="given">Sonja I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Borgida</namePart>
			<namePart type="given">Ayelet</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boutron-Ruault</namePart>
			<namePart type="given">Marie-Christine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brais</namePart>
			<namePart type="given">Lauren</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brennan</namePart>
			<namePart type="given">Paul</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bueno-de-Mesquita</namePart>
			<namePart type="given">Bas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Buring</namePart>
			<namePart type="given">Julie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chaffee</namePart>
			<namePart type="given">Kari G</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chanock</namePart>
			<namePart type="given">Stephen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cleary</namePart>
			<namePart type="given">Sean</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cotterchio</namePart>
			<namePart type="given">Michelle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Foretova</namePart>
			<namePart type="given">Lenka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fuchs</namePart>
			<namePart type="given">Charles</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">M Gaziano</namePart>
			<namePart type="given">J Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giovannucci</namePart>
			<namePart type="given">Edward</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goggins</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hackert</namePart>
			<namePart type="given">Thilo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Haiman</namePart>
			<namePart type="given">Christopher</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hartge</namePart>
			<namePart type="given">Patricia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hasan</namePart>
			<namePart type="given">Manal</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Helzlsouer</namePart>
			<namePart type="given">Kathy J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Herman</namePart>
			<namePart type="given">Joseph</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Holcatova</namePart>
			<namePart type="given">Ivana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Holly</namePart>
			<namePart type="given">Elizabeth A</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hoover</namePart>
			<namePart type="given">Robert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hung</namePart>
			<namePart type="given">Rayjean J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Janout</namePart>
			<namePart type="given">Vladimir</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klein</namePart>
			<namePart type="given">Eric A</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kurtz</namePart>
			<namePart type="given">Robert C</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laheru</namePart>
			<namePart type="given">Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lee</namePart>
			<namePart type="given">I-Min</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lu</namePart>
			<namePart type="given">Lingeng</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Malats</namePart>
			<namePart type="given">Núria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mannisto</namePart>
			<namePart type="given">Satu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Milne</namePart>
			<namePart type="given">Roger L</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Oberg</namePart>
			<namePart type="given">Ann L</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Orlow</namePart>
			<namePart type="given">Irene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Patel</namePart>
			<namePart type="given">Alpa V</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peters</namePart>
			<namePart type="given">Ulrike</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Porta</namePart>
			<namePart type="given">Miquel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Real</namePart>
			<namePart type="given">Francisco X</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rothman</namePart>
			<namePart type="given">Nathaniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sesso</namePart>
			<namePart type="given">Howard D</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Severi</namePart>
			<namePart type="given">Gianluca</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Silverman</namePart>
			<namePart type="given">Debra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Strobel</namePart>
			<namePart type="given">Oliver</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="masu0021">
			<namePart type="family">Sund</namePart>
			<namePart type="given">Malin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för kirurgisk och perioperativ vetenskap</affiliation>
			<affiliation>Sund</affiliation>
			<description>orcid.org=0000-0002-7516-9543</description>
			<description>diva-portal.org=authority-person:62927</description>
		</name>
		<name type="corporate">
			<namePart>Sund</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Thornquist</namePart>
			<namePart type="given">Mark D</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tobias</namePart>
			<namePart type="given">Geoffrey S</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wactawski-Wende</namePart>
			<namePart type="given">Jean</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wareham</namePart>
			<namePart type="given">Nick</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Weiderpass</namePart>
			<namePart type="given">Elisabete</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wentzensen</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wheeler</namePart>
			<namePart type="given">William</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yu</namePart>
			<namePart type="given">Herbert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zeleniuch-Jacquotte</namePart>
			<namePart type="given">Anne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kraft</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Li</namePart>
			<namePart type="given">Donghui</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jacobs</namePart>
			<namePart type="given">Eric J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Petersen</namePart>
			<namePart type="given">Gloria M</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wolpin</namePart>
			<namePart type="given">Brian M</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Risch</namePart>
			<namePart type="given">Harvey A</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amundadottir</namePart>
			<namePart type="given">Laufey T</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yu</namePart>
			<namePart type="given">Kai</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klein</namePart>
			<namePart type="given">Alison P</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stolzenberg-Solomon</namePart>
			<namePart type="given">Rachael Z</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="792">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-19T20:35:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154571</identifier>
		<identifier type="doi">10.1093/jnci/djy155</identifier>
		<identifier type="pmid">30541042</identifier>
		<identifier type="isi">000474267400006</identifier>
		<identifier type="articleId">djy155</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2120">
			<topic>Oncology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2120">
			<topic>onkologi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Genome-wide association studies (GWAS) identify associations of individual single-nucleotide polymorphisms (SNPs) with cancer risk but usually only explain a fraction of the inherited variability. Pathway analysis of genetic variants is a powerful tool to identify networks of susceptibility genes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods:&lt;/strong&gt; We conducted a large agnostic pathway-based meta-analysis of GWAS data using the summary-based adaptive rank truncated product method to identify gene sets and pathways associated with pancreatic ductal adenocarcinoma (PDAC) in 9040 cases and 12 496 controls. We performed expression quantitative trait loci (eQTL) analysis and functional annotation of the top SNPs in genes contributing to the top associated pathways and gene sets. All statistical tests were two-sided.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; We identified 14 pathways and gene sets associated with PDAC at a false discovery rate of less than 0.05. After Bonferroni correction (P ≤ 1.3 × 10-5), the strongest associations were detected in five pathways and gene sets, including maturity-onset diabetes of the young, regulation of beta-cell development, role of epidermal growth factor (EGF) receptor transactivation by G protein-coupled receptors in cardiac hypertrophy pathways, and the Nikolsky breast cancer chr17q11-q21 amplicon and Pujana ATM Pearson correlation coefficient (PCC) network gene sets. We identified and validated rs876493 and three correlating SNPs (PGAP3) and rs3124737 (CASP7) from the Pujana ATM PCC gene set as eQTLs in two normal derived pancreas tissue datasets.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; Our agnostic pathway and gene set analysis integrated with functional annotation and eQTL analysis provides insight into genes and pathways that may be biologically relevant for risk of PDAC, including those not previously identified.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of the National Cancer Institute</title>
			</titleInfo>
			<identifier type="issn">0027-8874</identifier>
			<identifier type="eissn">1460-2105</identifier>
			<part>
				<detail type="volume">
					<number>111</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">NIH (National Institute of Health) [HHSN261200800001E]</note>
		<recordInfo>
			<recordOrigin>masu0021</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-19</recordCreationDate>
			<recordChangeDate>2019-12-17</recordChangeDate>
			<recordIdentifier>diva2:1272791</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Månsson</namePart>
			<namePart type="given">Johanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stjernqvist</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="frse0009">
			<namePart type="family">Serenius</namePart>
			<namePart type="given">Fredrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för klinisk vetenskap</affiliation>
			<affiliation>Uppsala University, Sweden</affiliation>
			<description>diva-portal.org=authority-person:63642</description>
		</name>
		<name type="personal">
			<namePart type="family">Ådén</namePart>
			<namePart type="given">Ulrika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Källén</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="738">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agreement Between Bayley-III Measurements and WISC-IV Measurements in Typically Developing Children</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-05T15:22:06</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162873</identifier>
		<identifier type="doi">10.1177/0734282918781431</identifier>
		<identifier type="isi">000480632800006</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>developmental assessment</topic>
		</subject>
		<subject lang="eng">
			<topic>Wechsler tests</topic>
		</subject>
		<subject lang="eng">
			<topic>intelligence</topic>
		</subject>
		<subject lang="eng">
			<topic>cognition</topic>
		</subject>
		<subject lang="eng">
			<topic>assessment</topic>
		</subject>
		<subject lang="eng">
			<topic>preschool</topic>
		</subject>
		<subject lang="eng">
			<topic>rticipants</topic>
		</subject>
		<subject lang="eng">
			<topic>scale development</topic>
		</subject>
		<subject lang="eng">
			<topic>testing</topic>
		</subject>
		<subject lang="eng">
			<topic>measurement</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30221">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Pediatrics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30221">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Pediatrik</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="501">
			<topic>Social Sciences</topic>
			<topic>Psychology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="501">
			<topic>Samhällsvetenskap</topic>
			<topic>Psykologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The study aim was to explore the relationship between a developmental assessment at preschool age and an intelligence quotient (IQ) assessment at school age. One hundred sixty-two children were assessed at 2.5 years with the Bayley Scales of Infant and Toddler Development-Third Edition (Bayley-III) and then at 6.5 years with the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV). The Bayley-III Cognitive Index score was the Bayley entity that showed the highest correlation with WISC-IV Full-Scale IQ (FSIQ; r = .41). There was a significant difference between the individual WISC-IV FSIQ and the Bayley-III Cognitive Index scores. Analyses showed an average difference of -4 units and 95% limits of agreement of -18.5 to 26.4 units. A multivariate model identified the Bayley-III Cognitive Index score as the most important predictor for FSIQ and General Ability Index (GAI), respectively, in comparison with demographic factors. The model explained 24% of the total FSIQ variation and 26% of the GAI variation. It was concluded that the Bayley-III measurement was an insufficient predictor of later IQ.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Psychoeducational Assessment</title>
			</titleInfo>
			<identifier type="issn">0734-2829</identifier>
			<identifier type="eissn">1557-5144</identifier>
			<part>
				<detail type="volume">
					<number>37</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>603</start>
					<end>616</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-05</recordCreationDate>
			<recordChangeDate>2019-09-05</recordChangeDate>
			<recordIdentifier>diva2:1348842</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Pape</namePart>
			<namePart type="given">Kathrine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Svanes</namePart>
			<namePart type="given">Cecilie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Malinovschi</namePart>
			<namePart type="given">Andrei</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Benediktsdottir</namePart>
			<namePart type="given">Bryndis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lodge</namePart>
			<namePart type="given">Caroline</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Janson</namePart>
			<namePart type="given">Christer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Moratalla</namePart>
			<namePart type="given">Jesus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sánchez-Ramos</namePart>
			<namePart type="given">José Luis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="lebr0005">
			<namePart type="family">Bråbäck</namePart>
			<namePart type="given">Lennart</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<description>diva-portal.org=authority-person:62784</description>
		</name>
		<name type="personal">
			<namePart type="family">Holm</namePart>
			<namePart type="given">Mathias</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jögi</namePart>
			<namePart type="given">Rain</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jacobsen Bertelsen</namePart>
			<namePart type="given">Randi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sigsgaard</namePart>
			<namePart type="given">Torben</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Johannessen</namePart>
			<namePart type="given">Ane</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schlünssen</namePart>
			<namePart type="given">Vivi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="730">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Yrkes- och miljömedicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agreement of offspring-reported parental smoking status</title>
			<subTitle>the RHINESSA generation study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BMC</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-25T08:37:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155622</identifier>
		<identifier type="doi">10.1186/s12889-019-6414-0</identifier>
		<identifier type="pmid">30665381</identifier>
		<identifier type="isi">000459898400003</identifier>
		<identifier type="articleId">94</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12889-019-6414-0</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Agreement</topic>
		</subject>
		<subject lang="eng">
			<topic>Generation study</topic>
		</subject>
		<subject lang="eng">
			<topic>Parental smoking</topic>
		</subject>
		<subject lang="eng">
			<topic>Self-report</topic>
		</subject>
		<subject lang="eng">
			<topic>Sensitivity</topic>
		</subject>
		<subject lang="eng">
			<topic>Smoking during pregnancy</topic>
		</subject>
		<subject lang="eng">
			<topic>Specificity</topic>
		</subject>
		<subject lang="eng">
			<topic>Tobacco smoking</topic>
		</subject>
		<subject lang="eng">
			<topic>Validation study</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30303">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Occupational Health and Environmental Health</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30303">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Arbetsmedicin och miljömedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: With increasing interest in exposure effects across generations, it is crucial to assess the validity of information given on behalf of others.&lt;/p&gt;&lt;p&gt;Aims: To compare adult's report of their parent’s smoking status against parent's own report and examine predictors for discrepant answers.&lt;/p&gt;&lt;p&gt;Methods: We studied 7185 offspring (18-51 years) and one of their parents, &lt;em&gt;n&lt;/em&gt; = 5307 (27-67 years) participating in the Respiratory Health in Northern Europe, Spain and Australia (RHINESSA) generation study. Information about parent's smoking status during offspring's childhood and mother's smoking status during pregnancy was obtained by questionnaires from parents and their offspring. We calculated sensitivity, specificity and Cohen's Kappa [κ] for agreement using parent's own report as the gold standard. We performed logistic regression to examine if offspring's sex, age, educational level, asthma status, own smoking status or parental status, as well as the parent's sex and amount of smoking during childhood predicted disagreement.&lt;/p&gt;&lt;p&gt;Results: The sensitivity for offspring's correct report of parent's smoking status during childhood (0-10 years) was 0.82 (95% CI 0.81–0.84), specificity was 0.95 (95% CI 0.95–0.96) and a good agreement was observed, κ = 0.79 (95% CI 0.78–0.80). Offspring's report of mothers' smoking status during pregnancy showed a lower sensitivity, 0.66 (95% CI 0.60–0.71), a slightly lower specificity, 0.92 (95% CI 0.90–0.95) and a good agreement, κ = 0.61 (95% CI 0.55–0.67). In multivariate logistic regression analysis, offspring &lt;em&gt;not&lt;/em&gt; having children was a predictor for discrepant answers (odds ratio [OR] 2.11 [95% CI 1.21–3.69]). Low amount of parents' tobacco consumption, &amp;lt; 10 cigarettes/day (OR 2.72 [95% CI 1.71–4.31]) also predicted disagreement compared to ≥10 cigarettes per day, and so did offspring's reports of fathers' smoking status (OR 1.73 [95% CI 1.09–2.74]) compared to mothers' smoking status. Offspring's sex, asthma status, educational level, smoking status or age was not related to discrepant answers.&lt;/p&gt;&lt;p&gt;Conclusions: Adults report their parent's smoking status during their childhood, as well as their mothers' smoking status when pregnant with them, quite accurately. In the absence of parents' direct report, offspring's reports could be valuable.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>BMC Public Health</title>
			</titleInfo>
			<identifier type="issn">1471-2458</identifier>
			<identifier type="eissn">1471-2458</identifier>
			<part>
				<detail type="volume">
					<number>19</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1282503/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>lrtjon02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-25</recordCreationDate>
			<recordChangeDate>2019-03-27</recordChangeDate>
			<recordIdentifier>diva2:1282503</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="suetan98">
			<namePart type="family">Tafvelin</namePart>
			<namePart type="given">Susanne</namePart>
			<namePart type="date">1975-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<affiliation>Procome research group, Medical Management Centre, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm</affiliation>
			<description>orcid.org=0000-0003-4263-8080</description>
			<description>diva-portal.org=authority-person:64232</description>
		</name>
		<name type="personal">
			<namePart type="family">Hasson</namePart>
			<namePart type="given">Henna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Agreement of Safety Climate</title>
			<subTitle>Does it Affect Employees' and Managers' Health and Work Performance?</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Lippincott Williams &amp; Wilkins</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-03T12:35:45</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162900</identifier>
		<identifier type="doi">10.1097/JOM.0000000000001542</identifier>
		<identifier type="pmid">30946697</identifier>
		<identifier type="isi">000480777300003</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>agreement</topic>
		</subject>
		<subject lang="eng">
			<topic>health</topic>
		</subject>
		<subject lang="eng">
			<topic>safety climate</topic>
		</subject>
		<subject lang="eng">
			<topic>work performance</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30303">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Occupational Health and Environmental Health</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30303">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Arbetsmedicin och miljömedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Objective: To investigate whether agreement and disagreement between teams and their managers on safety climate relates to their health and work performance. Methods: Questionnaire ratings of 47 managers and 211 employees on safety climate and self-rated health, stress, work ability, and work performance were analyzed using polynomial regression with response surface analyses. Results: Teams' stress was lower when there was agreement between the team and the manager on safety climate, and their work performance was lower when the manager rated safety climate higher than the team did. Managers' health, but not their work performance, was higher for managers who were in agreement with their teams. Conclusions: Agreement between managers and teams on safety climate was related to both employee and manager health outcomes. Disagreement (managers' ratings higher than teams') was negatively related to employee work performance.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Occupational and Environmental Medicine</title>
			</titleInfo>
			<identifier type="issn">1076-2752</identifier>
			<identifier type="eissn">1536-5948</identifier>
			<part>
				<detail type="volume">
					<number>61</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>E125</start>
					<end>E131</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-03</recordCreationDate>
			<recordChangeDate>2019-09-03</recordChangeDate>
			<recordIdentifier>diva2:1348093</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Howell</namePart>
			<namePart type="given">Matthew</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="alal0027">
			<namePart type="family">Aliashkevich</namePart>
			<namePart type="given">Alena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<description>diva-portal.org=authority-person:67888</description>
		</name>
		<name type="personal">
			<namePart type="family">Sundararajan</namePart>
			<namePart type="given">Kousik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Daniel</namePart>
			<namePart type="given">Jeremy J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lariviere</namePart>
			<namePart type="given">Patrick J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goley</namePart>
			<namePart type="given">Erin D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="feca0003">
			<namePart type="family">Cava</namePart>
			<namePart type="given">Felipe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<description>diva-portal.org=authority-person:62587</description>
		</name>
		<name type="personal">
			<namePart type="family">Brown</namePart>
			<namePart type="given">Pamela J. B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5051">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå Centre for Microbial Research (UCMR)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>&lt;em&gt;Agrobacterium tumefaciens&lt;/em&gt; divisome proteins regulate the transition from polar growth to cell division</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Wiley-Blackwell Publishing Inc.</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-05-27T14:44:26</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158586</identifier>
		<identifier type="doi">10.1111/mmi.14212</identifier>
		<identifier type="pmid">30693575</identifier>
		<identifier type="isi">000464655800015</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30109">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Microbiology in the medical area</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30109">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Mikrobiologi inom det medicinska området</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The mechanisms that restrict peptidoglycan biosynthesis to the pole during elongation and re-direct peptidoglycan biosynthesis to mid-cell during cell division in polar-growing Alphaproteobacteria are largely unknown. Here, we explore the role of early division proteins of Agrobacterium tumefaciens including three FtsZ homologs, FtsA and FtsW in the transition from polar growth to mid-cell growth and ultimately cell division. Although two of the three FtsZ homologs localize to mid-cell, exhibit GTPase activity and form co-polymers, only one, FtsZ(AT), is required for cell division. We find that FtsZ(AT) is required not only for constriction and cell separation, but also for initiation of peptidoglycan synthesis at mid-cell and cessation of polar peptidoglycan biosynthesis. Depletion of FtsZ(AT) in A. tumefaciens causes a striking phenotype: cells are extensively branched and accumulate growth active poles through tip splitting events. When cell division is blocked at a later stage by depletion of FtsA or FtsW, polar growth is terminated and ectopic growth poles emerge from mid-cell. Overall, this work suggests that A. tumefaciens FtsZ makes distinct contributions to the regulation of polar growth and cell division.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Molecular Microbiology</title>
			</titleInfo>
			<identifier type="issn">0950-382X</identifier>
			<identifier type="eissn">1365-2958</identifier>
			<part>
				<detail type="volume">
					<number>111</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>1074</start>
					<end>1092</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-05-27</recordCreationDate>
			<recordChangeDate>2019-05-27</recordChangeDate>
			<recordIdentifier>diva2:1318343</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="ulffog87">
			<namePart type="family">Forsberg</namePart>
			<namePart type="given">Ulf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0002-3581-5678</description>
			<description>diva-portal.org=authority-person:66034</description>
		</name>
		<name type="personal" authority="umu" xlink:href="pejo0078">
			<namePart type="family">Jonsson</namePart>
			<namePart type="given">Per</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:66033</description>
		</name>
		<name type="personal" authority="umu" xlink:href="best0006">
			<namePart type="family">Stegmayr</namePart>
			<namePart type="given">Bernd</namePart>
			<namePart type="date">1949-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0003-2694-7035</description>
			<description>diva-portal.org=authority-person:62791</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Air contamination during medical treatment results in deposits of microemboli in the lungs</title>
			<subTitle>an autopsy study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-13T11:44:14</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162833</identifier>
		<identifier type="doi">10.1177/0391398819840363</identifier>
		<identifier type="pmid">30973284</identifier>
		<identifier type="isi">000480759400001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Microbubbles</topic>
		</subject>
		<subject lang="eng">
			<topic>microemboli</topic>
		</subject>
		<subject lang="eng">
			<topic>hemodialysis</topic>
		</subject>
		<subject lang="eng">
			<topic>pulmonary fibrosis</topic>
		</subject>
		<subject lang="eng">
			<topic>air bubbles</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30402">
			<topic>Medical and Health Sciences</topic>
			<topic>Medical Biotechnology</topic>
			<topic>Biomedical Laboratory Science/Technology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30402">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinsk bioteknologi</topic>
			<topic>Biomedicinsk laboratorievetenskap/teknologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30299">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Other Clinical Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30299">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Annan klinisk medicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Introduction: Microbubbles of air may enter into patients during conventional hemodialysis, infusions of fluids, or by injections. The aim of this study was to investigate whether the air that enters the patient during hemodialysis can be detected in the lungs after death, and if so, whether this may be related to tissue damage. Methods: The material consisted of lung tissue from five chronic hemodialysis patients who died either during (two) or after hemodialysis (range 10 min from start until 3333 min after the last hemodialysis session); as reference group tissue was taken from seven patients who died due to amyotrophic lateral sclerosis. The lung tissue was investigated by microscopy after autopsy using a fluorescein-marked polyclonal antibody against fibrinogen as a marker for clots preformed before death. Results: All five hemodialysis patients had microbubbles of air in the lung tissue, whereas two of seven amyotrophic lateral sclerosis patients had such findings (Fisher's test p = 0.0278, relative risk = 3.5, confidence interval: 1.08-11.3). There were more microbubbles of air/10 randomly investigated microscopic fields of tissue in the hemodialysis patients than the amyotrophic lateral sclerosis patients (Student's test, p &amp;lt; 0.05). All hemodialysis patients had a medium graded extent of pulmonary fibrosis that was not found in any of the ALS patients. The microbubbles of air were surrounded by fibrin as a sign of development of clots around the air bubbles while the patients were still alive. Conclusion: Exposure to microbubbles of air during various treatments such as hemodialysis may result in microemboli. Future studies should clarify whether microbubbles of air contribute to tissue scarring. We suggest preventive measures against the exposure to microbubbles of air during especially repeated exposures such as hemodialysis.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Artificial Organs</title>
			</titleInfo>
			<identifier type="issn">0391-3988</identifier>
			<identifier type="eissn">1724-6040</identifier>
			<part>
				<detail type="volume">
					<number>42</number>
				</detail>
				<detail type="issue">
					<number>9</number>
				</detail>
				<extent>
					<start>477</start>
					<end>481</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-13</recordCreationDate>
			<recordChangeDate>2019-09-13</recordChangeDate>
			<recordIdentifier>diva2:1351119</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="czad0002">
			<namePart type="family">Adamiak</namePart>
			<namePart type="given">Czeslaw</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för geografi</affiliation>
			<affiliation>Department of Spatial Planning and Tourism, Faculty of Earth Sciences, Nicolaus Copernicus University, 87-100 Toruń, Poland</affiliation>
			<description>diva-portal.org=authority-person:72082</description>
		</name>
		<name type="personal">
			<namePart type="family">Szyda</namePart>
			<namePart type="given">Barbara</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dubownik</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Alvarez</namePart>
			<namePart type="given">David</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881251">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för geografi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Airbnb Offer in Spain-Spatial Analysis of the Pattern and Determinants of Its Distribution</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-29T08:46:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158382</identifier>
		<identifier type="doi">10.3390/ijgi8030155</identifier>
		<identifier type="isi">000464232600003</identifier>
		<identifier type="articleId">155</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/ijgi8030155</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>peer-to-peer accommodation</topic>
		</subject>
		<subject lang="eng">
			<topic>sharing economy</topic>
		</subject>
		<subject lang="eng">
			<topic>collaborative economy</topic>
		</subject>
		<subject lang="eng">
			<topic>Airbnb</topic>
		</subject>
		<subject lang="eng">
			<topic>residential tourism</topic>
		</subject>
		<subject lang="eng">
			<topic>cond homes</topic>
		</subject>
		<subject lang="eng">
			<topic>Spain</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50202">
			<topic>Social Sciences</topic>
			<topic>Economics and Business</topic>
			<topic>Business Administration</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50202">
			<topic>Samhällsvetenskap</topic>
			<topic>Ekonomi och näringsliv</topic>
			<topic>Företagsekonomi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The rising number of homes and apartments rented out through Airbnb and similar peer-to-peer accommodation platforms cause concerns about the impact of such activity on the tourism sector and property market. To date, spatial analysis on peer-to-peer rental activity has been usually limited in scope to individual large cities. In this study, we take into account the whole territory of Spain, with special attention given to cities and regions with high tourist activity. We use a dataset of about 250 thousand Airbnb listings in Spain obtained from the Airbnb webpage, aggregate the numbers of these offers in 8124 municipalities and 79 tourist areas/sites, measure their concentration, spatial autocorrelation, and develop regression models to find the determinants of Airbnb rentals' distribution. We conclude that apart from largest cities, Airbnb is active in holiday destinations of Spain, where it often serves as an intermediary for the rental of second or investment homes and apartments. The location of Airbnb listings is mostly determined by the supply of empty or secondary dwellings, distribution of traditional tourism accommodation, coastal location, and the level of internationalization of tourism demand.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>ISPRS International Journal of Geo-Information</title>
			</titleInfo>
			<identifier type="issn">2220-9964</identifier>
			<part>
				<detail type="volume">
					<number>8</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1307643/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>bonnym04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-29</recordCreationDate>
			<recordChangeDate>2019-04-29</recordChangeDate>
			<recordIdentifier>diva2:1307643</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="ruma0001">
			<namePart type="family">Mannelqvist</namePart>
			<namePart type="given">Ruth</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Juridiska institutionen</affiliation>
			<description>orcid.org=0000-0002-1710-7723</description>
			<description>diva-portal.org=authority-person:64233</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="840">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Juridiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="swe">
			<title>Aktivitetsersättning och arbetsförmåga</title>
			<subTitle>Bristande aktivitet och hypotetiska bedömningar</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">swe</languageTerm>
		</language>
		<originInfo>
			<publisher>Socialmedicinsk tidskrift</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-10T18:34:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166089</identifier>
		<location>
			<url displayLabel="URL" note="free">http://socialmedicinsktidskrift.se/index.php/smt/article/view/2033</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="swe">
			<topic>sjukförsäkring</topic>
		</subject>
		<subject lang="swe">
			<topic>aktivitetsersättning</topic>
		</subject>
		<subject lang="swe">
			<topic>arbetsförmåga</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50501">
			<topic>Social Sciences</topic>
			<topic>Law</topic>
			<topic>Law (excluding Law and Society)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50501">
			<topic>Samhällsvetenskap</topic>
			<topic>Juridik</topic>
			<topic>Juridik (exklusive juridik och samhälle)</topic>
		</subject>
		<relatedItem type="host">
			<titleInfo>
				<title>Socialmedicinsk Tidskrift</title>
			</titleInfo>
			<identifier type="issn">0037-833X</identifier>
			<part>
				<detail type="volume">
					<number>96</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>655</start>
					<end>664</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Forte, Forskningsrådet för hälsa, arbetsliv och välfärd</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1377061/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>ruma0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-10</recordCreationDate>
			<recordChangeDate>2019-12-11</recordChangeDate>
			<recordIdentifier>diva2:1377061</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Wilson</namePart>
			<namePart type="given">Lauren E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-5953-2293</description>
		</name>
		<name type="personal">
			<namePart type="family">Xu</namePart>
			<namePart type="given">Zongli</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="soha0105">
			<namePart type="family">Harlid</namePart>
			<namePart type="given">Sophia</namePart>
			<namePart type="date">1978-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<description>orcid.org=0000-0001-8540-6891</description>
			<description>diva-portal.org=authority-person:66892</description>
		</name>
		<name type="personal">
			<namePart type="family">White</namePart>
			<namePart type="given">Alexandra J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Troester</namePart>
			<namePart type="given">Melissa A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sandler</namePart>
			<namePart type="given">Dale P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Taylor</namePart>
			<namePart type="given">Jack A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="778">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<namePart>Onkologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Alcohol and DNA Methylation</title>
			<subTitle>An Epigenome-Wide Association Study in Blood and Normal Breast Tissue</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-07-26T10:57:12</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161732</identifier>
		<identifier type="doi">10.1093/aje/kwz032</identifier>
		<identifier type="pmid">30938765</identifier>
		<identifier type="isi">000473760200008</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>alcohol consumption</topic>
		</subject>
		<subject lang="eng">
			<topic>breast cancer</topic>
		</subject>
		<subject lang="eng">
			<topic>DNA methylation</topic>
		</subject>
		<subject lang="eng">
			<topic>epigenome-wide association study</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30107">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Medical Genetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30107">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Medicinsk genetik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The biological mechanisms driving associations between alcohol consumption and chronic diseases might include epigenetic modification of DNA methylation. We explored the hypothesis that alcohol consumption is associated with methylation in an epigenome-wide association study of blood and normal breast tissue DNA. Infinium HumanMethylation450 BeadChip (Illumina Inc., San Diego, California) array data on blood DNA methylation was examined in a discovery set of 2,878 non-Hispanic white women from the Sister Study (United States, 2004-2015) who provided detailed questionnaire information on lifetime alcohol use. Robust linear regression modeling was used to identify significant associations (false discovery rate of Q &amp;lt; 0.05) between the number of alcoholic drinks per week and DNA methylation at 5,458 cytosine-phosphate-guanine (CpG) sites. Associations were replicated (P &amp;lt; 0.05) for 677 CpGs in an independent set of 187 blood DNA samples from the Sister Study and for 628 CpGs in an independent set of 171 normal breast DNA samples; 1,207 CpGs were replicated in either blood or normal breast, with 98 CpGs replicated in both tissues. Individual gene effects were notable for phosphoglycerate dehydrogenase (PGHDH), peptidyl-prolyl cis-trans isomerase (PPIF), solute carrier 15 (SLC15), solute carrier family 43 member 1 (SLC43A1), and solute carrier family 7 member 11 (SLC7A11). We also found that high alcohol consumption was associated with significantly lower global methylation as measured by the average of CpGs on the entire array.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>American Journal of Epidemiology</title>
			</titleInfo>
			<identifier type="issn">0002-9262</identifier>
			<identifier type="eissn">1476-6256</identifier>
			<part>
				<detail type="volume">
					<number>188</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
				<extent>
					<start>1055</start>
					<end>1065</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-07-26</recordCreationDate>
			<recordChangeDate>2019-07-26</recordChangeDate>
			<recordIdentifier>diva2:1339172</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="mnajon03">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Magdalena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Skellefteå Research Unit</affiliation>
			<description>diva-portal.org=authority-person:63731</description>
		</name>
		<name type="corporate">
			<namePart>Skellefteå Research Unit</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="lasjon01">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Skellefteå Research Unit</affiliation>
			<description>diva-portal.org=authority-person:63732</description>
		</name>
		<name type="corporate">
			<namePart>Skellefteå Research Unit</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mawe0024">
			<namePart type="family">Wennberg</namePart>
			<namePart type="given">Maria</namePart>
			<namePart type="date">1974-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Näringsforskning</affiliation>
			<description>diva-portal.org=authority-person:63597</description>
		</name>
		<name type="personal" authority="umu" xlink:href="maslid94">
			<namePart type="family">Lind</namePart>
			<namePart type="given">Marcus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Skellefteå Research unit</affiliation>
			<description>orcid.org=0000-0003-4423-4135</description>
			<description>diva-portal.org=authority-person:63733</description>
		</name>
		<name type="corporate">
			<namePart>Skellefteå Research unit</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="731">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Näringsforskning</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Alcohol Consumption and Risk of First-Time Venous Thromboembolism in Men and Women</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Georg Thieme Verlag KG</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-24T11:25:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157495</identifier>
		<identifier type="doi">10.1055/s-0039-1681100</identifier>
		<identifier type="pmid">30900224</identifier>
		<identifier type="isi">000474924300013</identifier>
		<identifier type="scopus">2-s2.0-85066132287</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>venous thromboembolism</topic>
		</subject>
		<subject lang="eng">
			<topic>venous thrombosis</topic>
		</subject>
		<subject lang="eng">
			<topic>alcohol consumption</topic>
		</subject>
		<subject lang="eng">
			<topic>alcohol intake</topic>
		</subject>
		<subject lang="eng">
			<topic>alcohol drinking</topic>
		</subject>
		<subject lang="eng">
			<topic>alcohol dependence</topic>
		</subject>
		<subject lang="eng">
			<topic>risk marker</topic>
		</subject>
		<subject lang="eng">
			<topic>prospective studies</topic>
		</subject>
		<subject lang="eng">
			<topic>cohort studies</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30299">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Other Clinical Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30299">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Annan klinisk medicin</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2104">
			<topic>Medicine</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2104">
			<topic>medicin</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;&lt;strong&gt;BACKGROUND:&lt;/strong&gt; The relationship between alcohol intake and risk of venous thromboembolism (VTE) is unclear. Men and women differ in their drinking habits, which may affect a possible association.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;OBJECTIVE:&lt;/strong&gt; This article investigates the association between alcohol consumption, alcohol dependence and VTE in the total population as well as in men and women separately.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;METHODS: &lt;/strong&gt;We performed a prospective, population-based cohort study in northern Sweden. Study participants were 108,025 (51% women) persons aged 30 to 60 years who underwent a health examination between 1985 and 2014. We assessed alcohol consumption and defined alcohol dependence using a questionnaire. The outcome was a validated first-time VTE.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;RESULTS:&lt;/strong&gt; The mean follow-up time was 13.9 years, and 2,054 participants had a first-time VTE. The mean alcohol consumption was 3.5 standard drinks weekly in men and 1.5 in women. Alcohol dependence was found in 10% of men and 3% of women. There was an association between alcohol consumption (hazard ratio [HR], 1.02; 95% confidence interval [CI], 1.00-1.03 per standard drink weekly) as well as alcohol dependence (HR, 1.27; 95% CI, 1.06-1.52) and VTE after adjustments. In men, the risk of VTE increased over quartiles of weekly alcohol consumption (&lt;em&gt;p&lt;/em&gt; for trend 0.02), with a HR of 1.22 (95% CI, 1.01-1.47) for the highest quartile. Alcohol dependence was associated with VTE in men (HR, 1.30; 95% CI, 1.07-1.59). In women, there were no significant associations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;CONCLUSION:&lt;/strong&gt; High alcohol consumption and alcohol dependence were associated with increased risk of first-time VTE in men, but not in women.&lt;/p&gt;</abstract>
		<note type="project">Venous thromboEmbolism In Northern Sweden</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Thrombosis and Haemostasis</title>
			</titleInfo>
			<identifier type="issn">0340-6245</identifier>
			<part>
				<detail type="volume">
					<number>119</number>
				</detail>
				<detail type="issue">
					<number>6</number>
				</detail>
				<extent>
					<start>962</start>
					<end>970</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Forte, Forskningsrådet för hälsa, arbetsliv och välfärd</note>
		<note type="funder">Västerbottens läns landsting</note>
		<recordInfo>
			<recordOrigin>mnajon03</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-24</recordCreationDate>
			<recordChangeDate>2019-09-09</recordChangeDate>
			<recordIdentifier>diva2:1298519</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Hildebrand Karlén</namePart>
			<namePart type="given">Malin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lindqvist Bagge</namePart>
			<namePart type="given">Ann-Sophie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fahlke</namePart>
			<namePart type="given">Claudia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="kear0001">
			<namePart type="family">Armelius</namePart>
			<namePart type="given">Kerstin</namePart>
			<namePart type="date">1944-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>diva-portal.org=authority-person:63183</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Alcohol intoxicated witnesses' interpretation of social behavior in intimate partner violence</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-06T13:25:37</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161923</identifier>
		<identifier type="doi">10.1002/acp.3505</identifier>
		<identifier type="isi">000475404200003</identifier>
		<identifier type="scopus">2-s2.0-85059076596</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>aggression</topic>
		</subject>
		<subject lang="eng">
			<topic>alcohol intoxication</topic>
		</subject>
		<subject lang="eng">
			<topic>antisocial behavior</topic>
		</subject>
		<subject lang="eng">
			<topic>eyewitness</topic>
		</subject>
		<subject lang="eng">
			<topic>social behavior</topic>
		</subject>
		<subject lang="eng">
			<topic>violence</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50102">
			<topic>Social Sciences</topic>
			<topic>Psychology</topic>
			<topic>Applied Psychology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50102">
			<topic>Samhällsvetenskap</topic>
			<topic>Psykologi</topic>
			<topic>Tillämpad psykologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Alcohol intoxication affects social information processing, though research is scarce regarding how alcohol affected eyewitnesses' perception of social interaction within an applied forensic context. In the present study, the effects of alcohol intoxication on eyewitnesses' perception of interaction in intimate partner violence (IPV) were investigated. The participants (&lt;em&gt;n&lt;/em&gt; = 152) were randomized to an experimental (alcohol) or control group (juice). After consumption, they viewed a filmed IPV scenario where both interacting parties were confrontational. Afterwards, they rated the involved parties' behavior. Several behaviors were perceived in a similar manner by intoxicated and sober participants, but intoxicated participants perceived both parties' attacking behaviors and some of the man's prosocial behaviors differently than sober participants. Hence, alcohol affected some, but not all, kinds of social behaviors investigated in the present study. This would be of interest to legal praxis and to future studies on intoxicated witnesses to interpersonal violence.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Applied Cognitive Psychology</title>
			</titleInfo>
			<identifier type="issn">0888-4080</identifier>
			<identifier type="eissn">1099-0720</identifier>
			<part>
				<detail type="volume">
					<number>33</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>468</start>
					<end>479</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-06</recordCreationDate>
			<recordChangeDate>2019-08-06</recordChangeDate>
			<recordIdentifier>diva2:1340792</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="suetan98">
			<namePart type="family">Tafvelin</namePart>
			<namePart type="given">Susanne</namePart>
			<namePart type="date">1975-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>diva-portal.org=authority-person:64232</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anslil01">
			<namePart type="family">Stenling</namePart>
			<namePart type="given">Andreas</namePart>
			<namePart type="date">1982-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>diva-portal.org=authority-person:64150</description>
		</name>
		<name type="personal" authority="umu" xlink:href="rotluk98">
			<namePart type="family">Lundmark</namePart>
			<namePart type="given">Robert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<affiliation>Department of Learning, Informatics, Management and Ethics Karolinska Institutet, Medical Management Centre, Stockholm, Sweden</affiliation>
			<description>orcid.org=0000-0001-9484-6047</description>
			<description>diva-portal.org=authority-person:68118</description>
		</name>
		<name type="personal" authority="umu" xlink:href="krwe0001">
			<namePart type="family">Westerberg</namePart>
			<namePart type="given">Kristina</namePart>
			<namePart type="date">1953-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>diva-portal.org=authority-person:64296</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Aligning job redesign with leadership training to improve supervisor support</title>
			<subTitle>a quasi-experimental study of the integration of HR practices</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Routledge</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-02-20T14:48:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156602</identifier>
		<identifier type="doi">10.1080/1359432X.2018.1541887</identifier>
		<identifier type="isi">000456815300005</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/1359432X.2018.1541887</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>HR practices</topic>
		</subject>
		<subject lang="eng">
			<topic>job redesign</topic>
		</subject>
		<subject lang="eng">
			<topic>leadership training</topic>
		</subject>
		<subject lang="eng">
			<topic>supervisor support</topic>
		</subject>
		<subject lang="eng">
			<topic>intervention mediated effects</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50102">
			<topic>Social Sciences</topic>
			<topic>Psychology</topic>
			<topic>Applied Psychology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50102">
			<topic>Samhällsvetenskap</topic>
			<topic>Psykologi</topic>
			<topic>Tillämpad psykologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;In this quasi-experimental study, we examine the alignment of a job redesign initiative with leadership training aimed at increasing supervisors' opportunities for providing support to employees. In addition, we examine intervention-mediated effects on climate for innovation through increases in perceived supervisor support. To test the hypothesized process, we used employee ratings (N = 524) of perceived supervisor support and climate for innovation collected at three time points over 2 years in the home help services in seven Swedish municipalities. Results of latent growth curve analyses showed that employees in the intervention group had a stronger and positive slope of perceived supervisor support relative to the comparison group. Further, the growth trajectories of perceived supervisor support were positively associated with climate for innovation at the 24-month follow-up. The study contributes to the human resource management literature by showing that alignment of employment practices such as training with work practices such as job redesign may be a promising strategy for achieving positive outcomes at multiple levels in organizations.&lt;/p&gt;</abstract>
		<note type="project">Bio4Energy</note>
		<relatedItem type="host">
			<titleInfo>
				<title>European Journal of Work and Organizational Psychology</title>
			</titleInfo>
			<identifier type="issn">1359-432X</identifier>
			<identifier type="eissn">1464-0643</identifier>
			<part>
				<detail type="volume">
					<number>28</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>74</start>
					<end>84</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Forte, Forskningsrådet för hälsa, arbetsliv och välfärd [2014-073]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1290418/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-02-20</recordCreationDate>
			<recordChangeDate>2019-09-06</recordChangeDate>
			<recordIdentifier>diva2:1290418</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="liaern01">
			<namePart type="family">Eriksson</namePart>
			<namePart type="given">Linda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>diva-portal.org=authority-person:68030</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anes0001">
			<namePart type="family">Esberg</namePart>
			<namePart type="given">Anders</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>orcid.org=0000-0002-4430-8125</description>
			<description>diva-portal.org=authority-person:63842</description>
		</name>
		<name type="personal">
			<namePart type="family">Haworth</namePart>
			<namePart type="given">Simon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="pealin91">
			<namePart type="family">Lif Holgerson</namePart>
			<namePart type="given">Pernilla</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>orcid.org=0000-0002-2779-5865</description>
			<description>diva-portal.org=authority-person:64471</description>
		</name>
		<name type="personal" authority="umu" xlink:href="injo0003">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Ingegerd</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för odontologi</affiliation>
			<description>orcid.org=0000-0002-9227-8434</description>
			<description>diva-portal.org=authority-person:63135</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="754">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för odontologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Allelic Variation in Taste Genes Is Associated with Taste and Diet Preferences and Dental Caries</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-29T16:02:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162681</identifier>
		<identifier type="doi">10.3390/nu11071491</identifier>
		<identifier type="pmid">31261961</identifier>
		<identifier type="isi">000478885400090</identifier>
		<identifier type="articleId">1491</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/nu11071491</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>taste perception</topic>
		</subject>
		<subject lang="eng">
			<topic>taste preference</topic>
		</subject>
		<subject lang="eng">
			<topic>taste genes</topic>
		</subject>
		<subject lang="eng">
			<topic>diet preference</topic>
		</subject>
		<subject lang="eng">
			<topic>diet selection</topic>
		</subject>
		<subject lang="eng">
			<topic>caries</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30304">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nutrition and Dietetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30304">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Näringslära</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30216">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Dentistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30216">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Odontologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Taste and diet preferences are complex and influenced by both environmental and host traits while affecting both food selection and associated health outcomes. The present study genotyped 94 single nucleotide polymorphisms (SNPs) in previously reported taste and food intake related genes and assessed associations with taste threshold (TT) and preferred intensity (PT) of sweet, sour and bitter, food preferences, habitual diet intake, and caries status in healthy young Swedish men and women (n = 127). Polymorphisms in the GNAT3, SLC2A4, TAS1R1 and TAS1R2 genes were associated with variation in TT and PT for sweet taste as well as sweet food intake. Increasing PT for sweet was associated with increasing preference and intake of sugary foods. Similarly, increasing TT for sour was associated with increasing intake of sour foods, whereas the associations between food preference/intake and TT/PT for bitter was weak in this study group. Finally, allelic variation in the GNAT3, SLC2A2, SLC2A4, TAS1R1 and TAS1R2 genes was associated with caries status, whereas TT, PT and food preferences were not. It was concluded that variations in taste receptor, glucose transporter and gustducin encoding genes are related to taste perception, food preference and intake as well as the sugar-dependent caries disease.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Nutrients</title>
			</titleInfo>
			<identifier type="issn">2072-6643</identifier>
			<identifier type="eissn">2072-6643</identifier>
			<part>
				<detail type="volume">
					<number>11</number>
				</detail>
				<detail type="issue">
					<number>7</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1346999/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-29</recordCreationDate>
			<recordChangeDate>2019-08-29</recordChangeDate>
			<recordIdentifier>diva2:1346999</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Bousquet</namePart>
			<namePart type="given">Jean</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hellings</namePart>
			<namePart type="given">Peter W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Agache</namePart>
			<namePart type="given">Ioana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amat</namePart>
			<namePart type="given">Flore</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Annesi-Maesano</namePart>
			<namePart type="given">Isabella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ansotegui</namePart>
			<namePart type="given">Ignacio J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Anto</namePart>
			<namePart type="given">Josep M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bachert</namePart>
			<namePart type="given">Claus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bateman</namePart>
			<namePart type="given">Eric D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bedbrook</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bennoor</namePart>
			<namePart type="given">Kazi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bewick</namePart>
			<namePart type="given">Mickael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bindslev-Jensen</namePart>
			<namePart type="given">Carsten</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8940-038X</description>
		</name>
		<name type="personal">
			<namePart type="family">Bosnic-Anticevich</namePart>
			<namePart type="given">Sinthia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bosse</namePart>
			<namePart type="given">Isabelle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brozek</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brussino</namePart>
			<namePart type="given">Luisa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Canonica</namePart>
			<namePart type="given">Giorgio W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cardona</namePart>
			<namePart type="given">Victoria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2197-9767</description>
		</name>
		<name type="personal">
			<namePart type="family">Casale</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sarabia</namePart>
			<namePart type="given">Alfonso M. Cepeda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chavannes</namePart>
			<namePart type="given">Niels H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8607-9199</description>
		</name>
		<name type="personal">
			<namePart type="family">Cecchi</namePart>
			<namePart type="given">Lorenzo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0658-2449</description>
		</name>
		<name type="personal">
			<namePart type="family">de Sousa</namePart>
			<namePart type="given">Jaime Correia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-6459-7908</description>
		</name>
		<name type="personal">
			<namePart type="family">Costa</namePart>
			<namePart type="given">Elisio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1158-1480</description>
		</name>
		<name type="personal">
			<namePart type="family">Cruz</namePart>
			<namePart type="given">Alvaro A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Czarlewski</namePart>
			<namePart type="given">Wienczyslawa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Carlo</namePart>
			<namePart type="given">Giuseppe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Feo</namePart>
			<namePart type="given">Giulia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Demoly</namePart>
			<namePart type="given">Pascal</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Devillier</namePart>
			<namePart type="given">Philippe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dykewicz</namePart>
			<namePart type="given">Mark S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">El-Gamal</namePart>
			<namePart type="given">Yehia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Eller</namePart>
			<namePart type="given">Esben E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fonseca</namePart>
			<namePart type="given">Joao A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0887-8796</description>
		</name>
		<name type="personal">
			<namePart type="family">Fontaine</namePart>
			<namePart type="given">Jean-Francois</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fokkens</namePart>
			<namePart type="given">Wytske J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guzman</namePart>
			<namePart type="given">Maria-Antonieta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Haahtela</namePart>
			<namePart type="given">Tari</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Illario</namePart>
			<namePart type="given">Maddalena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ivancevich</namePart>
			<namePart type="given">Juan-Carlos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Just</namePart>
			<namePart type="given">Jocelyne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaidashev</namePart>
			<namePart type="given">Igor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-4708-0859</description>
		</name>
		<name type="personal">
			<namePart type="family">Khaitov</namePart>
			<namePart type="given">Musa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-4961-9640</description>
		</name>
		<name type="personal">
			<namePart type="family">Kalayci</namePart>
			<namePart type="given">Omer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keil</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klimek</namePart>
			<namePart type="given">Ludger</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kowalski</namePart>
			<namePart type="given">Marek L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuna</namePart>
			<namePart type="given">Piotr</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kvedariene</namePart>
			<namePart type="given">Violeta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larenas-Linnemann</namePart>
			<namePart type="given">Desiree</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laune</namePart>
			<namePart type="given">Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Le</namePart>
			<namePart type="given">Lan T. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carlsen</namePart>
			<namePart type="given">Karin Lodrup</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lourenco</namePart>
			<namePart type="given">Olga</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8401-5976</description>
		</name>
		<name type="personal">
			<namePart type="family">Mahboub</namePart>
			<namePart type="given">Bassam</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mair</namePart>
			<namePart type="given">Alpana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Menditto</namePart>
			<namePart type="given">Enrica</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Milenkovic</namePart>
			<namePart type="given">Branislava</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morais-Almeida</namePart>
			<namePart type="given">Mario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mosges</namePart>
			<namePart type="given">Ralph</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mullol</namePart>
			<namePart type="given">Joaquim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Murray</namePart>
			<namePart type="given">Ruth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Naclerio</namePart>
			<namePart type="given">Robert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Namazova-Baranova</namePart>
			<namePart type="given">Leyla</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-7902-6427</description>
		</name>
		<name type="personal">
			<namePart type="family">Novellino</namePart>
			<namePart type="given">Ettore</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">O'Hehir</namePart>
			<namePart type="given">Robyn E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-3489-7595</description>
		</name>
		<name type="personal">
			<namePart type="family">Ohta</namePart>
			<namePart type="given">Ken</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Okamoto</namePart>
			<namePart type="given">Yoshitaka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Okubo</namePart>
			<namePart type="given">Kimi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Onorato</namePart>
			<namePart type="given">Gabrielle L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palkonen</namePart>
			<namePart type="given">Susanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panzner</namePart>
			<namePart type="given">Petr</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-1291-450X</description>
		</name>
		<name type="personal">
			<namePart type="family">Papadopoulos</namePart>
			<namePart type="given">Nikos G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Park</namePart>
			<namePart type="given">Hae-Sim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Paulino</namePart>
			<namePart type="given">Ema</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pawankar</namePart>
			<namePart type="given">Ruby</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pfaar</namePart>
			<namePart type="given">Oliver</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Plavec</namePart>
			<namePart type="given">Davor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2020-8119</description>
		</name>
		<name type="personal">
			<namePart type="family">Popov</namePart>
			<namePart type="given">Ted A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Potter</namePart>
			<namePart type="given">Paul</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Prokopakis</namePart>
			<namePart type="given">Emmanuel P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rottem</namePart>
			<namePart type="given">Menachem</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ryan</namePart>
			<namePart type="given">Dermot</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Salimaki</namePart>
			<namePart type="given">Johanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Samolinski</namePart>
			<namePart type="given">Boleslaw</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sanchez-Borges</namePart>
			<namePart type="given">Mario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schunemann</namePart>
			<namePart type="given">Holger J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sheikh</namePart>
			<namePart type="given">Aziz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-7022-3056</description>
		</name>
		<name type="personal">
			<namePart type="family">Sisul</namePart>
			<namePart type="given">Juan-Carlos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rajabian-Soderlund</namePart>
			<namePart type="given">Rojin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sooronbaev</namePart>
			<namePart type="given">Talant</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stellato</namePart>
			<namePart type="given">Cristiana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-1294-8355</description>
		</name>
		<name type="personal">
			<namePart type="family">To</namePart>
			<namePart type="given">Teresa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Todo-Bom</namePart>
			<namePart type="given">Ana-Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tomazic</namePart>
			<namePart type="given">Peter-Valentin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Toppila-Salmi</namePart>
			<namePart type="given">Sanna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valero</namePart>
			<namePart type="given">Antonio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valiulis</namePart>
			<namePart type="given">Arunas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valovirta</namePart>
			<namePart type="given">Erkka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ventura</namePart>
			<namePart type="given">Maria-Teresa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wagenmann</namePart>
			<namePart type="given">Martin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">De Yun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wallace</namePart>
			<namePart type="given">Dana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waserman</namePart>
			<namePart type="given">Susan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wickman</namePart>
			<namePart type="given">Magnus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yorgancioglu</namePart>
			<namePart type="given">Arzu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Luo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhong</namePart>
			<namePart type="given">Nanshan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zidarn</namePart>
			<namePart type="given">Mihaela</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zuberbier</namePart>
			<namePart type="given">Torsten</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bousquet</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hellings</namePart>
			<namePart type="given">P. W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aberer</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Agache</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Akdis</namePart>
			<namePart type="given">C. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Akdis</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Alberti</namePart>
			<namePart type="given">M. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Almeida</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amat</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Angles</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Annesi-Maesano</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ansotegui</namePart>
			<namePart type="given">I. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Anto</namePart>
			<namePart type="given">J. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arnavielle</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Asayag</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Asarnoj</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Arshad</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Avolio</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bacci</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bachert</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Baiardini</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barbara</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barbagallo</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Baroni</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barreto</namePart>
			<namePart type="given">B. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Basagana</namePart>
			<namePart type="given">X.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bateman</namePart>
			<namePart type="given">E. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bedolla-Barajas</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bedbrook</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bewick</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beghe</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bel</namePart>
			<namePart type="given">E. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bergmann</namePart>
			<namePart type="given">K. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bennoor</namePart>
			<namePart type="given">K. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Benson</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bertorello</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Biaoszewski</namePart>
			<namePart type="given">A. Z.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bieber</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bialek</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bindslev-Jensen</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bjermer</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blain</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blasi</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blua</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marciniak</namePart>
			<namePart type="given">M. Bochenska</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bogus-Buczynska</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boner</namePart>
			<namePart type="given">A. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bonini</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bonini</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bosnic-Anticevich</namePart>
			<namePart type="given">C. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bosse</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bouchard</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boulet</namePart>
			<namePart type="given">L. P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bourret</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bousquet</namePart>
			<namePart type="given">P. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Braido</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Briedis</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brightling</namePart>
			<namePart type="given">C. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brozek</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bucca</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Buhl</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Buonaiuto</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panaitescu</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cabanas</namePart>
			<namePart type="given">M. T. Burguete</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Burte</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bush</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Caballero-Fonseca</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Caillot</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Caimmi</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Calderon</namePart>
			<namePart type="given">M. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Camargos</namePart>
			<namePart type="given">P. A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Camuzat</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Canfora</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Canonica</namePart>
			<namePart type="given">G. W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cardona</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carlsen</namePart>
			<namePart type="given">K. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carreiro-Martins</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carriazo</namePart>
			<namePart type="given">A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carr</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cartier</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Casale</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Castellano</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cecchi</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sarabia</namePart>
			<namePart type="given">A. M. Cepeda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chavannes</namePart>
			<namePart type="given">N. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chiron</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chivato</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chkhartishvili</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chuchalin</namePart>
			<namePart type="given">A. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chung</namePart>
			<namePart type="given">K. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ciaravolo</namePart>
			<namePart type="given">M. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ciceran</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cingi</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ciprandi</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Coehlo</namePart>
			<namePart type="given">A. C. Carvalho</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Colas</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Colgan</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Coll</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Conforti</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Sousa</namePart>
			<namePart type="given">J. Correia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cortes-Grimaldo</namePart>
			<namePart type="given">R. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Corti</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Costa</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Costa-Dominguez</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Courbis</namePart>
			<namePart type="given">A. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cox</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Crescenzo</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cruz</namePart>
			<namePart type="given">A. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Custovic</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Czarlewski</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dahlen</namePart>
			<namePart type="given">S. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dario</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">da Silva</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dauvilliers</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Darsow</namePart>
			<namePart type="given">U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Blay</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Carlo</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dedeu</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Emerson</namePart>
			<namePart type="given">M. de Fatima</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Feo</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Vries</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">De Martino</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rubini</namePart>
			<namePart type="given">N. de Paula Motta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Deleanu</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Demoly</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Denburg</namePart>
			<namePart type="given">J. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Devillier</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ercolano</namePart>
			<namePart type="given">S. Di Capua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Di Carluccio</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Didier</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dokic</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dominguez-Silva</namePart>
			<namePart type="given">M. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Douagui</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dray</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dubakiene</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Durham</namePart>
			<namePart type="given">S. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Du Toit</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dykewicz</namePart>
			<namePart type="given">M. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">El-Gamal</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="paek0001">
			<namePart type="family">Eklund</namePart>
			<namePart type="given">Patrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för datavetenskap</affiliation>
			<description>diva-portal.org=authority-person:62859</description>
		</name>
		<name type="personal">
			<namePart type="family">Eller</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Emuzyte</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Farrell</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Farsi</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Mello</namePart>
			<namePart type="given">J. Ferreira, Jr.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ferrero</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fink-Wagner</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fiocchi</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fokkens</namePart>
			<namePart type="given">W. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fonseca</namePart>
			<namePart type="given">J. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fontaine</namePart>
			<namePart type="given">J. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Forti</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fuentes-Perez</namePart>
			<namePart type="given">J. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Galvez-Romero</namePart>
			<namePart type="given">J. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gamkrelidze</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Aymerich</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Cobas</namePart>
			<namePart type="given">C. Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Cruz</namePart>
			<namePart type="given">M. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gemicioglu</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Genova</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Christoff</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gereda</namePart>
			<namePart type="given">J. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Wijk</namePart>
			<namePart type="given">R. Gerth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gomez</namePart>
			<namePart type="given">R. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gomez-Vera</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Diaz</namePart>
			<namePart type="given">S. Gonzalez</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gotua</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Grisle</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guidacci</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guldemond</namePart>
			<namePart type="given">N. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gutter</namePart>
			<namePart type="given">Z.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guzman</namePart>
			<namePart type="given">M. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Haahtela</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hajjam</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hernandez</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hourihane</namePart>
			<namePart type="given">J. O 'B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Huerta-Villalobos</namePart>
			<namePart type="given">Y. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Humbert</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Iaccarino</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Illario</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ivancevich</namePart>
			<namePart type="given">J. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jares</namePart>
			<namePart type="given">E. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jassem</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Johnston</namePart>
			<namePart type="given">S. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Joos</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jung</namePart>
			<namePart type="given">K. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jutel</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaidashev</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kalayci</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kalyoncu</namePart>
			<namePart type="given">A. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Karjalainen</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kardas</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keil</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keith</namePart>
			<namePart type="given">P. K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Khaitov</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Khaltaev</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kleine-Tebbe</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klimek</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kowalski</namePart>
			<namePart type="given">M. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuitunen</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kull</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuna</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kupczyk</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kvedariene</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Krzych-Fata</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lacwik</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larenas-Linnemann</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Laune</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lauri</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lavrut</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Le</namePart>
			<namePart type="given">L. T. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lessa</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Levato</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Li</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lieberman</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lipiec</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lipworth</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Carlsen</namePart>
			<namePart type="given">K. C. Lodrup</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Louis</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lourenco</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Luna-Pech</namePart>
			<namePart type="given">J. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maciej</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Magnan</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mahboub</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maier</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mair</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Majer</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Malva</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mandajieva</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Manning</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keenoy</namePart>
			<namePart type="given">E. De Manuel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marshall</namePart>
			<namePart type="given">G. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Masjedi</namePart>
			<namePart type="given">M. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maspero</namePart>
			<namePart type="given">J. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mathieu-Dupas</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Campos</namePart>
			<namePart type="given">J. J. Matta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Matos</namePart>
			<namePart type="given">A. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maurer</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mavale-Manuel</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mayora</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Medina-Avalos</namePart>
			<namePart type="given">M. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Melen</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Melo-Gomes</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Meltzer</namePart>
			<namePart type="given">E. O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Menditto</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mercier</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Miculinic</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mihaltan</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Milenkovic</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Moda</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mogica-Martinez</namePart>
			<namePart type="given">M. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mohammad</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Momas</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Montefort</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Monti</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bogado</namePart>
			<namePart type="given">D. Mora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morais-Almeida</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morato-Castro</namePart>
			<namePart type="given">F. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mosges</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mota-Pinto</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Santo</namePart>
			<namePart type="given">P. Moura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mullol</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Munter</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Muraro</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Murray</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Naclerio</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nadif</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nalin</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Napoli</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Namazova-Baranova</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Neffen</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Niedeberger</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nekam</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Neou</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nieto</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nogueira-Silva</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nogues</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Novellino</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nyembue</namePart>
			<namePart type="given">T. D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">O'Hehir</namePart>
			<namePart type="given">R. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Odzhakova</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ohta</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Okamoto</namePart>
			<namePart type="given">Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Okubo</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Onorato</namePart>
			<namePart type="given">G. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cisneros</namePart>
			<namePart type="given">M. Ortega</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ouedraogo</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pali-Scholl</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palkonen</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panzner</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Papadopoulos</namePart>
			<namePart type="given">N. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Park</namePart>
			<namePart type="given">H. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Papi</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Passalacqua</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Paulino</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pawankar</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pedersen</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pepin</namePart>
			<namePart type="given">J. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pereira</namePart>
			<namePart type="given">A. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Persico</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pfaar</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Phillips</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Picard</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pigearias</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pin</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pitsios</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Plavec</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pohl</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Popov</namePart>
			<namePart type="given">T. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Portejoie</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Potter</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pozzi</namePart>
			<namePart type="given">A. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Price</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Prokopakis</namePart>
			<namePart type="given">E. P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Puy</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pugin</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ross</namePart>
			<namePart type="given">R. E. Pulido</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Przemecka</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rabe</namePart>
			<namePart type="given">K. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Raciborski</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rajabian-Soderlund</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Reitsma</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ribeirinho</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rimmer</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rivero-Yeverino</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rizzo</namePart>
			<namePart type="given">J. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rizzo</namePart>
			<namePart type="given">M. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Robalo-Cordeiro</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodenas</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodo</namePart>
			<namePart type="given">X.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gonzalez</namePart>
			<namePart type="given">M. Rodriguez</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodriguez-Manas</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rolland</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valle</namePart>
			<namePart type="given">S. Rodrigues</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodriguez</namePart>
			<namePart type="given">M. Roman</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Romano</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rodriguez-Zagal</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rolla</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Roller-Wirnsberger</namePart>
			<namePart type="given">R. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Romano</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rosado-Pinto</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rosario</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rottem</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ryan</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sagara</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Salimaki</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Samolinski</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sanchez-Borges</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sastre-Dominguez</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scadding</namePart>
			<namePart type="given">G. K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schunemann</namePart>
			<namePart type="given">H. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scichilone</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schmid-Grendelmeier</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Serpa</namePart>
			<namePart type="given">F. S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shamai</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sheikh</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sierra</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Simons</namePart>
			<namePart type="given">F. E. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Siroux</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sisul</namePart>
			<namePart type="given">J. C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Skrindo</namePart>
			<namePart type="given">I.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sole</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Somekh</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sondermann</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sooronbaev</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sova</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sorensen</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sorlini</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Spranger</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stellato</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stelmach</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stukas</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sunyer</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Strozek</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Szylling</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tebyrica</namePart>
			<namePart type="given">J. N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thibaudon</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">To</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Todo-Bom</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tomazic</namePart>
			<namePart type="given">P. V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Toppila-Salmi</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Trama</namePart>
			<namePart type="given">U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Triggiani</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ulrik</namePart>
			<namePart type="given">C. Suppli</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Urrutia-Pereira</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valenta</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valero</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valiulis</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valovirta</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Eerd</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Ganse</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Hague</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vandenplas</namePart>
			<namePart type="given">O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ventura</namePart>
			<namePart type="given">M. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vezzani</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vasankari</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vatrella</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Verissimo</namePart>
			<namePart type="given">M. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Viart</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Viegi</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vicheva</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vontetsianos</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wagenmann</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Walker</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wallace</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">D. Y.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waserman</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Werfel</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Westman</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wickman</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Williams</namePart>
			<namePart type="given">D. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Williams</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wilson</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wright</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wroczynski</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yakovliev</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yawn</namePart>
			<namePart type="given">B. P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yiallouros</namePart>
			<namePart type="given">P. K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yorgancioglu</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yusuf</namePart>
			<namePart type="given">O. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zar</namePart>
			<namePart type="given">H. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhong</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zernotti</namePart>
			<namePart type="given">M. E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zidarn</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zuberbier</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zubrinich</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zurkuhlen</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="863">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för datavetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018)</title>
			<subTitle>Change management in allergic rhinitis and asthma multimorbidity using mobile technology</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-21T11:02:42</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162501</identifier>
		<identifier type="doi">10.1016/j.jaci.2018.08.049</identifier>
		<identifier type="pmid">30273709</identifier>
		<identifier type="isi">000460272900005</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Change management</topic>
		</subject>
		<subject lang="eng">
			<topic>rhinitis</topic>
		</subject>
		<subject lang="eng">
			<topic>asthma</topic>
		</subject>
		<subject lang="eng">
			<topic>Allergic Rhinitis and Its Impact on Asthma</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30219">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Respiratory Medicine and Allergy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30219">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Lungmedicin och allergi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Allergy and Clinical Immunology</title>
			</titleInfo>
			<identifier type="issn">0091-6749</identifier>
			<identifier type="eissn">1097-6825</identifier>
			<part>
				<detail type="volume">
					<number>143</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>864</start>
					<end>879</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-21</recordCreationDate>
			<recordChangeDate>2019-08-21</recordChangeDate>
			<recordIdentifier>diva2:1344517</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="heha0026">
			<namePart type="family">Hagman</namePart>
			<namePart type="given">Henrik</namePart>
			<namePart type="date">1980-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<description>diva-portal.org=authority-person:64532</description>
		</name>
		<name type="personal">
			<namePart type="family">Bostrom</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lundberg</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="raba0001">
			<namePart type="family">Backman</namePart>
			<namePart type="given">Rainer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<description>diva-portal.org=authority-person:63792</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="870">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad fysik och elektronik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Alloy degradation in a co-firing biomass CFB vortex finder application at 880 degrees C</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-18T11:40:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157937</identifier>
		<identifier type="doi">10.1016/j.corsci.2019.01.038</identifier>
		<identifier type="isi">000462108000014</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.corsci.2019.01.038</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Na</topic>
		</subject>
		<subject lang="eng">
			<topic>K</topic>
		</subject>
		<subject lang="eng">
			<topic>Cl</topic>
		</subject>
		<subject lang="eng">
			<topic>O-2</topic>
		</subject>
		<subject lang="eng">
			<topic>CO</topic>
		</subject>
		<subject lang="eng">
			<topic>CO2</topic>
		</subject>
		<subject lang="eng">
			<topic>HCl</topic>
		</subject>
		<subject lang="eng">
			<topic>SO2</topic>
		</subject>
		<subject lang="eng">
			<topic>NH3</topic>
		</subject>
		<subject lang="eng">
			<topic>N-2</topic>
		</subject>
		<subject lang="eng">
			<topic>Nitride</topic>
		</subject>
		<subject lang="eng">
			<topic>Carbide</topic>
		</subject>
		<subject lang="eng">
			<topic>Sulfide</topic>
		</subject>
		<subject lang="eng">
			<topic>Oxide</topic>
		</subject>
		<subject lang="eng">
			<topic>Chloride</topic>
		</subject>
		<subject lang="eng">
			<topic>Volatilization</topic>
		</subject>
		<subject lang="eng">
			<topic>Vortex finder</topic>
		</subject>
		<subject lang="eng">
			<topic>CFB boiler</topic>
		</subject>
		<subject lang="eng">
			<topic>High-temperature corrosion</topic>
		</subject>
		<subject lang="eng">
			<topic>Alloy 310S</topic>
		</subject>
		<subject lang="eng">
			<topic>Alloy 800H/HT</topic>
		</subject>
		<subject lang="eng">
			<topic>Alloy 600</topic>
		</subject>
		<subject lang="eng">
			<topic>Co-combustion</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20402">
			<topic>Engineering and Technology</topic>
			<topic>Chemical Engineering</topic>
			<topic>Corrosion Engineering</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20402">
			<topic>Teknik och teknologier</topic>
			<topic>Kemiteknik</topic>
			<topic>Korrosionsteknik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Mechanisms of alloy degradation in a fireside N-S-O-C-H-Cl-Na-K atmosphere at 880 degrees C were elucidated using SEM-EDS, chemical equilibrium calculations, and XRD. Alloys 310S, 800H/HT, and 600 were studied after 0, 8000, and 16,000 h exposure in a boiler co-firing biomass waste. For 310S and 800H/HT it was shown that nitrogen formed internal Cr nitrides lowering the Cr activity and inhibiting internal alloy Cr permeation, and that NaCl and Na2SO4 reacted with Cr oxide to form chromate and to accelerate the S and the Cl pickup. Alloy 600 showed no nitride or major chromate formation.&lt;/p&gt;</abstract>
		<note type="project">Bio4Energy</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Corrosion Science</title>
			</titleInfo>
			<identifier type="issn">0010-938X</identifier>
			<identifier type="eissn">1879-0496</identifier>
			<part>
				<detail type="volume">
					<number>150</number>
				</detail>
				<extent>
					<start>136</start>
					<end>150</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1305784/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-18</recordCreationDate>
			<recordChangeDate>2019-08-30</recordChangeDate>
			<recordIdentifier>diva2:1305784</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Campbell</namePart>
			<namePart type="given">David</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Callary</namePart>
			<namePart type="given">Stuart</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Field</namePart>
			<namePart type="given">John</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="kjni0001">
			<namePart type="family">Nilsson</namePart>
			<namePart type="given">Kjell G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Ortopedi</affiliation>
			<description>diva-portal.org=authority-person:63828</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="796">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Ortopedi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>All-polyethylene tibial components in young patients have stable fixation; a comparison RSA study</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-29T13:26:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157680</identifier>
		<identifier type="doi">10.1016/j.knee.2018.12.003</identifier>
		<identifier type="pmid">30638681</identifier>
		<identifier type="isi">000470052400014</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>All-polyethylene</topic>
		</subject>
		<subject lang="eng">
			<topic>Knee arthroplasty</topic>
		</subject>
		<subject lang="eng">
			<topic>Radiostereometry</topic>
		</subject>
		<subject lang="eng">
			<topic>Tibial migration</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30211">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Orthopaedics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30211">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Ortopedi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;BACKGROUND: All-polyethylene (AP) tibial components in patients aged greater than 60 years have stable tibial migration patterns and favorable survival rates when compared to identical Metal-backed (MB) designs. Tibial component migration in younger patients has not been reported. The aim of this study was to examine the migration characteristics of patients aged less than 60 years compared to a previous cohort of AP and MB tibial components of identical design in older patients.&lt;/p&gt;&lt;p&gt;METHODS: A prospective consecutive study examined tibial component migration in 21 patients aged less than 60 years undergoing a cemented total knee arthroplasty with an AP tibial component by radiostereometric analysis (RSA) to 24 months. Results were compared to the authors' previous series of 21 patients aged greater than 60 years that were randomized to either an AP or MB tibial component.&lt;/p&gt;&lt;p&gt;RESULTS: Both age groups of patients implanted with an AP component had stable migration patterns with no patient having greater than 0.2° rotation or 0.2 mm maximum total point motion. Five of 11 MB tibial components displayed continued migration between one and two years. Subsidence was similar in all groups, whilst maximum total point motion was greater for the MB cohort (0.34 mm, 0.33 mm, 0.61 mm; AP &amp;lt;60, AP &amp;gt;60, MB).&lt;/p&gt;&lt;p&gt;CONCLUSIONS: Young patients implanted with an AP tibial component had stable tibial migration patterns comparable to older patients with the same AP implant. Regardless of age, AP tibial components were at least as stable as MB tibial components.&lt;/p&gt;&lt;p&gt;LEVEL OF EVIDENCE: Level II, Prospective comparative study.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Knee (Oxford)</title>
			</titleInfo>
			<identifier type="issn">0968-0160</identifier>
			<identifier type="eissn">1873-5800</identifier>
			<part>
				<detail type="volume">
					<number>26</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
				<extent>
					<start>392</start>
					<end>399</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>anjo0012</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-29</recordCreationDate>
			<recordChangeDate>2019-06-20</recordChangeDate>
			<recordIdentifier>diva2:1300743</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Zeguo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="lefr0001">
			<namePart type="family">Freidovich</namePart>
			<namePart type="given">Leonid B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<description>orcid.org=0000-0003-0730-9441</description>
			<description>diva-portal.org=authority-person:63506</description>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Honghua</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="870">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad fysik och elektronik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Almost periodic motion planning and control for double rotary pendulum with experimental validation</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>WILEY</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-13T09:02:36</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162005</identifier>
		<identifier type="doi">10.1002/asjc.2154</identifier>
		<identifier type="isi">000476849300001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>double rotary pendulum</topic>
		</subject>
		<subject lang="eng">
			<topic>periodic motion planning</topic>
		</subject>
		<subject lang="eng">
			<topic>underactuated mechanical systems</topic>
		</subject>
		<subject lang="eng">
			<topic>virtual lonomic constraints</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20202">
			<topic>Engineering and Technology</topic>
			<topic>Electrical Engineering, Electronic Engineering, Information Engineering</topic>
			<topic>Control Engineering</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20202">
			<topic>Teknik och teknologier</topic>
			<topic>Elektroteknik och elektronik</topic>
			<topic>Reglerteknik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The aim is to develop a systematic procedure for planning feasible motions for a double rotary pendulum. This pendulum has one directly actuated horizontal link and two passive links, moving in a rotating vertical plane. We plan a nontrivial oscillatory motion for the passive links that is consistent with the horizontal link rotating at a given average speed and also design a stabilizing controller to approximately induce such a motion. For the motion planning, a numerical optimization procedure is proposed in the form of a sequence of three simpler problems to systematically derive initial guesses for the final optimization search. For the controller design, firstly the system is linearized along a nominal trajectory, and then a parametrized family of candidate stabilizing controllers is designed. For each set of parameters, a necessary and sufficient stability condition can be checked for the derived linear time varying periodic system. Therefore, a numerical optimization procedure is used to find the controller gain for the linear system based on the stability condition. The performance of the closed-loop system is illustrated via numerical simulations and verified via experiments with an educational platform produced by PendCon, demonstrating achieving oscillations with required characteristics. However, the formal proofs for convergence and even for existence of almost periodic solutions are left for future studies.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Asian journal of control</title>
			</titleInfo>
			<identifier type="issn">1561-8625</identifier>
			<identifier type="eissn">1561-8625</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-13</recordCreationDate>
			<recordChangeDate>2019-08-13</recordChangeDate>
			<recordIdentifier>diva2:1342186</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Paslawski</namePart>
			<namePart type="given">Wojciech</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zareba-Paslawska</namePart>
			<namePart type="given">Justyna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zhang</namePart>
			<namePart type="given">Xiaoqun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Holzl</namePart>
			<namePart type="given">Katharina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wadensten</namePart>
			<namePart type="given">Henrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shariatgorji</namePart>
			<namePart type="given">Mohammadreza</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Janelidze</namePart>
			<namePart type="given">Shorena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hansson</namePart>
			<namePart type="given">Oskar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="lafo0001">
			<namePart type="family">Forsgren</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Klinisk neurovetenskap</affiliation>
			<description>diva-portal.org=authority-person:62555</description>
		</name>
		<name type="personal">
			<namePart type="family">Andren</namePart>
			<namePart type="given">Per E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-4062-7743</description>
		</name>
		<name type="personal">
			<namePart type="family">Svenningsson</namePart>
			<namePart type="given">Per</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="10950">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för farmakologi och klinisk neurovetenskap</namePart>
			<namePart>Klinisk neurovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>alpha-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>NATL ACAD SCIENCES</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-14T08:28:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161992</identifier>
		<identifier type="doi">10.1073/pnas.1821409116</identifier>
		<identifier type="pmid">31270237</identifier>
		<identifier type="isi">000476715500067</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>apolipoproteins</topic>
		</subject>
		<subject lang="eng">
			<topic>alpha-synuclein</topic>
		</subject>
		<subject lang="eng">
			<topic>Parkinson's disease</topic>
		</subject>
		<subject lang="eng">
			<topic>cerebrospinal fluid</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30223">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Clinical Laboratory Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30223">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Klinisk laboratoriemedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The progressive accumulation, aggregation, and spread of alpha-synuclein (alpha SN) are common hallmarks of Parkinson's disease (PD) pathology. Moreover, numerous proteins interact with alpha SN species, influencing its toxicity in the brain. In the present study, we extended analyses of alpha SN-interacting proteins to cerebrospinal fluid (CSF). Using coimmunoprecipitation, followed by mass spectrometry, we found that alpha SN colocalize with apolipoproteins on lipoprotein vesicles. We confirmed these interactions using several methods, including the enrichment of lipoproteins with a recombinant alpha SN, and the subsequent uptake of prepared vesicles by human dopaminergic neuronal-like cells. Further, we report an increased level of ApoE in CSF from early PD patients compared with matched controls in 3 independent cohorts. Moreover, in contrast to controls, we observed the presence of ApoE-positive neuromelanin-containing dopaminergic neurons in substantia nigra of PD patients. In conclusion, the cooccurrence of alpha SN on lipoprotein vesicles, and their uptake by dopaminergic neurons along with an increase of ApoE in early PD, proposes a mechanism(s) for alpha SN spreading in the extracellular milieu of PD.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Proceedings of the National Academy of Sciences of the United States of America</title>
			</titleInfo>
			<identifier type="issn">0027-8424</identifier>
			<identifier type="eissn">1091-6490</identifier>
			<part>
				<detail type="volume">
					<number>116</number>
				</detail>
				<detail type="issue">
					<number>30</number>
				</detail>
				<extent>
					<start>15226</start>
					<end>15235</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1342586/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-14</recordCreationDate>
			<recordChangeDate>2019-08-14</recordChangeDate>
			<recordIdentifier>diva2:1342586</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="pada0023">
			<namePart type="family">Davis</namePart>
			<namePart type="given">Paul A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>diva-portal.org=authority-person:67932</description>
		</name>
		<name type="personal">
			<namePart type="family">Halvarsson</namePart>
			<namePart type="given">Anton</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="wilu0004">
			<namePart type="family">Lundstrom</namePart>
			<namePart type="given">Wictor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>diva-portal.org=authority-person:73225</description>
		</name>
		<name type="personal">
			<namePart type="family">Lundqvist</namePart>
			<namePart type="given">Carolina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Alpine Ski Coaches' and Athletes' Perceptions of Factors Influencing Adaptation to Stress in the Classroom and on the Slopes</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>FRONTIERS MEDIA SA</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-20T14:38:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162326</identifier>
		<identifier type="doi">10.3389/fpsyg.2019.01641</identifier>
		<identifier type="isi">000477840200001</identifier>
		<identifier type="articleId">1641</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>emotions</topic>
		</subject>
		<subject lang="eng">
			<topic>coping</topic>
		</subject>
		<subject lang="eng">
			<topic>mixed methods</topic>
		</subject>
		<subject lang="eng">
			<topic>dual career athletes</topic>
		</subject>
		<subject lang="eng">
			<topic>student athlete</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50102">
			<topic>Social Sciences</topic>
			<topic>Psychology</topic>
			<topic>Applied Psychology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50102">
			<topic>Samhällsvetenskap</topic>
			<topic>Psykologi</topic>
			<topic>Tillämpad psykologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Research examining the student-athlete experience proposes a number of factors that can be both sources of stress and/or support. The dual career pathway offers a number of potential positive outcomes including psychological, social, and financial benefits; however, challenges including time management, fatigue, and restricted social activities are well documented. In consideration of the multidimensional student-athlete experience and the numerous factors that influence the complexity of potential stress, a mixed methods research study design was used in the study. First, data collected from surveys completed by 173 elite junior alpine skiers were analyzed to identify the degree to which athletes report experiencing stress associated with specific aspects pertaining to training, life, and organizational factors. These factors were then explored through semi-structured interviews with six coaches at the associated national elite sport schools. Taken collectively, athletes' reports of psychophysiological training stress on the Multidimensional Training Distress Scale were low. Scores on the college studentathletes' life stress scale revealed very low levels of general life stress; although the subscales associated with "performance demand" and "academic requirements" scored marginally higher. Scores on the Organizational Stressor Indicator for Sport Performers indicated low levels of organizational stress. The interviews with coaches elucidated the underlying factors potentially influencing athletes' positive adaptations to stress as they reported programming a number of strategies to reduce negative outcomes. Coaches aimed to teach athletes self-awareness and regulation strategies through the use of the training diaries and ongoing communication to promote positive adaptation to stress. A number of coaches also worked with sport psychology consultants to optimize athletes' training and study situations. Traditionally, research has noted high levels of stress in student-athletes due to co-occurring demands (school &amp;amp; sport); however, the data in the present study suggests that optimizing support mechanisms across domains can promote positive adaptations to potential sources of stress.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Frontiers in Psychology</title>
			</titleInfo>
			<identifier type="issn">1664-1078</identifier>
			<identifier type="eissn">1664-1078</identifier>
			<part>
				<detail type="volume">
					<number>10</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1344247/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-20</recordCreationDate>
			<recordChangeDate>2019-08-22</recordChangeDate>
			<recordIdentifier>diva2:1344247</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="yize0002">
			<namePart type="family">Zeng</namePart>
			<namePart type="given">Yingxu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:67929</description>
		</name>
		<name type="personal">
			<namePart type="family">Mtintsilana</namePart>
			<namePart type="given">Asanda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goedecke</namePart>
			<namePart type="given">Julia H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Micklesfield</namePart>
			<namePart type="given">Lisa K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="tool0003">
			<namePart type="family">Olsson</namePart>
			<namePart type="given">Tommy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:62478</description>
		</name>
		<name type="personal" authority="umu" xlink:href="elnpon01">
			<namePart type="family">Chorell</namePart>
			<namePart type="given">Elin</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:64036</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Alterations in the metabolism of phospholipids, bile acids and branched-chain amino acids predicts development of type 2 diabetes in black South African women</title>
			<subTitle>a prospective cohort study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-24T12:25:20</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-160603</identifier>
		<identifier type="doi">10.1016/j.metabol.2019.04.001</identifier>
		<identifier type="pmid">30954560</identifier>
		<identifier type="isi">000470307800007</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Type 2 diabetes</topic>
		</subject>
		<subject lang="eng">
			<topic>Insulin resistance</topic>
		</subject>
		<subject lang="eng">
			<topic>Metabolomics</topic>
		</subject>
		<subject lang="eng">
			<topic>Branched-chain amino acids</topic>
		</subject>
		<subject lang="eng">
			<topic>Phospholipids</topic>
		</subject>
		<subject lang="eng">
			<topic>Bile acids</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30205">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Endocrinology and Diabetes</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30205">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Endokrinologi och diabetes</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: South Africa (SA) has the highest global projected increase in diabetes risk. Factors typically associated with insulin resistance and type 2 diabetes risk in Caucasians are not significant correlates in black African populations. Therefore, we aimed to identify circulating metabolite patterns that predict type 2 diabetes development in this high-risk, yet understudied SA population.&lt;/p&gt;&lt;p&gt;Methods: We conducted a prospective cohort study in black SA women with normal glucose tolerance (NGT). Participants were followed for 13 years and developed (i) type 2 diabetes (&lt;em&gt;n&lt;/em&gt; = 20, NGT-T2D), (ii) impaired glucose tolerance (IGT) (&lt;em&gt;n&lt;/em&gt; = 27, NGT-IGT), or (iii) remained NGT (&lt;em&gt;n&lt;/em&gt; = 28, NGT-NGT). Mass-spectrometry based metabolomics and multivariate analyses were used to elucidate metabolite patterns at baseline and at follow-up that were associated with type 2 diabetes development.&lt;/p&gt;&lt;p&gt;Results: Metabolites of phospholipid, bile acid and branched-chain amino acid (BCAA) metabolism, differed significantly between the NGT-T2D and NGT-NGT groups. At baseline: the NGT-T2D group had i) a higher lysophosphatidylcholine:lysophosphatidylethanolamine ratio containing linoleic acid (LPC(C18:2):LPE(C18:2)), ii) lower proliferation-related bile acids (ursodeoxycholic- and chenodeoxycholic acid), iii) higher levels of leucine and its catabolic intermediates (ketoleucine and C5-carnitine), compared to the NGT-NGT group. At follow-up: the NGT-T2D group had i) lower LPC(C18:2) levels, ii) higher apoptosis-related bile acids (deoxycholic- and glycodeoxycholic acid), and iii) higher levels of all BCAAs and their catabolic intermediates.&lt;/p&gt;&lt;p&gt;Conclusions: Changes in lysophospholipid metabolism and the bile acid pool occur during the development of type 2 diabetes in black South African women. Further, impaired leucine catabolism precedes valine and isoleucine catabolism in the development of type 2 diabetes. These metabolite patterns can be useful to identify and monitor type 2 diabetes risk &amp;gt;10 years prior to disease onset and provide insight into the pathophysiology of type 2 diabetes in this high risk, but under-studied population.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Metabolism</title>
				<subTitle>Clinical and Experimental</subTitle>
			</titleInfo>
			<identifier type="issn">0026-0495</identifier>
			<identifier type="eissn">1532-8600</identifier>
			<part>
				<detail type="volume">
					<number>95</number>
				</detail>
				<extent>
					<start>57</start>
					<end>64</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Wellcome trust</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-24</recordCreationDate>
			<recordChangeDate>2019-06-24</recordChangeDate>
			<recordIdentifier>diva2:1329130</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="mial0035">
			<namePart type="family">Alhouayek</namePart>
			<namePart type="given">Mireille</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för farmakologi och klinisk neurovetenskap</affiliation>
			<affiliation>Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Universite catholique de Louvain, Bruxelles, Belgium</affiliation>
			<description>diva-portal.org=authority-person:67924</description>
		</name>
		<name type="personal" authority="umu" xlink:href="liabop98">
			<namePart type="family">Boldrup</namePart>
			<namePart type="given">Linda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>diva-portal.org=authority-person:63693</description>
		</name>
		<name type="personal" authority="umu" xlink:href="chfo0001">
			<namePart type="family">Fowler</namePart>
			<namePart type="given">Christopher J</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för farmakologi och klinisk neurovetenskap</affiliation>
			<description>orcid.org=0000-0002-6658-7874</description>
			<description>diva-portal.org=authority-person:63819</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="717">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för farmakologi och klinisk neurovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="747">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Altered mRNA Expression of Genes Involved in Endocannabinoid Signalling in Squamous Cell Carcinoma of the Oral Tongue</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-27T13:08:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163070</identifier>
		<identifier type="doi">10.1080/07357907.2019.1638394</identifier>
		<identifier type="pmid">31423851</identifier>
		<identifier type="isi">000482287600001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/07357907.2019.1638394</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Squamous cell carcinoma of the oral tongue</topic>
		</subject>
		<subject lang="eng">
			<topic>endocannabinoids</topic>
		</subject>
		<subject lang="eng">
			<topic>cyclooxygenase-2</topic>
		</subject>
		<subject lang="eng">
			<topic>N-acyl- osphatidylethanolamine phospholipase D</topic>
		</subject>
		<subject lang="eng">
			<topic>monoacylglycerol lipase</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Little is known about the endocannabinoid (eCB) system in squamous cell carcinoma of the oral tongue (SCCOT). Here we have investigated, at the mRNA level, expression of genes coding for the components of the eCB system in tumour and non-malignant samples from SCCOT patients. Expression of NAPEPLD and PLA2G4E, coding for eCB anabolic enzymes, was higher in the tumour tissue than in non-malignant tissue. Among genes coding for eCB catabolic enzymes, expression of MGLL was lower in tumour tissue while PTGS2 was increased. It is concluded that the eCB system may be dysfunctional in SCCOT.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Cancer Investigation</title>
			</titleInfo>
			<identifier type="issn">0735-7907</identifier>
			<identifier type="eissn">1532-4192</identifier>
			<part>
				<detail type="volume">
					<number>37</number>
				</detail>
				<detail type="issue">
					<number>8</number>
				</detail>
				<extent>
					<start>327</start>
					<end>338</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1373491/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>bonnym04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-27</recordCreationDate>
			<recordChangeDate>2019-11-27</recordChangeDate>
			<recordIdentifier>diva2:1373491</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Treleaven</namePart>
			<namePart type="given">Julia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Takasaki</namePart>
			<namePart type="given">Hiro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="heagrp96">
			<namePart type="family">Grip</namePart>
			<namePart type="given">Helena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Radiofysik</affiliation>
			<description>diva-portal.org=authority-person:62540</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="779">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<namePart>Radiofysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Altered trunk head co-ordination in those with persistent neck pain</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-02-21T12:17:04</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156301</identifier>
		<identifier type="doi">10.1016/j.msksp.2018.11.010</identifier>
		<identifier type="pmid">30476827</identifier>
		<identifier type="isi">000456572900010</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Trunk</topic>
		</subject>
		<subject lang="eng">
			<topic>Head motion</topic>
		</subject>
		<subject lang="eng">
			<topic>Neck pain</topic>
		</subject>
		<subject lang="eng">
			<topic>Sensorimotor</topic>
		</subject>
		<subject lang="eng">
			<topic>Cervico-collic reflex</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30307">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Physiotherapy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30307">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Sjukgymnastik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Decreased neck motion and sensorimotor deficits have been identified in those with neck pain. It is thought that these might be related to altered reflex mechanisms between the neck, eyes and the vestibular system. Trunk, head co-ordination might also be altered in neck pain.&lt;/p&gt;&lt;p&gt;Objectives: This study investigated trunk head co-ordination ability in subjects with neck pain compared to asymptomatic controls.&lt;/p&gt;&lt;p&gt;Method: Twenty-four subjects with persistent neck pain and twenty-six age and gender matched healthy controls performed 3 trials of 3 trunk movements whilst trying to keep the head still - (1) alternate trunk movement to the left and right (2) trunk movement to the left (3) trunk movement to the right. Wireless motion sensors positioned over the sternum and the forehead measured trunk and head range and velocity of motion.&lt;/p&gt;&lt;p&gt;Analysis: ANOVA was used to compare trunk and head range and velocity of motion during the 3 tasks.&lt;/p&gt;&lt;p&gt;Results: Neck pain subjects had significantly less trunk movement (p &amp;lt; 0.05) and velocity (p = &amp;lt; 0.02) as well as significantly increased head movement (p = &amp;lt; 0.03) during most tasks compared to control subjects.&lt;/p&gt;&lt;p&gt;Discussion: The results of the study suggest that neck pain subjects have difficulty moving their trunk independently of their head. They are less able to keep the head still while moving the trunk and perform the tasks more slowly. These findings might be related to altered reflex activity of the cervico-collic reflex and sensorimotor control. Further research is required.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>39</number>
				</detail>
				<extent>
					<start>45</start>
					<end>50</end>
				</extent>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Musculoskeletal Science and Practice</title>
			</titleInfo>
			<identifier type="issn">2468-7812</identifier>
			<part>
				<detail type="volume">
					<number>39</number>
				</detail>
				<extent>
					<start>45</start>
					<end>50</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-02-21</recordCreationDate>
			<recordChangeDate>2019-02-21</recordChangeDate>
			<recordIdentifier>diva2:1290712</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="jusa0019">
			<namePart type="family">Sarneel</namePart>
			<namePart type="given">Judith M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<affiliation>Ecology &amp; Biodiversity, Institute of Environmental Biology, Utrecht University, Utrecht, Netherlands; Plant Ecophysiology, Institute of Environmental Biology, Utrecht University, Utrecht, Netherlands</affiliation>
			<description>orcid.org=0000-0001-6187-499X</description>
			<description>diva-portal.org=authority-person:65194</description>
		</name>
		<name type="personal">
			<namePart type="family">Hefting</namePart>
			<namePart type="given">Mariet M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kowalchuk</namePart>
			<namePart type="given">George A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="chni0001">
			<namePart type="family">Nilsson</namePart>
			<namePart type="given">Christer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<description>diva-portal.org=authority-person:62635</description>
		</name>
		<name type="personal">
			<namePart type="family">Van der Velden</namePart>
			<namePart type="given">Merit</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Visser</namePart>
			<namePart type="given">Eric J. W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Voesenek</namePart>
			<namePart type="given">Laurentius A. C. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="roja0001">
			<namePart type="family">Jansson</namePart>
			<namePart type="given">Roland</namePart>
			<namePart type="date">1967-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<description>diva-portal.org=authority-person:62897</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="879">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för ekologi, miljö och geovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Alternative transient states and slow plant community responses after changed flooding regimes</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-18T10:45:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157948</identifier>
		<identifier type="doi">10.1111/gcb.14569</identifier>
		<identifier type="pmid">30638293</identifier>
		<identifier type="isi">000461817500013</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1111/gcb.14569</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>alternative stable states</topic>
		</subject>
		<subject lang="eng">
			<topic>drought events</topic>
		</subject>
		<subject lang="eng">
			<topic>flood regime change</topic>
		</subject>
		<subject lang="eng">
			<topic>hydrological alterations</topic>
		</subject>
		<subject lang="eng">
			<topic>hysteresis</topic>
		</subject>
		<subject lang="eng">
			<topic>riparian vegetation</topic>
		</subject>
		<subject lang="eng">
			<topic>river restoration</topic>
		</subject>
		<subject lang="eng">
			<topic>species traits</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10611">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Ecology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10611">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Ekologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10502">
			<topic>Earth and Related Environmental Sciences</topic>
			<topic>Environmental Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10502">
			<topic>Geovetenskap och miljövetenskap</topic>
			<topic>Miljövetenskap</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Climate change will have large consequences for flooding frequencies in freshwater systems. In interaction with anthropogenic activities (flow regulation, channel restoration and catchment land-use) this will both increase flooding and drought across the world. Like in many other ecosystems facing changed environmental conditions, it remains difficult to predict the rate and trajectory of vegetation responses to changed conditions. Given that critical ecosystem services (e.g. bank stabilization, carbon subsidies to aquatic communities or water purification) depend on riparian vegetation composition, it is important to understand how and how fast riparian vegetation responds to changing flooding regimes. We studied vegetation changes over 19 growing seasons in turfs that were transplanted in a full-factorial design between three riparian elevations with different flooding frequencies. We found that (a) some transplanted communities may have developed into an alternative stable state and were still different from the target community, and (b) pathways of vegetation change were highly directional but alternative trajectories did occur, (c) changes were rather linear but faster when flooding frequencies increased than when they decreased, and (d) we observed fastest changes in turfs when proxies for mortality and colonization were highest. These results provide rare examples of alternative transient trajectories and stable states under field conditions, which is an important step towards understanding their drivers and their frequency in a changing world.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Global Change Biology</title>
			</titleInfo>
			<identifier type="issn">1354-1013</identifier>
			<identifier type="eissn">1365-2486</identifier>
			<part>
				<detail type="volume">
					<number>25</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>1358</start>
					<end>1367</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1305743/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-18</recordCreationDate>
			<recordChangeDate>2019-04-18</recordChangeDate>
			<recordIdentifier>diva2:1305743</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Liu</namePart>
			<namePart type="given">Cong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Renjie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sera</namePart>
			<namePart type="given">Francesco</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vicedo-Cabrera</namePart>
			<namePart type="given">Ana M</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guo</namePart>
			<namePart type="given">Yuming</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tong</namePart>
			<namePart type="given">Shilu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Coelho</namePart>
			<namePart type="given">Micheline S Z S</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Saldiva</namePart>
			<namePart type="given">Paulo H N</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lavigne</namePart>
			<namePart type="given">Eric</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Matus</namePart>
			<namePart type="given">Patricia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Valdes Ortega</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Osorio Garcia</namePart>
			<namePart type="given">Samuel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pascal</namePart>
			<namePart type="given">Mathilde</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Stafoggia</namePart>
			<namePart type="given">Massimo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scortichini</namePart>
			<namePart type="given">Matteo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hashizume</namePart>
			<namePart type="given">Masahiro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Honda</namePart>
			<namePart type="given">Yasushi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hurtado-Díaz</namePart>
			<namePart type="given">Magali</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cruz</namePart>
			<namePart type="given">Julio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nunes</namePart>
			<namePart type="given">Baltazar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Teixeira</namePart>
			<namePart type="given">João P</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kim</namePart>
			<namePart type="given">Ho</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tobias</namePart>
			<namePart type="given">Aurelio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Íñiguez</namePart>
			<namePart type="given">Carmen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="befo0001">
			<namePart type="family">Forsberg</namePart>
			<namePart type="given">Bertil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<description>orcid.org=0000-0002-0159-6657</description>
			<description>diva-portal.org=authority-person:62755</description>
		</name>
		<name type="personal" authority="umu" xlink:href="chas0002">
			<namePart type="family">Åström</namePart>
			<namePart type="given">Christofer</namePart>
			<namePart type="date">1983-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<description>diva-portal.org=authority-person:63685</description>
		</name>
		<name type="personal">
			<namePart type="family">Ragettli</namePart>
			<namePart type="given">Martina S</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Guo</namePart>
			<namePart type="given">Yue-Leon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Bing-Yu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bell</namePart>
			<namePart type="given">Michelle L</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wright</namePart>
			<namePart type="given">Caradee Y</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scovronick</namePart>
			<namePart type="given">Noah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garland</namePart>
			<namePart type="given">Rebecca M</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Milojevic</namePart>
			<namePart type="given">Ai</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kyselý</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Urban</namePart>
			<namePart type="given">Aleš</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="haor0004">
			<namePart type="family">Orru</namePart>
			<namePart type="given">Hans</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Avdelningen för hållbar hälsa</affiliation>
			<affiliation>The Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia</affiliation>
			<description>orcid.org=0000-0002-7965-9451</description>
			<description>diva-portal.org=authority-person:63634</description>
		</name>
		<name type="personal">
			<namePart type="family">Indermitte</namePart>
			<namePart type="given">Ene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jaakkola</namePart>
			<namePart type="given">Jouni J K</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ryti</namePart>
			<namePart type="given">Niilo R I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Katsouyanni</namePart>
			<namePart type="given">Klea</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Analitis</namePart>
			<namePart type="given">Antonis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zanobetti</namePart>
			<namePart type="given">Antonella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schwartz</namePart>
			<namePart type="given">Joel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chen</namePart>
			<namePart type="given">Jianmin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wu</namePart>
			<namePart type="given">Tangchun</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cohen</namePart>
			<namePart type="given">Aaron</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gasparrini</namePart>
			<namePart type="given">Antonio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kan</namePart>
			<namePart type="given">Haidong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881550">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Avdelningen för hållbar hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Ambient Particulate Air Pollution and Daily Mortality in 652 Cities</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<place>
				<placeTerm>Waltham</placeTerm>
			</place>
			<publisher>Massachusetts Medical Society</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-23T14:28:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162609</identifier>
		<identifier type="doi">10.1056/NEJMoa1817364</identifier>
		<identifier type="pmid">31433918</identifier>
		<identifier type="isi">000483203400006</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30303">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Occupational Health and Environmental Health</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30303">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Arbetsmedicin och miljömedicin</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10502">
			<topic>Natural Sciences</topic>
			<topic>Earth and Related Environmental Sciences</topic>
			<topic>Environmental Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10502">
			<topic>Naturvetenskap</topic>
			<topic>Geovetenskap och miljövetenskap</topic>
			<topic>Miljövetenskap</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;BACKGROUND: The systematic evaluation of the results of time-series studies of air pollution is challenged by differences in model specification and publication bias.&lt;/p&gt;&lt;p&gt;METHODS: We evaluated the associations of inhalable particulate matter (PM) with an aerodynamic diameter of 10 μm or less (PM&lt;sub&gt;10&lt;/sub&gt;) and fine PM with an aerodynamic diameter of 2.5 μm or less (PM&lt;sub&gt;2.5&lt;/sub&gt;) with daily all-cause, cardiovascular, and respiratory mortality across multiple countries or regions. Daily data on mortality and air pollution were collected from 652 cities in 24 countries or regions. We used overdispersed generalized additive models with random-effects meta-analysis to investigate the associations. Two-pollutant models were fitted to test the robustness of the associations. Concentration-response curves from each city were pooled to allow global estimates to be derived.&lt;/p&gt;&lt;p&gt;RESULTS: On average, an increase of 10 μg per cubic meter in the 2-day moving average of PM&lt;sub&gt;10&lt;/sub&gt; concentration, which represents the average over the current and previous day, was associated with increases of 0.44% (95% confidence interval [CI], 0.39 to 0.50) in daily all-cause mortality, 0.36% (95% CI, 0.30 to 0.43) in daily cardiovascular mortality, and 0.47% (95% CI, 0.35 to 0.58) in daily respiratory mortality. The corresponding increases in daily mortality for the same change in PM&lt;sub&gt;2.5&lt;/sub&gt; concentration were 0.68% (95% CI, 0.59 to 0.77), 0.55% (95% CI, 0.45 to 0.66), and 0.74% (95% CI, 0.53 to 0.95). These associations remained significant after adjustment for gaseous pollutants. Associations were stronger in locations with lower annual mean PM concentrations and higher annual mean temperatures. The pooled concentration-response curves showed a consistent increase in daily mortality with increasing PM concentration, with steeper slopes at lower PM concentrations.&lt;/p&gt;&lt;p&gt;CONCLUSIONS: Our data show independent associations between short-term exposure to PM&lt;sub&gt;10&lt;/sub&gt; and PM&lt;sub&gt;2.5&lt;/sub&gt; and daily all-cause, cardiovascular, and respiratory mortality in more than 600 cities across the globe. These data reinforce the evidence of a link between mortality and PM concentration established in regional and local studies. (Funded by the National Natural Science Foundation of China and others.).&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>New England Journal of Medicine</title>
			</titleInfo>
			<identifier type="issn">0028-4793</identifier>
			<identifier type="eissn">1533-4406</identifier>
			<part>
				<detail type="volume">
					<number>381</number>
				</detail>
				<detail type="issue">
					<number>8</number>
				</detail>
				<extent>
					<start>705</start>
					<end>715</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>lrtjon02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-23</recordCreationDate>
			<recordChangeDate>2019-10-31</recordChangeDate>
			<recordIdentifier>diva2:1345319</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Carlsen</namePart>
			<namePart type="given">Hanne Krage</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Psykiatri Affektiva, Sahlgrenska University Hospital, 416 50 Gothenburg, Sweden. Occupational and Environmental Medicine, Gothenburg University, 40530 Gothenburg, Sweden.</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="anou0004">
			<namePart type="family">Oudin</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<affiliation>Occupational and Environmental Medicine, Lund University, 223 63 Lund, Sweden.</affiliation>
			<description>diva-portal.org=authority-person:63599</description>
		</name>
		<name type="personal">
			<namePart type="family">Steingrimsson</namePart>
			<namePart type="given">Steinn</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Psykiatri Affektiva, Sahlgrenska University Hospital, 416 50 Gothenburg, Sweden. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="daas0014">
			<namePart type="family">Oudin Åström</namePart>
			<namePart type="given">Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Yrkes- och miljömedicin</affiliation>
			<description>diva-portal.org=authority-person:63600</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="730">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Yrkes- och miljömedicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Ambient Temperature and Associations with Daily Visits to a Psychiatric Emergency Unit in Sweden</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-30T10:53:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155863</identifier>
		<identifier type="doi">10.3390/ijerph16020286</identifier>
		<identifier type="pmid">30669579</identifier>
		<identifier type="isi">000459112100121</identifier>
		<identifier type="articleId">E286</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/ijerph16020286</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>climate</topic>
		</subject>
		<subject lang="eng">
			<topic>environmental epidemiology</topic>
		</subject>
		<subject lang="eng">
			<topic>mental illness</topic>
		</subject>
		<subject lang="eng">
			<topic>psychiatric disorders</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30303">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Occupational Health and Environmental Health</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30303">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Arbetsmedicin och miljömedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;High or low ambient temperatures pose a risk factor for the worsening or onset of psychiatric disorders. The aim of this study was to investigate the association between ambient temperature and psychiatric emergency visits in an urban region in a temperate climate. The daily number of visits to a psychiatric emergency room (PEVs) at Sahlgrenska University Hospital, Gothenburg, Sweden and the daily mean temperature were extracted for the study period 1 July 2012 to 31 December 2017. Case-crossover analysis with distributed lag non-linear models was used to analyse the data by season. The warm season was defined as May to August and the cold season as November to February. Shorter lags periods were used for the warm season than the cold season. In the analysis, temperatures at the 95th percentile was associated with 14% (95% confidence interval (CI): 2%, 28%) increase in PEVs at lag 0⁻3 and 22% (95%CI: 6%, 40%) for lags 0⁻14 during the warm season, relative to the seasonal minimum effect temperature (MET). During the cold season temperatures at the 5th percentile were associated with 25% (95% CI: -8%, 13%) and 18% (95% CI: -30%, 98%) increase in PEVs at lags 0⁻14 and 0⁻21 respectively. We observed an increased number of PEVs at high and low temperatures; however, not to a statistically significant extent for low temperatures. Our findings are similar to what has been found for somatic diseases and in studies of other mental health outcomes in regions with more extreme climates. This merits the inclusion of individuals with psychiatric disorders in awareness planning for climate warning systems.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Environmental Research and Public Health</title>
			</titleInfo>
			<identifier type="issn">1661-7827</identifier>
			<identifier type="eissn">1660-4601</identifier>
			<part>
				<detail type="volume">
					<number>16</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1283886/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>lrtjon02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-30</recordCreationDate>
			<recordChangeDate>2019-04-16</recordChangeDate>
			<recordIdentifier>diva2:1283886</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Chauhan</namePart>
			<namePart type="given">Deepika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Srivastava</namePart>
			<namePart type="given">Pulkit Anupam</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="bari0004">
			<namePart type="family">Ritzl</namePart>
			<namePart type="given">Barbara</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Yennamalli</namePart>
			<namePart type="given">Ragothaman M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="feca0003">
			<namePart type="family">Cava</namePart>
			<namePart type="given">Felipe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Umeå Centre for Microbial Research (UCMR)</affiliation>
			<description>diva-portal.org=authority-person:62587</description>
		</name>
		<name type="personal">
			<namePart type="family">Priyadarshini</namePart>
			<namePart type="given">Richa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5051">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Umeå Centre for Microbial Research (UCMR)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Amino Acid-Dependent Alterations in Cell Wall and Cell Morphology of Deinococcus indicus DR1</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Frontiers Media S.A.</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-05T15:20:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161695</identifier>
		<identifier type="doi">10.3389/fmicb.2019.01449</identifier>
		<identifier type="isi">000473576800001</identifier>
		<identifier type="articleId">1449</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3389/fmicb.2019.01449</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Deinococcus indicus</topic>
		</subject>
		<subject lang="eng">
			<topic>morphological alterations</topic>
		</subject>
		<subject lang="eng">
			<topic>amino acids</topic>
		</subject>
		<subject lang="eng">
			<topic>cell wall</topic>
		</subject>
		<subject lang="eng">
			<topic>muropeptides</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10606">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Microbiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10606">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Mikrobiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30109">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Microbiology in the medical area</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30109">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Mikrobiologi inom det medicinska området</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Deinococcus radiodurans exhibits growth medium-dependent morphological variation in cell shape, but there is no evidence whether this phenomenon is observed in other members of the Deinococcaceae family. In this study, we isolated a red-pigmented, aerobic, Deinococcus indicus strain DR1 from Dadri wetland, India. This D. indicus strain exhibited cell-morphology transition from rod-shaped cells to multi-cell chains in a growth-medium-dependent fashion. In response to addition of 1% casamino acids in the minimal growth medium, rod-shaped cells formed multi-cell chains. Addition of all 20 amino acids to the minimal medium was able to recapitulate the phenotype. Specifically, a combination of L-methionine, L-lysine, L-aspartate, and L-threonine caused morphological alterations. The transition from rod shape to multi-cell chains is due to delay in daughter cell separation after cell division. Minimal medium supplemented with L-ornithine alone was able to cause cell morphology changes. Furthermore, a comparative UPLC analysis of PG fragments isolated from D. indicus cells propagated in different growth media revealed alterations in the PG composition. An increase in the overall cross-linkage of PG was observed in muropeptides from nutrient-rich TSB and NB media versus PYE medium. Overall our study highlights that environmental conditions influence PG composition and cell morphology in D. indicus.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Frontiers in Microbiology</title>
			</titleInfo>
			<identifier type="issn">1664-302X</identifier>
			<identifier type="eissn">1664-302X</identifier>
			<part>
				<detail type="volume">
					<number>10</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Kempestiftelserna</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1340498/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-05</recordCreationDate>
			<recordChangeDate>2019-08-05</recordChangeDate>
			<recordIdentifier>diva2:1340498</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="olsu0002">
			<namePart type="family">Suhr</namePart>
			<namePart type="given">Ole Bernt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0002-1175-2369</description>
			<description>diva-portal.org=authority-person:63128</description>
		</name>
		<name type="personal" authority="umu" xlink:href="jowi0065">
			<namePart type="family">Wixner</namePart>
			<namePart type="given">Jonas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0002-1536-1277</description>
			<description>diva-portal.org=authority-person:65399</description>
		</name>
		<name type="personal" authority="umu" xlink:href="inrann97">
			<namePart type="family">Anan</namePart>
			<namePart type="given">Intissar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:65167</description>
		</name>
		<name type="personal" authority="umu" xlink:href="halu0014">
			<namePart type="family">Lundgren</namePart>
			<namePart type="given">Hans-Erik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:65281</description>
		</name>
		<name type="personal" authority="umu" xlink:href="prwi0001">
			<namePart type="family">Wijayatunga</namePart>
			<namePart type="given">Priyantha</namePart>
			<namePart type="date">1967-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Statistik</affiliation>
			<description>diva-portal.org=authority-person:64791</description>
		</name>
		<name type="personal">
			<namePart type="family">Westermark</namePart>
			<namePart type="given">Per</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ihse</namePart>
			<namePart type="given">Elisabet</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="11053">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Public Library Science</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-01T12:52:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157583</identifier>
		<identifier type="doi">10.1371/journal.pone.0211983</identifier>
		<identifier type="pmid">30811423</identifier>
		<identifier type="isi">000459806400043</identifier>
		<identifier type="articleId">e0211983</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1371/journal.pone.0211983</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30401">
			<topic>Medical and Health Sciences</topic>
			<topic>Medical Biotechnology</topic>
			<topic>Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30401">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinsk bioteknologi</topic>
			<topic>Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: The amyloid fibril in hereditary transthyretin (TTR) Val30Met (pVal50Met) amyloid (ATTR Val30Met) amyloidosis is composed of either a mixture of full-length and TTR fragments (Type A) or of only full-length TTR (Type B). The type of amyloid fibril exerts an impact on the phenotype of the disease, and on the outcome of diagnostic procedures and therapy. The aim of the present study was to investigate if the type of amyloid fibril remains the same within ATTR Val30Met amyloidosis families. Methods: Fifteen families were identified in whom at least two first-degree relatives had their amyloid fibril composition determined. The type of ATTR was determined by Western blot in all but two patients. For these two patients a positive 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy indicated ATTR Type A. Results: In 14 of the 15 families, the same amyloid fibril composition was noted irrespective of differences in age at onset. In the one family, different ATTR fibril types was found in two brothers with similar ages at onset. Conclusions: Family predisposition appears to have an impact on amyloid fibril composition in members of the family irrespective of their age at onset of disease, but if genetically determined, the gene/genes are likely to be situated at another location than the TTR gene in the genome.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>PLoS ONE</title>
			</titleInfo>
			<identifier type="issn">1932-6203</identifier>
			<identifier type="eissn">1932-6203</identifier>
			<part>
				<detail type="volume">
					<number>14</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1301191/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>healim97</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-01</recordCreationDate>
			<recordChangeDate>2019-04-01</recordChangeDate>
			<recordIdentifier>diva2:1301191</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Yadagiri</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Narayanaswamy</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="shre0009">
			<namePart type="family">Revoju</namePart>
			<namePart type="given">Srikanth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>orcid.org=0000-0001-5746-017x</description>
			<description>diva-portal.org=authority-person:68184</description>
		</name>
		<name type="personal" authority="umu" xlink:href="beel0001">
			<namePart type="family">Eliasson</namePart>
			<namePart type="given">Bertil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:63877</description>
		</name>
		<name type="personal">
			<namePart type="family">Sharma</namePart>
			<namePart type="given">Ganesh D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Singh</namePart>
			<namePart type="given">Surya Prakash</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An all-small-molecule organic solar cell derived from naphthalimide for solution-processed high-efficiency nonfullerene acceptors</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Royal Society of Chemistry</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-03-11T10:52:22</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156893</identifier>
		<identifier type="doi">10.1039/c8tc05692g</identifier>
		<identifier type="isi">000458780300026</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="10402">
			<topic>Natural Sciences</topic>
			<topic>Chemical Sciences</topic>
			<topic>Physical Chemistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10402">
			<topic>Naturvetenskap</topic>
			<topic>Kemi</topic>
			<topic>Fysikalisk kemi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Two small molecules BYG-1 and BYG-2 with fluorene donor and benzothiadiazole acceptor units connected to the terminal naphthamide group via ethyne linker were designed and synthesized. In this work we have discussed the effect of fluorine atoms connected with electron withdrawing benzothiadiazole unit to the fluorene core (BYG-1). In this study, we have fabricated solar cells with small-molecular donor and acceptor materials in the device architecture of bulk-heterojunction, using highly conjugated BYG-1 and BYG-2 as electron acceptors along with an appropriate small molecule donor (SMD). After improving the device architecture of the active layer using a suitable donor-to-acceptor weight ratio with solvent vapour annealing, we achieved power conversion efficiencies of 8.67% and 7.12% for BYG-1 and BYG-2, respectively. The superior photovoltaic performance of the fluorine-substituted BYG-1 can be attributed to its higher crystallinity, more balanced charge transport mobilities and efficient exciton dissociation.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Materials Chemistry C</title>
			</titleInfo>
			<identifier type="issn">2050-7526</identifier>
			<identifier type="eissn">2050-7534</identifier>
			<part>
				<detail type="volume">
					<number>7</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>709</start>
					<end>717</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-03-11</recordCreationDate>
			<recordChangeDate>2019-03-11</recordChangeDate>
			<recordIdentifier>diva2:1295213</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="bewe0010">
			<namePart type="family">Wessels</namePart>
			<namePart type="given">Bernard</namePart>
			<namePart type="date">1985-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>orcid.org=0000-0003-0717-1630</description>
			<description>diva-portal.org=authority-person:67943</description>
		</name>
		<name type="personal" authority="umu" xlink:href="case0038">
			<namePart type="family">Seyfferth</namePart>
			<namePart type="given">Carolin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>orcid.org=0000-0002-8962-3778</description>
			<description>diva-portal.org=authority-person:67942</description>
		</name>
		<name type="personal" authority="umu" xlink:href="saes0009">
			<namePart type="family">Escamez</namePart>
			<namePart type="given">Sacha</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>orcid.org=0000-0001-7049-6978</description>
			<description>diva-portal.org=authority-person:64476</description>
		</name>
		<name type="personal">
			<namePart type="family">Vain</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8153-907X</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kaan0125">
			<namePart type="family">Antos</namePart>
			<namePart type="given">Kamil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för integrativ medicinsk biologi (IMB)</affiliation>
			<description>diva-portal.org=authority-person:73033</description>
		</name>
		<name type="personal">
			<namePart type="family">Vahala</namePart>
			<namePart type="given">Jorma</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Delhomme</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-3053-0796</description>
		</name>
		<name type="personal">
			<namePart type="family">Kangasjarvi</namePart>
			<namePart type="given">Jaakko</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8959-1809</description>
		</name>
		<name type="personal">
			<namePart type="family">Eder</namePart>
			<namePart type="given">Michaela</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Felten</namePart>
			<namePart type="given">Judith</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0444-822X</description>
		</name>
		<name type="personal" authority="umu" xlink:href="hatu0002">
			<namePart type="family">Tuominen</namePart>
			<namePart type="given">Hannele</namePart>
			<namePart type="date">1964-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<description>diva-portal.org=authority-person:64148</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="867">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysiologisk botanik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="874">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Umeå Plant Science Centre (UPSC)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="734">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för integrativ medicinsk biologi (IMB)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An AP2/ERF transcription factor ERF139 coordinates xylem cell expansion and secondary cell wall deposition</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Wiley-Blackwell</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-06T08:53:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161696</identifier>
		<identifier type="doi">10.1111/nph.15960</identifier>
		<identifier type="pmid">31125440</identifier>
		<identifier type="isi">000474107100001</identifier>
		<identifier type="scopus">2-s2.0-85068612698</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>cell expansion</topic>
		</subject>
		<subject lang="eng">
			<topic>ethylene response factor (ERF)</topic>
		</subject>
		<subject lang="eng">
			<topic>hybrid aspen</topic>
		</subject>
		<subject lang="eng">
			<topic>lignin</topic>
		</subject>
		<subject lang="eng">
			<topic>Populus</topic>
		</subject>
		<subject lang="eng">
			<topic>secondary growth</topic>
		</subject>
		<subject lang="eng">
			<topic>xylem development</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10607">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Botany</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10607">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Botanik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Differentiation of xylem elements involves cell expansion, secondary cell wall (SCW) deposition and programmed cell death. Transitions between these phases require strict spatiotemporal control.&lt;/p&gt;&lt;p&gt;The function of &lt;em&gt;Populus ERF139&lt;/em&gt; (&lt;em&gt;Potri.013G101100&lt;/em&gt;) in xylem differentiation was characterized in transgenic overexpression and dominant repressor lines of &lt;em&gt;ERF139&lt;/em&gt; in hybrid aspen (&lt;em&gt;Populus tremula × tremuloides&lt;/em&gt;). Xylem properties, SCW chemistry and downstream targets were analyzed in both types of transgenic trees using microscopy techniques, Fourier transform‐infrared spectroscopy, pyrolysis‐GC/MS, wet chemistry methods and RNA sequencing.&lt;/p&gt;&lt;p&gt;Opposite phenotypes were observed in the secondary xylem vessel sizes and SCW chemistry in the two different types of transgenic trees, supporting the function of ERF139 in suppressing the radial expansion of vessel elements and stimulating accumulation of guaiacyl‐type lignin and possibly also xylan. Comparative transcriptomics identified genes related to SCW biosynthesis (LAC5, LBD15, MYB86) and salt and drought stress‐responsive genes (ANAC002, ABA1) as potential direct targets of ERF139.&lt;/p&gt;&lt;p&gt;The phenotypes of the transgenic trees and the stem expression profiles of &lt;em&gt;ERF139&lt;/em&gt;potential target genes support the role of ERF139 as a transcriptional regulator of xylem cell expansion and SCW formation, possibly in response to osmotic changes of the cells.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>New Phytologist</title>
			</titleInfo>
			<identifier type="issn">0028-646X</identifier>
			<identifier type="eissn">1469-8137</identifier>
			<part>
				<detail type="volume">
					<number>224</number>
				</detail>
				<detail type="issue">
					<number>4</number>
				</detail>
				<extent>
					<start>1585</start>
					<end>1599</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Forskningsrådet Formas [213-2011-1148]</note>
		<note type="funder">Forskningsrådet Formas [239-2011-1915]</note>
		<note type="funder">Kempestiftelserna [SMK-1649]</note>
		<note type="funder">Kempestiftelserna [SMK-1533]</note>
		<note type="funder">Stiftelsen för strategisk forskning (SSF) [RBP14-0011]</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse [2016-0341]</note>
		<note type="funder">Bio4Energy</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-06</recordCreationDate>
			<recordChangeDate>2020-01-08</recordChangeDate>
			<recordIdentifier>diva2:1340595</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Mariela</namePart>
			<namePart type="given">Morveli-Espinoza</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Federal University of Technology - Paraná (UTFPR), Curitiba, Brazil</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="juca0010">
			<namePart type="family">Nieves</namePart>
			<namePart type="given">Juan Carlos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för datavetenskap</affiliation>
			<description>orcid.org=0000-0003-4072-8795</description>
		</name>
		<name type="personal">
			<namePart type="family">Ayslan</namePart>
			<namePart type="given">Trevizan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Federal University of Technology - Paraná (UTFPR), Curitiba, Brazil</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">J.</namePart>
			<namePart type="given">Puyol-Gruart</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Artificial Intelligence Research Institute (IIIA-CSIC), Barcelona, Spain</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Cesar</namePart>
			<namePart type="given">Tacla</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Federal University of Technology - Paraná (UTFPR), Curitiba, Brazil</affiliation>
		</name>
		<name type="corporate" authority="umu" xlink:href="863">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för datavetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An Argumentation-based Approach for Identifying and Dealing with Incompatibilities among Procedural Goals</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-17T21:56:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154428</identifier>
		<identifier type="doi">10.1016/j.ijar.2018.10.015</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Intelligent agents</topic>
		</subject>
		<subject lang="eng">
			<topic>Goals conflicts</topic>
		</subject>
		<subject lang="eng">
			<topic>Argumentation</topic>
		</subject>
		<subject lang="eng">
			<topic>Goals incompatibility</topic>
		</subject>
		<subject lang="eng">
			<topic>Practical reasoning</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20206">
			<topic>Engineering and Technology</topic>
			<topic>Electrical Engineering, Electronic Engineering, Information Engineering</topic>
			<topic>Computer Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20206">
			<topic>Teknik och teknologier</topic>
			<topic>Elektroteknik och elektronik</topic>
			<topic>Datorsystem</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2135">
			<topic>computer and systems sciences</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2135">
			<topic>data- och systemvetenskap</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;During the first step of practical reasoning, i.e. deliberation, an intelligent agent generates a set of pursuable goals and then selects which of them he commits to achieve. An intelligent agent may in general generate multiple pursuable goals, which may be incompatible among them. In this paper, we focus on the definition, identification and resolution of these incompatibilities. The suggested approach considers the three forms of incompatibility introduced by Castelfranchi and Paglieri, namely the terminal incompatibility, the instrumental or resources incompatibility and the superfluity. We characterize computationally these forms of incompatibility by means of arguments that represent the plans that allow an agent to achieve his goals. Thus, the incompatibility among goals is defined based on the conflicts among their plans, which are represented by means of attacks in an argumentation framework. We also work on the problem of goals selection; we propose to use abstract argumentation theory to deal with this problem, i.e. by applying argumentation semantics. We use a modified version of the “cleaner world” scenario in order to illustrate the performance of our proposal.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Approximate Reasoning</title>
			</titleInfo>
			<identifier type="issn">0888-613X</identifier>
			<identifier type="eissn">1873-4731</identifier>
			<part>
				<detail type="volume">
					<number>105</number>
				</detail>
				<extent>
					<start>1</start>
					<end>26</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>juca0010</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-17</recordCreationDate>
			<recordChangeDate>2019-01-25</recordChangeDate>
			<recordIdentifier>diva2:1271665</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Mathias</namePart>
			<namePart type="given">Kaaren</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kermode</namePart>
			<namePart type="given">Michelle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="misa0002">
			<namePart type="family">San Sebastian</namePart>
			<namePart type="given">Miguel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0001-7234-3510</description>
			<description>diva-portal.org=authority-person:62485</description>
		</name>
		<name type="personal">
			<namePart type="family">Davar</namePart>
			<namePart type="given">Bhargavi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="isgo0005">
			<namePart type="family">Goicolea</namePart>
			<namePart type="given">Isabel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0002-8114-4705</description>
			<description>diva-portal.org=authority-person:62482</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="5303">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An asymmetric burden</title>
			<subTitle>experiences of men and women as caregivers of people with psycho-social disabilities in rural North India</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2018-12-11T13:09:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-154005</identifier>
		<identifier type="doi">10.1177/1363461518792728</identifier>
		<identifier type="pmid">30141376</identifier>
		<identifier type="isi">000454141000004</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>India</topic>
		</subject>
		<subject lang="eng">
			<topic>caregiver burden</topic>
		</subject>
		<subject lang="eng">
			<topic>gender</topic>
		</subject>
		<subject lang="eng">
			<topic>gender inequality</topic>
		</subject>
		<subject lang="eng">
			<topic>global mental health</topic>
		</subject>
		<subject lang="eng">
			<topic>psycho-social disability</topic>
		</subject>
		<subject lang="eng">
			<topic>qualitative</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Caring for a family member with a psycho-social disability can be both rewarding and burdensome. This study analyses the experiences of caregivers of people with psychosocial disabilities (PPSDs) in rural communities in North India using relational gender theory. In-depth interviews with 18 female and male caregivers of PPSDs probed the social, emotional and health impacts of their caregiving role. Nine themes were identified that were grouped under three meta-themes: intra-personal, inter-personal and institutional impacts. Under the intra-personal meta-theme, all caregivers experienced high tension, with women describing almost overwhelming stress. Women minimised their role as caregivers, and felt negative and hopeless about their futures, while men had a more positive view of the future and themselves. Embodied experiences of psychological and social distress were consistently described by women, but not by men. Within the interpersonal meta-theme, men experienced opportunity for social connection and social support that was seldom available to women. Interpersonal violence with other household members was described by both men and women. Within the institutional meta-theme, both men and women described strength in unity, and gestures leading to the reordering of gender relations. These findings underline the significant and diffuse impacts of a gender order that values males and disadvantages females as caregivers of PPSDs, with the asymmetry of a greater burden for women. The findings point to the urgent need for global mental health policies that support and empower caregivers and that strengthen gender equality.&lt;/p&gt;</abstract>
		<note>&lt;p&gt;Article first published online: August 24, 2018&lt;/p&gt;</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Transcultural Psychiatry</title>
			</titleInfo>
			<identifier type="issn">1363-4615</identifier>
			<identifier type="eissn">1461-7471</identifier>
			<part>
				<detail type="volume">
					<number>56</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>76</start>
					<end>102</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>lemu0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2018-12-11</recordCreationDate>
			<recordChangeDate>2019-01-15</recordChangeDate>
			<recordIdentifier>diva2:1269799</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Shafikov</namePart>
			<namePart type="given">Marsel Z.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="shta0002">
			<namePart type="family">Tang</namePart>
			<namePart type="given">Shi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>orcid.org=0000-0003-1274-5918</description>
			<description>diva-portal.org=authority-person:63146</description>
		</name>
		<name type="personal" authority="umu" xlink:href="chla0032">
			<namePart type="family">Larsen</namePart>
			<namePart type="given">Christian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>orcid.org=0000-0002-2480-3786</description>
			<description>diva-portal.org=authority-person:65535</description>
		</name>
		<name type="personal">
			<namePart type="family">Bodensteiner</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kozhevnikov</namePart>
			<namePart type="given">Valery N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="lued0001">
			<namePart type="family">Edman</namePart>
			<namePart type="given">Ludvig</namePart>
			<namePart type="date">1967-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysik</affiliation>
			<description>orcid.org=0000-0003-2495-7037</description>
			<description>diva-portal.org=authority-person:63147</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="866">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An efficient heterodinuclear Ir(III)/Pt(II) complex</title>
			<subTitle>synthesis, photophysics and application in light-emitting electrochemical cells</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>ROYAL SOC CHEMISTRY</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-22T13:47:15</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164505</identifier>
		<identifier type="doi">10.1039/c9tc02930c</identifier>
		<identifier type="isi">000483684600026</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="10302">
			<topic>Natural Sciences</topic>
			<topic>Physical Sciences</topic>
			<topic>Atom and Molecular Physics and Optics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10302">
			<topic>Naturvetenskap</topic>
			<topic>Fysik</topic>
			<topic>Atom- och molekylfysik och optik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;We report on the design, synthesis, characterization and successful application of a heterodinuclear Ir(III)/Pt(II) complex endowed with two 4,6-diphenylpyrimidine ligands and two acetylacetonate ligands, with one of the former being the rigid bridging unit between the two metal centers. The heterodinuclear complex exhibits red phosphorescence with a high quantum yield of Phi(PL) = 85% and a short room-temperature decay time of tau = 640 ns in degassed toluene solution. The high efficiency of the spin-forbidden T-1 -&amp;gt; S-0 transition is demonstrated to originate in a strong spin-orbit coupling of the T-1 state with a manifold of excited singlet states, which contributes to the record-breaking zero-field splitting of the T-1 state of 240 cm(-1). The high-solubility and non-ionic hetero-dinuclear complex was employed as the emissive guest compound in host-guest light-emitting electrochemical cells, and such optimized devices delivered vibrant red emission (lambda(peak) = 615 nm) with a second-fast turn-on and a high external quantum efficiency of 2.7% at a luminance of 265 cd m(-2).&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Materials Chemistry C</title>
			</titleInfo>
			<identifier type="issn">2050-7526</identifier>
			<identifier type="eissn">2050-7534</identifier>
			<part>
				<detail type="volume">
					<number>7</number>
				</detail>
				<detail type="issue">
					<number>34</number>
				</detail>
				<extent>
					<start>10672</start>
					<end>10682</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>parsug04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-22</recordCreationDate>
			<recordChangeDate>2019-11-22</recordChangeDate>
			<recordIdentifier>diva2:1372307</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="gala0013">
			<namePart type="family">Lanot</namePart>
			<namePart type="given">Gauthier</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Nationalekonomi</affiliation>
			<description>orcid.org=0000-0001-9244-7018</description>
			<description>diva-portal.org=authority-person:62527</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mave0001">
			<namePart type="family">Vesterberg</namePart>
			<namePart type="given">Mattias</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Nationalekonomi</affiliation>
			<description>diva-portal.org=authority-person:62892</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="11052">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Nationalekonomi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An empirical model of the decision to switch between electricity price contracts</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2017-11-07T21:38:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-141553</identifier>
		<identifier type="doi">10.1080/2573234X.2019.1645575</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/2573234X.2019.1645575</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Binary Decision</topic>
		</subject>
		<subject lang="eng">
			<topic>Bayesian Learning</topic>
		</subject>
		<subject lang="eng">
			<topic>Contract Choice</topic>
		</subject>
		<subject lang="eng">
			<topic>Price</topic>
		</subject>
		<subject lang="eng">
			<topic>Survival Analysis</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50201">
			<topic>Social Sciences</topic>
			<topic>Economics and Business</topic>
			<topic>Economics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50201">
			<topic>Samhällsvetenskap</topic>
			<topic>Ekonomi och näringsliv</topic>
			<topic>Nationalekonomi</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2145">
			<topic>Economics</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2145">
			<topic>nationalekonomi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="24001">
			<topic>marketing</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="24001">
			<topic>marknadsföring</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2136">
			<topic>ekonomisk historia</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2136">
			<topic>Economic History</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;In this paper, we explore how sensitive the timing of switches between electricity contracts is to current and past prices. We present a model for time series of individual binary decisions which depends on the history of past and present prices. The model is based on the Bayesian learning procedure which is at the core of sequential decision-making. Given a-priori distributions of the information conditional on the state of the world, we show that the model captures dependence on past prices in a straightforward fashion. We estimate by maximum likelihood the parameters of the model on a sample of Swedish households who decide over time between competing electricity price contracts. The estimated parameters suggest that households do respond to prices by switching between contracts and that the response to price can be sizeable for alternative price processes. Importantly, the model structure implies that in general, the response to a price change will not be immediate but delayed.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<part>
				<detail type="volume">
					<number>2</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Business Analytics</title>
			</titleInfo>
			<identifier type="issn">2573-234X</identifier>
			<identifier type="eissn">2573-2358</identifier>
			<part>
				<detail type="volume">
					<number>2</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1155382/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>gala0013</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2017-11-07</recordCreationDate>
			<recordChangeDate>2019-10-14</recordChangeDate>
			<recordIdentifier>diva2:1155382</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="evle0001">
			<namePart type="family">Leffler</namePart>
			<namePart type="given">Eva</namePart>
			<namePart type="date">1956-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Pedagogiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:62701</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="845">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Pedagogiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An Entrepreneurial Attitude</title>
			<subTitle>Implications for Teachers' Leadership Skills?</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Routledge</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-17T21:34:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164242</identifier>
		<identifier type="doi">10.1080/15700763.2019.1668021</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/15700763.2019.1668021</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="50301">
			<topic>Social Sciences</topic>
			<topic>Educational Sciences</topic>
			<topic>Pedagogy</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50301">
			<topic>Samhällsvetenskap</topic>
			<topic>Utbildningsvetenskap</topic>
			<topic>Pedagogik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Entrepreneurship in school is a widespread issue within the school system and it is therefore important to problematise teachers and their role when entrepreneurship is emphasized in their school practice. The teachers in this study, from the secondary and upper secondary levels, were all participating in a Swedish three-year school improvement programme on entrepreneurship in school. Based on a questionnaire and interviews, the results were categorized into four main teacher leadership skills: teachership, leadership, professional leadership, and "professionship". This study high-lights the importance of teachers' relationship to their students, new thinking about teaching and learning, and subject knowledge.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Leadership and Policy in Schools</title>
			</titleInfo>
			<identifier type="issn">1570-0763</identifier>
			<identifier type="eissn">1744-5043</identifier>
			<part>
				<extent>
					<start>1</start>
					<end>16</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>ulsa0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-17</recordCreationDate>
			<recordChangeDate>2019-10-22</recordChangeDate>
			<recordIdentifier>diva2:1362092</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="pati0006">
			<namePart type="family">Tinc</namePart>
			<namePart type="given">Pamela J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<affiliation>Northeast Center for Occupational Health and Safety: Agriculture, Forestry,and Fishing, Cooperstown, NY, USA</affiliation>
			<description>orcid.org=0000-0002-7232-9417</description>
			<description>diva-portal.org=authority-person:68198</description>
		</name>
		<name type="personal">
			<namePart type="family">Sorensen</namePart>
			<namePart type="given">Julie A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="lawe0001">
			<namePart type="family">Weinehall</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<description>diva-portal.org=authority-person:63810</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kralil01">
			<namePart type="family">Lindvall</namePart>
			<namePart type="given">Kristina</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<description>diva-portal.org=authority-person:66362</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An exploration of rollover protective structures (ROPS) rebate program media coverage</title>
			<subTitle>strategies for implementation and sustainment</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Springer</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-30T09:32:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163613</identifier>
		<identifier type="doi">10.1186/s12889-019-7586-3</identifier>
		<identifier type="pmid">31510988</identifier>
		<identifier type="isi">000485299600004</identifier>
		<identifier type="articleId">1257</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12889-019-7586-3</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Rollover protection</topic>
		</subject>
		<subject lang="eng">
			<topic>Media advocacy</topic>
		</subject>
		<subject lang="eng">
			<topic>Implementation</topic>
		</subject>
		<subject lang="eng">
			<topic>Discourse analysis</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2071">
			<topic>Occupational and Environmental Medicine</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2071">
			<topic>arbets- och miljömedicin</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Media advocacy plays an important role in public health initiatives, as it can provide vital information to target populations, policy makers, or other relevant stakeholders. Unfortunately, little is currently known about the use of media advocacy to promote occupational safety and health programs. This study explores media coverage related to the Rollover Protection Structure (ROPS) Rebate Programs, which were designed to encourage the use of rollover protection on agricultural tractors, thus reducing the risk of tractor overturn fatalities. The Program’s portrayal in the media, as well as the role that the media has played in implementing and sustaining these Programs.&lt;/p&gt;&lt;p&gt;Methods: Media articles pertaining to any of the state-based or National ROPS Rebate Programs and published between November 1, 2006 and October 31, 2018 were included for review. Discourse analysis was used to understand the messages portrayed by the media and how those messages shaped the outcomes of the ROPS Rebate Programs.&lt;/p&gt;&lt;p&gt;Results: During the study period, 212 unique articles were published about the ROPS Rebate Programs. While these articles all portrayed the ROPS Rebate Programs in a largely positive light, they were used at different stages, from pre-implementation through sustainment of the ROPS Rebate Programs, and to different extents.&lt;/p&gt;&lt;p&gt;Conclusions: Media articles have played an important role in implementing and sustaining the ROPS Rebate Programs. Based on the results of this study, more robust and continuous media coverage are important for the longevity and success of public health programs.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>BMC Public Health</title>
			</titleInfo>
			<identifier type="issn">1471-2458</identifier>
			<identifier type="eissn">1471-2458</identifier>
			<part>
				<detail type="volume">
					<number>19</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1355569/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>pati0006</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-30</recordCreationDate>
			<recordChangeDate>2019-11-13</recordChangeDate>
			<recordIdentifier>diva2:1355569</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="saaotn01">
			<namePart type="family">Einarsson</namePart>
			<namePart type="given">Sandra</namePart>
			<namePart type="date">1981-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för kostvetenskap</affiliation>
			<description>orcid.org=0000-0003-4770-3726</description>
			<description>diva-portal.org=authority-person:70575</description>
		</name>
		<name type="personal">
			<namePart type="family">Laurell</namePart>
			<namePart type="given">Göran</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-7760-246X</description>
		</name>
		<name type="personal">
			<namePart type="family">Tiblom Ehrsson</namePart>
			<namePart type="given">Ylva</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-7435-167X</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="841">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för kostvetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An explorative study on energy balance in patients with head and neck cancer</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-14T08:41:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164019</identifier>
		<identifier type="doi">10.1080/01635581.2019.1676454</identifier>
		<identifier type="pmid">31608662</identifier>
		<identifier type="isi">000490390900001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1080/01635581.2019.1676454</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30304">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Nutrition and Dietetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30304">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Näringslära</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Involuntary body weight loss in head and neck cancer is common. Fundamental for weight loss is an energy imbalance where total energy expenditure exceeds energy intake.&lt;/p&gt;&lt;p&gt;Aim: To map energy intake and parameters of energy expenditure at the start of and after radiotherapy, and their relation to weight change, body mass index, and immune markers in patients with head and neck cancer.&lt;/p&gt;&lt;p&gt;Materials and Methods: Data from 20 patients on energy intake (24-hour dietary intake recalls), total energy expenditure (SenseWear Armband Pro3), resting energy expenditure (indirect calorimetry), body weight, body mass index, and immune markers in serum (C-reactive protein and Interleukin-6) were collected at the start of and after radiotherapy (median 8 mo, range 5–13).&lt;/p&gt;&lt;p&gt;Results: No statistical significance was shown between the two measurement points for energy intake or for the different parameters of energy expenditure. Median values for energy balance were 0.93 and 0.96 for the start of treatment and follow-up, respectively. Twelve and 13 patients had a negative energy balance at the start of radiotherapy and at follow-up, respectively.&lt;/p&gt;&lt;p&gt;Conclusion: A negative energy balance was seen for the majority of patients, which stresses the importance of nutritional treatment at the start of and after radiotherapy.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Nutrition and Cancer</title>
			</titleInfo>
			<identifier type="issn">0163-5581</identifier>
			<identifier type="eissn">1532-7914</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<note type="funder">Cancerfonden [CAN 2008/772]</note>
		<note type="funder">Cancerfonden [CAN 2015/363]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1360503/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>saaotn01</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-14</recordCreationDate>
			<recordChangeDate>2019-11-08</recordChangeDate>
			<recordIdentifier>diva2:1360503</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="klle0001">
			<namePart type="family">Leffler</namePart>
			<namePart type="given">Klara</namePart>
			<namePart type="date">1988-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<description>diva-portal.org=authority-person:70779</description>
		</name>
		<name type="personal">
			<namePart type="family">Zhou</namePart>
			<namePart type="given">Zhiyong</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Department of Statistics, Zhejiang University City College, China</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="juyu0002">
			<namePart type="family">Yu</namePart>
			<namePart type="given">Jun</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för matematik och matematisk statistik</affiliation>
			<affiliation>Mathematical Statistics</affiliation>
			<description>orcid.org=0000-0001-5673-620x</description>
			<description>diva-portal.org=authority-person:63104</description>
		</name>
		<name type="corporate">
			<namePart>Mathematical Statistics</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="869">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för matematik och matematisk statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An extended block restricted isometry property for sparse recovery with non-Gaussian noise</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Global Science Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-17T08:44:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163366</identifier>
		<identifier type="doi">10.4208/jcm.1905-m2018-0256</identifier>
		<location>
			<url displayLabel="URL">https://admin.global-sci.org/uploads/online_news/JCM/201909170945-12503.pdf</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Compressed sensing</topic>
		</subject>
		<subject lang="eng">
			<topic>block sparsity</topic>
		</subject>
		<subject lang="eng">
			<topic>partial support information</topic>
		</subject>
		<subject lang="eng">
			<topic>signal reconstruction</topic>
		</subject>
		<subject lang="eng">
			<topic>convex optimization</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20205">
			<topic>Engineering and Technology</topic>
			<topic>Electrical Engineering, Electronic Engineering, Information Engineering</topic>
			<topic>Signal Processing</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20205">
			<topic>Teknik och teknologier</topic>
			<topic>Elektroteknik och elektronik</topic>
			<topic>Signalbehandling</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10106">
			<topic>Natural Sciences</topic>
			<topic>Mathematics</topic>
			<topic>Probability Theory and Statistics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10106">
			<topic>Naturvetenskap</topic>
			<topic>Matematik</topic>
			<topic>Sannolikhetsteori och statistik</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10105">
			<topic>Computational Mathematics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10105">
			<topic>Beräkningsmatematik</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2199">
			<topic>matematisk statistik</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2199">
			<topic>Mathematical Statistics</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;We study the recovery conditions of weighted mixed ℓ2/ℓp minimization for block sparse signal reconstruction from compressed measurements when partial block supportinformation is available. We show theoretically that the extended block restricted isometry property can ensure robust recovery when the data fidelity constraint is expressed in terms of an ℓq norm of the residual error, thus establishing a setting wherein we arenot restricted to Gaussian measurement noise. We illustrate the results with a series of numerical experiments.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of Computational Mathematics</title>
			</titleInfo>
			<identifier type="issn">0254-9409</identifier>
			<identifier type="eissn">1991-7139</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<note type="funder">Vetenskapsrådet</note>
		<recordInfo>
			<recordOrigin>juyu0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-17</recordCreationDate>
			<recordChangeDate>2019-11-19</recordChangeDate>
			<recordIdentifier>diva2:1351857</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="peby0002">
			<namePart type="family">Byass</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<affiliation>Institute of Applied Health Sciences, University of Aberdeen, Scotland, UK; Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa</affiliation>
			<description>diva-portal.org=authority-person:62912</description>
		</name>
		<name type="personal">
			<namePart type="family">Hussain-Alkhateeb</namePart>
			<namePart type="given">Laith</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">D'Ambruoso</namePart>
			<namePart type="given">Lucia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Clark</namePart>
			<namePart type="given">Samuel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Davies</namePart>
			<namePart type="given">Justine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fottrell</namePart>
			<namePart type="given">Edward</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bird</namePart>
			<namePart type="given">Jon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kabudula</namePart>
			<namePart type="given">Chodziwadziwa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="stto0004">
			<namePart type="family">Tollman</namePart>
			<namePart type="given">Stephen M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<affiliation>Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa; INDEPTH Network, Accra, Ghana</affiliation>
			<description>diva-portal.org=authority-person:63190</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kaka0045">
			<namePart type="family">Kahn</namePart>
			<namePart type="given">Kathleen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<affiliation>Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa; INDEPTH Network, Accra, Ghana</affiliation>
			<description>diva-portal.org=authority-person:62930</description>
		</name>
		<name type="personal">
			<namePart type="family">Schiöler</namePart>
			<namePart type="given">Linus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Petzold</namePart>
			<namePart type="given">Max</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An integrated approach to processing WHO-2016 verbal autopsy data</title>
			<subTitle>the InterVA-5 model</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-17T15:15:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-160291</identifier>
		<identifier type="doi">10.1186/s12916-019-1333-6</identifier>
		<identifier type="pmid">31146736</identifier>
		<identifier type="isi">000469778700001</identifier>
		<identifier type="articleId">102</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12916-019-1333-6</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Verbal autopsy</topic>
		</subject>
		<subject lang="eng">
			<topic>Mortality surveillance</topic>
		</subject>
		<subject lang="eng">
			<topic>Civil registration</topic>
		</subject>
		<subject lang="eng">
			<topic>InterVA</topic>
		</subject>
		<subject lang="eng">
			<topic>Cause of death</topic>
		</subject>
		<subject lang="eng">
			<topic>World Health Organization</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Verbal autopsy is an increasingly important methodology for assigning causes to otherwise uncertified deaths, which amount to around 50% of global mortality and cause much uncertainty for health planning. The World Health Organization sets international standards for the structure of verbal autopsy interviews and for cause categories that can reasonably be derived from verbal autopsy data. In addition, computer models are needed to efficiently process large quantities of verbal autopsy interviews to assign causes of death in a standardised manner. Here, we present the InterVA-5 model, developed to align with the WHO-2016 verbal autopsy standard. This is a harmonising model that can process input data from WHO-2016, as well as earlier WHO-2012 and Tariff-2 formats, to generate standardised cause-specific mortality profiles for diverse contexts.&lt;/p&gt;&lt;p&gt;The software development involved building on the earlier InterVA-4 model, and the expanded knowledge base required for InterVA-5 was informed by analyses from a training dataset drawn from the Population Health Metrics Research Collaboration verbal autopsy reference dataset, as well as expert input.&lt;/p&gt;&lt;p&gt;Results: The new model was evaluated against a test dataset of 6130 cases from the Population Health Metrics Research Collaboration and 4009 cases from the Afghanistan National Mortality Survey dataset. Both of these sources contained around three quarters of the input items from the WHO-2016, WHO-2012 and Tariff-2 formats. Cause-specific mortality fractions across all applicable WHO cause categories were compared between causes assigned in participating tertiary hospitals and InterVA-5 in the test dataset, with concordance correlation coefficients of 0.92 for children and 0.86 for adults.&lt;/p&gt;&lt;p&gt;The InterVA-5 model’s capacity to handle different input formats was evaluated in the Afghanistan dataset, with concordance correlation coefficients of 0.97 and 0.96 between the WHO-2016 and the WHO-2012 format for children and adults respectively, and 0.92 and 0.87 between the WHO-2016 and the Tariff-2 format respectively.&lt;/p&gt;&lt;p&gt;Conclusions: Despite the inherent difficulties of determining “truth” in assigning cause of death, these findings suggest that the InterVA-5 model performs well and succeeds in harmonising across a range of input formats. As more primary data collected under WHO-2016 become available, it is likely that InterVA-5 will undergo minor re-versioning in the light of practical experience. The model is an important resource for measuring and evaluating cause-specific mortality globally.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>BMC Medicine</title>
			</titleInfo>
			<identifier type="issn">1741-7015</identifier>
			<identifier type="eissn">1741-7015</identifier>
			<part>
				<detail type="volume">
					<number>17</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1325997/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-17</recordCreationDate>
			<recordChangeDate>2019-06-17</recordChangeDate>
			<recordIdentifier>diva2:1325997</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="zaha0008">
			<namePart type="family">Haider</namePart>
			<namePart type="given">Zahra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>orcid.org=0000-0002-0759-3932</description>
			<description>diva-portal.org=authority-person:67962</description>
		</name>
		<name type="personal" authority="umu" xlink:href="pala0006">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Pär</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>diva-portal.org=authority-person:63609</description>
		</name>
		<name type="personal" authority="umu" xlink:href="maslas98">
			<namePart type="family">Landfors</namePart>
			<namePart type="given">Mattias</namePart>
			<namePart type="date">1977-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>diva-portal.org=authority-person:65453</description>
		</name>
		<name type="personal" authority="umu" xlink:href="liaann99">
			<namePart type="family">Köhn</namePart>
			<namePart type="given">Linda</namePart>
			<namePart type="date">1979-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<description>diva-portal.org=authority-person:65289</description>
		</name>
		<name type="personal">
			<namePart type="family">Schmiegelow</namePart>
			<namePart type="given">Kjeld</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Flaegstad</namePart>
			<namePart type="given">Trond</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kanerva</namePart>
			<namePart type="given">Jukka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Heyman</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="magn0001">
			<namePart type="family">Hultdin</namePart>
			<namePart type="given">Magnus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<description>diva-portal.org=authority-person:65322</description>
		</name>
		<name type="personal" authority="umu" xlink:href="soiden99">
			<namePart type="family">Degerman</namePart>
			<namePart type="given">Sofie</namePart>
			<namePart type="date">1977-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>orcid.org=0000-0002-2783-0712</description>
			<description>diva-portal.org=authority-person:64844</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="747">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="749">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<namePart>Patologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="776">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-02-20T11:56:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156637</identifier>
		<identifier type="doi">10.1002/cam4.1917</identifier>
		<identifier type="pmid">30575306</identifier>
		<identifier type="isi">000456858100032</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1002/cam4.1917</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>BEX1</topic>
		</subject>
		<subject lang="eng">
			<topic>DNA methylation</topic>
		</subject>
		<subject lang="eng">
			<topic>HOXA</topic>
		</subject>
		<subject lang="eng">
			<topic>pediatric acute lymphoblastic leukemia</topic>
		</subject>
		<subject lang="eng">
			<topic>TAL1</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30202">
			<topic>Hematology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30202">
			<topic>Hematologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30221">
			<topic>Pediatrics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30221">
			<topic>Pediatrik</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10602">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Biochemistry and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10602">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Biokemi och molekylärbiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Classification of pediatric T‐cell acute lymphoblastic leukemia (T‐ALL) patients into CIMP (CpG Island Methylator Phenotype) subgroups has the potential to improve current risk stratification. To investigate the biology behind these CIMP subgroups, diagnostic samples from Nordic pediatric T‐ALL patients were characterized by genome‐wide methylation arrays, followed by targeted exome sequencing, telomere length measurement, and RNA sequencing. The CIMP subgroups did not correlate significantly with variations in epigenetic regulators. However, the CIMP+ subgroup, associated with better prognosis, showed indicators of longer replicative history, including shorter telomere length (&lt;em&gt;P&lt;/em&gt; = 0.015) and older epigenetic (&lt;em&gt;P&lt;/em&gt; &amp;lt; 0.001) and mitotic age (&lt;em&gt;P&lt;/em&gt; &amp;lt; 0.001). Moreover, the CIMP+ subgroup had significantly higher expression of ANTP homeobox oncogenes, namely &lt;em&gt;TLX3, HOXA9, HOXA10,&lt;/em&gt; and &lt;em&gt;NKX2‐1&lt;/em&gt;, and novel genes in T‐ALL biology including &lt;em&gt;PLCB4, PLXND1&lt;/em&gt;, and &lt;em&gt;MYO18B&lt;/em&gt;. The CIMP− subgroup, with worse prognosis, was associated with higher expression of &lt;em&gt;TAL1&lt;/em&gt; along with frequent STIL‐TAL1 fusions (2/40 in CIMP+ vs 11/24 in CIMP−), as well as stronger expression of &lt;em&gt;BEX1&lt;/em&gt;. Altogether, our findings suggest different routes for leukemogenic transformation in the T‐ALL CIMP subgroups, indicated by different replicative histories and distinct methylomic and transcriptomic profiles. These novel findings can lead to new therapeutic strategies.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Cancer Medicine</title>
			</titleInfo>
			<identifier type="issn">2045-7634</identifier>
			<identifier type="eissn">2045-7634</identifier>
			<part>
				<detail type="volume">
					<number>8</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>311</start>
					<end>324</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Kempestiftelserna</note>
		<note type="funder">Barncancerfonden</note>
		<note type="funder">Västerbottens läns landsting</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1290314/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>zaha0008</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-02-20</recordCreationDate>
			<recordChangeDate>2019-02-20</recordChangeDate>
			<recordIdentifier>diva2:1290314</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="tivo0002">
			<namePart type="family">Vollmer</namePart>
			<namePart type="given">Tino</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin-Brandenburg School for Regenerative Therapies (BSRT) &amp; Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Berlin, Germany</affiliation>
			<description>orcid.org=0000-0002-0358-3876</description>
			<description>diva-portal.org=authority-person:74413</description>
		</name>
		<name type="personal" authority="umu" xlink:href="bolj0001">
			<namePart type="family">Ljungberg</namePart>
			<namePart type="given">Börje</namePart>
			<namePart type="date">1949-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Urologi och andrologi</affiliation>
			<description>orcid.org=0000-0002-4121-3753</description>
			<description>diva-portal.org=authority-person:62754</description>
		</name>
		<name type="personal">
			<namePart type="family">Jankowski</namePart>
			<namePart type="given">Vera</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jankowski</namePart>
			<namePart type="given">Joachim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Glorieux</namePart>
			<namePart type="given">Griet</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="best0006">
			<namePart type="family">Stegmayr</namePart>
			<namePart type="given">Bernd</namePart>
			<namePart type="date">1949-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>orcid.org=0000-0003-2694-7035</description>
			<description>diva-portal.org=authority-person:62791</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="799">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Urologi och andrologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-06T15:36:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165676</identifier>
		<identifier type="doi">10.1038/s41598-019-50929-z</identifier>
		<identifier type="pmid">31601841</identifier>
		<identifier type="isi">000489555200037</identifier>
		<identifier type="articleId">14525</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1038/s41598-019-50929-z</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30214">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Urology and Nephrology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30214">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Urologi och njurmedicin</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Identifying the key toxic players within an in-vivo toxic syndrome is crucial to develop targeted therapies. Here, we established a novel method that characterizes the effect of single substances by means of an ex-vivo incubation set-up. We found that primary human spermatozoa elicit a distinct motile response on a (uremic) toxic milieu. Specifically, this approach describes the influence of a bulk toxic environment (uremia) as well as single substances (uremic toxins) by real-time analyzing motile cellular behavior. We established the human spermatozoa-based toxicity testing (HSTT) for detecting single substance-induced toxicity to be used as a screening tool to identify in-vivo toxins. Further, we propose an application of the HSTT as a method of clinical use to evaluate toxin-removing interventions (hemodialysis).&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Scientific Reports</title>
			</titleInfo>
			<identifier type="issn">2045-2322</identifier>
			<identifier type="eissn">2045-2322</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1376009/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>bonnym04</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-06</recordCreationDate>
			<recordChangeDate>2019-12-06</recordChangeDate>
			<recordIdentifier>diva2:1376009</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<genre authority="diva" type="publicationSubTypeCode">editorialMaterial</genre>
		<name type="personal">
			<namePart type="family">Bjornestad</namePart>
			<namePart type="given">Elin Eb</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Kirurgisk serviceklinikk, Klinikkoverlege, Helse Bergen HF, Norway</affiliation>
			<description>orcid.org=0000-0002-8420-9367</description>
		</name>
		<name type="personal" authority="umu" xlink:href="milhay96">
			<namePart type="family">Haney</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Anestesiologi och intensivvård</affiliation>
			<description>orcid.org=0000-0002-4049-8910</description>
			<description>diva-portal.org=authority-person:62763</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="794">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Anestesiologi och intensivvård</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An obstetric anaesthetist</title>
			<subTitle>A key to successful conversion of epidural analgesia to surgical anaesthesia for caesarean delivery?</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-02T09:01:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165623</identifier>
		<identifier type="doi">10.1111/aas.13493</identifier>
		<identifier type="pmid">31628671</identifier>
		<identifier type="isi">000493784700001</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1111/aas.13493</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30201">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Anesthesiology and Intensive Care</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30201">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Anestesi och intensivvård</topic>
		</subject>
		<relatedItem type="host">
			<titleInfo>
				<title>Acta Anaesthesiologica Scandinavica</title>
			</titleInfo>
			<identifier type="issn">0001-5172</identifier>
			<identifier type="eissn">1399-6576</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1374477/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>gojo0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-02</recordCreationDate>
			<recordChangeDate>2019-12-03</recordChangeDate>
			<recordIdentifier>diva2:1374477</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="caabon02">
			<namePart type="family">Bernhardsson</namePart>
			<namePart type="given">Carolina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<affiliation>Umeå Plant Science Centre, Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Science, Umeå, Sweden; Department of Plant Biology, Uppsala BioCenter, Swedish University of Agricultural Science, Uppsala, Sweden</affiliation>
			<description>diva-portal.org=authority-person:66439</description>
		</name>
		<name type="personal" authority="umu" xlink:href="amvi0004">
			<namePart type="family">Vidalis</namePart>
			<namePart type="given">Amaryllis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<affiliation>Department of Population Genetics, Center of Life and Food Sciences Weihenstephan, Technische Universität München</affiliation>
			<description>orcid.org=0000-0002-7111-9530</description>
			<description>diva-portal.org=authority-person:66122</description>
		</name>
		<name type="personal" authority="umu" xlink:href="xiwa0012">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Xi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<affiliation>Department of Plant Biology, Uppsala BioCenter, Swedish University of Agricultural Science, Uppsala, Sweden</affiliation>
			<description>diva-portal.org=authority-person:72467</description>
		</name>
		<name type="personal" authority="umu" xlink:href="dosc0001">
			<namePart type="family">Scofield</namePart>
			<namePart type="given">Douglas</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<affiliation>Uppsala Multidisciplinary Center for Advanced Computational Science; Department of Ecology and Genetics: Evolutionary Biology, Uppsala University, Uppsala, Sweden</affiliation>
			<description>orcid.org=0000-0001-5235-6461</description>
			<description>diva-portal.org=authority-person:10178</description>
		</name>
		<name type="personal" authority="umu" xlink:href="basc0004">
			<namePart type="family">Schiffthaler</namePart>
			<namePart type="given">Bastian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<description>diva-portal.org=authority-person:68213</description>
		</name>
		<name type="personal">
			<namePart type="family">Baison</namePart>
			<namePart type="given">John</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="rona0006">
			<namePart type="family">Street</namePart>
			<namePart type="given">Nathaniel</namePart>
			<namePart type="date">1979-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för fysiologisk botanik</affiliation>
			<affiliation>Umeå universitet, Umeå Plant Science Centre (UPSC)</affiliation>
			<description>orcid.org=0000-0001-6031-005x</description>
			<description>diva-portal.org=authority-person:64272</description>
		</name>
		<name type="personal">
			<namePart type="family">Garcia-Gil</namePart>
			<namePart type="given">M. Rosario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="pain0001">
			<namePart type="family">Ingvarsson</namePart>
			<namePart type="given">Pär K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<affiliation>Department of Plant Biology, Uppsala BioCenter, Swedish University of Agricultural Science, Uppsala, Sweden</affiliation>
			<description>orcid.org=0000-0001-9225-7521</description>
			<description>diva-portal.org=authority-person:63176</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="879">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för ekologi, miljö och geovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="874">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Umeå Plant Science Centre (UPSC)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="867">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för fysiologisk botanik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An Ultra-Dense Haploid Genetic Map for Evaluating the Highly Fragmented Genome Assembly of Norway Spruce (Picea abies)</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Genetics Society of America</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-10T13:19:37</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159871</identifier>
		<identifier type="doi">10.1534/g3.118.200840</identifier>
		<identifier type="pmid">30898899</identifier>
		<identifier type="isi">000467271400031</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>genetic map</topic>
		</subject>
		<subject lang="eng">
			<topic>Norway spruce</topic>
		</subject>
		<subject lang="eng">
			<topic>Picea abies</topic>
		</subject>
		<subject lang="eng">
			<topic>sequence capture</topic>
		</subject>
		<subject lang="eng">
			<topic>genome assembly</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10609">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Genetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10609">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Genetik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Norway spruce (Picea abies (L.) Karst.) is a conifer species of substanital economic and ecological importance. In common with most conifers, the P. abies genome is very large (similar to 20 Gbp) and contains a high fraction of repetitive DNA. The current P. abies genome assembly (v1.0) covers approximately 60% of the total genome size but is highly fragmented, consisting of &amp;gt;10 million scaffolds. The genome annotation contains 66,632 gene models that are at least partially validated (), however, the fragmented nature of the assembly means that there is currently little information available on how these genes are physically distributed over the 12 P. abies chromosomes. By creating an ultra-dense genetic linkage map, we anchored and ordered scaffolds into linkage groups, which complements the fine-scale information available in assembly contigs. Our ultra-dense haploid consensus genetic map consists of 21,056 markers derived from 14,336 scaffolds that contain 17,079 gene models (25.6% of the validated gene models) that we have anchored to the 12 linkage groups. We used data from three independent component maps, as well as comparisons with previously published Picea maps to evaluate the accuracy and marker ordering of the linkage groups. We demonstrate that approximately 3.8% of the anchored scaffolds and 1.6% of the gene models covered by the consensus map have likely assembly errors as they contain genetic markers that map to different regions within or between linkage groups. We further evaluate the utility of the genetic map for the conifer research community by using an independent data set of unrelated individuals to assess genome-wide variation in genetic diversity using the genomic regions anchored to linkage groups. The results show that our map is sufficiently dense to enable detailed evolutionary analyses across the P. abies genome.&lt;/p&gt;</abstract>
		<note type="project">Bio4Energy</note>
		<relatedItem type="host">
			<titleInfo>
				<title>G3</title>
				<subTitle>Genes, Genomes, Genetics</subTitle>
			</titleInfo>
			<identifier type="issn">2160-1836</identifier>
			<identifier type="eissn">2160-1836</identifier>
			<part>
				<detail type="volume">
					<number>9</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>1623</start>
					<end>1632</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Knut och Alice Wallenbergs Stiftelse</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-10</recordCreationDate>
			<recordChangeDate>2019-09-06</recordChangeDate>
			<recordIdentifier>diva2:1322040</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Nagi</namePart>
			<namePart type="given">Saad S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-8773-8232</description>
		</name>
		<name type="personal">
			<namePart type="family">Marshall</namePart>
			<namePart type="given">Andrew G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Makdani</namePart>
			<namePart type="given">Adarsh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="jaew0002">
			<namePart type="family">Jarocka</namePart>
			<namePart type="given">Ewa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Fysiologi</affiliation>
			<description>diva-portal.org=authority-person:68291</description>
		</name>
		<name type="personal">
			<namePart type="family">Liljencrantz</namePart>
			<namePart type="given">Jaquette</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ridderstrom</namePart>
			<namePart type="given">Mikael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Ortopedi</affiliation>
			<description>orcid.org=0000-0002-8578-4283</description>
		</name>
		<name type="personal">
			<namePart type="family">Shaikh</namePart>
			<namePart type="given">Sumaiya</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">O'Neill</namePart>
			<namePart type="given">Francis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-6009-1026</description>
		</name>
		<name type="personal">
			<namePart type="family">Saade</namePart>
			<namePart type="given">Dimah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1938-9952</description>
		</name>
		<name type="personal">
			<namePart type="family">Donkervoort</namePart>
			<namePart type="given">Sandra</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Foley</namePart>
			<namePart type="given">A. Reghan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Minde</namePart>
			<namePart type="given">Jan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Ortopedi</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Trulsson</namePart>
			<namePart type="given">Mats</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cole</namePart>
			<namePart type="given">Jonathan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bonnemann</namePart>
			<namePart type="given">Carsten G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chesler</namePart>
			<namePart type="given">Alexander T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bushnell</namePart>
			<namePart type="given">M. Catherine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">McGlone</namePart>
			<namePart type="given">Francis</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Olausson</namePart>
			<namePart type="given">Hakan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="737">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för integrativ medicinsk biologi (IMB)</namePart>
			<namePart>Fysiologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="796">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Ortopedi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>An ultrafast system for signaling mechanical pain in human skin</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Association for the Advancement of Science</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-16T15:41:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-166419</identifier>
		<identifier type="doi">10.1126/sciadv.aaw1297</identifier>
		<identifier type="pmid">31281886</identifier>
		<identifier type="isi">000478770400048</identifier>
		<identifier type="scopus">2-s2.0-85068598091</identifier>
		<identifier type="articleId">eaaw1297</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1126/sciadv.aaw1297</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30105">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Neurosciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30105">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Neurovetenskaper</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;The canonical view is that touch is signaled by fast-conducting, thickly myelinated afferents, whereas pain is signaled by slow-conducting, thinly myelinated (“fast” pain) or unmyelinated (“slow” pain) afferents. While other mammals have thickly myelinated afferents signaling pain (ultrafast nociceptors), these have not been demonstrated in humans. Here, we performed single-unit axonal recordings (microneurography) from cutaneous mechanoreceptive afferents in healthy participants. We identified A-fiber high-threshold mechanoreceptors (A-HTMRs) that were insensitive to gentle touch, encoded noxious skin indentations, and displayed conduction velocities similar to A-fiber low-threshold mechanoreceptors. Intraneural electrical stimulation of single ultrafast A-HTMRs evoked painful percepts. Testing in patients with selective deafferentation revealed impaired pain judgments to graded mechanical stimuli only when thickly myelinated fibers were absent. This function was preserved in patients with a loss-of-function mutation in mechanotransduction channel PIEZO2. These findings demonstrate that human mechanical pain does not require PIEZO2 and can be signaled by fast-conducting, thickly myelinated afferents.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Science Advances</title>
			</titleInfo>
			<identifier type="eissn">2375-2548</identifier>
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<detail type="issue">
					<number>7</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1379230/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-16</recordCreationDate>
			<recordChangeDate>2019-12-16</recordChangeDate>
			<recordIdentifier>diva2:1379230</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="chla0093">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">Charlotta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för kirurgisk och perioperativ vetenskap</affiliation>
			<affiliation>Hospital of Östersund, Östersund, Sweden</affiliation>
			<description>diva-portal.org=authority-person:72012</description>
		</name>
		<name type="personal">
			<namePart type="family">Hedberg</namePart>
			<namePart type="given">Charlotta Linder</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lundgren</namePart>
			<namePart type="given">Ewa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Söderström</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="katu0012">
			<namePart type="family">Tunón</namePart>
			<namePart type="given">Katarina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Obstetrik och gynekologi</affiliation>
			<description>diva-portal.org=authority-person:68227</description>
		</name>
		<name type="personal" authority="umu" xlink:href="pano0023">
			<namePart type="family">Nordin</namePart>
			<namePart type="given">Pär</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kirurgi</affiliation>
			<description>diva-portal.org=authority-person:63031</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="792">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="743">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Obstetrik och gynekologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="793">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för kirurgisk och perioperativ vetenskap</namePart>
			<namePart>Kirurgi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Anal incontinence after caesarean and vaginal delivery in Sweden</title>
			<subTitle>a national population-based study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-17T14:07:32</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157949</identifier>
		<identifier type="doi">10.1016/S0140-6736(18)32002-6</identifier>
		<identifier type="pmid">30799061</identifier>
		<identifier type="isi">000462038400030</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30220">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Obstetrics, Gynecology and Reproductive Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30220">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Reproduktionsmedicin och gynekologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Elective caesarean delivery is increasing rapidly in many countries, and one of the reasons might be that caesarean delivery is widely believed to protect against pelvic floor disorders, including anal incontinence. Previous studies on this issue have been small and with conflicting results. The aim of present study was to compare the risk of developing anal incontinence in women who had a caesarean delivery, in those who had a vaginal delivery, and in two age-matched control groups (nulliparous women and men).&lt;/p&gt;&lt;p&gt;Methods: In this observational population-based study, we included all women in the Swedish Medical Birth Register who gave birth by caesarean delivery or vaginal delivery during 1973-2015 in Sweden and were diagnosed with anal incontinence according to ICD 8-10 in the Swedish National Patient Register during 2001-15. Exclusion criteria were multiple birth delivery, mixed vaginal and caesarean delivery, and four or more deliveries. We compared the diagnosis of anal incontinence between women previously delivered solely by caesarean delivery and those who solely had delivered vaginally. We also compared it with two age-matched control groups of nulliparous women and men from the Swedish Total Population Register. Finally, we analysed risk factors for anal incontinence in the caesarean delivery and vaginal delivery groups.&lt;/p&gt;&lt;p&gt;Findings: 3 755 110 individuals were included in the study. Between 1973 and 2015, 185 219 women had a caesarean delivery only and 1 400 935 delivered vaginally only. 416 (0.22 %) of the 185 219 women in the caesarean delivery group were diagnosed with anal incontinence compared with 5171 (0.37%) of 1 400 935 women in the vaginal delivery group. The odds ratio (OR) for being diagnosed with anal incontinence after vaginal delivery compared with caesarean delivery was 1 center dot 65 (95% CI 1 center dot 49-1 center dot 82; p&amp;lt;0.0001). When the combination vaginal delivery and caesarean delivery was compared with the nulliparous control group, the OR of being diagnosed with anal incontinence was 2 center dot 05 (1 center dot 92-2 center dot 19; p&amp;lt;0.0001). For the nulliparous women compared with men, the OR for anal incontinence was 1 center dot 89 (1 center dot 75-2 center dot 05; p&amp;lt;0.0001). The strongest risk factors for anal incontinence after vaginal delivery were high maternal age, high birthweight of the child, and instrumental delivery. The only risk factor for anal incontinence after caesarean delivery was maternal age.&lt;/p&gt;&lt;p&gt;Interpretation: The risk of developing anal incontinence increases after pregnancy and delivery. Women with known risk factors for anal incontinence should perhaps be offered a more qualified post-partum examination to enable early intervention in case of injury. Further knowledge for optimal management are needed. Copyright (c) 2019 Elsevier Ltd. All rights reserved.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>The Lancet</title>
			</titleInfo>
			<identifier type="issn">0140-6736</identifier>
			<identifier type="eissn">1474-547X</identifier>
			<part>
				<detail type="volume">
					<number>393</number>
				</detail>
				<detail type="issue">
					<number>10177</number>
				</detail>
				<extent>
					<start>1233</start>
					<end>1239</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-17</recordCreationDate>
			<recordChangeDate>2019-04-17</recordChangeDate>
			<recordIdentifier>diva2:1305592</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="shaz0006">
			<namePart type="family">Azizi</namePart>
			<namePart type="given">Shoaib</namePart>
			<namePart type="date">1989-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<affiliation>Energy efficiency</affiliation>
			<description>diva-portal.org=authority-person:68701</description>
		</name>
		<name type="corporate">
			<namePart>Energy efficiency</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal" authority="umu" xlink:href="gigo0003">
			<namePart type="family">Nair</namePart>
			<namePart type="given">Gireesh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<description>diva-portal.org=authority-person:63073</description>
		</name>
		<name type="personal" authority="umu" xlink:href="thol0001">
			<namePart type="family">Olofsson</namePart>
			<namePart type="given">Thomas</namePart>
			<namePart type="date">1968-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för tillämpad fysik och elektronik</affiliation>
			<description>orcid.org=0000-0002-8704-8538</description>
			<description>diva-portal.org=authority-person:63263</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="870">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för tillämpad fysik och elektronik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Analysing the house-owners’ perceptions on benefits and barriers of energy renovation in Swedish single-family houses</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-17T15:34:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-160337</identifier>
		<identifier type="doi">10.1016/j.enbuild.2019.05.034</identifier>
		<identifier type="scopus">2-s2.0-85066929243</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Energy efficient renovation</topic>
		</subject>
		<subject lang="eng">
			<topic>Investment decision</topic>
		</subject>
		<subject lang="eng">
			<topic>Perceptions</topic>
		</subject>
		<subject lang="eng">
			<topic>Implementation</topic>
		</subject>
		<subject lang="eng">
			<topic>House-owners</topic>
		</subject>
		<subject lang="eng">
			<topic>Sweden</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20702">
			<topic>Engineering and Technology</topic>
			<topic>Environmental Engineering</topic>
			<topic>Energy Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20702">
			<topic>Teknik och teknologier</topic>
			<topic>Naturresursteknik</topic>
			<topic>Energisystem</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="8103">
			<topic>environmental science</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="8103">
			<topic>miljövetenskap</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Single-family houses offer a large potential for energy savings by energy renovation (ER). Homeowners’ motivation to implement ER derives from the benefits and barriers they perceive. Benefits are the positive consequences that can motivate homeowners to act and barriers are the challenges that demotivate them to undertake ER. Different benefits and barriers do not homogenously affect every homeowner. Identifying motivating benefits and demotivating barriers for each specific group among homeowners can shed lights on ER decision-making and enable policies that are more effective. The objective of this study is to contextualize the implementation of ER by understanding how the perceived benefits and barriers influence homeowners. This study links the expected consequences, which are benefits and barriers to the influential factors on ER, which are used to group the homeowners.&lt;/p&gt;&lt;p&gt;The analysis is based on a questionnaire survey mailed to 1550 owners of single-family houses in northern Sweden. The perceptions of homeowners on benefits and barriers of ER are significantly different between the groups that are motivated and unmotivated to implement ER. Despite the perceived importance of some of the benefits such as energy cost reduction, they may not be determinative for the homeowners’ decision to undertake ER. The homeowners are more likely to implement ER for reasons other than energy use reduction such as for improving the indoor environment. The barriers such as the difficulty of finding a low-interest loan and reliable information sources are found to impede the intention to implement ER among different groups. Policy implications to facilitate ER in single-family houses are discussed.&lt;/p&gt;</abstract>
		<note type="project">renovatin center</note>
		<relatedItem type="host">
			<titleInfo>
				<title>Energy and Buildings</title>
			</titleInfo>
			<identifier type="issn">0378-7788</identifier>
			<identifier type="eissn">1872-6178</identifier>
			<part>
				<detail type="volume">
					<number>198</number>
				</detail>
				<extent>
					<start>187</start>
					<end>196</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>shaz0006</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-17</recordCreationDate>
			<recordChangeDate>2019-08-14</recordChangeDate>
			<recordIdentifier>diva2:1326010</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Maquibar</namePart>
			<namePart type="given">Amaia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Estalella</namePart>
			<namePart type="given">Itziar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vives-Cases</namePart>
			<namePart type="given">Carmen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anhu0001">
			<namePart type="family">Hurtig</namePart>
			<namePart type="given">Anna-Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0001-7087-1467</description>
			<description>diva-portal.org=authority-person:62484</description>
		</name>
		<name type="personal" authority="umu" xlink:href="isgo0005">
			<namePart type="family">Goicolea</namePart>
			<namePart type="given">Isabel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<description>orcid.org=0000-0002-8114-4705</description>
			<description>diva-portal.org=authority-person:62482</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Analysing training in gender-based violence for undergraduate nursing students in Spain</title>
			<subTitle>A mixed-methods study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-18T10:05:21</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159588</identifier>
		<identifier type="doi">10.1016/j.nedt.2019.01.017</identifier>
		<identifier type="pmid">30999062</identifier>
		<identifier type="isi">000467510200012</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Intimate partner violence</topic>
		</subject>
		<subject lang="eng">
			<topic>Nursing students</topic>
		</subject>
		<subject lang="eng">
			<topic>Curricula</topic>
		</subject>
		<subject lang="eng">
			<topic>Mixed methods</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Health-care professionals, and nurses especially among them, play an essential role in the health sector's response to gender-based violence. To be able to successfully address this major public health issue they need specific training in the topic.&lt;/p&gt;&lt;p&gt;Objective: To analyse training on gender-based violence that nursing students receive at universities in Spain.&lt;/p&gt;&lt;p&gt;Design: Mixed-methods approach.&lt;/p&gt;&lt;p&gt;Setting: Spain.&lt;/p&gt;&lt;p&gt;Methods: Systematic review of public documents followed by in-depth interviews with university lecturers.&lt;/p&gt;&lt;p&gt;Results: Eighty per cent (92/115) of nursing training programmes included content regarding gender-based violence. There was great variability in the topics included in the training. Health consequences due to gender based violence exposure and the role of the health sector in addressing these health consequences were the most frequently included topics. Ethical issues and legislation were the least frequent ones, as these were only dealt with in one and 18 training programmes, respectively. In the qualitative analysis of the interviews, two categories were identified: 'Supportive legislation and supportive lecturers are essential for integrating gender-based violence training' and 'Approach to gender-based violence shapes the contents and the subject in which it is incorporated'. The first category refers to the main drivers for training integration, while the second category refers to how lecturers' perceptions influenced the way in which training was implemented.&lt;/p&gt;&lt;p&gt;Conclusions: As many as 80% of the nursing education programmes included specific training in gender-based violence, although with great variability in the contents among the universities. For this study's participants, enacted legislation, and lecturers interested in the topic and in decision-making positions were key drivers for this extensive implementation. The variability observed across universities might be explained by lecturers' different approaches to gender-based violence and the nursing profession.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Nurse Education Today</title>
			</titleInfo>
			<identifier type="issn">0260-6917</identifier>
			<identifier type="eissn">1532-2793</identifier>
			<part>
				<detail type="volume">
					<number>77</number>
				</detail>
				<extent>
					<start>71</start>
					<end>76</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-18</recordCreationDate>
			<recordChangeDate>2019-06-18</recordChangeDate>
			<recordIdentifier>diva2:1326393</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="irah0007">
			<namePart type="family">Ahmad</namePart>
			<namePart type="given">Irfan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Institute of Biomedical and Allied Health Sciences, University of Health Sciences, Lahore, Pakistan</affiliation>
			<description>diva-portal.org=authority-person:68464</description>
		</name>
		<name type="personal" authority="umu" xlink:href="naka0032">
			<namePart type="family">Karah</namePart>
			<namePart type="given">Nabil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:63241</description>
		</name>
		<name type="personal" authority="umu" xlink:href="afna0003">
			<namePart type="family">Nadeem</namePart>
			<namePart type="given">Aftab</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:71128</description>
		</name>
		<name type="personal" authority="umu" xlink:href="suwa0005">
			<namePart type="family">Wai</namePart>
			<namePart type="given">Sun Nyunt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<description>diva-portal.org=authority-person:62883</description>
		</name>
		<name type="personal" authority="umu" xlink:href="beuh0001">
			<namePart type="family">Uhlin</namePart>
			<namePart type="given">Bernt Eric</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<description>diva-portal.org=authority-person:63242</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Analysis of colony phase variation switch in Acinetobacter baumannii clinical isolates</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Public Library Science</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-01-25T14:20:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-155634</identifier>
		<identifier type="doi">10.1371/journal.pone.0210082</identifier>
		<identifier type="pmid">30608966</identifier>
		<identifier type="isi">000454952800043</identifier>
		<identifier type="articleId">e0210082</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1371/journal.pone.0210082</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30109">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Microbiology in the medical area</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30109">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Mikrobiologi inom det medicinska området</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Reversible switching between opaque and translucent colony formation is a novel feature of Acinetobacter baumannii that has been associated with variations in the cell morphology, surface motility, biofilm formation, antibiotic resistance and virulence. Here, we assessed a number of phenotypic alterations related to colony switching in A. baumannii clinical isolates belonging to different multi-locus sequence types. Our findings demonstrated that these phenotypic alterations were mostly strain-specific. In general, the translucent subpopulations of A. baumannii produced more dense biofilms, were more piliated, and released larger amounts of outer membrane vesicles (OMVs). In addition, the translucent subpopulations caused reduced fertility of Caenorhabditis elegans. When assessed for effects on the immune response in RAW 264.7 macrophages, the OMVs isolated from opaque subpopulations of A. baumannii appeared to be more immunogenic than the OMVs from the translucent form. However, also the OMVs from the translucent subpopulations had the potential to evoke an immune response. Therefore, we suggest that OMVs may be considered for development of new immunotherapeutic treatments against A. baumannii infections.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>PLoS ONE</title>
			</titleInfo>
			<identifier type="issn">1932-6203</identifier>
			<identifier type="eissn">1932-6203</identifier>
			<part>
				<detail type="volume">
					<number>14</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [2015-03007]</note>
		<note type="funder">Vetenskapsrådet [2015-06824]</note>
		<note type="funder">Vetenskapsrådet [2016-06598]</note>
		<note type="funder">Vetenskapsrådet [349-2007-8673]</note>
		<note type="funder">Vetenskapsrådet [829-2006-7431]</note>
		<note type="funder">Kempestiftelserna [JCK-1527]</note>
		<note type="funder">Kempestiftelserna [JCK-1724]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1282682/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-01-25</recordCreationDate>
			<recordChangeDate>2019-01-25</recordChangeDate>
			<recordIdentifier>diva2:1282682</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Zbornikova</namePart>
			<namePart type="given">Eva</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Knejzlik</namePart>
			<namePart type="given">Zdenek</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="vaha0006">
			<namePart type="family">Hauryliuk</namePart>
			<namePart type="given">Vasili</namePart>
			<namePart type="date">1980-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)</affiliation>
			<affiliation>Umeå universitet, Molekylär Infektionsmedicin, Sverige (MIMS)</affiliation>
			<affiliation>University of Tartu, Institute of Technology, Tartu,Estonia</affiliation>
			<description>orcid.org=0000-0003-2389-5057</description>
			<description>diva-portal.org=authority-person:62741</description>
		</name>
		<name type="personal">
			<namePart type="family">Krasny</namePart>
			<namePart type="given">Libor</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rejman</namePart>
			<namePart type="given">Dominik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="801">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för molekylärbiologi (Medicinska fakulteten)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="5052">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Molekylär Infektionsmedicin, Sverige (MIMS)</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Analysis of nucleotide pools in bacteria using HPLC-MS in HILIC mode</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-12T10:07:53</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164375</identifier>
		<identifier type="doi">10.1016/j.talanta.2019.120161</identifier>
		<identifier type="pmid">31450400</identifier>
		<identifier type="isi">000485856500085</identifier>
		<identifier type="articleId">UNSP 120161</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Nucleotide</topic>
		</subject>
		<subject lang="eng">
			<topic>HPLC-MS</topic>
		</subject>
		<subject lang="eng">
			<topic>HILIC</topic>
		</subject>
		<subject lang="eng">
			<topic>ppGpp</topic>
		</subject>
		<subject lang="eng">
			<topic>Stringent response</topic>
		</subject>
		<subject lang="eng">
			<topic>Escherichia coli</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10401">
			<topic>Natural Sciences</topic>
			<topic>Chemical Sciences</topic>
			<topic>Analytical Chemistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10401">
			<topic>Naturvetenskap</topic>
			<topic>Kemi</topic>
			<topic>Analytisk kemi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Nucleotides, nucleosides and their derivatives are present in all cells at varying concentrations that change with the nutritional, and energetic status of the cell. Precise measurement of the concentrations of these molecules is instrumental for understanding their regulatory effects. Such measurement is challenging due to the inherent instability of these molecules and, despite many decades of research, the reported values differ widely. Here, we present a comprehensive and easy-to-use approach for determination of the intracellular concentrations of &amp;gt; 25 target molecular species. The approach uses rapid filtration and cold acidic extraction followed by high performance liquid chromatography (HPLC) in the hydrophilic interaction liquid chromatography (HILIC) mode using zwitterionic columns coupled with UV and MS detectors. The method reliably detects and quantifies all the analytes expected to be observed in the bacterial cell and paves the way for future studies correlating their concentrations with biological effects.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Talanta</title>
				<subTitle>The International Journal of Pure and Applied Analytical Chemistry</subTitle>
			</titleInfo>
			<identifier type="issn">0039-9140</identifier>
			<identifier type="eissn">1873-3573</identifier>
			<part>
				<detail type="volume">
					<number>205</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-12</recordCreationDate>
			<recordChangeDate>2019-11-12</recordChangeDate>
			<recordIdentifier>diva2:1369479</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="adxi0002">
			<namePart type="family">Shamshir</namePart>
			<namePart type="given">Adel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:74697</description>
		</name>
		<name type="personal" authority="umu" xlink:href="tosp0001">
			<namePart type="family">Sparrman</namePart>
			<namePart type="given">Tobias</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>diva-portal.org=authority-person:63267</description>
		</name>
		<name type="personal" authority="umu" xlink:href="pewe0001">
			<namePart type="family">Westlund</namePart>
			<namePart type="given">Per-Olof</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kemiska institutionen</affiliation>
			<description>orcid.org=0000-0002-9277-4534</description>
			<description>diva-portal.org=authority-person:62843</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="868">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Kemiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Analysis of the behaviour of confined molecules using &lt;sup&gt;2&lt;/sup&gt;&lt;em&gt;H T&lt;/em&gt;&lt;sub&gt;1&lt;/sub&gt; nuclear magnetic relaxation dispersion</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Taylor &amp; Francis</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-02T12:49:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162676</identifier>
		<identifier type="doi">10.1080/00268976.2019.1645367</identifier>
		<identifier type="isi">000479433000001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Spin-lattice relaxation time of acetonitrile-d3</topic>
		</subject>
		<subject lang="eng">
			<topic>NMRD</topic>
		</subject>
		<subject lang="eng">
			<topic>molecular origin of the retention time</topic>
		</subject>
		<subject lang="eng">
			<topic>4-site exchange model</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10402">
			<topic>Natural Sciences</topic>
			<topic>Chemical Sciences</topic>
			<topic>Physical Chemistry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10402">
			<topic>Naturvetenskap</topic>
			<topic>Kemi</topic>
			<topic>Fysikalisk kemi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;A four-site exchange model is developed in order to explain deuterium -nuclear magnetic relaxation dispersion (NMRD) profiles of acetonitrile in silica pore systems. The four-site exchange model comprises a bulk, surface and two types of burried or cavity sites. It is found that the residence time of acetonitrile- at a flat Si-surface is less than 100 ps. No bilayer-like ordering of acetonitrile is formed at the Si-surface because no quadrupole splitting was observed. The dispersion in the deuterium T1-NMRD profiles are due to relatively few so-called beta-sites with molecular residence time in the range 0.2-2 micro seconds. This deuterium T-NMR dispersion experiment suggest that the retention time of different analysts can be studied in terms of their residence time in beta sites.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Molecular Physics</title>
			</titleInfo>
			<identifier type="issn">0026-8976</identifier>
			<identifier type="eissn">1362-3028</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-02</recordCreationDate>
			<recordChangeDate>2020-01-08</recordChangeDate>
			<recordIdentifier>diva2:1347737</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Hadimeri</namePart>
			<namePart type="given">Ursula</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wärme</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nasic</namePart>
			<namePart type="given">Salmir</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fransson</namePart>
			<namePart type="given">Sven-Göran</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wigelius</namePart>
			<namePart type="given">Ann</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="best0006">
			<namePart type="family">Stegmayr</namePart>
			<namePart type="given">Bernd</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<description>diva-portal.org=authority-person:62791</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="776">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Angiography and phlebography in a hemodialysis population</title>
			<subTitle>A retrospective analysis of interventional results</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Sage Publications</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-08T10:07:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161902</identifier>
		<identifier type="doi">10.1177/0391398819863429</identifier>
		<identifier type="pmid">31303134</identifier>
		<identifier type="isi">000476206500001</identifier>
		<identifier type="scopus">2-s2.0-85069887785</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1177/0391398819863429</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Arteriovenous fistula</topic>
		</subject>
		<subject lang="eng">
			<topic>angiography</topic>
		</subject>
		<subject lang="eng">
			<topic>hemodialysis</topic>
		</subject>
		<subject lang="eng">
			<topic>percutaneous transluminal angioplasty</topic>
		</subject>
		<subject lang="eng">
			<topic>fistulography</topic>
		</subject>
		<subject lang="eng">
			<topic>phlebography</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Objective: To clarify the reasons and beneficial effects and duration of arteriovenous fistula patency after radiological interventions in arteriovenous fistula. The patients investigated were referred due to arteriovenous fistula access flow problems.&lt;/p&gt;&lt;p&gt;Material and methods: In 174 patients, 522 radiological investigations and endovascular treatments such as percutaneous transluminal angioplasty were analyzed, retrospectively. All investigations were performed due to clinical suspicion of impaired arteriovenous fistula function.&lt;/p&gt;&lt;p&gt;Results: Arterial stenosis was significantly more frequent among patients with diabetic nephropathy (p &amp;lt; 0.001) and interstitial nephritis (p &amp;lt; 0.001). According to the venous stenosis, the diagnosis did not affect the frequency (p = 0.22) or the degree (p = 0.39) of stenosis. The degree of stenosis prior to percutaneous transluminal angioplasty correlated significantly with the degree of remaining stenosis after intervention (p &amp;lt; 0.001). Of the 174 patients, 123 (71%) performed a total of 318 investigations including percutaneous transluminal angioplasty. Repeated percutaneous transluminal angioplasty was performed significantly more often in patients with diabetic nephropathy. The median times to the first percutaneous transluminal angioplasty and to the subsequent percutaneous transluminal angioplasties were 9.5 and 5 months, respectively. Arteriovenous fistula in patients with diabetic nephropathy performed similar to most other diagnoses, although performing more percutaneous transluminal angioplasty/patient than most other diagnoses.&lt;/p&gt;&lt;p&gt;Conclusion: Many patients could maintain long-term patency of arteriovenous fistula, including those with diabetic nephropathy, with repeated interventions; this motivates a closer follow-up for these patients. Clinically significant stenosis should be dilated as meticulously and as soon as possible. Occlusions of the arteriovenous fistula in most instances can be successfully thrombolyzed or dilated upon early diagnosis.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Artificial Organs</title>
			</titleInfo>
			<identifier type="issn">0391-3988</identifier>
			<identifier type="eissn">1724-6040</identifier>
			<part>
				<detail type="volume">
					<number>42</number>
				</detail>
				<detail type="issue">
					<number>12</number>
				</detail>
				<extent>
					<start>675</start>
					<end>683</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1341224/FULLTEXT02.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-08</recordCreationDate>
			<recordChangeDate>2020-01-08</recordChangeDate>
			<recordIdentifier>diva2:1341224</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Jönsson</namePart>
			<namePart type="given">Sofia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Becirovic-Agic</namePart>
			<namePart type="given">Mediha</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Isackson</namePart>
			<namePart type="given">Henrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tveitarås</namePart>
			<namePart type="given">Maria K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Skogstrand</namePart>
			<namePart type="given">Trude</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Narfström</namePart>
			<namePart type="given">Fredrik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Karlsen</namePart>
			<namePart type="given">Tine, V</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lidén</namePart>
			<namePart type="given">Åsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Leh</namePart>
			<namePart type="given">Sabine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="maer0239">
			<namePart type="family">Ericsson</namePart>
			<namePart type="given">Madelene</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>diva-portal.org=authority-person:63475</description>
		</name>
		<name type="personal" authority="umu" xlink:href="nist6501">
			<namePart type="family">Nilsson</namePart>
			<namePart type="given">Stefan K.</namePart>
			<namePart type="date">1979-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk biovetenskap</affiliation>
			<description>diva-portal.org=authority-person:63478</description>
		</name>
		<name type="personal">
			<namePart type="family">Reed</namePart>
			<namePart type="given">Rolf K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hultström</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-4675-1099</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="747">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Angiotensin II and salt-induced decompensation in Balb/CJ mice is aggravated by fluid retention related to low oxidative stress</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Physiological Society</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-10T13:46:56</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159399</identifier>
		<identifier type="doi">10.1152/ajprenal.00483.2018</identifier>
		<identifier type="pmid">30785350</identifier>
		<identifier type="isi">000467160100016</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>fluid balance</topic>
		</subject>
		<subject lang="eng">
			<topic>kidney function</topic>
		</subject>
		<subject lang="eng">
			<topic>mice</topic>
		</subject>
		<subject lang="eng">
			<topic>microarray</topic>
		</subject>
		<subject lang="eng">
			<topic>oxidative stress</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30106">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Physiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30106">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Fysiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Balb/CJ mice are more sensitive to treatment with angiotensin II (ANG II) and high-salt diet compared with C57BL/6J mice. Together with higher mortality, they develop edema, signs of heart failure, and acute kidney injury. The aim of the present study was to identify differences in renal gene regulation that may affect kidney function and fluid balance, which could contribute to decompensation in Balb/CJ mice after ANG II + salt treatment. Male Balb/CJ and C57BL/6J mice were divided into the following five different treatment groups: control, ANG II, salt, ANG II + salt. and ANG II + salt + N-acetylcysteine. Gene expression microarrays were used to explore differential gene expression after treatment and between the strains. Published data from the Mouse Genome Database were used to identify the associated genomic differences. The glomerular filtration rate (GFR) was measured using inulin clearance, and fluid balance was measured using metabolic cages. Gene ontology enrichment analysis of gene expression microarrays identified glutathione transferase (antioxidant system) as highly enriched among differentially expressed genes. Balb/CJ mice had similar GFR compared with C57BL/6J mice but excreted less Na+ and water, although net fluid and electrolyte balance did not differ, suggesting that Balb/CJ mice may be inherently more prone to decompensation. Interestingly, C57BL/6J mice had higher urinary oxidative stress despite their relative protection from decompensation. In addition, treatment with the antioxidant N-acetylcysteine decreased oxidative stress in C57BL/6J mice, reduced urine excretion, and increased mortality. Balb/CJ mice are more sensitive than C57BL/6J to ANG II + salt, in part mediated by lower oxidative stress, which favors fluid and Na+ retention.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>American Journal of Physiology - Renal Physiology</title>
			</titleInfo>
			<identifier type="issn">1931-857X</identifier>
			<identifier type="eissn">1522-1466</identifier>
			<part>
				<detail type="volume">
					<number>316</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>F914</start>
					<end>F933</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-10</recordCreationDate>
			<recordChangeDate>2019-06-10</recordChangeDate>
			<recordIdentifier>diva2:1322072</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Maaroufi</namePart>
			<namePart type="given">Nadia, I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-8028-1409</description>
		</name>
		<name type="personal">
			<namePart type="family">Nordin</namePart>
			<namePart type="given">Annika</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="krpa0001">
			<namePart type="family">Palmqvist</namePart>
			<namePart type="given">Kristin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för ekologi, miljö och geovetenskap</affiliation>
			<description>diva-portal.org=authority-person:64487</description>
		</name>
		<name type="personal">
			<namePart type="family">Hasselquist</namePart>
			<namePart type="given">Niles J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Forsmark</namePart>
			<namePart type="given">Benjamin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rosenstock</namePart>
			<namePart type="given">Nicholas P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wallander</namePart>
			<namePart type="given">Håkan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gundale</namePart>
			<namePart type="given">Michael J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="879">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för ekologi, miljö och geovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Anthropogenic nitrogen enrichment enhances soil carbon accumulation by impacting saprotrophs rather than ectomycorrhizal fungal activity</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>John Wiley &amp; Sons</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-13T10:24:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162001</identifier>
		<identifier type="doi">10.1111/gcb.14722</identifier>
		<identifier type="pmid">31166650</identifier>
		<identifier type="isi">000477200000001</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>carbon sequestration</topic>
		</subject>
		<subject lang="eng">
			<topic>ecological stoichiometry</topic>
		</subject>
		<subject lang="eng">
			<topic>Gadgil effect</topic>
		</subject>
		<subject lang="eng">
			<topic>high-throughput sequencing</topic>
		</subject>
		<subject lang="eng">
			<topic>ingrowth sh bags</topic>
		</subject>
		<subject lang="eng">
			<topic>ITS amplicons</topic>
		</subject>
		<subject lang="eng">
			<topic>litter decomposition</topic>
		</subject>
		<subject lang="eng">
			<topic>root exclosure</topic>
		</subject>
		<subject lang="eng">
			<topic>soil organic matter</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10611">
			<topic>Natural Sciences</topic>
			<topic>Biological Sciences</topic>
			<topic>Ecology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10611">
			<topic>Naturvetenskap</topic>
			<topic>Biologiska vetenskaper</topic>
			<topic>Ekologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;There is evidence that anthropogenic nitrogen (N) deposition enhances carbon (C) sequestration in boreal forest soils. However, it is unclear how free-living saprotrophs (bacteria and fungi, SAP) and ectomycorrhizal (EM) fungi responses to N addition impact soil C dynamics. Our aim was to investigate how SAP and EM communities are impacted by N enrichment and to estimate whether these changes influence decay of litter and humus. We conducted a long-term experiment in northern Sweden, maintained since 2004, consisting of ambient, low N additions (0, 3, 6, and 12 kg N ha(-1) year(-1)) simulating current N deposition rates in the boreal region, as well as a high N addition (50 kg N ha(-1) year(-1)). Our data showed that long-term N enrichment impeded mass loss of litter, but not of humus, and only in response to the highest N addition treatment. Furthermore, our data showed that EM fungi reduced the mass of N and P in both substrates during the incubation period compared to when only SAP organisms were present. Low N additions had no effect on microbial community structure, while the high N addition decreased fungal and bacterial biomasses and altered EM fungi and SAP community composition. Actinomycetes were the only bacterial SAP to show increased biomass in response to the highest N addition. These results provide a mechanistic understanding of how anthropogenic N enrichment can influence soil C accumulation rates and suggest that current N deposition rates in the boreal region (&amp;lt;= 12 kg N ha(-1) year(-1)) are likely to have a minor impact on the soil microbial community and the decomposition of humus and litter.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Global Change Biology</title>
			</titleInfo>
			<identifier type="issn">1354-1013</identifier>
			<identifier type="eissn">1365-2486</identifier>
			<part>
				<detail type="volume">
					<number>25</number>
				</detail>
				<detail type="issue">
					<number>9</number>
				</detail>
				<extent>
					<start>2900</start>
					<end>2914</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-13</recordCreationDate>
			<recordChangeDate>2019-10-14</recordChangeDate>
			<recordIdentifier>diva2:1342230</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Trabert</namePart>
			<namePart type="given">Britton</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-1539-6090</description>
		</name>
		<name type="personal">
			<namePart type="family">Waterboer</namePart>
			<namePart type="given">Tim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="anid0002">
			<namePart type="family">Idahl</namePart>
			<namePart type="given">Annika</namePart>
			<namePart type="date">1965-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Obstetrik och gynekologi</affiliation>
			<description>orcid.org=0000-0002-7865-4560</description>
			<description>diva-portal.org=authority-person:62503</description>
		</name>
		<name type="personal">
			<namePart type="family">Brenner</namePart>
			<namePart type="given">Nicole</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brinton</namePart>
			<namePart type="given">Louise A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Butt</namePart>
			<namePart type="given">Julia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Coburn</namePart>
			<namePart type="given">Sally B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hartge</namePart>
			<namePart type="given">Patricia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hufnagel</namePart>
			<namePart type="given">Katrin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Inturrisi</namePart>
			<namePart type="given">Federica</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lissowska</namePart>
			<namePart type="given">Jolanta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mentzer</namePart>
			<namePart type="given">Alexander</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-4502-2209</description>
		</name>
		<name type="personal">
			<namePart type="family">Peplonska</namePart>
			<namePart type="given">Beata</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sherman</namePart>
			<namePart type="given">Mark E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wills</namePart>
			<namePart type="given">Gillian S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Woodhall</namePart>
			<namePart type="given">Sarah C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pawlita</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wentzensen</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="743">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Obstetrik och gynekologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-10T11:43:25</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159636</identifier>
		<identifier type="doi">10.1093/jnci/djy084</identifier>
		<identifier type="pmid">29790947</identifier>
		<identifier type="isi">000467900500006</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30220">
			<topic>Obstetrics, Gynecology and Reproductive Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30220">
			<topic>Reproduktionsmedicin och gynekologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: Pelvic inflammatory disease (PID) has been associated with ovarian cancer risk. To clarify the role of Chlamydia trachomatis and other infectious agents in the development of ovarian cancer, we evaluated the association of serologic markers with incident ovarian cancer using a staged approach in two independent populations.&lt;/p&gt;&lt;p&gt;Methods: Studies included: 1) a case-control study in Poland (244 ovarian cancers/556 control subjects) and 2) a prospective nested case-control study in the PLCO Cancer Screening Trial (160 ovarian cancers/159 control subjects). Associations of serologic marker levels with ovarian cancer risk at diagnostic as well as higher thresholds, identified in Poland and independently evaluated in PLCO, were estimated using multivariable adjusted logistic regression.&lt;/p&gt;&lt;p&gt;Results: In the Polish study, antibodies (based on laboratory cut-point) against the chlamydia plasmid-encoded Pgp3 protein (serological gold standard) were associated with increased ovarian cancer risk (adjusted odds ratio [OR] = 1.63, 95% confidence interval [CI] = 1.20 to 2.22); when a positive result was redefined at higher levels, ovarian cancer risk was increased (cut-point 2: OR = 2.00, 95% CI = 1.38 to 2.89; cut-point 3 [max OR]: OR = 2.19, 95% CI = 1.29 to 3.73). In the prospective PLCO study, Pgp3 antibodies were associated with elevated risk at the laboratory cut-point (OR = 1.43, 95% CI = 0.78 to 2.63) and more stringent cut-points (cut-point 2: OR = 2.25, 95% CI = 1.07 to 4.71); cut-point 3: OR = 2.53, 95% CI = 0.63 to 10.08). In both studies, antibodies against other infectious agents measured were not associated with risk.&lt;/p&gt;&lt;p&gt;Conclusions: In two independent populations, antibodies against prior/current C. trachomatis (Pgp3) were associated with a doubling in ovarian cancer risk, whereas markers of other infectious agents were unrelated. These findings lend support for an association between PID and ovarian cancer.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Journal of the National Cancer Institute</title>
			</titleInfo>
			<identifier type="issn">0027-8874</identifier>
			<identifier type="eissn">1460-2105</identifier>
			<part>
				<detail type="volume">
					<number>111</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
				<extent>
					<start>129</start>
					<end>136</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-10</recordCreationDate>
			<recordChangeDate>2019-06-10</recordChangeDate>
			<recordIdentifier>diva2:1321947</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="anbo0110">
			<namePart type="family">Boman</namePart>
			<namePart type="given">Antonia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Reumatologi</affiliation>
			<description>diva-portal.org=authority-person:68672</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mibr0003">
			<namePart type="family">Brink</namePart>
			<namePart type="given">Mikael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Reumatologi</affiliation>
			<description>orcid.org=0000-0001-7675-3488</description>
			<description>diva-portal.org=authority-person:62728</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anslst97">
			<namePart type="family">Lundquist</namePart>
			<namePart type="given">Anders</namePart>
			<namePart type="date">1978-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Statistik</affiliation>
			<description>orcid.org=0000-0003-1524-0851</description>
			<description>diva-portal.org=authority-person:63687</description>
		</name>
		<name type="personal">
			<namePart type="family">Hansson</namePart>
			<namePart type="given">Monica</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mathsson-Alm</namePart>
			<namePart type="given">Linda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rönnelid</namePart>
			<namePart type="given">Johan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-1186-3226</description>
		</name>
		<name type="personal" authority="umu" xlink:href="evbe0009">
			<namePart type="family">Berglin</namePart>
			<namePart type="given">Ewa</namePart>
			<namePart type="termsOfAddress">MD, PhD</namePart>
			<namePart type="date">1955-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Reumatologi</affiliation>
			<description>diva-portal.org=authority-person:63727</description>
		</name>
		<name type="personal">
			<namePart type="family">Holmdahl</namePart>
			<namePart type="given">Rikard</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-4969-2576</description>
		</name>
		<name type="personal">
			<namePart type="family">Skriner</namePart>
			<namePart type="given">Karl</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Serre</namePart>
			<namePart type="given">Guy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klareskog</namePart>
			<namePart type="given">Lars</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="sora0001">
			<namePart type="family">Rantapää-Dahlqvist</namePart>
			<namePart type="given">Solbritt</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Reumatologi</affiliation>
			<description>orcid.org=0000-0001-8259-3863</description>
			<description>diva-portal.org=authority-person:62730</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="729">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Reumatologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="11053">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Handelshögskolan vid Umeå universitet</namePart>
			<namePart>Statistik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis</title>
			<subTitle>a prospective longitudinal inception cohort study</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BMJ Publishing Group Ltd</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-12-10T08:16:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165746</identifier>
		<identifier type="doi">10.1136/rmdopen-2019-000946</identifier>
		<identifier type="pmid">31565241</identifier>
		<identifier type="isi">000496133800042</identifier>
		<identifier type="articleId">UNSP e000946</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1136/rmdopen-2019-000946</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30210">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Rheumatology and Autoimmunity</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30210">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Reumatologi och inflammation</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Introduction: Anticitrullinated peptide antibody (ACPA) responses for 22 citrullinated peptides in patients with early rheumatoid arthritis (RA) were analysed and related to radiological and clinical outcome during the first 2 years in a prospective inception cohort.&lt;/p&gt;&lt;p&gt;Methods: The ACPA reactivities were assessed in 1022 patients with early RA (symptoms &amp;lt;12 months) using the custom-made microarray chip (Thermo Fisher Scientific, Uppsala, Sweden) in a prospective longitudinal study of observational assessments of Disease Activity Score (DAS28 and its components) and radiology during the first 24 months, accounting for the treatment.&lt;/p&gt;&lt;p&gt;Results: Frequency of ACPA reactivities varied between 13.3% and 63.1%. Of the anticyclic citrullinated peptide-2 (anti-CCP2) antibody-negative patients, ACPA reactivities were positive in 32.6%. Smoking, human leucocyte antigen-shared epitope (HLA-SE), anti-CCP2/rheumatoid factor, protein tyrosine phosphatase non-receptor type 22 (1858C/T) and DAS28 were significantly associated with number of ACPA reactivities. The ACPA reactivities modified differently the development of DAS28 over 24 months (identified using trajectories). Anti-Filaggrin307-324, anti-hnRNP (Peptide)-Z1 and anti-F4-CIT-R antibodies anticipated lower DAS28 values (p&amp;lt;0.01–0.05), while positivity for anti-Fibrinogen(Fib)β62-78(74), and anti-Fibα563-583 predicted higher DAS28 (p&amp;lt;0.01 both). Interaction between anti-Fibß36-52, anti-Pept-5 and anti-Bla-26 antibodies, respectively, and DAS28 during 24 months decreased significantly the DAS28 values (p&amp;lt;0.01–0.05). Corticosteroids and biologicals were related to DAS28-area under the curve and Larsen score 24 months. Anti-vimentin2-17 antibodies remained significantly associated with Larsen score at baseline and 24 months, respectively, and radiological progression, besides biologicals at 24 months adjusted for sex and age.&lt;/p&gt;&lt;p&gt;Conclusions: Several ACPA reactivities modified significantly the DAS28 development during the first 24 months and were significantly associated with Larsen score at baseline, 24 months and radiological progression.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>RMD Open</title>
			</titleInfo>
			<identifier type="eissn">2056-5933</identifier>
			<part>
				<detail type="volume">
					<number>5</number>
				</detail>
				<detail type="issue">
					<number>2</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Vetenskapsrådet [K2013-52X-2030707-3]</note>
		<note type="funder">Vetenskapsrådet [Dnr:2018-02551]</note>
		<note type="funder">Konung Gustaf V:s Jubileumsfond</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1376654/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-12-10</recordCreationDate>
			<recordChangeDate>2019-12-10</recordChangeDate>
			<recordIdentifier>diva2:1376654</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Butt</namePart>
			<namePart type="given">Julia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jenab</namePart>
			<namePart type="given">Mazda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pawlita</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Overvad</namePart>
			<namePart type="given">Kim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-6429-7921</description>
		</name>
		<name type="personal">
			<namePart type="family">Tjonneland</namePart>
			<namePart type="given">Anne</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Olsen</namePart>
			<namePart type="given">Anja</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boutron-Ruault</namePart>
			<namePart type="given">Marie-Christine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-5956-5693</description>
		</name>
		<name type="personal">
			<namePart type="family">Carbonnel</namePart>
			<namePart type="given">Franck</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mancini</namePart>
			<namePart type="given">Francesca Romana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaaks</namePart>
			<namePart type="given">Rudolf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kühn</namePart>
			<namePart type="given">Tilman</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boeing</namePart>
			<namePart type="given">Heiner</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Trichopoulou</namePart>
			<namePart type="given">Antonia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Karakatsani</namePart>
			<namePart type="given">Anna</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Palli</namePart>
			<namePart type="given">Domenico</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pala</namePart>
			<namePart type="given">Valeria Maria</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0001-5438-970X</description>
		</name>
		<name type="personal">
			<namePart type="family">Tumino</namePart>
			<namePart type="given">Rosario</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2666-414X</description>
		</name>
		<name type="personal">
			<namePart type="family">Sacerdote</namePart>
			<namePart type="given">Carlotta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panico</namePart>
			<namePart type="given">Salvatore</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bueno-de-Mesquita</namePart>
			<namePart type="given">Bas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">van Gils</namePart>
			<namePart type="given">Carla H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vermeulen</namePart>
			<namePart type="given">Roel C. H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Weiderpass</namePart>
			<namePart type="given">Elisabete</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Quiros</namePart>
			<namePart type="given">Jose Ramon</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Duell</namePart>
			<namePart type="given">Eric Jeffrey</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sanchez</namePart>
			<namePart type="given">Maria-Jose</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dorronsoro</namePart>
			<namePart type="given">Miren</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Maria Huerta</namePart>
			<namePart type="given">Jose</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ardanaz</namePart>
			<namePart type="given">Eva</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="beyvan99">
			<namePart type="family">van Guelpen</namePart>
			<namePart type="given">Bethany</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<description>orcid.org=0000-0002-9692-101x</description>
			<description>diva-portal.org=authority-person:63812</description>
		</name>
		<name type="personal" authority="umu" xlink:href="soha0105">
			<namePart type="family">Harlid</namePart>
			<namePart type="given">Sophia</namePart>
			<namePart type="date">1978-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Onkologi</affiliation>
			<description>orcid.org=0000-0001-8540-6891</description>
			<description>diva-portal.org=authority-person:66892</description>
		</name>
		<name type="personal">
			<namePart type="family">Perez-Cornago</namePart>
			<namePart type="given">Aurora</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gunter</namePart>
			<namePart type="given">Marc J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Murphy</namePart>
			<namePart type="given">Neil</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Freisling</namePart>
			<namePart type="given">Heinz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aune</namePart>
			<namePart type="given">Dagfinn</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waterboer</namePart>
			<namePart type="given">Tim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hughes</namePart>
			<namePart type="given">David J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="778">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<namePart>Onkologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Association for Cancer Research</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-08T13:58:31</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167011</identifier>
		<identifier type="doi">10.1158/1055-9965.EPI-19-0313</identifier>
		<identifier type="pmid">31481495</identifier>
		<identifier type="isi">000498660400017</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: There is a lack of prospective data on the potential association of &lt;em&gt;Fusobacterium nucleatum&lt;/em&gt; (&lt;em&gt;F. nucleatum&lt;/em&gt;) and colorectal cancer risk. In this study, we assessed whether antibody responses to &lt;em&gt;F. nucleatum&lt;/em&gt; are associated with colorectal cancer risk in prediagnostic serum samples in the European Prospective Investigation into Nutrition and Cancer (EPIC) cohort.&lt;/p&gt;&lt;p&gt;Methods: We applied a multiplex serology assay to simultaneously measure antibody responses to 11 &lt;em&gt;F. nucleatum&lt;/em&gt; antigens in prediagnostic serum samples from 485 colorectal cancer cases and 485 matched controls. Conditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CI).&lt;/p&gt;&lt;p&gt;Results: We observed neither a statistically significant colorectal cancer risk association for antibodies to individual &lt;em&gt;F. nucleatum&lt;/em&gt; proteins nor for combined positivity to any of the 11 proteins (OR, 0.81; 95% CI, 0.62–1.06).&lt;/p&gt;&lt;p&gt;Conclusions: Antibody responses to &lt;em&gt;F. nucleatum&lt;/em&gt; proteins in prediagnostic serum samples from a subset of colorectal cancer cases and matched controls within the EPIC study were not associated with colorectal cancer risk.&lt;/p&gt;&lt;p&gt;Impact: Our findings in prospectively ascertained serum samples contradict the existing literature on the association of &lt;em&gt;F. nucleatum&lt;/em&gt; with colorectal cancer risk. Future prospective studies, specifically detecting &lt;em&gt;F. nucleatum&lt;/em&gt; in stool or tissue biopsies, are needed to complement our findings.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Cancer Epidemiology, Biomarkers and Prevention</title>
			</titleInfo>
			<identifier type="issn">1055-9965</identifier>
			<identifier type="eissn">1538-7755</identifier>
			<part>
				<detail type="volume">
					<number>28</number>
				</detail>
				<detail type="issue">
					<number>9</number>
				</detail>
				<extent>
					<start>1552</start>
					<end>1555</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Cancerfonden</note>
		<note type="funder">Vetenskapsrådet</note>
		<note type="funder">Region Skåne</note>
		<note type="funder">Västerbottens läns landsting</note>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-08</recordCreationDate>
			<recordChangeDate>2020-01-08</recordChangeDate>
			<recordIdentifier>diva2:1383695</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="xinguu04">
			<namePart type="family">Gu</namePart>
			<namePart type="given">Xiaolian</namePart>
			<namePart type="date">1976-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<description>orcid.org=0000-0002-6574-3628</description>
			<description>diva-portal.org=authority-person:65140</description>
		</name>
		<name type="personal" authority="umu" xlink:href="liwa0014">
			<namePart type="family">Wang</namePart>
			<namePart type="given">Lixiao</namePart>
			<namePart type="date">1975-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<description>diva-portal.org=authority-person:67306</description>
		</name>
		<name type="personal" authority="umu" xlink:href="liabop98">
			<namePart type="family">Boldrup</namePart>
			<namePart type="given">Linda</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<description>diva-portal.org=authority-person:63693</description>
		</name>
		<name type="personal">
			<namePart type="family">Coates</namePart>
			<namePart type="given">Philip J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="rofa0013">
			<namePart type="family">Fåhraeus</namePart>
			<namePart type="given">Robin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<affiliation>RECAMO, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic; Équipe Labellisée Ligue Contre le Cancer, INSERM UMRS1162, Institut de Génétique Moléculaire, Université Paris 7, IUH Hôpital St. Louis, 75010 Paris, France</affiliation>
			<description>diva-portal.org=authority-person:62979</description>
		</name>
		<name type="personal" authority="umu" xlink:href="nisg0001">
			<namePart type="family">Sgaramella</namePart>
			<namePart type="given">Nicola</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<description>diva-portal.org=authority-person:63692</description>
		</name>
		<name type="personal" authority="umu" xlink:href="towi0017">
			<namePart type="family">Wilms</namePart>
			<namePart type="given">Torben</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Öron- näs- och halssjukdomar</affiliation>
			<description>diva-portal.org=authority-person:63695</description>
		</name>
		<name type="personal" authority="umu" xlink:href="kaanyr77">
			<namePart type="family">Nylander</namePart>
			<namePart type="given">Karin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Patologi</affiliation>
			<description>orcid.org=0000-0002-4831-4100</description>
			<description>diva-portal.org=authority-person:62592</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="749">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<namePart>Patologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="745">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Öron- näs- och halssjukdomar</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>AP001056.1, A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MDPI</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-06-10T11:26:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159881</identifier>
		<identifier type="doi">10.3390/cancers11030347</identifier>
		<identifier type="pmid">30862109</identifier>
		<identifier type="isi">000468550200077</identifier>
		<identifier type="articleId">347</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.3390/cancers11030347</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>AP001056.1</topic>
		</subject>
		<subject lang="eng">
			<topic>lncRNA</topic>
		</subject>
		<subject lang="eng">
			<topic>enhancer</topic>
		</subject>
		<subject lang="eng">
			<topic>SCCHN</topic>
		</subject>
		<subject lang="eng">
			<topic>ICOSLG</topic>
		</subject>
		<subject lang="eng">
			<topic>tumor immunity</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30108">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Cell and Molecular Biology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30108">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Cell- och molekylärbiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30203">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cancer and Oncology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30203">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Cancer och onkologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;A growing number of long non-coding RNAs (lncRNAs) have been linked to squamous cell carcinoma of the head and neck (SCCHN). A subclass of lncRNAs, termed enhancer RNAs (eRNAs), are derived from enhancer regions and could contribute to enhancer function. In this study, we developed an integrated data analysis approach to identify key eRNAs in SCCHN. Tissue-specific enhancer-derived RNAs and their regulated genes previously predicted using the computational pipeline PreSTIGE, were considered as putative eRNA-target pairs. The interactive web servers, TANRIC (the Atlas of Noncoding RNAs in Cancer) and cBioPortal, were used to explore the RNA levels and clinical data from the Cancer Genome Atlas (TCGA) project. Requiring that key eRNAs should show significant associations with overall survival (Kaplan-Meier log-rank test, p &amp;lt; 0.05) and the predicted target (correlation coefficient r &amp;gt; 0.4, p &amp;lt; 0.001), we identified five key eRNA candidates. The most significant survival-associated eRNA was AP001056.1 with ICOSLG encoding an immune checkpoint protein as its regulated target. Another 1640 genes also showed significant correlation with AP001056.1 (r &amp;gt; 0.4, p &amp;lt; 0.001), with the "immune system process" being the most significantly enriched biological process (adjusted p &amp;lt; 0.001). Our results suggest that AP001056.1 is a key immune-related eRNA in SCCHN with a positive impact on clinical outcome.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Cancers</title>
			</titleInfo>
			<identifier type="issn">2072-6694</identifier>
			<part>
				<detail type="volume">
					<number>11</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Cancerfonden [18 05 42]</note>
		<note type="funder">Cancerfonden [18 02 96]</note>
		<note type="funder">Västerbottens läns landsting</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1321919/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-06-10</recordCreationDate>
			<recordChangeDate>2019-06-10</recordChangeDate>
			<recordIdentifier>diva2:1321919</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="this0013">
			<namePart type="family">Islam</namePart>
			<namePart type="given">Tohidul</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:68705</description>
		</name>
		<name type="personal" authority="umu" xlink:href="angh0001">
			<namePart type="family">Gharibyan</namePart>
			<namePart type="given">Anna L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:65247</description>
		</name>
		<name type="personal">
			<namePart type="family">Golchin</namePart>
			<namePart type="given">Solmaz A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Pettersson</namePart>
			<namePart type="given">Nina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="krbr0001">
			<namePart type="family">Brännström</namePart>
			<namePart type="given">Kristoffer</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:62637</description>
		</name>
		<name type="personal" authority="umu" xlink:href="ishe0017">
			<namePart type="family">Hedberg</namePart>
			<namePart type="given">Isabell</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<description>diva-portal.org=authority-person:74238</description>
		</name>
		<name type="personal">
			<namePart type="family">Virta</namePart>
			<namePart type="given">Merit-Miriam</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
		</name>
		<name type="personal">
			<namePart type="family">Olofsson</namePart>
			<namePart type="given">Linnea</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
		</name>
		<name type="personal" authority="umu" xlink:href="anol0042">
			<namePart type="family">Olofsson</namePart>
			<namePart type="given">Anders</namePart>
			<namePart type="date">1970-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för medicinsk kemi och biofysik</affiliation>
			<affiliation>Mr.</affiliation>
			<affiliation>Anders Olofsson</affiliation>
			<description>orcid.org=0000-0002-8743-8720</description>
			<description>diva-portal.org=authority-person:62640</description>
		</name>
		<name type="corporate">
			<namePart>Anders Olofsson</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="791">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk kemi och biofysik</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Apolipoprotein E impairs amyloid-β fibril elongation and maturation</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-11-20T10:34:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-165305</identifier>
		<identifier type="doi">10.1111/febs.15075</identifier>
		<identifier type="pmid">31571352</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>abeta</topic>
		</subject>
		<subject lang="eng">
			<topic>amyloid</topic>
		</subject>
		<subject lang="eng">
			<topic>apolipoprotein E</topic>
		</subject>
		<subject lang="eng">
			<topic>elongation</topic>
		</subject>
		<subject lang="eng">
			<topic>surface plasmon resonance</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="301">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="301">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30401">
			<topic>Medical and Health Sciences</topic>
			<topic>Medical Biotechnology</topic>
			<topic>Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30401">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinsk bioteknologi</topic>
			<topic>Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)</topic>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="12650">
			<topic>biologisk kemi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="12650">
			<topic>biological chemistry</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Alzheimer's disease (AD) is strongly linked to amyloid depositions of the Aβ peptide (Aβ). The lipid-binding protein apolipoprotein E (ApoE) has been found to interfere with Aβ amyloid formation and to exert a strong clinical impact to the pathology of AD. The APOE gene exists in three allelic isoforms represented by APOE ε2, APOE ε3, and APOE ε4. Carriers of the APOE ε4 variant display a gene dose-dependent increased risk of developing the disease. Aβ amyloids are formed via a nucleation-dependent mechanism where free monomers are added onto a nucleus in a template-dependent manner. Using a combination of surface plasmon resonance and thioflavin-T assays, we here show that ApoE can target the process of fibril elongation and that its interference effectively prevents amyloid maturation. We expose a complex equilibrium where the concentration of ApoE, Aβ monomers, and the amount of already formed Aβ fibrils will affect the relative proportion and formation rate of mature amyloids versus alternative assemblies. The result illustrates a mechanism which may affect both the clearance rate of Aβ assemblies in vivo and the population of cytotoxic Aβ assemblies.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>The FEBS Journal</title>
			</titleInfo>
			<identifier type="issn">1742-464X</identifier>
			<identifier type="eissn">1742-4658</identifier>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Epub ahead of print</note>
		<recordInfo>
			<recordOrigin>amli0002</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-11-20</recordCreationDate>
			<recordChangeDate>2019-11-20</recordChangeDate>
			<recordIdentifier>diva2:1371511</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Neumann</namePart>
			<namePart type="given">J. T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Twerenbold</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ojeda</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Soerensen</namePart>
			<namePart type="given">N. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Chapman</namePart>
			<namePart type="given">A. R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shah</namePart>
			<namePart type="given">A. S. V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Anand</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boeddinghaus</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nestelberger</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Badertscher</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mokhtari</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pickering</namePart>
			<namePart type="given">J. W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Troughton</namePart>
			<namePart type="given">R. W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Greenslade</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Parsonage</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mueller-Hennessen</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gori</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jernberg</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morris</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Liebetrau</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hamm</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Katus</namePart>
			<namePart type="given">H. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Muenzel</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Landmesser</namePart>
			<namePart type="given">U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Salomaa</namePart>
			<namePart type="given">V.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Iacoviello</namePart>
			<namePart type="given">L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ferrario</namePart>
			<namePart type="given">M. M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giampaoli</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kee</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thorand</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peters</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Borchini</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jorgensen</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="stso0001">
			<namePart type="family">Söderberg</namePart>
			<namePart type="given">Stefan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kardiologi</affiliation>
			<description>diva-portal.org=authority-person:63004</description>
		</name>
		<name type="personal">
			<namePart type="family">Sans</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tunstall-Pedoe</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuulasmaa</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Renne</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lackner</namePart>
			<namePart type="given">K. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Worster</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Body</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ekelund</namePart>
			<namePart type="given">U.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kavsak</namePart>
			<namePart type="given">P. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Keller</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lindahl</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wild</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giannitsis</namePart>
			<namePart type="given">E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Than</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cullen</namePart>
			<namePart type="given">L. A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mills</namePart>
			<namePart type="given">N. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mueller</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zeller</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Westermann</namePart>
			<namePart type="given">D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blankenberg</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="9950">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Kardiologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Application of High-Sensitivity Troponin in Suspected Myocardial Infarction</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>MASSACHUSETTS MEDICAL SOC</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-27T13:44:45</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162346</identifier>
		<identifier type="doi">10.1056/NEJMoa1803377</identifier>
		<identifier type="pmid">31242362</identifier>
		<identifier type="isi">000478840000009</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;BackgroundData regarding high-sensitivity troponin concentrations in patients presenting to the emergency department with symptoms suggestive of myocardial infarction may be useful in determining the probability of myocardial infarction and subsequent 30-day outcomes. MethodsIn 15 international cohorts of patients presenting to the emergency department with symptoms suggestive of myocardial infarction, we determined the concentrations of high-sensitivity troponin I or high-sensitivity troponin T at presentation and after early or late serial sampling. The diagnostic and prognostic performance of multiple high-sensitivity troponin cutoff combinations was assessed with the use of a derivation-validation design. A risk-assessment tool that was based on these data was developed to estimate the risk of index myocardial infarction and of subsequent myocardial infarction or death at 30 days. ResultsAmong 22,651 patients (9604 in the derivation data set and 13,047 in the validation data set), the prevalence of myocardial infarction was 15.3%. Lower high-sensitivity troponin concentrations at presentation and smaller absolute changes during serial sampling were associated with a lower likelihood of myocardial infarction and a lower short-term risk of cardiovascular events. For example, high-sensitivity troponin I concentrations of less than 6 ng per liter and an absolute change of less than 4 ng per liter after 45 to 120 minutes (early serial sampling) resulted in a negative predictive value of 99.5% for myocardial infarction, with an associated 30-day risk of subsequent myocardial infarction or death of 0.2%; a total of 56.5% of the patients would be classified as being at low risk. These findings were confirmed in an external validation data set. ConclusionsA risk-assessment tool, which we developed to integrate the high-sensitivity troponin I or troponin T concentration at emergency department presentation, its dynamic change during serial sampling, and the time between the obtaining of samples, was used to estimate the probability of myocardial infarction on emergency department presentation and 30-day outcomes.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>New England Journal of Medicine</title>
			</titleInfo>
			<identifier type="issn">0028-4793</identifier>
			<identifier type="eissn">1533-4406</identifier>
			<part>
				<detail type="volume">
					<number>380</number>
				</detail>
				<detail type="issue">
					<number>26</number>
				</detail>
				<extent>
					<start>2529</start>
					<end>2540</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>eikjon94</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-27</recordCreationDate>
			<recordChangeDate>2019-08-27</recordChangeDate>
			<recordIdentifier>diva2:1346210</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Tymofiyeva</namePart>
			<namePart type="given">Olga</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yuan</namePart>
			<namePart type="given">Justin P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Huang</namePart>
			<namePart type="given">Chiung-Yu</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Connolly</namePart>
			<namePart type="given">Colm G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="evhe0046">
			<namePart type="family">Henje Blom</namePart>
			<namePart type="given">Eva</namePart>
			<namePart type="date">1962-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Barn- och ungdomspsykiatri</affiliation>
			<affiliation>Department of Psychiatry and the Langley Porter Psychiatric Institute, Division of Child and Adolescent Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, USA</affiliation>
			<description>diva-portal.org=authority-person:68026</description>
		</name>
		<name type="personal">
			<namePart type="family">Xu</namePart>
			<namePart type="given">Duan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Yang</namePart>
			<namePart type="given">Tony T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="741">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för klinisk vetenskap</namePart>
			<namePart>Barn- och ungdomspsykiatri</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Application of machine learning to structural connectome to predict symptom reduction in depressed adolescents with cognitive behavioral therapy (CBT)</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-10-22T10:28:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-164435</identifier>
		<identifier type="doi">10.1016/j.nicl.2019.101914</identifier>
		<identifier type="pmid">31491813</identifier>
		<identifier type="isi">000485804400115</identifier>
		<identifier type="articleId">101914</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/j.nicl.2019.101914</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Machine learning</topic>
		</subject>
		<subject lang="eng">
			<topic>Adolescent depression</topic>
		</subject>
		<subject lang="eng">
			<topic>Diffusion MRI</topic>
		</subject>
		<subject lang="eng">
			<topic>Connectomics</topic>
		</subject>
		<subject lang="eng">
			<topic>Brain network</topic>
		</subject>
		<subject lang="eng">
			<topic>CBT</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30215">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Psychiatry</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30215">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Psykiatri</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Purpose: Adolescent major depressive disorder (MDD) is a highly prevalent, incapacitating and costly illness. Many depressed teens do not improve with cognitive behavioral therapy (CBT), a first-line treatment for adolescent MDD, and face devastating consequences of increased risk of suicide and many negative health outcomes. "Who will improve with CBT?" is a crucial question that remains unanswered, and treatment planning for adolescent depression remains biologically unguided. The purpose of this study was to utilize machine learning applied to patients' brain imaging data in order to help predict depressive symptom reduction with CBT.&lt;/p&gt;&lt;p&gt;Methods: We applied supervised machine learning to diffusion MRI-based structural connectome data in order to predict symptom reduction in 30 depressed adolescents after three months of CBT. A set of 21 attributes was chosen, including the baseline depression score, age, gender, two global network properties, and node strengths of brain regions previously implicated in depression. The practical and robust J48 pruned tree classifier was utilized with a 10-fold cross-validation.&lt;/p&gt;&lt;p&gt;Results: The classification resulted in an 83% accuracy of predicting depressive symptom reduction. The resulting tree of size seven with only three attributes highlights the role of the right thalamus in predicting depressive symptom reduction with CBT. Additional analysis showed a significant negative correlation between the change in the depressive symptoms and the node strength of the right thalamus.&lt;/p&gt;&lt;p&gt;Conclusions: Our results demonstrate that a machine learning algorithm that exclusively uses structural connectome data and the baseline depression score can predict with a high accuracy depressive symptom reduction in adolescent MDD with CBT. This knowledge can help improve treatment planning for adolescent depression.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>NeuroImage</title>
				<subTitle> Clinical</subTitle>
			</titleInfo>
			<identifier type="issn">0353-8842</identifier>
			<identifier type="eissn">2213-1582</identifier>
			<part>
				<detail type="volume">
					<number>23</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1362957/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>linlin02</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-10-22</recordCreationDate>
			<recordChangeDate>2019-10-22</recordChangeDate>
			<recordIdentifier>diva2:1362957</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Brunner</namePart>
			<namePart type="given">Fabian J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waldeyer</namePart>
			<namePart type="given">Christoph</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ojeda</namePart>
			<namePart type="given">Francisco</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Salomaa</namePart>
			<namePart type="given">Veikko</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kee</namePart>
			<namePart type="given">Frank</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sans</namePart>
			<namePart type="given">Susana</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thorand</namePart>
			<namePart type="given">Barbara</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giampaoli</namePart>
			<namePart type="given">Simona</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Brambilla</namePart>
			<namePart type="given">Paolo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tunstall-Pedoe</namePart>
			<namePart type="given">Hugh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Moitry</namePart>
			<namePart type="given">Marie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Iacoviello</namePart>
			<namePart type="given">Licia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Veronesi</namePart>
			<namePart type="given">Giovanni</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Grassi</namePart>
			<namePart type="given">Guido</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mathiesen</namePart>
			<namePart type="given">Ellisiv B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="stso0001">
			<namePart type="family">Söderberg</namePart>
			<namePart type="given">Stefan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Kardiologi</affiliation>
			<description>diva-portal.org=authority-person:63004</description>
		</name>
		<name type="personal">
			<namePart type="family">Linneberg</namePart>
			<namePart type="given">Allan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-0994-0184</description>
		</name>
		<name type="personal">
			<namePart type="family">Brenner</namePart>
			<namePart type="given">Hermann</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amouyel</namePart>
			<namePart type="given">Philippe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ferrieres</namePart>
			<namePart type="given">Jean</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Tamosiunas</namePart>
			<namePart type="given">Abdonas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nikitin</namePart>
			<namePart type="given">Yuriy P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Drygas</namePart>
			<namePart type="given">Wojciech</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Melander</namePart>
			<namePart type="given">Olle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jöckel</namePart>
			<namePart type="given">Karl-Heinz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Leistner</namePart>
			<namePart type="given">David M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shaw</namePart>
			<namePart type="given">Jonathan E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Panagiotakos</namePart>
			<namePart type="given">Demosthenes B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Simons</namePart>
			<namePart type="given">Leon A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kavousi</namePart>
			<namePart type="given">Maryam</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vasan</namePart>
			<namePart type="given">Ramachandran S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dullaart</namePart>
			<namePart type="given">Robin P. F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wannamethee</namePart>
			<namePart type="given">S. Goya</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Riserus</namePart>
			<namePart type="given">Ulf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Shea</namePart>
			<namePart type="given">Steven</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">de Lemos</namePart>
			<namePart type="given">James A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Omland</namePart>
			<namePart type="given">Torbjorn</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kuulasmaa</namePart>
			<namePart type="given">Kari</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Landmesser</namePart>
			<namePart type="given">Ulf</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Blankenberg</namePart>
			<namePart type="given">Stefan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zeller</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lackner</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wild</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peters</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Meisinger</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Voelzke</namePart>
			<namePart type="given">H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Doerr</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nauck</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schoettker</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lorenz</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Makarova</namePart>
			<namePart type="given">N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schmidt</namePart>
			<namePart type="given">B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klotsche</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Koenig</namePart>
			<namePart type="given">W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kontto</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mannisto</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jaaskelainen</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Niiranen</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jousilahti</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Metspalu</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Alver</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Donfrancesco</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Signorini</namePart>
			<namePart type="given">S. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gianfagna</namePart>
			<namePart type="given">F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Costanzo</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Woodward</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dobson</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giles</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hodge</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Magliano</namePart>
			<namePart type="given">D. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wilsgaard</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lyngbakken</namePart>
			<namePart type="given">M. N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hveem</namePart>
			<namePart type="given">K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Eliasson</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Engstrom</namePart>
			<namePart type="given">G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ingelsson</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Jorgensen</namePart>
			<namePart type="given">T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Twerenbold</namePart>
			<namePart type="given">R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dallongeville</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Malyutina</namePart>
			<namePart type="given">S.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pajak</namePart>
			<namePart type="given">A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bobak</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Whincup</namePart>
			<namePart type="given">P.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Pitsavos</namePart>
			<namePart type="given">C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Benjamin</namePart>
			<namePart type="given">E. J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bakker</namePart>
			<namePart type="given">S. J. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ikram</namePart>
			<namePart type="given">M. K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="9950">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<namePart>Kardiologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Application of non-HDL cholesterol for population-based cardiovascular risk stratification</title>
			<subTitle>results from the Multinational Cardiovascular Risk Consortium</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Elsevier</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-09T11:39:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167054</identifier>
		<identifier type="doi">10.1016/S0140-6736(19)32519-X</identifier>
		<identifier type="pmid">31810609</identifier>
		<identifier type="isi">000502546300027</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1016/S0140-6736(19)32519-X</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30206">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Cardiac and Cardiovascular Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30206">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Kardiologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30205">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Endocrinology and Diabetes</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30205">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Endokrinologi och diabetes</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: The relevance of blood lipid concentrations to long-term incidence of cardiovascular disease and the relevance of lipid-lowering therapy for cardiovascular disease outcomes is unclear. We investigated the cardiovascular disease risk associated with the full spectrum of bloodstream non-HDL cholesterol concentrations. We also created an easy-to-use tool to estimate the long-term probabilities for a cardiovascular disease event associated with non-HDL cholesterol and modelled its risk reduction by lipid-lowering treatment.&lt;/p&gt;&lt;p&gt;Methods: In this risk-evaluation and risk-modelling study, we used Multinational Cardiovascular Risk Consortium data from 19 countries across Europe, Australia, and North America. Individuals without prevalent cardiovascular disease at baseline and with robust available data on cardiovascular disease outcomes were included. The primary composite endpoint of atherosclerotic cardiovascular disease was defined as the occurrence of the coronary heart disease event or ischaemic stroke. Sex-specific multivariable analyses were computed using non-HDL cholesterol categories according to the European guideline thresholds, adjusted for age, sex, cohort, and classical modifiable cardiovascular risk factors. In a derivation and validation design, we created a tool to estimate the probabilities of a cardiovascular disease event by the age of 75 years, dependent on age, sex, and risk factors, and the associated modelled risk reduction, assuming a 50% reduction of non-HDL cholesterol.&lt;/p&gt;&lt;p&gt;Findings: Of the 524 444 individuals in the 44 cohorts in the Consortium database, we identified 398 846 individuals belonging to 38 cohorts (184 055 [48·7%] women; median age 51·0 years [IQR 40·7–59·7]). 199 415 individuals were included in the derivation cohort (91 786 [48·4%] women) and 199 431 (92 269 [49·1%] women) in the validation cohort. During a maximum follow-up of 43·6 years (median 13·5 years, IQR 7·0–20·1), 54 542 cardiovascular endpoints occurred. Incidence curve analyses showed progressively higher 30-year cardiovascular disease event-rates for increasing non-HDL cholesterol categories (from 7·7% for non-HDL cholesterol &amp;lt;2·6 mmol/L to 33·7% for ≥5·7 mmol/L in women and from 12·8% to 43·6% in men; p&amp;lt;0·0001). Multivariable adjusted Cox models with non-HDL cholesterol lower than 2·6 mmol/L as reference showed an increase in the association between non-HDL cholesterol concentration and cardiovascular disease for both sexes (from hazard ratio 1·1, 95% CI 1·0–1·3 for non-HDL cholesterol 2·6 to &amp;lt;3·7 mmol/L to 1·9, 1·6–2·2 for ≥5·7 mmol/L in women and from 1·1, 1·0–1·3 to 2·3, 2·0–2·5 in men). The derived tool allowed the estimation of cardiovascular disease event probabilities specific for non-HDL cholesterol with high comparability between the derivation and validation cohorts as reflected by smooth calibration curves analyses and a root mean square error lower than 1% for the estimated probabilities of cardiovascular disease. A 50% reduction of non-HDL cholesterol concentrations was associated with reduced risk of a cardiovascular disease event by the age of 75 years, and this risk reduction was greater the earlier cholesterol concentrations were reduced.&lt;/p&gt;&lt;p&gt;Interpretation: Non-HDL cholesterol concentrations in blood are strongly associated with long-term risk of atherosclerotic cardiovascular disease. We provide a simple tool for individual long-term risk assessment and the potential benefit of early lipid-lowering intervention. These data could be useful for physician–patient communication about primary prevention strategies.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>The Lancet</title>
			</titleInfo>
			<identifier type="issn">0140-6736</identifier>
			<identifier type="eissn">1474-547X</identifier>
			<part>
				<detail type="volume">
					<number>394</number>
				</detail>
				<detail type="issue">
					<number>10215</number>
				</detail>
				<extent>
					<start>2173</start>
					<end>2183</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1384077/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-09</recordCreationDate>
			<recordChangeDate>2020-01-09</recordChangeDate>
			<recordIdentifier>diva2:1384077</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Paina</namePart>
			<namePart type="given">Ligia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Namazzi</namePart>
			<namePart type="given">Gertrude</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="mote0007">
			<namePart type="family">Tetui</namePart>
			<namePart type="given">Moses</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för folkhälsa och klinisk medicin</affiliation>
			<affiliation>Umeå universitet, Institutionen för epidemiologi och global hälsa</affiliation>
			<affiliation>Department of Health Policy, Planning and Management, Makerere University School of Public Health, New Mulago Complex, Kampala, Uganda</affiliation>
			<description>diva-portal.org=authority-person:63100</description>
		</name>
		<name type="personal">
			<namePart type="family">Mayora</namePart>
			<namePart type="given">Chrispus</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kananura</namePart>
			<namePart type="given">Rornald Muhumuza</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kiwanuka</namePart>
			<namePart type="given">Suzanne N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Waiswa</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Mutebi</namePart>
			<namePart type="given">Aloysius</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ekirapa-Kiracho</namePart>
			<namePart type="given">Elizabeth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="723">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för folkhälsa och klinisk medicin</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="881250">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för epidemiologi och global hälsa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Applying the model of diffusion of innovations to understand facilitators for the implementation of maternal and neonatal health programmes in rural Uganda</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>BioMed Central</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-07-11T14:08:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-161519</identifier>
		<identifier type="doi">10.1186/s12992-019-0483-9</identifier>
		<identifier type="pmid">31196193</identifier>
		<identifier type="isi">000471604000001</identifier>
		<identifier type="articleId">38</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1186/s12992-019-0483-9</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Uganda</topic>
		</subject>
		<subject lang="eng">
			<topic>Innovation</topic>
		</subject>
		<subject lang="eng">
			<topic>Maternal health</topic>
		</subject>
		<subject lang="eng">
			<topic>Health systems research</topic>
		</subject>
		<subject lang="eng">
			<topic>Vouchers</topic>
		</subject>
		<subject lang="eng">
			<topic>Diffusion</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30302">
			<topic>Medical and Health Sciences</topic>
			<topic>Health Sciences</topic>
			<topic>Public Health, Global Health, Social Medicine and Epidemiology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30302">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Hälsovetenskaper</topic>
			<topic>Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;In Uganda, more than 336 out of every 100,000 women die annually during childbirth. Pregnant women, particularly in rural areas, often lack the financial resources and means to access health facilities in a timely manner for quality antenatal, delivery, and post-natal services. For nearly the past decade, the Makerere University School of Public Health researchers, through various projects, have been spearheading innovative interventions, embedded in implementation research, to reduce barriers to access to care. In this paper, we describe two of projects that were initially conceived to tackle the financial barriers to access to care - through a voucher program in the community - on the demand side - and a series of health systems strengthening activities at the district and facility level - on the supply side. Over time, the projects diverged in the content of the intervention and the modality in which they were implemented, providing an opportunity for reflection on innovation and scaling up. In this short report, we used an adaptation of Greenhalgh's Model of Diffusion to reflect on these projects' approaches to implementing innovative interventions, with the ultimate goal of reducing maternal and neonatal mortality in rural Uganda. We found that the adapted model of diffusion of innovations facilitated the emergence of insights on barriers and facilitators to the implementation of health systems interventions. Health systems research projects would benefit from analyses beyond the implementation period, in order to better understand how adoption and diffusion happen, or not, over time, after the external catalyst departs.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Globalization and Health</title>
			</titleInfo>
			<identifier type="issn">1744-8603</identifier>
			<identifier type="eissn">1744-8603</identifier>
			<part>
				<detail type="volume">
					<number>15</number>
				</detail>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1337076/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-07-11</recordCreationDate>
			<recordChangeDate>2019-07-11</recordChangeDate>
			<recordIdentifier>diva2:1337076</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Battram</namePart>
			<namePart type="given">Thomas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Richmond</namePart>
			<namePart type="given">Rebecca C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-0574-5071</description>
		</name>
		<name type="personal">
			<namePart type="family">Baglietto</namePart>
			<namePart type="given">Laura</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Haycock</namePart>
			<namePart type="given">Philip C.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Perduca</namePart>
			<namePart type="given">Vittorio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bojesen</namePart>
			<namePart type="given">Stig E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gaunt</namePart>
			<namePart type="given">Tom R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hemani</namePart>
			<namePart type="given">Gibran</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-0920-1055</description>
		</name>
		<name type="personal">
			<namePart type="family">Guida</namePart>
			<namePart type="given">Florence</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0002-9652-2430</description>
		</name>
		<name type="personal">
			<namePart type="family">Carreras-Torres</namePart>
			<namePart type="given">Robert</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hung</namePart>
			<namePart type="given">Rayjean</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Amos</namePart>
			<namePart type="given">Christopher, I</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Freeman</namePart>
			<namePart type="given">Joshua R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sandanger</namePart>
			<namePart type="given">Torkjel M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nøst</namePart>
			<namePart type="given">Therese H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nordestgaard</namePart>
			<namePart type="given">Børge G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Teschendorff</namePart>
			<namePart type="given">Andrew E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Polidoro</namePart>
			<namePart type="given">Silvia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Vineis</namePart>
			<namePart type="given">Paolo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Severi</namePart>
			<namePart type="given">Gianluca</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hodge</namePart>
			<namePart type="given">Allison M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Giles</namePart>
			<namePart type="given">Graham G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="kjgr0002">
			<namePart type="family">Grankvist</namePart>
			<namePart type="given">Kjell</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Klinisk kemi</affiliation>
			<description>orcid.org=0000-0003-4289-2097</description>
			<description>diva-portal.org=authority-person:62501</description>
		</name>
		<name type="personal" authority="umu" xlink:href="mijo0025">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Mikael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för strålningsvetenskaper</affiliation>
			<description>diva-portal.org=authority-person:63749</description>
		</name>
		<name type="personal">
			<namePart type="family">Johansson</namePart>
			<namePart type="given">Mattias</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Smith</namePart>
			<namePart type="given">George Davey</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Relton</namePart>
			<namePart type="given">Caroline L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<description>orcid.org=0000-0003-2052-4840</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="748">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för medicinsk biovetenskap</namePart>
			<namePart>Klinisk kemi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="776">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för strålningsvetenskaper</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Appraising the causal relevance of DNA methylation for risk of lung cancer</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>Oxford University Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2020-01-08T16:08:00</dateOther>
		</originInfo>
		<note type="publicationChannel"/>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-167007</identifier>
		<identifier type="doi">10.1093/ije/dyz190</identifier>
		<identifier type="pmid">31549173</identifier>
		<identifier type="isi">000501732200019</identifier>
		<location>
			<url displayLabel="Fulltext" note="free">https://doi.org/10.1093/ije/dyz190</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Lung cancer</topic>
		</subject>
		<subject lang="eng">
			<topic>DNA methylation</topic>
		</subject>
		<subject lang="eng">
			<topic>Mendelian randomization</topic>
		</subject>
		<subject lang="eng">
			<topic>ALSPAC</topic>
		</subject>
		<subject lang="eng">
			<topic>ARIES</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="30107">
			<topic>Medical and Health Sciences</topic>
			<topic>Basic Medicine</topic>
			<topic>Medical Genetics</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30107">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Medicinska och farmaceutiska grundvetenskaper</topic>
			<topic>Medicinsk genetik</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;Background: DNA methylation changes in peripheral blood have recently been identified in relation to lung cancer risk. Some of these changes have been suggested to mediate part of the effect of smoking on lung cancer. However, limitations with conventional mediation analyses mean that the causal nature of these methylation changes has yet to be fully elucidated.&lt;/p&gt;&lt;p&gt;Methods: We first performed a meta-analysis of four epigenome-wide association studies (EWAS) of lung cancer (918 cases, 918 controls). Next, we conducted a two-sample Mendelian randomization analysis, using genetic instruments for methylation at CpG sites identified in the EWAS meta-analysis, and 29 863 cases and 55 586 controls from the TRICL-ILCCO lung cancer consortium, to appraise the possible causal role of methylation at these sites on lung cancer.&lt;/p&gt;&lt;p&gt;Results: Sixteen CpG sites were identified from the EWAS meta-analysis [false discovery rate (FDR) &amp;lt; 0.05], for 14 of which we could identify genetic instruments. Mendelian randomization provided little evidence that DNA methylation in peripheral blood at the 14 CpG sites plays a causal role in lung cancer development (FDR &amp;gt; 0.05), including for cg05575921-&lt;em&gt;AHRR&lt;/em&gt; where methylation is strongly associated with both smoke exposure and lung cancer risk.&lt;/p&gt;&lt;p&gt;Conclusions: The results contrast with previous observational and mediation analysis, which have made strong claims regarding the causal role of DNA methylation. Thus, previous suggestions of a mediating role of methylation at sites identified in peripheral blood, such as cg05575921-&lt;em&gt;AHRR&lt;/em&gt;, could be unfounded. However, this study does not preclude the possibility that differential DNA methylation at other sites is causally involved in lung cancer development, especially within lung tissue.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>International Journal of Epidemiology</title>
			</titleInfo>
			<identifier type="issn">0300-5771</identifier>
			<identifier type="eissn">1464-3685</identifier>
			<part>
				<detail type="volume">
					<number>48</number>
				</detail>
				<detail type="issue">
					<number>5</number>
				</detail>
				<extent>
					<start>1493</start>
					<end>1504</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<note type="funder">Wellcome trust [203746]</note>
		<note type="funder">Wellcome trust [102215/2/13/2]</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1383781/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>malu0033</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2020-01-08</recordCreationDate>
			<recordChangeDate>2020-01-08</recordChangeDate>
			<recordIdentifier>diva2:1383781</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="juca0010">
			<namePart type="family">Nieves</namePart>
			<namePart type="given">Juan Carlos</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för datavetenskap</affiliation>
			<description>orcid.org=0000-0003-4072-8795</description>
			<description>diva-portal.org=authority-person:63761</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="863">
			<namePart>Umeå universitet</namePart>
			<namePart>Teknisk-naturvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för datavetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Approximating agreements in formal argumentation dialogues</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>IOS Press</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-02T10:48:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162918</identifier>
		<identifier type="doi">10.3233/AIC-190622</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>Artificial Intelligence</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="20206">
			<topic>Engineering and Technology</topic>
			<topic>Electrical Engineering, Electronic Engineering, Information Engineering</topic>
			<topic>Computer Systems</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="20206">
			<topic>Teknik och teknologier</topic>
			<topic>Elektroteknik och elektronik</topic>
			<topic>Datorsystem</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;In many real applications, to reach an agreement between the participants of a dialogue, which can be for instance a negotiation, is not easy. Indeed, there are application domains such as the medical domain where to reach a consensus among medical professionals is not feasible and might be even regarded as counterproductive. In this paper, we introduce an approach for expressing qualitative preferences between the goals of a dialogue considering ordered disjunction rules. By applying argumentation semantics and degrees of satisfaction of goals, we introduce the so-called &lt;em&gt;dialogue agreement degree&lt;/em&gt;. Moreover, by considering sets of dialogue agreement degrees, we define a &lt;em&gt;lattice of agreement degrees&lt;/em&gt;. We argue that a lattice of agreement degrees suggests different approximations between the current state of a dialogue and its aimed goals; hence, a lattice of agreement degrees can help to define different heuristics in the settings of strategic argumentation.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>AI Communications</title>
			</titleInfo>
			<identifier type="issn">0921-7126</identifier>
			<identifier type="eissn">1875-8452</identifier>
			<part>
				<detail type="volume">
					<number>32</number>
				</detail>
				<extent>
					<start>335</start>
					<end>346</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>juca0010</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-02</recordCreationDate>
			<recordChangeDate>2019-10-14</recordChangeDate>
			<recordIdentifier>diva2:1347692</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Shanks</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bloch</namePart>
			<namePart type="given">K. Markenroth</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="kala0094">
			<namePart type="family">Laurell</namePart>
			<namePart type="given">Katarina</namePart>
			<namePart type="date">1967-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Klinisk neurovetenskap</affiliation>
			<description>orcid.org=0000-0002-7504-8354</description>
			<description>diva-portal.org=authority-person:63223</description>
		</name>
		<name type="personal">
			<namePart type="family">Cesarini</namePart>
			<namePart type="given">K. G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fahlstroem</namePart>
			<namePart type="given">M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Larsson</namePart>
			<namePart type="given">E-M</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Virhammar</namePart>
			<namePart type="given">J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="10950">
			<namePart>Umeå universitet</namePart>
			<namePart>Medicinska fakulteten</namePart>
			<namePart>Institutionen för farmakologi och klinisk neurovetenskap</namePart>
			<namePart>Klinisk neurovetenskap</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Aqueductal CSF Stroke Volume Is Increased in Patients with Idiopathic Normal Pressure Hydrocephalus and Decreases after Shunt Surgery</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Society of Neuroradiology</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-04-04T09:02:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-157768</identifier>
		<identifier type="doi">10.3174/ajnr.A5972</identifier>
		<identifier type="pmid">30792248</identifier>
		<identifier type="isi">000461201600016</identifier>
		<identifier type="scopus">2-s2.0-85062962080</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng" authority="hsv" xlink:href="30207">
			<topic>Medical and Health Sciences</topic>
			<topic>Clinical Medicine</topic>
			<topic>Neurology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="30207">
			<topic>Medicin och hälsovetenskap</topic>
			<topic>Klinisk medicin</topic>
			<topic>Neurologi</topic>
		</subject>
		<abstract lang="eng">&lt;p&gt;BACKGROUND AND PURPOSE: Increased CSF stroke volume through the cerebral aqueduct has been proposed as a possible indicator of positive surgical outcome in patients with idiopathic normal pressure hydrocephalus; however, consensus is lacking. In this prospective study, we aimed to compare CSF flow parameters in patients with idiopathic normal pressure hydrocephalus with those in healthy controls and change after shunt surgery and to investigate whether any parameter could predict surgical outcome.&lt;/p&gt;&lt;p&gt;MATERIALS AND METHODS: Twenty-one patients with idiopathic normal pressure hydrocephalus and 21 age- and sex-matched healthy controls were prospectively included and examined clinically and with MR imaging of the brain. Eighteen patients were treated with shunt implantation and were re-examined clinically and with MR imaging the day before the operation and 3 months postoperatively. All MR imaging scans included a phase-contrast sequence.&lt;/p&gt;&lt;p&gt;RESULTS: The median aqueductal CSF stroke volume was significantly larger in patients compared with healthy controls (103.5 μL; interquartile range, 69.8–142.8 μL) compared with 62.5 μL (interquartile range, 58.3–73.8 μL; &lt;em&gt;P&lt;/em&gt; &amp;lt; .01) and was significantly reduced 3 months after shunt surgery from 94.8 μL (interquartile range, 81–241 μL) to 88 μL (interquartile range, 51.8–173.3 μL; &lt;em&gt;P&lt;/em&gt; &amp;lt; .05). Net flow in the caudocranial direction (retrograde) was present in 11/21 patients and in 10/21 controls. Peak flow and net flow did not differ between patients and controls. There were no correlations between any CSF flow parameters and surgical outcomes.&lt;/p&gt;&lt;p&gt;CONCLUSIONS: Aqueductal CSF stroke volume was increased in patients with idiopathic normal pressure hydrocephalus and decreased after shunt surgery, whereas retrograde aqueductal net flow did not seem to be specific for patients with idiopathic normal pressure hydrocephalus. On the basis of the results, the usefulness of CSF flow parameters to predict outcome after shunt surgery seem to be limited.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>American Journal of Neuroradiology</title>
			</titleInfo>
			<identifier type="issn">0195-6108</identifier>
			<identifier type="eissn">1936-959X</identifier>
			<part>
				<detail type="volume">
					<number>40</number>
				</detail>
				<detail type="issue">
					<number>3</number>
				</detail>
				<extent>
					<start>453</start>
					<end>459</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>jaek0007</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-04-04</recordCreationDate>
			<recordChangeDate>2019-11-19</recordChangeDate>
			<recordIdentifier>diva2:1302236</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal" authority="umu" xlink:href="jonern95">
			<namePart type="family">Holm</namePart>
			<namePart type="given">Johan</namePart>
			<namePart type="date">1976-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Juridiska institutionen</affiliation>
			<description>orcid.org=0000-0002-6597-0628</description>
			<description>diva-portal.org=authority-person:66215</description>
		</name>
		<name type="personal" authority="umu" xlink:href="ored0001">
			<namePart type="family">Edström</namePart>
			<namePart type="given">Örjan</namePart>
			<namePart type="date">1952-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Juridiska institutionen</affiliation>
			<description>orcid.org=0000-0001-9044-8658</description>
			<description>diva-portal.org=authority-person:64515</description>
		</name>
		<name type="personal" authority="umu" xlink:href="ruma0001">
			<namePart type="family">Mannelqvist</namePart>
			<namePart type="given">Ruth</namePart>
			<namePart type="date">1966-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Juridiska institutionen</affiliation>
			<description>orcid.org=0000-0002-1710-7723</description>
			<description>diva-portal.org=authority-person:64233</description>
		</name>
		<name type="personal" authority="umu" xlink:href="anpe0002">
			<namePart type="family">Pettersson-Strömbäck</namePart>
			<namePart type="given">Anita</namePart>
			<namePart type="date">1965-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Institutionen för psykologi</affiliation>
			<description>diva-portal.org=authority-person:65694</description>
		</name>
		<name type="corporate" authority="umu" xlink:href="840">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Juridiska institutionen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="848">
			<namePart>Umeå universitet</namePart>
			<namePart>Samhällsvetenskapliga fakulteten</namePart>
			<namePart>Institutionen för psykologi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="swe">
			<title>Arbetsgivaren och den organisatoriska arbetsmiljön</title>
			<subTitle>Arbetsbelastning, juridiskt ansvar och upplevda problem</subTitle>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">swe</languageTerm>
		</language>
		<originInfo>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-09-18T16:08:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">electronic</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163403</identifier>
		<location>
			<url displayLabel="URL" note="free">https://journals.lub.lu.se/aoa/issue/view/2863</url>
		</location>
		<typeOfResource>text</typeOfResource>
		<subject lang="swe">
			<topic>arbetsmiljö</topic>
		</subject>
		<subject lang="swe">
			<topic>arbetsmiljölag</topic>
		</subject>
		<subject lang="swe">
			<topic>arbetsplatsundersökning</topic>
		</subject>
		<subject lang="swe">
			<topic>rättspraxis</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="50501">
			<topic>Social Sciences</topic>
			<topic>Law</topic>
			<topic>Law (excluding Law and Society)</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="50501">
			<topic>Samhällsvetenskap</topic>
			<topic>Juridik</topic>
			<topic>Juridik (exklusive juridik och samhälle)</topic>
		</subject>
		<abstract lang="swe">&lt;p&gt;Arbetsgivares juridiska ansvar för arbetsmiljö och ett hållbart arbete återfinns i en mängd olika bestämmelser av varierande karaktär, samt i domar och beslut från Arbetsmiljöverket, vilket inte underlättar vare sig överskådlighet och förståelse av regelverkets innebörd. Avsikten är att i den här artikeln dels analysera arbetsgivares juridiska ansvar för arbetstagares arbetsbelastning inom arbetsmiljörätten, dels undersöka hur problem med arbetsbelastning upplevs samt om, och i så fall hur, dessa problem hanteras inom såväl manligt och kvinnligt dominerade arbetsplatser som inom privat och offentlig verksamhet.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Arbetsmarknad &amp; Arbetsliv</title>
			</titleInfo>
			<identifier type="issn">1400-9692</identifier>
			<part>
				<detail type="volume">
					<number>25</number>
				</detail>
				<detail type="issue">
					<number>1</number>
				</detail>
				<extent>
					<start>49</start>
					<end>67</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<location>
			<url displayLabel="fulltext:print" note="free" access="raw object">http://umu.diva-portal.org/smash/get/diva2:1352426/FULLTEXT01.pdf</url>
		</location>
		<recordInfo>
			<recordOrigin>jonern95</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-09-18</recordCreationDate>
			<recordChangeDate>2019-09-23</recordChangeDate>
			<recordIdentifier>diva2:1352426</recordIdentifier>
		</recordInfo>
	</mods>
	<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd">
		<genre authority="diva" type="contentTypeCode">refereed</genre>
		<genre authority="svep" type="contentType">ref</genre>
		<genre authority="diva" type="contentType" lang="eng">Refereed</genre>
		<genre authority="diva" type="contentType" lang="swe">Refereegranskat</genre>
		<genre authority="diva" type="contentType" lang="nor">Fagfellevurdert</genre>
		<genre authority="diva" type="publicationTypeCode">article</genre>
		<genre authority="svep" type="publicationType">art</genre>
		<genre authority="diva" type="publicationType" lang="eng">Article in journal</genre>
		<genre authority="diva" type="publicationType" lang="swe">Artikel i tidskrift</genre>
		<genre authority="diva" type="publicationType" lang="nor">Artikkel i tidsskrift</genre>
		<genre authority="kev" type="publicationType" lang="eng">article</genre>
		<name type="personal">
			<namePart type="family">Stephens</namePart>
			<namePart type="given">Lucas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fuller</namePart>
			<namePart type="given">Dorian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Boivin</namePart>
			<namePart type="given">Nicole</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rick</namePart>
			<namePart type="given">Torben</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gauthier</namePart>
			<namePart type="given">Nicolas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kay</namePart>
			<namePart type="given">Andrea</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marwick</namePart>
			<namePart type="given">Ben</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Geralda</namePart>
			<namePart type="given">Chelsey</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Armstrong</namePart>
			<namePart type="given">Denise</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Barton</namePart>
			<namePart type="given">C. Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Denham</namePart>
			<namePart type="given">Tim</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Douglass</namePart>
			<namePart type="given">Kristina</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Driver</namePart>
			<namePart type="given">Jonathan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Janz</namePart>
			<namePart type="given">Lisa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Roberts</namePart>
			<namePart type="given">Patrick</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Rogers</namePart>
			<namePart type="given">J. Daniel</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thakar</namePart>
			<namePart type="given">Heather</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Altaweel</namePart>
			<namePart type="given">Mark</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Johnson</namePart>
			<namePart type="given">Amber L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sampietro Vattuone</namePart>
			<namePart type="given">Maria Marta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Aldenderfer</namePart>
			<namePart type="given">Mark</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Archila</namePart>
			<namePart type="given">Sonia</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Artioli</namePart>
			<namePart type="given">Gilberto</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Bale</namePart>
			<namePart type="given">Martin T.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beach</namePart>
			<namePart type="given">Timothy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Borrell</namePart>
			<namePart type="given">Ferran</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Braje</namePart>
			<namePart type="given">Todd</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal" authority="umu" xlink:href="phbu0001">
			<namePart type="family">Buckland</namePart>
			<namePart type="given">Philip I.</namePart>
			<namePart type="termsOfAddress">Dr.</namePart>
			<namePart type="date">1973-</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
			<affiliation>Umeå universitet, Miljöarkeologiska laboratoriet</affiliation>
			<affiliation>Miljöarkeologiska laboratoriet</affiliation>
			<description>diva-portal.org=authority-person:62395</description>
		</name>
		<name type="corporate">
			<namePart>Miljöarkeologiska laboratoriet</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">oth</roleTerm>
			</role>
			<description>Research Group</description>
		</name>
		<name type="personal">
			<namePart type="family">Jiménez Cano</namePart>
			<namePart type="given">Nayeli Guadalupe</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Capriles</namePart>
			<namePart type="given">José M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Diez Castillo</namePart>
			<namePart type="given">Agustín</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">\c Cilingiro\u glu</namePart>
			<namePart type="given">\c Ciler</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Negus Cleary</namePart>
			<namePart type="given">Michelle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Conolly</namePart>
			<namePart type="given">James</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Coutros</namePart>
			<namePart type="given">Peter R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Covey</namePart>
			<namePart type="given">R. Alan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Cremaschi</namePart>
			<namePart type="given">Mauro</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Crowther</namePart>
			<namePart type="given">Alison</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Der</namePart>
			<namePart type="given">Lindsay</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">di Lernia</namePart>
			<namePart type="given">Savino</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Doershuk</namePart>
			<namePart type="given">John F.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Doolittle</namePart>
			<namePart type="given">William E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Edwards</namePart>
			<namePart type="given">Kevin J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Erlandson</namePart>
			<namePart type="given">Jon M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Evans</namePart>
			<namePart type="given">Damian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fairbairn</namePart>
			<namePart type="given">Andrew</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Faulkner</namePart>
			<namePart type="given">Patrick</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Feinman</namePart>
			<namePart type="given">Gary</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fernandes</namePart>
			<namePart type="given">Ricardo</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fitzpatrick</namePart>
			<namePart type="given">Scott M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Fyfe</namePart>
			<namePart type="given">Ralph</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Garcea</namePart>
			<namePart type="given">Elena</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goldstein</namePart>
			<namePart type="given">Steve</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Goodman</namePart>
			<namePart type="given">Reed Charles</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Dalpoim Guedes</namePart>
			<namePart type="given">Jade</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Herrmann</namePart>
			<namePart type="given">Jason</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hiscock</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hommel</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Horsburgh</namePart>
			<namePart type="given">K. Ann</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Hritz</namePart>
			<namePart type="given">Carrie</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ives</namePart>
			<namePart type="given">John W.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Junno</namePart>
			<namePart type="given">Aripekka</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kahn</namePart>
			<namePart type="given">Jennifer G.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaufman</namePart>
			<namePart type="given">Brett</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kearns</namePart>
			<namePart type="given">Catherine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kidder</namePart>
			<namePart type="given">Tristram R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lanoë</namePart>
			<namePart type="given">Fran\c cois</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lawrence</namePart>
			<namePart type="given">Dan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lee</namePart>
			<namePart type="given">Gyoung-Ah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Levin</namePart>
			<namePart type="given">Maureece J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Lindskoug</namePart>
			<namePart type="given">Henrik B.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">López-Sáez</namePart>
			<namePart type="given">José Antonio</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Macrae</namePart>
			<namePart type="given">Scott</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marchant</namePart>
			<namePart type="given">Rob</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Marston</namePart>
			<namePart type="given">John M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">McClure</namePart>
			<namePart type="given">Sarah</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">McCoy</namePart>
			<namePart type="given">Mark D.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Miller</namePart>
			<namePart type="given">Alicia Ventresca</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Morrison</namePart>
			<namePart type="given">Michael</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Motuzaite Matuzeviciute</namePart>
			<namePart type="given">Giedre</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Müller</namePart>
			<namePart type="given">Johannes</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Nayak</namePart>
			<namePart type="given">Ayushi</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Noerwidi</namePart>
			<namePart type="given">Sofwan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peres</namePart>
			<namePart type="given">Tanya M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Peterson</namePart>
			<namePart type="given">Christian E.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Proctor</namePart>
			<namePart type="given">Lucas</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Randall</namePart>
			<namePart type="given">Asa R.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Renette</namePart>
			<namePart type="given">Steve</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Robbins Schug</namePart>
			<namePart type="given">Gwen</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ryzewski</namePart>
			<namePart type="given">Krysta</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Saini</namePart>
			<namePart type="given">Rakesh</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Scheinsohn</namePart>
			<namePart type="given">Vivian</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Schmidt</namePart>
			<namePart type="given">Peter</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Sebillaud</namePart>
			<namePart type="given">Pauline</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Seitsonen</namePart>
			<namePart type="given">Oula</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Simpson</namePart>
			<namePart type="given">Ian A.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">So\ltysiak</namePart>
			<namePart type="given">Arkadiusz</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Speakman</namePart>
			<namePart type="given">Robert J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Spengler</namePart>
			<namePart type="given">Robert N.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Steffen</namePart>
			<namePart type="given">Martina L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Storozum</namePart>
			<namePart type="given">Michael J.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Strickland</namePart>
			<namePart type="given">Keir M.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thompson</namePart>
			<namePart type="given">Jessica</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thurston</namePart>
			<namePart type="given">T. L.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ulm</namePart>
			<namePart type="given">Sean</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ustunkaya</namePart>
			<namePart type="given">M. Cemre</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Welker</namePart>
			<namePart type="given">Martin H.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">West</namePart>
			<namePart type="given">Catherine</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Williams</namePart>
			<namePart type="given">Patrick Ryan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wright</namePart>
			<namePart type="given">David K.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Wright</namePart>
			<namePart type="given">Nathan</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zahir</namePart>
			<namePart type="given">Muhammad</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Zerboni</namePart>
			<namePart type="given">Andrea</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Beaudoin</namePart>
			<namePart type="given">Ella</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Munevar Garcia</namePart>
			<namePart type="given">Santiago</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Powell</namePart>
			<namePart type="given">Jeremy</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Thornton</namePart>
			<namePart type="given">Alexa</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Kaplan</namePart>
			<namePart type="given">Jed O.</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Gaillard</namePart>
			<namePart type="given">Marie-José</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Klein Goldewijk</namePart>
			<namePart type="given">Kees</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="personal">
			<namePart type="family">Ellis</namePart>
			<namePart type="given">Erle</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">aut</roleTerm>
			</role>
		</name>
		<name type="corporate" authority="umu" xlink:href="7303">
			<namePart>Umeå universitet</namePart>
			<namePart>Humanistiska fakulteten</namePart>
			<namePart>Institutionen för idé- och samhällsstudier</namePart>
			<namePart>Miljöarkeologiska laboratoriet</namePart>
			<role>
				<roleTerm type="code" authority="marcrelator">pbl</roleTerm>
			</role>
		</name>
		<titleInfo lang="eng">
			<title>Archaeological assessment reveals Earth’s early transformation through land use</title>
		</titleInfo>
		<language>
			<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
		</language>
		<originInfo>
			<publisher>American Association for the Advancement of Science</publisher>
			<dateIssued>2019</dateIssued>
			<dateOther type="availableFrom">2019-08-30T13:53:00</dateOther>
		</originInfo>
		<physicalDescription>
			<form authority="marcform">print</form>
		</physicalDescription>
		<identifier type="uri">http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-162906</identifier>
		<identifier type="doi">10.1126/science.aax1192</identifier>
		<identifier type="pmid">31467217</identifier>
		<identifier type="isi">000483975800041</identifier>
		<typeOfResource>text</typeOfResource>
		<subject lang="eng">
			<topic>land use</topic>
		</subject>
		<subject lang="eng">
			<topic>agricultural history</topic>
		</subject>
		<subject lang="eng">
			<topic>state of knowledge</topic>
		</subject>
		<subject lang="eng">
			<topic>human impact</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="60103">
			<topic>Humanities and the Arts</topic>
			<topic>History and Archaeology</topic>
			<topic>Archaeology</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="60103">
			<topic>Humaniora och konst</topic>
			<topic>Historia och arkeologi</topic>
			<topic>Arkeologi</topic>
		</subject>
		<subject lang="eng" authority="hsv" xlink:href="10599">
			<topic>Natural Sciences</topic>
			<topic>Earth and Related Environmental Sciences</topic>
			<topic>Other Earth and Related Environmental Sciences</topic>
		</subject>
		<subject lang="swe" authority="hsv" xlink:href="10599">
			<topic>Naturvetenskap</topic>
			<topic>Geovetenskap och miljövetenskap</topic>
			<topic>Annan geovetenskap och miljövetenskap</topic>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="2022">
			<topic>Archaeology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="2022">
			<topic>arkeologi</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="eng" authority="umu" xlink:href="15250">
			<topic>environmental archaeology</topic>
			<genre>Research subject</genre>
		</subject>
		<subject lang="swe" authority="umu" xlink:href="15250">
			<topic>miljöarkeologi</topic>
			<genre>Research subject</genre>
		</subject>
		<abstract lang="eng">&lt;p&gt;Humans began to leave lasting impacts on Earth’s surface starting 10,000 to 8000 years ago. Through a synthetic collaboration with archaeologists around the globe, Stephens et al. compiled a comprehensive picture of the trajectory of human land use worldwide during the Holocene (see the Perspective by Roberts). Hunter-gatherers, farmers, and pastoralists transformed the face of Earth earlier and to a greater extent than has been widely appreciated, a transformation that was essentially global by 3000 years before the present.Science, this issue p. 897; see also p. 865Environmentally transformative human use of land accelerated with the emergence of agriculture, but the extent, trajectory, and implications of these early changes are not well understood. An empirical global assessment of land use from 10,000 years before the present (yr B.P.) to 1850 CE reveals a planet largely transformed by hunter-gatherers, farmers, and pastoralists by 3000 years ago, considerably earlier than the dates in the land-use reconstructions commonly used by Earth scientists. Synthesis of knowledge contributed by more than 250 archaeologists highlighted gaps in archaeological expertise and data quality, which peaked for 2000 yr B.P. and in traditionally studied and wealthier regions. Archaeological reconstruction of global land-use history illuminates the deep roots of Earth’s transformation and challenges the emerging Anthropocene paradigm that large-scale anthropogenic global environmental change is mostly a recent phenomenon.&lt;/p&gt;</abstract>
		<relatedItem type="host">
			<titleInfo>
				<title>Science</title>
			</titleInfo>
			<identifier type="issn">0036-8075</identifier>
			<identifier type="eissn">1095-9203</identifier>
			<part>
				<detail type="volume">
					<number>365</number>
				</detail>
				<detail type="issue">
					<number>6456</number>
				</detail>
				<extent>
					<start>897</start>
					<end>902</end>
				</extent>
			</part>
		</relatedItem>
		<note type="publicationStatus" lang="eng">Published</note>
		<recordInfo>
			<recordOrigin>phbu0001</recordOrigin>
			<recordContentSource>umu</recordContentSource>
			<recordCreationDate>2019-08-30</recordCreationDate>
			<recordChangeDate>2019-11-15</recordChangeDate>
			<recordIdentifier>diva2:1347205</recordIdentifier>
		</recordInfo>
	</mods>
</modsCollection>
